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Abstract  
Background: Complex interventions, those that incorporate multiple interacting 
components, are difficult to define, measure and implement. The aim of this 
research was to develop and evaluate the complex intervention, very early 
mobilisation (VEM) in acute stroke care. The clinical effectiveness and cost-
effectiveness of VEM were evaluated whilst simultaneously considering the 
implications for future implementation. 
Methods: A mixed methods approach was used: systematic review, predictive 
modelling, observational study design, individual patient data meta-analysis, 
qualitative methods and economic evaluation. Statistical models to accurately 
predict mobility post-stroke were developed. A multicentre observational study 
was conducted to establish pre-implementation activity levels of acute stroke 
patients. Data from two completed and comparable feasibility trials were used 
to estimate the clinical and economic impact of VEM. A qualitative process 
evaluation was conducted to identify the barriers and facilitators to 
implementing VEM, if shown to be effective. 
Results: Two predictive models were developed with age and stroke type 
common factors to both. Pre-implementation activity levels were low. Patients 
who underwent VEM were 3-times more likely to be independent at 3 months 
than were standard care (SC) patients. The incremental cost-effectiveness ratio 
associated with VEM in comparison to SC indicated VEM to be potentially cost-
effective from a societal perspective. Barriers and facilitators identified for each 
stage of the stroke pathway and a set of HCPs’ beliefs towards VEM were 
formulated.  
Conclusions: This research has adhered to current guidance provided by the 
Medical Research Council to develop and evaluate VEM. The clinical 
effectiveness and cost-effectiveness of VEM were estimated. The ongoing  A Very 
Early Rehabilitation Trial phase III will provide definitive evidence for the 
effectiveness of VEM and the wider consequences for stroke care. This research 
has provided the support and the foundations for the development of a clear 
implementation strategy for VEM.
 iii 
Executive Summary  
Background  
The socio-economic impact of stroke is global and vast. Stroke accounts for 10% 
of deaths worldwide.1 Those who survive may be left with significant limitations 
and restrictions in activities of daily living (ADL). Rehabilitation post-stroke aims 
to increase activity and participation. The optimum time to commence 
rehabilitation post-stroke and the intensity of rehabilitation to provide have 
been long-standing questions in the stroke research community.  
Stroke rehabilitation is a complex intervention and although recommended in 
clinical guidelines2 it remains controversial and lacks definition.3 A key feature 
of rehabilitation is mobilisation. Mobilisation is defined as “out-of -bed physical 
activity” which may include transferring, for example, on or off the toilet, 
sitting out of bed, standing and walking.4 Complex interventions, those that 
incorporate multiple interacting components, are difficult to define, measure 
and implement. Very early mobilisation (VEM) is an example of a complex 
intervention in acute stroke care. A Very Early Rehabilitation Trial (AVERT) 
phase III is currently underway to determine the clinical and cost-effectiveness 
of VEM, however, the results are not due until 2013. Even if the AVERT phase III 
shows positive findings in support of VEM, it will remain unclear how best to 
implement the intervention into routine practice.  
The aim of this research was to develop and evaluate a complex intervention in 
acute stroke by adopting the Medical Research Council (MRC) complex 
intervention framework as the methodological approach and using VEM as the 
clinical example. The clinical effectiveness and cost-effectiveness of VEM were 
evaluated whilst simultaneously considering the implications for future 
implementation. The objectives of the research are fully explained on Page 33. 
Methods  
A systematic and staged approach was adopted to address the aim of this 
research based on the recommendations available from the MRC for the 
development and evaluation of complex interventions.5 As recommended in this 
guidance a combination of methods were used: systematic review, predictive 
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modelling, observational study design, individual patient data meta-analysis (IPD 
MA), qualitative methods and economic evaluation.  
Systematic review and predictive modelling  
The Glasgow Royal Infirmary Stroke Register was used to develop statistical 
models for use to accurately predict independent walking 30 days post-stroke. 
Three methods were used to inform factor selection for model development: 
systematic review (Model 1), clinical opinion (Model 2) and univariate analysis 
(Model 3). Backward stepwise regression was used to identify significant 
independent predictors. Calibration plots, goodness to fit and receiver operating 
characteristic (ROC) curves were used to test model properties. The predictors 
identified were used to adjust for case-mix in the observational study. 
Observational study design  
A cross sectional multicentre observational study was conducted to establish a 
pre-implementation level of physical activity in acute stroke patients recruited 
from a Scottish healthcare setting. Novel and established methods to monitor 
activity were used and compared: accelerometry, a method considered novel in 
this population, and a behavioural mapping technique. Patients were followed-
up at three and six months to assess the relationship between activity levels in 
the acute stages and function at three and six months. The primary outcome was 
the proportion of time spent upright.  
Individual patient data meta-analysis  
An IPD MA using data from two completed and comparable stroke rehabilitation 
trials (AVERT phase II and the UK Very Early Rehabilitation or Intensive 
Telemetry after Stroke [VERITAS]) was undertaken to estimate the clinical 
impact of VEM. The primary outcome was independence at three months. 
Secondary outcomes assessed at one week were as follows; level of stroke 
impairment, immobility-related complications and excessive fatigue.  
Qualitative process evaluation  
A qualitative process evaluation was conducted to identify the barriers and 
facilitators to implementing VEM, and to establish healthcare professionals’ 
(HCPs) beliefs towards VEM. Doctors, nurses and therapists currently working in 
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acute stroke units (ASUs) in Scotland were invited to participate in a 
multidisciplinary focus group or a semi-structured interview. Data were analysed 
thematically.  
Economic evaluation 
A systematic review was conducted to identify the approaches used for the 
economic evaluation of stroke rehabilitation. Informed by the findings from this 
review, a cost-consequence analysis (CCA) and cost-effectiveness analyses using 
data from AVERT phase II and VERITAS were conducted to model the economic 
impact of VEM. For the cost-effectiveness analyses incremental cost-
effectiveness ratios (ICERs) were calculated, where appropriate. One-way 
sensitivity analyses were performed on key unit costs by varying one measure at 
a time.  
Results  
Baseline factors predictive of mobility after stroke 
Two predictive models were developed and validated using registry data. The 
final Model 1 consisted of the factors identified by the systematic review and 
Model 2 and Model 3 consisted of the same factors identified by both univariate 
and clinical opinion. Age and stroke type were factors common to both models. 
In addition, Model 1 identified level of consciousness and leg power and Model 2 
identified living arrangements of admission, level of severity, level of disability 
and level of ADL. Models were very accurate in distinguishing patients who will 
or will not walk independently (area under ROC curve was 0.80 for Model 1 and 
0.87 for Model 2). 
Baseline levels of activity in acute stroke patients 
Sixty-six patients were recruited to the observational study from three hospitals. 
The median time from stroke onset to the day of monitoring was 5.5 days. This 
study provided a precise estimate of the time spent upright (standing or walking) 
in a sample of acute stroke patients (8.2%; 95% confidence interval [CI], 6.2 to 
10.1). The majority of total upright time was the result of short episodes of < 10 
minutes spent in upright activity. The opposite pattern was observed for 
sedentary (sitting or lying) events whereby the majority of total sedentary time 
was accumulated in prolonged periods of time.  
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Clinical impact of very early mobilisation 
All patients in AVERT phase II (n = 71) and VERITAS (n = 32) were included in the 
IPD MA. Patients who underwent VEM were three-times more likely to be 
independent at three months than were standard care (SC) patients (adjusted 
OR 3.11, 95% CI, 1.03 to 9.33). The risk of experiencing immobility-related 
complications at one week for VEM patients remained significantly lower than 
that of SC patients (adjusted OR 0.23, 95% CI, 0.07 to 0.71). The odds of 
excessive fatigue were not higher for VEM patients than for SC patients after 
adjustment of baseline factors (adjusted OR 0.79, 95% CI, 0.27 to 2.31). The 
reduction in the level of stroke severity was non-significant (adjusted coefficient 
-0.59, 95% CI, -2.44 to 1.27). 
Barriers, facilitators and beliefs of very early mobilisation 
Thirty-one HCPs (17 therapists, 10 nurses and four doctors) across seven hospital 
sites, of which three sites were actively recruiting to AVERT phase III, 
participated. The barriers most frequently identified to mobilising a patient 
within 24 hours included medical instability, perceived risks of mobilisation and 
the time of admission to the stroke unit. The facilitators most frequently 
identified to mobilising a patient within 24 hours included the belief that bed 
rest delays recovery, early admission to the ASU and early team communication. 
A set of beliefs towards VEM currently held by HCPs were formulated.  
Economic impact of very early mobilisation 
Twenty-one studies that had conducted an economic evaluation of stroke 
rehabilitation were included in the systematic review. The economic evaluations 
in the majority of these studies were inadequate based on their ability to 
identify, measure and value all resources and benefits pertinent to the 
complexity of stroke rehabilitation. On investigating the economic impact of 
VEM, a CCA was conducted to overcome this limitation and identify the wide-
reaching effects. The ICER associated with VEM in comparison to SC was an 
additional £203 per additional patient achieving independence. The ICER 
calculated suggests that VEM is potentially cost-effective when considering the 
National Institute of Health and Clinical Excellence threshold of £20,000 to 
£30,000. 
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Discussion 
Strengths and limitations of the methods used 
This research has adhered to current MRC guidance for the development and 
evaluation of complex interventions. Explorative modelling techniques, evidence 
synthesis of best-available data and alternative methods to randomised 
controlled trials have been used.  
Recommendations based on the finding of the two systematic reviews, where 
possible, were applied in subsequent predictive and economic modelling. The 
systematic reviews involved comprehensive searches of electronic databases and 
sources of grey literature, and were conducted in accordance to Preferred 
Reporting Items for Systematic Review and Meta-Analysis guidelines. The final 
development of the predictive models did have limitations. The selection of 
factors was based on the opinions of only two clinical experts. A delphi-method 
where a panel of experts are used to provide consensus would have provided a 
more robust approach. Additionally, the models were not externally validated or 
evaluated in clinical practice.  
Novel and established methods for monitoring activity were used and compared 
in the observational study. The integration of the accelerometer (AC) data with 
behavioural mapping data not only provided objective data on patient location 
and stroke processes but also offers a model of analysis for use in future studies. 
Despite synchronising the AC data with the observational data, no firm 
conclusions can be drawn about the accuracy of the activPAL™ in detecting 
stepping as this was not a validity study.  
The use of evidence synthesis to increase statistical power and provide 
information not available in the data sets has been of value in determining the 
clinical and economic impact of VEM. However, the sample was too undersized 
to make final conclusions about the clinical effectiveness and cost-effectiveness 
of VEM. 
The findings from the qualitative process evaluation are representative of a 
relevant sample of HCPs working in acute stroke care. Triangulation of data 
(using the observational data and the qualitative data) highlighted discrepancies 
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between what staff believe they do and what they actually do, an important 
consideration when interventions involve changing current practice and in this 
early stage of implementation. The main limitation of this qualitative analysis is 
the lack of use of a theoretical framework which may have assisted in identifying 
the determinants of change and if those determinants are modifiable. 
Additionally, no nursing assistants participated in the focus groups and as it is 
this group of staff who deliver a large proportion of patient care and are 
involved in the day-to-day mobilisation of patients this is considered a 
limitation. 
Interpretation of findings  
The predictive models developed have not been evaluated in clinical practice, 
such as in a cluster randomised trial, therefore cannot yet be recommended for 
use in clinical practice. The models could be used in clinical audits, to compare 
patient outcomes in observational studies or to inform the stratification of 
patients in rehabilitation trials.  
The clinical problem of low levels of activity in acute stroke patients has been 
confirmed in a Scottish healthcare setting; however, the prolonged periods of 
time spent in sedentary behaviour may be more cause for concern. This 
observational data offers a rich data source to assess the impact of new activity-
based rehabilitation interventions or to identify changes in practice over time. 
Given the small sample size of the individual studies included in the IPD MA this 
should only be considered as an illustration of the method, rather than allowing 
any confident deductions to be made regarding the effectiveness of VEM. The 
use of IPD MA in complex intervention research has highlighted the value of 
researcher collaboration with deliberate matching of protocol and outcome 
measures to allow data from two similar trials of methodological quality to be 
combined. 
The barriers and facilitators identified, and the set of HCPs beliefs formulated 
can be used to explain current mobilisation practice. Problems areas and 
optimum ways of working have been identified and explored. This is an essential 
stage in changing practice of HCPs. The focus should now be on developing 
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tailored implementation strategies specific to each stage of implementation 
(dissemination through to sustainability). 
The systematic review of economic studies highlighted the need for the adoption 
of a wider cost and benefit perspective beyond that of the health service in the 
economic evaluations of complex interventions such as stroke rehabilitation. 
Early supported discharge and interventions such as VEM are associated with a 
shift of care from the healthcare system to the community and patients 
themselves which may result in more ‘out of pocket’ expenses for patients and 
informal carers. Therefore, where the focus of the economic perspective is 
health outcome it is also important to consider the consequences for other 
people such as informal carers in addition to the patient.  
Conclusion 
A number of research methods were used including evidence synthesis, 
observational study design, qualitative methods and economic evaluation to 
develop and evaluate VEM. Very early mobilisation was shown to be potentially 
clinically effective for a number of key clinical outcomes and potentially cost-
effective from a societal perspective. Access to the patient within 24 hours and 
medical instability were considered by staff to be the main barriers to 
implementing VEM in real-life.  
The AVERT phase III trial will provide definitive evidence about the clinical and 
cost-effectiveness taking into account the wide clinical and cost implications of 
VEM. Only after this can the trial make recommendations about the use of VEM 
in acute stroke care and can the real-life implementation begin. This research 
has provided the support and the foundations for the development of a clear 
implementation strategy for VEM.
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data and performed the cost-consequence and cost-effectiveness analyses.  
Dr Olivia Wu cross-checked decisions made when screening references for 
inclusion and data extracted. 
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1 Introduction  
1.1 Stroke 
Stroke is defined as “rapidly developing clinical signs of focal (or global) 
disturbance of cerebral function with symptoms lasting 24 hours or longer or 
leading to death, with no apparent cause other than vascular origin.” 6 There are 
two main types of stroke - ischaemic and haemorrhagic. Ischaemic stroke is the 
result of reduced cerebral blood flow with a consequent loss of neural functions. 
If the reduction in blood flow is sufficiently severe, a series of events occur at 
cellular level and leads to an infarction. Haemorrhagic stroke occurs due to 
rupture of a blood vessel in the brain. The signs and symptoms of stroke vary 
depending on the site affected and may include numbness or weakness of one 
side of the body, sudden loss of vision, dizziness, communication problems, 
problems with balance or co-ordination, or headache. 
The socio-economic impact of stroke is global and vast. Stroke accounts for 10% 
of deaths worldwide.1 In 2005 stroke caused an estimated 5.7 million deaths and 
without intervention the number of deaths is projected to rise to 6.5 million in 
2015 and to 7.8 million in 2030.7 The International Classification of Functioning, 
Disability and Health (ICF) can be used to classify the effects of stroke into three 
main domains: body functions or structures (such as mobility and cognition), 
activity (such as walking or reading) and participation (such as housework or 
employment).8 Those who survive may be left with significant limitations and 
restrictions in activities of daily living (ADL). It has been estimated that 
approximately 15 million people suffer from a stroke, with five million left with 
residual disability. Stroke was ranked the seventh leading cause of disability-
adjusted life-years lost in 2002 with this to increase to sixth in 2030.9 This 
disability-adjusted life-years metric was developed by the World Health 
Organisation and measures the global burden of disease integrated health life 
lost due to both mortality and living with disability. The costs associated with 
stroke prevention and treatment were significant. In the United States of 
America total costs accounted to $65.5 billion with direct costs contributing to 
67% of these costs while the remaining 33% was due to indirect costs such as loss 
in productivity.10 In Europe direct costs have been estimated as €18.5 billion 
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(68.5%) and indirect costs as €8.5 billion (31.5%).11 The societal costs of stroke in 
the United Kingdom (UK) have been estimated as £8.9 billion a year, with direct 
costs accounting for approximately 50% of the total, informal care 27% and 
indirect cost 24%.12 Due to the high burden of disability, much of post-stroke 
care relies upon rehabilitation interventions13 and may absorb a high proportion 
of direct costs.  
Stroke patients are usually admitted to hospital in the initial stages and receive 
treatment in a number of ways and in different settings. There is vast evidence 
that patients who receive organised care in a stroke unit are more likely to be 
alive, independent and living at home one year post-stroke.14 15 13 Organised 
stroke unit care is provided by “multidisciplinary teams that exclusively manage 
stroke patients in a dedicated unit (stroke, acute, rehabilitation, 
comprehensive), with a mobile stroke team or within a generic disability service 
(mixed rehabilitation ward)”.13 The key features of organised inpatient stroke 
care are: i) co-ordinated multidisciplinary rehabilitation; ii) staff with specialist 
interest in stroke or rehabilitation; iii) routine involvement of carers in the 
rehabilitation process; and iv) regular programmes of education and training.13 
This existing evidence for stroke care underpins current national guidelines and 
strategy documents for the management of stroke patients.2 16 17  
1.2 Rehabilitation post-stroke 
Stroke rehabilitation is a major component of stroke care. Stroke rehabilitation 
is difficult to define13 and has been broadly defined as “a problem solving 
process aiming at reducing the disability and handicap (promoting activity and 
participation) resulting from a disease.”18 The aims of stroke rehabilitation are 
as follows:  
• To maximise the patient’s role fulfilment and independence in their 
environment, all within the limitations imposed by the underlying pathology 
and impairments and by the availability of resources19 
• To help the person to make the best adaptation possible to any difference 
between roles achieved and roles desired19 
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The ICF outlines nine domains of activity and participation which can provide the 
focus for rehabilitation efforts which include communication, mobility and self-
care.8 With respect to this framework, rehabilitation aims to maximise the 
individual’s activity, participation and quality of life, and minimise impact on 
carers. 
The process of rehabilitation involves assessment, goal-setting, delivering 
intervention based on individual needs and reassessment.20 An understanding of 
the recovery of stroke is required to develop and plan rehabilitation 
interventions such as the timing of certain interventions. Spontaneous recovery 
is a result of brain repair or reorganisation and is believed to occur in the first 
three to six months after stroke. Statistical models suggest that although 
outcome is defined within the first weeks, post-stroke functional improvement 
has been found to extend beyond six months but at a reduced rate.21 22  
1.3 Evaluation of stroke rehabilitation  
Rehabilitation offers the opportunity to reduce the burden of disability; 
however, given that it is resource-intensive, it is essential to evaluate its clinical 
effectiveness and cost-effectiveness. Stroke units that incorporate rehabilitation 
have shown to be most beneficial in reducing death and dependency.23 Stroke 
rehabilitation is a complex intervention and intricate to evaluate13 24 as it 
involves a number of components, interactions and outcomes.5 25 For example, 
an inpatient exercise-based intervention typically has an education and a 
prescribing component. It also relies on a number of different interactions 
between the patient and the therapist and their beliefs i.e. the patients’ 
lifestyle beliefs and adherence to treatment. Outcomes in rehabilitation are 
non-linear and wide-reaching, and the intervention itself occurs within a 
complex system where variations in stroke care between different settings are 
known to exist.26 Therefore, the evaluation of stroke rehabilitation poses 
challenges in identifying the individual and interdependent effects of 
components and choosing a realistic outcome measure.27 
Further issues relating to the evaluation of interventions considered to be 
complex may include ensuring an appropriate level of standardisation when 
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delivering the intervention, avoiding treatment contamination and blinding of 
participants. Standardisation and the ability to control influencing factors are 
key factors of randomised controlled trials (RCT). This process of standardisation 
is more difficult in health care interventions. Hawe et al (2004) argue that it is 
not the components of the intervention that should be standardised such as an 
education package but rather the steps in the change process (referred to as the 
key functions).28 These key functions can then take on different ‘forms’ 
according to local context yet achieve the same objective. The intervention that 
Hawe et al (2004) use as an example is a community intervention to prevent 
depression. The principles of this community intervention are to “improve 
detection, management and referral of patients in primary care”, the standard 
form that this should take is “a series of three in-service training workshops to 
general practitioners with preset curriculums” but could vary in the delivery 
(function). For example, local authorities could be “provided with materials and 
resources to devise in-service training tailored to local schedules, venues, and 
preferred learning methods”.28 Rehabilitation provided to patients may differ 
according to capability and the intervention protocol may allow for some 
flexibility in how this it is delivered. Standardisation of the intervention and the 
monitoring adherence within a trial setting is raised in Chapter 4. 
Treatment contamination is an issue for trials of rehabilitation which aim to 
change social behaviours. Cluster randomised trials, which involves separating 
the groups by location may prevent this, however intracluster correlations have 
implications for sample size. One way to overcome this is to integrate 
preventative measures to contamination into the intervention protocol. For 
example, not permitting trial staff to discuss the details of the intervention with 
non-trial staff. The issue of contamination and the impact this could have during 
and after the trial is discussed in Chapter 5. 
Blinding patients and/or personnel delivering the intervention is often not 
possible in trials of complex interventions. Gaining ethical approval to blind both 
intervention and standard care (SC) patients may be an option and if it can be 
assumed that participants will not be able to distinguish between SC and the 
intervention. It may not be possible to blind the personnel involved in delivering 
the intervention to group allocation.  
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1.4 Developing and evaluating a complex intervention 
In response to these challenges (such as multiple outcomes, standardisation, 
blinding and contamination) the UK Medical Research Council (MRC) developed a 
framework and a guidance document to assist the development and evaluation 
of non-pharmaceutical interventions or ‘complex interventions’ as they are more 
formally referred to.28 The MRC defines complex interventions as those 
comprising of “a number of separate elements which seem essential to the 
proper functioning of the intervention although the ‘active ingredient’ of the 
intervention that is effective is difficult to specify.”5 29 The framework consists 
of four stages; feasibility/piloting, development, evaluation and 
implementation. The MRC guidance was recently updated and replaced the 
linear relationship between the four stages implied by the previous guidance 
with a cyclic model (Figure 1-1).5 This permits interaction between the stages 
and encourages, for example, the implementation stage to be considered early 
during the other three stages rather than solely after the evaluation stage. This 
updated version of the MRC guidance also focuses more on implementation. 
 
Figure 1-1 The Medical Research complex intervention framework 
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The evaluation stage aims to assess the clinical effectiveness and cost-
effectiveness of the intervention. The MRC framework advises researchers to 
select a study design most suited to the intervention under study with particular 
consideration given to the choice of outcomes and randomisation.5 The 
framework also supports the use of appropriate methodologies other than RCTs 
to address the stages of the framework. The evaluation stage also highlights the 
importance of understanding the change process by conducting, for example, a 
process evaluation. 
Process evaluations, using quantitative and/or qualitative methods, examine the 
way in which the interventions under study are implemented during the main 
evaluation and integrating these findings with the outcome data for the study 
allows for better interpretation.5 30 Embedding a process evaluation to monitor 
the quality of implementation of the trial intervention, identify the inhibitors 
and facilitators for future implementation,31 or explain variation in treatment 
effect for different locations or patients is crucial.5 Process evaluations also 
allow for an evaluation of pre-existing contextual factors which should be 
studied simultaneously to the evaluation. Contextual factors may include 
healthcare systems (the physical environment and organisational structures), 
characteristics of the population and the disease under study as well as how 
these change over time.32  
Implementation is defined as putting a guideline in place which involves 
effective strategies to overcomes barriers associated with change in clinical 
practice.33 The increasing level and diversity of research relating to healthcare 
implementation has recently led to the development and use of the term 
‘implementation science’.34  Implementation science has been defined as the 
investigation of methods, interventions and variables that influence adoption of 
evidence-based healthcare practices by individuals and organisations to improve 
clinical and operational decision making.35 Implementation science also includes 
testing the effectiveness of interventions to promote and sustain the use of 
evidence-based healthcare practices.34 The growing literature base presents 
several frameworks or models that refer to implementation. One model is Grol 
and Wensing’s (2006) ‘Model for Effective Implementation’.36 This model uses a 
staged approach with the first phase aiming to identify relevant practice issues 
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(problems or best practice) and to conduct a thorough analysis of current 
practice. The later stages of the model consist of the process of setting 
operational change objectives, development of implementation strategies and 
then finally the operationalisation of an implementation plan. 
An effective implementation strategy is critical for the successful uptake and 
sustainability of an intervention.37 Effective implementation ensures the 
intervention is workable and integrated in everyday healthcare practice.31 
Studies have shown that about 30-40% of patients do not receive care according 
to the best available evidence. A recent Cochrane review aimed to assess the 
effectiveness of intervention strategies developed to overcome barriers to 
change on professional practice or patient outcomes.38 An evidence-based 
approach is recommended to optimise effectiveness.39 However, the evidence of 
which strategies are most effective remains inconclusive. This is further 
complicated by the limited generalisability of implementation strategies due to 
the heterogeneity of behaviours within the interventions, target audience and 
environment.40 The application and effectiveness of such strategies to complex 
intervention research is unclear and little guidance exists.   
In order to ensure that effective interventions are implemented smoothly and in 
a way that optimises compliance within an NHS organisation, appropriate 
monitoring of complex interventions in clinical practice is critical.5 Monitoring 
the implementation of interventions reduces inequalities in care, improves 
quality of care and identifies the providers that are having difficulty executing 
parts of the intervention. Thus, it is important to monitor implementation early, 
simultaneously to evaluation and relative to the pre-implementation status to 
identify and solve problems.41 It is essential to facilitate and demonstrate the 
implementation of evidence-based therapies using effective monitoring systems 
and by identifying relevant process indicators to audit care. For example, 
process indicators associated with rehabilitation may include the facilities and 
equipment that are in place (structures) and admission processes and the routine 
provision of mobilisation (processes).  
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1.5 Very early mobilisation: an example of a complex 
intervention  
An example of a complex intervention in acute stroke rehabilitation currently 
under investigation in an international RCT is very early mobilisation (VEM). Very 
early mobilisation is defined as starting mobilisation (i.e. sitting out of bed, 
standing or walking) within 24 hours of onset of stroke symptoms and to continue 
this at frequent intervals throughout the patients stay in the acute stroke unit 
(ASU). Very early mobilisation encourages activity in these acute stages (within 
14 days) and is delivered by the multidisciplinary team (MDT), most usually 
nurses, physiotherapists and occupational therapists. Very early mobilisation is a 
complex intervention due to its multidimensional nature. It has several 
interacting components i.e. an education component and a prescribing 
component. It incorporates a number of behaviours required by those delivering 
or receiving the intervention i.e. the number and complexity of skills used by 
physiotherapists to provide the intervention to stroke patients. The delivery of 
very early mobilisation is likely to be patient specific (tailored to the individual 
needs of the patient) and context specific (delivered within a dynamic and 
complex healthcare system). This has implications for the definition, 
standardisation and monitoring of VEM. Very early mobilisation has potentially 
wide-ranging and interacting effects, making the evaluation of VEM more 
challenging than that of a drug. Therefore, VEM is an appropriate illustration of 
a complex intervention and was used as the clinical example in this thesis.  
Although early mobilisation of acute stroke patients is recommended in clinical 
guidelines,2 42 43 VEM remains controversial and specific recommendations cannot 
be made until further evidence to guide practice is available. Mobilisation 
practices vary between countries with patients mobilised within 24 hours of 
symptom onset the convention in some countries while in others the mobilisation 
of patients routinely occurs four to seven days after stroke. Delaying 
mobilisation is based on the belief that cerebral perfusion pressure in the 
penumbra region needs to be maintained, therefore a horizontal position may 
increase intracranial blood flow to ischaemic tissue and reduce the infarct.44 The 
emergence of the very early and more intensive rehabilitation intervention in 
humans has posed controversy. 
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Some development work of VEM has been undertaken in relation to establishing 
current activity levels of acute stroke patients and testing the feasibility of VEM 
in a clinical setting.45 46 The cyclic nature of the MRC framework indicates that 
developing theory and an evidence base is an iterative process and should not 
end when commencing the main evaluation. Other areas of development may 
include exploring the predictable variations of important rehabilitation 
outcomes such as mobility (Chapter 2), establishing activity levels in other 
countries (Chapter 3) and investigating methods for monitoring activity-based 
interventions in real-life (Chapter 3). 
Specific evaluation of VEM is more limited. One study has suggested that VEM is 
the single most distinctive characteristic of stroke unit care and the strongest 
predictor of improved outcome.47 A Cochrane review which included studies that 
investigated VEM versus delayed mobilisation after stroke concluded that there 
was insufficient evidence to make recommendations on the use of VEM in stroke. 
The individual patient data from these included studies provide the opportunity 
to synthesis the best available evidence to estimate the clinical effectiveness 
and cost-effectiveness of VEM (Chapter 4 and Chapter 6, respectively). 
A very early rehabilitation trial (AVERT) phase III is now well underway to 
determine the clinical and cost-effectiveness of VEM in stroke care.4 Therefore, 
it is important that during these development and evaluation stages, early 
consideration is given to the implications for the future implementation of VEM, 
if the results of AVERT phase III are in favour of the intervention (Chapter 5).
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Aim and objectives 
Complex interventions, defined as those that incorporate multiple interacting 
components, are difficult to define, measure and implement. Early 
rehabilitation is a complex intervention and although recommended in clinical 
guidelines it remains controversial and lacks definition. A Very Early 
Rehabilitation Trial phase III is currently underway to determine the clinical and 
cost-effectiveness of VEM in acute stroke, however the results are not due until 
2013. Even if the AVERT phase III trial shows positive findings in support of VEM, 
it will remain unclear how best to define, monitor and implement the 
intervention in routine practice.  
The aim of this thesis was to develop and evaluate a complex intervention in 
stroke by adopting the MRC complex intervention framework as the 
methodological approach and using VEM as the clinical example. The clinical 
effectiveness and cost-effectiveness of VEM was evaluated whilst simultaneously 
considering the implications for future implementation.  
To address this aim, developmental work was conducted to identify and 
comprehend the predictable variations in outcome post-stroke (Chapter 2). A 
pre-implementation level of physical activity was established and methods to 
monitor activity levels were investigated to allow the assessment of the future 
implementation of activity-based interventions such as VEM (Chapter 3). The 
evaluation stage investigated the clinical and economic impact of a VEM 
(Chapter 4 and 6). Evaluation also included the early stages of implementation 
as outlined in the Model for Effective Implementation.36 Relevant practice issues 
(problems or best practice) were identified and an analysis of current practice 
was undertaken (Chapter 5). This thesis covers only the early stages of 
implementation and provides the basis for further work to address the 
implementation stage of the MRC framework which is focused on the longer-term 
aspects of implementation such as surveillance and longer-term outcomes (see 
Figure 1-1). The development and evaluation stages of this thesis have strong 
connections to implementation.   
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The objectives for this thesis are as follows: 
Objective one  
To identify, using statistical models, the baseline factors that are predictive of 
mobility early after stroke in order to understand the predictable variations in 
outcome. 
Objective two  
To establish, using an observational study design, pre-implementation physical 
activity levels in acute stroke patients in order to monitor the future 
implementation of activity-based interventions such as very early mobilisation. 
Objective three 
To estimate, using individual patient data from two completed feasibility 
studies, the clinical impact of very early mobilisation in order to understand the 
implications of implementing very early mobilisation. 
Objective four 
To establish, using a qualitative process evaluation study design, healthcare 
professionals’ beliefs towards implementing very early mobilisation in order to 
understand the potential barriers and facilitators to very early mobilisation. 
Objective five 
To estimate, using economic evaluation, the economic impact of very early 
mobilisation in order to understand the implications of implementing very early 
mobilisation. 
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Structure of the thesis 
The example of a complex intervention used throughout the thesis is VEM. There 
are seven Chapters: Chapters 3 and 5 use primary research methods and 
Chapters 2, 4 and 6 use secondary research methods. Chapters 2 to 6 have an 
introduction, methods, results, discussion and conclusion section. At the 
beginning of each Chapter an overview to justify the reason for the research 
contained in the Chapter and how it links to the previous Chapter and the topic 
of implementation. Chapter 1 provides an overall background to the main topics 
of this thesis; stroke rehabilitation, complex interventions, implementation and 
VEM. Chapters 2 and 3 included the research for the developmental stage of the 
MRC framework and address objectives one to two. Chapters 4 to 6 include the 
research for the evaluation stage of the MRC framework and address objectives 
three to five. Chapter 7 provides an overall conclusion for the thesis. 
Chapter 1 introduces the clinical and economic impact of stroke, the 
importance of stroke rehabilitation and describes very early mobilisation, the 
example of a complex intervention, to be used in this thesis. 
Chapter 2 consists of a systematic review of studies aimed at predicting mobility 
post-stroke and the development of statistical predictive models. This addresses 
objective one. 
Chapter 3 is an observational study aimed to establish pre-implementation 
activity levels of acute stroke patients in order to monitor the future 
implementation of very early mobilisation. This addresses objective two. 
Chapter 4 is an individual patient data meta-analysis of two feasibility trials 
previously conducted to investigate the clinical impact of very early 
mobilisation. This addresses objective three. 
Chapter 5 is a qualitative process evaluation aimed to identify the barriers and 
facilitators to implementing very early mobilisation. This addresses objective 
four. 
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Chapter 6 consists of a systematic review of economic evaluations of stroke 
rehabilitation and an economic evaluation to model the economic impact of very 
early mobilisation. This addresses objective five. 
Chapter 7 summaries the findings from each of the Chapters, discusses the 
clinical application of the available evidence and provides a critique of the 
methods used. The thesis also makes some suggestions for the future study of 
very early mobilisation and more generally, complex interventions.  
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2 Establishing baseline factors predictive of 
mobility after stroke 
2.1 Introduction 
Stroke is the most common cause of disability and in particular, reduced 
mobility is a major burden for stroke patients, their families and the health 
service.48 One of the first questions a stroke patient will ask is if they will be 
able to walk again, and regaining mobility post-stroke is considered a primary 
goal of the stroke patient in early rehabilitation.49 50 Therefore, accurate 
estimates of the likelihood and timing of recovery of mobility post-stroke is of 
great clinical relevance, providing vital information to healthcare professionals 
(HCPs), patients and their families; the ability to predict outcome in patients 
with acute stroke is of value clinically and in research.51   
Currently there is no strong evidence to suggest that the effectiveness of 
rehabilitation interventions varies according to baseline factors. Understanding 
the predictable variations in outcome post-stroke will assist in informing future 
decisions about the suitability of certain rehabilitation interventions such as 
VEM. Therefore, a systematic review was conducted to identify baseline factors 
predictive of or associated with mobility early after stroke. The findings from a 
systematic review were used to develop statistical models to accurately predict 
mobility after stroke. The factors included in these statistical models were used 
to inform which data should be collected at baseline in the observational study 
(Chapter 3). Appropriate adjustment for patient case-mix can be made when 
investigating the relationship between baseline activity levels in acute stroke 
patients and function at three and six months (Chapter 3). 
A number of definitions for mobility exist such as the “activity of moving from 
place to place, generally by walking or using a wheelchair”.52 The ICF define 
mobility as “an individual’s ability to move about effectively in his 
surroundings.” 8 More recently, a definition of mobilisation in stroke 
rehabilitation has been introduced; “out-of bed physical activity” which may 
include transferring for example on or off the toilet, sitting out of bed, standing 
and walking.4 
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A number of studies have been carried out to identify the predictors of 
functional outcome or the level of disability at six months after stroke.53-55  
Previous stroke, older age, urinary and bowel incontinence, and visuo-spacial 
deficits are among some of the factors shown to be predictive of function.54 55 
One of the earlier studies identified a significant relationship between 
independent early sitting balance and independent ambulation; however, this 
was based on a retrospective audit of 40 stroke patients and the timing of 
outcome assessment for patients varied.56 A more recent prospective study of 
217 inpatient rehabilitation patients concluded that outcome of mobility one 
year after stroke can be predicted by functional status, sitting balance, time 
between stroke onset and admission to rehabilitation and age.57 Furthermore, 
functional status (measured using the Barthel Index [BI]) was the strongest 
predictor (explained 33% of the 48% total variance) which was in accord with 
others studies investigating the predictors of functional outcome.58 59 In one 
systematic review, early predictive indicators for both ambulation and ADL up to 
one year after stroke were investigated.60 Only studies that were of high 
scientific quality and were internally and statistically valid were included in this 
synthesis. Scientific quality was assessed according to internal, statistical and 
external validity using criteria used in a previous systematic review.55 Predictors 
identified by this review from studies included urinary incontinence, initial 
disability in ADL and ambulation, severe paresis or paralysis, complications of 
ischemic stroke and apraxia. The use of ADL has been criticised as a poor 
measure of mobility, for failing to detect changes in early recovery of mobility 
following stroke, with independence in ADL often being achieved through 
compensatory movement.61 Another review assessed predictive factors within 
one week of stroke onset and concluded that initial grade of paresis was the 
most important predictor of recovery of mobility at least three months after 
stroke.62 
Research in stroke has aimed at identifying the determinants of function in the 
longer term rather than the return of mobility in the early stages.63 64 An 
understanding of the factors that influence the recovery of mobility in the short 
term has particular bearing on the development and evaluation of rehabilitation 
practices in acute stroke. This is of particular importance considering the 
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increase in promising interventions that aim to improve recovery of mobility 
after stroke.65 Controversy remains around the length of time post-stroke that 
recovery continues to takes place. The existing literature has primarily focused 
on three months, with the maximum motor recovery believed to occur in the 
first four weeks post-stroke;66 67 however, there is some debate that recovery 
may continue for six months or more.68   
Aim 
The aim of this Chapter was to develop statistical models to accurately predict 
independent walking 30 days post-stroke.  
2.2 Predictors of post-stroke mobility: a systematic 
review 
A systematic review was undertaken prior to the development of the predictive 
models to review the methodological approaches and assess the quality of 
studies investigating the predictors of mobility post-stroke. As the findings of the 
systematic review will inform the predictive modelling the sections detailing the 
methods and findings of the systematic review are presented before the 
predictive modelling section. 
2.2.1 Methods  
Inclusion and exclusion criteria 
The review included studies of patients who had a clinical or objectively 
confirmed diagnosis (such as Computed Tomography [CT] scanning) of stroke. 
Studies of mixed populations which included patients with brain injury or 
transient ischemic attacks in addition to stroke patients were excluded unless 
the results for patients with stroke were reported separately. Only studies that 
assessed baseline factors within one week of stroke onset were included.51 The 
outcome of interest was mobility. This was defined by the ICF mobility items 
considered to be most relevant and commonly used in the assessment of mobility 
in acute stroke rehabilitation and included ambulation, transferring and stair 
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climbing. At least one of these mobility items had to be assessed within 30 days 
of onset of stroke. Studies that investigated upper limb mobility only were 
excluded. Due to the nature of this review, the study types of interest were 
observational cohort and case-control studies that identified factors predictive 
of or associated with mobility post-stroke. No limits were applied to the search 
with regards to language or year. 
Search strategy and data extraction 
The following electronic databases were first searched from inception to July 
2010: AMED (from 1985), CINHAL (from 1981), EMBASE (from 1980), MEDLINE In-
Process (from 1950), SIGLE (from 1985), Science Citation Index Expanded (SCI-
Expanded), ISI Web of Science (Web of Knowledge; from 1900), LILACS (from 
1982) and ZETOC (from 1993). The search was updated in March 2012. In order 
to identify relevant studies search strategies for each database (Appendix 1) 
were developed, with the assistance of an information specialist, using a 
combination of Medical Subject Headings (MeSH) and free text words such as 
‘mobility’, ‘prognosis’, ‘predictor’ or ‘determinant’. In addition, the references 
from the retrieved articles were hand searched for relevance and a citation 
search of Web of Science was conducted.  
The titles and abstracts of retrieved references from the search were screened 
by the author to exclude obviously irrelevant studies. The full articles of studies 
that satisfied the inclusion criteria were reviewed and data extracted using a 
standardised data collection form. Extracted data and decisions were cross-
checked with a second reviewer. Data extraction included full study 
characteristics – author(s), country of origin, date of publication and design. A 
description of the baseline factors collected, the outcome measures used and 
the timing of assessments were also recorded. Information from multivariate 
analysis models including the size and strength of effect (regression coefficients, 
odd ratios or p-values) were also noted. The methodological quality of the 
studies was assessed using a standard criteria which covers four domains:51 
external validity, internal validity, statistical validity and the evaluation of the 
model. These criteria were developed using the recommendations from the 
‘Task Force on Stroke Outcomes Research of Impairments, Disabilities and 
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Handicap’69 which aimed to increase the methodological quality of studies of 
stroke outcome and comply with methodological principles laid out for 
predictive research.70-72 
Originally, a meta-analysis was planned if compatible estimates of effect and 
variation were available. If homogeneity could be assumed the odds ratio (OR) or 
log ORs (from logistic regression outputs) would have been combined using the 
Mantel-Haenszel or inverse variance methods respectively.73 In the absence of 
such summary data the independent variables under investigation were 
tabulated along with p-values. 
2.2.2 Results 
The total number of studies identified by the search was 11,120. Following 
initial screening of titles and abstracts, all duplicate and irrelevant studies were 
excluded, and the full-text articles of 65 studies were assessed in detail 
(Appendix 2). Overall, five studies met the selection criteria, and were included 
in the review (Table 2-1).74-78 No further studies were included as a result of the 
update search run from July 2010 to March 2012 (Appendix 3). The studies were 
prospective cohorts studies ranging from 197 to 804 stroke patients, with the 
mean age of the patients ranging from 64.4 years to 74.4 years (based on data 
from four studies as one study did not report age). Although subarachnoid 
haemorrhage was a specific exclusion criterion in only two studies, none of the 
studies included any patients with subarachnoid haemorrhage.75 76 The studies 
can be broadly divided into two types – studies that assessed the association 
between baseline factors and the outcome by univariate analysis 74 76 78 and 
those that evaluated the predictive value of baseline factors by developing a 
statistical model.75 77 
All baseline information was collected on admission to the ASU with one study 
specifying a median onset to admission interval of 12 hours.76 The mobility 
outcome measured by all studies was walking. Only two studies had fixed 
assessment points with the time to achieving a specific mobility outcome within 
a set follow up period recorded – one at seven days and the other at one month 
post-stroke.75 77 Independent walking was defined as “walking speed of at least 
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1.5 meters per second” in one study, while a five-point scale (‘normal’ to 
‘bedridden’) were used in another.75 77 Two of the five studies were conducted 
at the same hospital site and described the pattern of recovery using four key 
areas of mobility (sitting balance, standing balance, 10 steps and 10-metre walk) 
according to the Oxfordshire Community Stroke Project Classification (OCSP).74 78 
In the remaining study the Scandinavian Stroke Scale (SSS) walking subsection 
was the outcome of interest.76
 Table 2-1 Table of evidence for included studies  
Author, location Study Design Inclusion 
(I)/exclusion (E) 
criteria  
Age(SD)/ 
Female (%) 
Factors (measure used) Mobility Outcome  Outcome Time point 
Friedman et al 
1991  
 
New Zealand 
Prospective 
cohort  
(n=197) 
I clinical definition 
of stroke E SAH  
 
Overall figures 
not available 
Age, sex, pre-stroke disability, prior stroke, 
initial level of consciousness, minimum arm 
and leg power (MRC Scale), cognitive 
performance (MMSE) homonymous 
hemianopia (confrontation of examiners 
fingers), visual extinction, line bisection 
error (200mm long line), constructional 
apraxia (ability to draw a house) 
Independent gait  
(a walking speed of at 
least 1.5m/s)  
 
Day 7, Month 1, 2, 3 
and 4 
Matsunga et al 
1997 
 
Japan 
Prospective 
cohort (n=577) 
I supratentorial 
infarction E 
bilateral infarction  
64.4 (13.1) 
 
165 (33.9%) 
Age, sex, level of consciousness (4pt 
scale), severity of paresis (hemiparesis or 
hemiplegia), side of lesion (CT), size of 
lesion (CT) 
Locomotion function  
(five point scale: normal, 
walk alone, walk with aids, 
wheelchair & bedridden) 
One month post-
stroke admission 
Baer and Smith 
2001 
 
United Kingdom 
 
 
Prospective 
cohort (n=238) 
 
 
I infarct as 
confirmed by CT 
E intracerebral 
haemorrhage 
71.8 (11.2) 
 
93 (50.3%) 
Stroke type - PACI (39.8%), LACI (26%), 
POCI (19.5%), TACI (14.6%)  
 
(OCSP, confirmed by CT) 
Time in days to achieve 
10 steps and 10m 
(standardised single 10m 
walking test) 
Time to complete a 10m 
walk (stopwatch) 
Daily  
Jorgensen et al 
1995 
 
Denmark 
 
Prospective 
cohort (n=804) 
E SAH  
 
 
 
 
74.5 (10.8) 
 
443 (53.9%) 
 
 
 
 
Leg power (SSS) 
 
 
Walking function  
(BI score (no walking 
function (0-5 points), 
walks with assistance (10 
points), independent 
walking function (15 
points) 
Weekly until death or 
on discharge of 
rehabilitation. Mean 
los = 35 (SD = 41) 
days 
 
Smith et al 1999 
 
United Kingdom 
Prospective 
cohort  
(n=238; 9 
omitted due to 
death/coma) 
I infarct or 
haemorrhage as 
confirmed by CT 
69.7 (11.9) 
 
119 (52%) 
Stroke type - PACI (35.4%), LACI (26.6%), 
POCI (6.6%), TACI (19.2%)  
 
Time to mobility 
milestones  
(including sitting balance, 
standing balance, walk)  
Daily 
Mean LOS = 56.9 
(SD = 67.7) days 
 
SAH: Subarachnoid Haemorrhage; MRC: Medical Research Council; MMSE: Mini-Mental State examination; CT: Computerised Tomography; PACI: Partial Anterior Circulation 
Infarction; LACI: Lacunar Infarct;  POCI: Posterior Circulation Infarcts; TACI: Total Anterior Circulation Infarct; OSCP: Oxfordshire Community Stroke Project; SSS: 
Scandinavian Stroke Scale; BI: Barthel Index; LOS: Length of Stay; SD: Standard Deviation 
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A total of 15 baseline factors were investigated in the studies included in the 
review: baseline demographics including age and sex; prior history including pre-
stroke disability and prior stroke; and clinical determinants including arm power, 
cognitive performance, consciousness, constructional apraxia, homonymous 
hemianopia, leg power, stroke classification, size of brain lesion, severity of 
paresis, side of lesion and visual extinction (Table 2-2). Five of these baseline 
factors were tested in more than one study with age, severity of paresis and 
stoke type significantly associated with or predictive of walking in at least two 
studies. Stroke type was significantly associated with walking in two of the 
studies 74 78 although not in the study conducted by Freidman.75 Two studies 
developed a predictive model and showed that sex was not predictive of walking 
while there was disagreement regarding the inclusion of the factor, level of 
consciousness. Arm power, cognitive performance, constructional apraxia, pre-
stroke disability, previous stroke, side of lesion and visual extinction were also 
tested and found to have no predictive value.75 77  
Overall, the studies did not meet the majority of the criteria for good predictive 
research (Appendix 4). All the studies provided descriptions of cohorts in 
relation to the inclusion and exclusion criteria used and all reported baseline 
demographics. Generally, the sample size used was considered appropriate with 
regards to the number of factors that were being investigated. In one study 
multivariate analysis was conducted only on a subset of patients who had not 
achieved independent walking at seven days,75 resulting in an insufficient event 
per variable (EPV) ratio for the number of independent factors included in the 
model. Sample size was viewed appropriate if a study had at least 10 outcome 
events for each factor used in the predictive model. None of the predictive 
models were evaluated in the dataset used to develop the model or externally 
validated in an independent dataset. Studies did not use validated outcome 
measures designed to assess mobility 74 75 77 78 or used the walking subsection of a 
global assessment tool.76  Two studies assessed mobility using four locally 
designed mobility milestones but did provide clear standardised descriptions of 
how these were assessed.74 78 
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Table 2-2 Baseline factors investigated by included studies 
 
 
 
 
 
Factor Friedman 
et al 1991 
Matsunga  
et al 1997 
Baer & 
Smith 2001 
Jorgensen 
et al 1995 
Smith  
et al 1999∗∗ 
Age  (p=0.05) (OR∗= 1.25)    
Level of consciousness  (OR = 1.26)    
Size of brain lesion  (OR = 1.38)    
Severity of paresis  (OR = 1.21)    
Hemianopia (p=0.02)     
Leg power  (p=0.03)    (p<0.01)  
Sex       
Side of lesion      
Pre-stroke disability      
Prior stroke      
Minimum arm power      
Cognitive performance      
Visual extinction      
Constructional apraxia      
Stroke type      
  Factor tested but not predictive  factor tested and predictive or associated 
∗   OR: Odds ratio was calculated from reported correlation coefficients 
∗∗  Based on time to achieving mobility outcome (>30 days) 
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2.3 Development of predictive models 
2.3.1 Methods 
The Glasgow Royal Infirmary Stroke Register which contains baseline and 
outcome data for 1029 consecutive patients admitted to an urban teaching 
hospital between 2000 and 2002 was used to develop the predictive model.  The 
mobility outcome used for the analysis was independent walking at 30 days post-
stroke as measured by the subsection of the BI. Patients were excluded from the 
analysis if this data were not available.  
The factors identified by the systematic review and present in the data set 
constituted Model 1. As the review identified a low number of studies 
investigating predictors in this early stage post-stroke two other methods were 
used to identify potentially predictive factors and thus developed two further 
predictive models; one based on factors selected by clinical opinion (Model 2) 
and the other using univariate analysis to select factors (Model 3). These 
methods of selecting factors for modelling avoid over fitting of the model which 
is associated with including all patient baseline factors in the model.72  
Clinical opinion was obtained from a physiotherapist and a doctor. Baseline 
factors were listed, along with a description and the intention for 
inclusion/exclusion with reason for any exclusion stated, and provided for 
independent appraisal. Justified disagreement resulted in the factor being 
subsequently included or excluded accordingly. The reasons for exclusion were 
classified into three categories: ‘irrelevant’; factors considered unlikely to be 
associated with the outcome, ‘better measure available’; duplication of factors 
i.e. diabetic medication was excluded in favour of presence of diabetes. To 
reduce the number of factors only one blood pressure variable was included. 
Diastolic blood pressure was excluded as there is some evidence that diastolic 
blood pressure is measured less reliably than systolic blood pressure.79 The third 
category was ‘missing data’ for factors with high levels of missing data (defined 
as missing for > 20% of patients) which may reflect that they are not easily 
collected in clinical practice.  
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Univariate analysis was conducted between the baseline factors and the 
outcome to determine inclusion for Model 3.72 80 Categorical factors were either 
dichotomised (stroke type, side of lesion and housing arrangements on 
admission) or the number of groups were reduced (i.e. smoking status, level of 
disability). This was done to minimise the number of factors entered into the 
models in order to make the models as parsimonious as possible.80 Continuous 
factors were categorised (i.e. level of stroke severity and ADL) using well-
established cutoff points if data were not normally distributed and did not have 
a linear relationship with the outcome. It is recognised that dichotomising data 
can result in biases and loss of efficiency,81 therefore the recommendation to 
categorise factors into three groups was adopted.82 
Data on age were normally distributed and there was some evidence that the 
association between age and the outcome was linear. Systolic blood pressure on 
admission and systolic blood pressure measured between day one and two was 
dichotomised using the cutoff point  ≥ 160 mmHg as there was no evidence that 
the association between blood pressure and the outcome was linear. The length 
of time from symptom recognition to admission was dichotomised at the median, 
again as the association between this factor and the outcome was not linear. 
Since the dependent variable in the data set was binary, logistic regression was 
the technique employed using backward stepwise regression to drop the least 
significant factors in turn. Odd ratios were calculated from the regression 
coefficients in order to convert to a natural scale and ease interpretation. A 
conservative level of significance (p ≤ 0.1) was used to prevent omission bias 
both on univariate and multivariate analysis.  
The performance of a predictive model should be assessed in terms of both 
calibration and discrimination.83 Calibration was investigated by plotting the 
actual proportion of patients who walked independently at 30 days against the 
probability predicted by the model. To do this the prediction scores (calculated 
from the regression coefficients) were split into deciles and the mean predicted 
probability calculated for each group. The mean predicted probability was then 
plotted against the observed proportion along with 95% CI for each predictive 
score group. These calibration plots were accompanied by the Hosmer-
Lemeshow test.71 Although, calibration may allow patients to be advised of their 
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chances of walking it does not distinguish between those patients who will and 
will not walk independently.84 It is the area under a receiving operating 
characteristic (ROC) curve which provides an assessment of how good the model 
is in discriminating between individuals with and without the outcome.72 A ROC 
curve plots the sensitivity (proportion of true positive predictions) against 1 
minus specificity (proportion of false positive predictions). An area of 0.5 implies 
a prediction that is not informative and considered no better than chance alone. 
The higher the area under the curve the better the model is at predicting the 
outcome. 
2.3.2 Results 
The patient baseline demographics and clinical factors are presented in Table 2-
3. The total number of baseline factors stored in the data set was 103. Outcome 
data were available for 820 patients with 487 patients (59.4%) independently 
walking at 30 days post-stroke.  
Table 2-3 Baseline demographics and clinical factors 
 n(%)∗ n(%)∗ 
Number of patients 1029 820 
Age (mean, SD)  68.9 (13.2) 69.2 (12.6) 
Female 518 (50.3) 406 (49.5) 
Stroke risk factors   
Hypertension 492 (47.8) 405 (49.4) 
Atrial fibrillation 115 (11.2) 98 (12.0) 
Coronary heart disease 335 (32.6) 273 (33.3)   
Diabetes 178 (17.3) 146 (17.8) 
Current Smoker (yes) 365 (35.5) 289 (35.2) 
Independent pre-stroke (mRS score 0-2) 823 (80.3) 667 (81.3) 
Living arrangements on admission   
Home alone 337 (32.8) 287 (35.0) 
Home not alone  605 (58.8) 470 (57.3) 
Other 87 (  8.5) 63 (  7.8) 
Stroke history   
Previous stroke 321 (31.2) 261 (31.8) 
SSS score (median, IQR) 46 (31-54) 47 (35-55) 
Oxfordshire classification   
TACS 231 (22.5) 150 (18.3) 
PACS 351 (34.1) 302 (36.8) 
LACS 287(27.9) 234 (28.5) 
POCS 78 (  7.6) 66 (  8.1) 
Unknown 82 (   8.0) 68 (  8.3) 
∗ Entries are n (%), unless stated otherwise 
mRS: Modified Rankin Score; NIHSS: National Institute Health Stroke Scale; TACS: Total 
Anterior Circulation Syndrome; PACS: Partial Anterior Circulation Syndrome; LACS: Lacunar 
Circulation Syndrome; POCS: Posterior Circulation Syndrome; SSS: Scandinavian Stroke 
Scale (a lower score indicate higher impairment) 
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Four out of the seven factors (age, stroke type, consciousness level and leg 
power) identified by the systematic review as significant predictors of mobility 
post-stroke were recorded in the data set and therefore constituted Model 1. 
The clinical experts identified 22 factors as potentially predictive of 
independent walking. This clinical appraisal process excluded 78 factors; better 
measure available (58.4%), irrelevant (27.3%), missing data (14.3%) (Appendix 5). 
On univariate analysis 32 factors were significantly associated with independent 
walking. A summary of the factors entered into the three models is in Appendix 
6. The final factors included in Model 1 after stepwise regression analyses were 
age (p < 0.01), stroke type (p < 0.01), consciousness level (p = 0.04) and leg 
power (p < 0.01). The output from the model including regression coefficients 
and p-values is in Table 2-4.   
 
Table 2-4 Results from multivariate analysis  
Factor Model 
coefficient 
95% CI p-value OR 
Model 1: systematic review (n=819)     
Age -0.04    -0.05,  -0.02 0.000     0.97 
Stroke type (TACS) -1.49    -1.96,  -1.02 0.000     0.23 
Consciousness (unaffected) 0.80     0.05,   1.55 0.036      2.23 
Leg power (unaffected) 1.09    0.74,   1.44 0.000        2.98 
Model 2: clinical opinion/univariate analysis (n=817) 
Age -0.02    -0.04,  -0.01 0.004    0.98 
Living arrangement (alone)  0.40    -0.01,  -0.82 0.056    1.50 
Stroke type (TACS) -0.52    -1.11,  -0.08 0.088     0.60 
Stroke severity (moderate) -0.84    -1.38,  -0.30 0.002    0.43 
Stroke severity (severe) -1.59    -2.62,  -0.55 0.003     0.20 
Disability (moderate) -1.17    -1.76,  -0.57 0.000     0.31 
Disability (severe) -3.20    -5.41,  -0.99 0.004     0.04 
Activities of daily living (moderate) -0.61     -1.25,   0.03 0.064   0.55 
Activities of daily living (severe) -1.37    -2.50,  -0.23 0.019     0.26 
The dependent variable is independent walking measured at 30 days post-stroke. The 
independent factors included in the final multivariate models are listed in the first column. Stroke 
type, consciousness, leg power, living alone, severity, disability and activities of daily living were 
assigned a value of 1 if the condition in brackets was satisfied (in the absence of the condition 
the variable was assigned a 0). 
Stroke severity was measured using the Scandinavian Stroke Scale; moderate: 26-42; severe: 0-
25. Disability was measured using the Modified Rankin Scale; moderate: 4; severe: 5 
Activities of daily living was measured using the Barthel Index; moderate: 3-9; severe: 0-2 
 
Positive regression coefficients and an OR greater than one means the patient is 
more likely to be walking independently than the patients in the reference 
category (always coded 0) at one month. For example, the odds of independent 
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walking for a patient who is fully conscious (coded 1) on admission are 2.23 
times the odds of independent walking for a patient who has a reduced 
consciousness level (coded 0). Similarly, negative coefficients and an OR less 
than one means the patient is less likely to be walking at one month. For 
example, a patient who has experienced a Total Anterior Circulation Syndrome, 
(TACS) (coded 1) the chances of independent walking are reduced by 
approximately 80% compared to a patient who had experienced any other type 
of stroke (coded 0). When developing models 2 and 3, the factors that remained 
after stepwise regression were the same (hereon referred collectively as Model 
2). For Model 2, the predictors of walking after stroke following stepwise 
regression were age (p < 0.01), living alone on admission (p = 0.07), stroke type 
(p = 0.09), level of severity (overall p-value = 0.02), level of disability (overall p-
value < 0.01) and level of ADL (overall p-value = 0.04). In particular, patients 
with a high level of disability on admission had significantly reduced chances of 
walking independently at three months (OR 0.04, p < 0.01, 95% CIs -5.41- to -
0.10). The CIs are wider than those of any other variable, indicating a degree of 
uncertainty, probably due to the lower number of patients in this group. The 
regression coefficients were then used to calculate a predictive score for 
individual patients (Box 1-1). These scores was then used to create the 
predictive score groups used to develop the calibration plots. 
Box 1-1  Calculating predictive scores using regression coefficients  
 
 
 
 
 
 
Adapted from Royston et al, British Medical Journal.72 
Calculating a predictive score from regression model to predict the probability of 
walking for a patient 30 days post-stroke 
 
Predictive score = 2.01 + ((age x -0.04) + (stroke type x -1.50) + (consciousness x 
0.80) + (leg power x 1.09)) 
 
The value of 2.01 is the intercept and the numbers each predictor is multiplied by is 
the corresponding estimated regression coefficient. The estimated regression 
coefficients are the log (odds ratios) for a change of 1 unit in the predictor. 
 
The predicted probability = exponential (predictive score) / (1+ exponential 
(predictive score)) 
 
For example, a patient aged 81 years classified as having a posterior circulation 
infarct, had reduced consciousness on admission and had normal leg power would 
have a predictive score of 0.23. Therefore, the predicted probability of independent 
walking for this patient is 0.56. 
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The calibration plots for both models (Figure 2-1) show that the predicted 
probabilities (black squares) generated by the model fit well with the actual 
data (black circles). In Model 2 the increase in probability of walking that occurs 
between the predictive score groups five and six is likely to be due to the 
number of predictive score groups used or reducing the number of disability 
classifications. The p-value for the Hosmer-Lemeshow goodness of fit test was 
0.31 for Model 1 and 0.83 for Model 2 showing that Model 2 has a better fit with 
the observed data than Model 1.  
 
Figure 2-1 Calibration plots of predicted and observed probabilities 
 
The predicted probabilities are represented by the black squares. The observed data are 
represented by the black circles. 
 
When testing the discriminative properties of the model the ROC curve value 
was 0.80 for Model 1 (Figure 2-2) and 0.87 for Model 2 (Figure 2-3) showing that 
both models are better than chance alone in predicting independent walking at 
30 days and are very accurate in distinguishing patients who will and those who 
will not walk independently at three months. The curve for Model 2 (Figure 2-1) 
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shows a steeper incline to the upper left hand corner of the graph indicating 
that a higher true positive rate can be achieved for the same true negative rate. 
Figure 2-2 Receiver operating characteristic curve for Model 1 
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Figure 2-3 Receiving operator characteristic curve for Model 2 
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Sensitivity is the true positive rate. 1-specificity is the true negative rate. 
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2.4 Discussion 
Summary of key findings: systematic review 
This systematic review identified baseline factors assessed within one week 
post-stroke that may be of value in predicting the recovery of walking in the 
acute stages post-stroke. Age, the severity of paresis, the degree of leg power, 
presence of hemianopia, size of brain lesion and type of stroke were predictors 
of walking within 30 days post-stroke. Age, the severity of paresis and reduced 
leg power were each shown to be predictive in more than one study. It could be 
speculated that severity of paresis and the degree of leg power are measuring 
the same thing. The severity of paresis was classified as either hemiparesis or 
hemiplegia, while leg power was measured using an ordinal scale or a continuous 
scale. As it was unclear whether severity of paresis referred exclusively to lower 
limbs and the same assessment tool was not used it was decided that these two 
factors be presented using the original definitions. Age has been frequently 
noted to have a positive association with function in the longer term.59 85 There 
was disagreement between the included studies as to whether level of 
consciousness and stroke type had any association with the recovery of walking. 
This may have been due to the differences in the measurement of these baseline 
factors and categorisation at the analysis stage. For instance, one study 
measured and analysed consciousness on a four point scale while another 
analysed this as a dichotomised factor (alert or not alert).75 77 Also, the time 
point at which consciousness was assessed after stroke onset may have varied 
between the studies. One study specified that level of consciousness was 
assessed within three days after onset of stroke while the other study conducted 
baseline assessments during the first five days after stroke.75 77 
The most commonly assessed mobility outcome was walking. Walking speed was 
used to define independent gait 75 and an unnamed five-point scale (ranging 
from ‘normal’ to ‘bedridden’) was used to define independent gait in the two 
studies that developed predictive models.77 Two of the association studies were 
conducted at the same hospital site and described the pattern of recovery in 
four key areas of mobility (sitting balance, standing balance, 10 steps and 10-
metre walk) according to the OCSP.74 78 The remaining association study used the 
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SSS sub-section for walking.76 Two studies used fixed assessment points with one 
study assessing patients at seven days and the other study assessing patients at 
one month post-stroke. The other studies did not have fixed assessment points 
and recorded the time to achieving a specific mobility outcome within a set 
follow-up period. 74 76 78 
The selection of factors for the two predictive models developed in the studies 
was based on univariate analysis. While it is common practice to include factors 
that are significant on univariate analysis it is also important to include those 
based on clinical opinion or are theoretically associated with the outcome. It has 
been speculated that variable screening based on statistical significance alone 
may lead to an unreliable model. For example, the presence of incontinence and 
balance impairment on admission are frequently cited as potential predictors of 
reduced mobility in the long-term.86-91 These factors were not investigated or 
controlled for in any of the included studies. No attempt was made to assess the 
performance of the predictive models identified by this review by evaluating 
accuracy, discriminatory power or clinical applicability in other cohorts. In 
summary, the main limitations highlighted by this review were that factors may 
have been missed due to the method used to select variables and no attempts 
were made to validate the models that were developed.  
Summary of key findings: predictive modelling 
Considering the limitations identified by the review, existing registry data were 
used to develop and test suitable models to accurately predict independent 
walking 30 days post-stroke. Two final predictive models were developed in this 
study; one using the factors identified in the systematic review and available in 
the data set and a further model which was based on factors that had been 
selected by both clinical opinion and univariate analysis. Model 1 showed age, 
stroke type, consciousness and leg power to be predictors of walking one month 
after stroke. Model 2 showed age, living arrangement, stroke type, stroke 
severity, disability and ADL to be predictors of walking one month after stroke. 
The model based on clinical opinion and univariate analysis (Model 2) showed 
better agreement between the predicted and observed data than that of the 
model solely based on the systematic review (Model 1). Both models appeared to 
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be able to discriminate well between those patients likely to walk and those who 
were not likely to walk. 
The predictive modelling component of this research aimed to overcome some of 
the methodological shortcomings highlighted by the systematic review. The 
development of predictive models used a structured approach to variable 
selection, reported a codebook for the baseline factors used in the model and 
assessed the performance of the models. The most appropriate method for 
variable selection is questionable. The factors finally included in Model 2 and 
Model 3 had been identified by clinical opinion and by univariate analysis 
suggesting that either one of the approaches is sufficient to select factors for 
inclusion. The comparison of these two methods with factor selection based 
purely on systematic review is limited in that not all the factors were available 
in the data set i.e. lesion size.  
The number of factors entered into Model 3 was 32 which could be considered 
high. Using the EPV ratio of 10:1, as previously explained, at least 320 outcome 
events would be needed. This would mean that 603 patients would be required 
for an event rate of 53% (literature estimate92). Therefore, using this general 
rule the sample size of 817 is sufficient to assess the factors that were entered 
into the model. A common limitation in predictive modelling is the management 
of data sets where data on potential predictive factors may be missing. A 
standard approach to manage this is to conduct a complete case analysis 
whereby patients that have missing data are excluded from the analysis or to 
exclude the factors that have a high degree of missing data. There is little 
guidance to the extent of data that should be missing before it warrants 
exclusion, hence the use of a > 20% cut-off in this analysis. This could lead to the 
exclusion of a defined subset of patients i.e. for example, unconscious patients, 
where it has not been possible to ascertain their smoking habits. An alternative 
approach, multiple imputation, does not only increase the statistical power of 
the analysis but helps eliminate the bias associated with excluding patients in a 
complete case analysis or exclusion of factors with a high number of missing 
data.  
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Strengths and limitations 
The number of studies eventually included in the systematic review from the 
search output was low (n = 5). The lack of distinction between motor and 
functional recovery in the neuromedical literature67 and differences in 
definitions for mobility may have implications for the indexing of such studies in 
electronic databases. To overcome this limitation, electronic indexing synonyms 
were used for key words to ensure the search was sensitive; however, this may 
have compromised the precision of the search. A few studies specified a global 
scale to measure function or disability which may have contained a subsection 
on gait. For these studies, the reviewer pursued full retrieval in case a 
breakdown of mobility items was available. The subsection of the BI was 
reported separately in one study however this was only available six months 
post-stroke.87 The main reason for exclusion of the retrieved articles was that 
the outcome or baseline assessment was conducted out with the timescales 
specified for this review.  
Only including studies that assessed baseline factors within seven days of stroke 
onset may seem stringent, yet the importance of timing in predictive research 
cannot be overlooked. Baseline factors shown to be highly predictive within the 
first two weeks may have different predictive properties if measured at a 
different timepoint, even a few days has been shown to have an influence on the 
performance of the model .53 60 Although the updated search did not identify any 
further studies, one study did investigate the optimal timing of clinical 
assessments using an intensive repeated-measures design.93  Veerbeek et al 
(2011) concluded that accurate prediction of independent walking at six months 
is feasible within 72 hours post-stroke using two simple bedside tests; sitting 
balance and muscle power of the affected leg. Furthermore, recent research has 
suggested the use of neuroimaging to accompany such clinical assessments to 
improve the accuracy of predicting motor recovery post-stroke.94 
An internal validation approach was used here, whereby model performance was 
tested in the same cohort of patients used to develop the model. There are 
limitations to this approach in that the generalisability of the model is not 
challenged; potentially resulting in the model performance being overly 
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optimistic. It is recommended that performance is best tested in a new cohort of 
patients as opposed to the original cohort, however, such external validation 
studies are rare.70 If predictive models are to become more routinely integrated 
into clinical practice it is important that the performance of the model is 
evaluated in a new cohort of patients. The face validity of a predictive tool is 
important and if it appears to make clinical sense the more likely it will be 
accepted in clinical practice. For example, some of the factors included in some 
of the studies identified during the systematic review may not be collected 
routinely in clinical practice (such as tests of line bisection and constructional 
apraxia).  
Application of predictive models 
Being able to predict mobility has important implications for the amount of care 
needed post-stroke and is of key importance to patients.49 78 More specifically 
the ability to ambulate independently is often used as a criterion in determining 
whether a patient is able to live at home or not.95 Complications relating to 
immobility such as chest infections and deep venous thrombosis account for a 
high proportion (51%) of deaths in the first 30 days post-stroke.96 Therefore, 
having knowledge about the patients expected level of mobility may allow 
planning of preventative measures. 
Little is stated in the literature about the real-life implementation of such 
prediction tools in practice and it would be valuable to establish current levels 
of understanding and usage by clinicians. The predictive model developed 
contains factors that can be easily collected in practice therefore increasing its 
clinical usability. It is acknowledged that algorithms generated from regression 
models are not always straightforward and accessible for use in clinical practice. 
Evaluating the cost-effectiveness of predictive models by comparing the 
resource use and outcomes for one group of patients where the predictive tool 
was applied with another group where the model was not applied are not usually 
conducted. This would allow the full impact of predictive tools to be assessed in 
terms of the cost implications and consequences for the patient and family 
where accurate or inaccurate information is provided.  
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As the models have not been fully evaluated they cannot yet be recommended 
for use in clinical practice. Instead, the models could be used in clinical audit to 
identify patients whose actual outcome differs from that predicted. Reasons for 
any differences could be identified to inform patient management or improve 
the predictive models. The models could be used to stratify patients in 
rehabilitation trials. This would reduce differences in baseline prediction 
between the treatment groups. The factors could be used to correct for case-
mix in observational studies which would allow patient outcomes from different 
cohorts (i.e. hospitals) to be compared. 
Future direction in predictive research 
The use of meta-analysis in predictive research is uncommon due to the 
availability of evidence for synthesis. In this review this could not be performed 
largely due to the shortage of comparable predictive studies investigating the 
same predictors and mobility outcome. Stratifying patients at baseline and 
reporting the grouped outcomes as seen in some of these studies presents 
another challenge for reviewers. The diversity of outcome assessments used to 
evaluate independent walking or return to walking probably reflects the lack of 
specific walking tools available.97 The use of individual patient data meta-
analysis (IPD MA) may overcome some of these limitations. It is the organisation 
of multicentre prospective predictive studies adhering to the same protocol 
collecting the same baseline factors and using the same universally accepted 
outcome measures which appears to be the favoured approach in this area of 
research.98  
The time taken to achieve certain mobility milestones was the primary outcome 
in three of the included studies.74 76 78 Proposing timescales for a certain event 
for different patient types is viewed as useful in goal-setting and as a prompt for 
further investigation if the patient does not achieve the milestone within the 
expected timeframe.78 This focus on time to event is even more problematic for 
meta-analysis, mainly due to the poor reporting of the hazard ratio and often 
requires a more complex analytical approach.98 The time to event is an 
important clinical question and with a reporting guideline equivalent to the 
Consolidated Standards of Reporting Trials may overcome this limitation and 
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facilitate future meta-analysis in this area. The Prognostic Systematic Review 
Methods Group, part of the Cochrane Collaboration,99 aims to improve the 
conduct, analysis and reporting of predictive research. This group should be used 
as a key reference point for research groups conducting future predictive 
research in stroke. 
2.5 Conclusion 
This Chapter includes research that addresses the development stage of the 
Medical Research Council complex intervention framework. Two new predictive 
models were developed with some attempt to overcome the limitations 
highlighted by the systematic review. The models were simple (consisted of a 
maximum of six factors) and included factors that could easily be collected in 
routine clinical practice. The models could be used in clinical audit to identify 
patients whose actual outcome differs from that predicted or be used to stratify 
patients in rehabilitation trials. The immediate application of these models was 
to correct for case-mix in the forthcoming observational study (Chapter 3). 
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3 Establishing baseline physical activity levels 
in acute stroke patients 
3.1 Introduction 
Much of today’s focus in healthcare is on the delivery of evidence-based 
practice, reflected by the increased number of audits being conducted. Using 
relevant process indicators of care and effective monitoring systems, it is 
important to demonstrate the implementation of evidence-based therapies.  
Increasing physical activity levels are a major component in stroke 
rehabilitation. Physical activity is defined as “any movement of the skeletal 
muscles of the body that results in energy expenditure.”100 There is suggestion 
that early intensive activity contributes to the success of stroke unit care and 
may improve outcomes.101 102 Studies investigating activity levels of stroke 
patients indicate that these are low and are the proportion of time that the 
patient spends in activity is low.26 46 103-109 Activity levels between patients and 
stroke units of different countries vary.107 110 Factors that have been used to 
explain these differences include patient and stroke characteristics, variations in 
practice and the rehabilitation environment.26 111  
There are a number of different methods that can be used to monitor activity in 
stroke patients such as observational methods and monitoring devices such as an 
accelerometer (AC).112 Continuous researcher observation has previously been 
regarded as the ‘gold standard’ and previous studies have observed stroke 
patients in a variety of settings including medical centres,104 stroke 
rehabilitation centres108 109 and ASUs to establish activity levels.26 46 107  
Researcher observation provides the opportunity to study the environment in 
which the activity occurred and understand more about the inconsistencies 
between what people say they do and what actually happens.113 Limitations with 
this approach do exist in that it is labour intensive and often includes periods 
when the patient cannot be observed, i.e. when the patient is in the toilet or 
moves away outside the observation area. Additionally, the potential bias of a 
researcher being present also needs to be considered.46 107 Behavioural 
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mapping, where time intervals are pre-determined, is an observational sampling 
method which has been used to establish activity levels in stroke patients and 
observe objective stroke care processes. Examples of processes which have been 
observed include the time spent in certain activities, structured therapy and 
interacting with ward staff and relatives.107 This method has been used in a 
number of studies and has proved easy to measure and useful in describing 
physical activity levels in stroke patients and the environment in which activity 
occurs.  
Accelerometry is the modern day equivalent to researcher observation and is 
now being proposed as the gold standard. Accelerometers provide a continuous, 
detailed objective analysis of activity levels and patterns. Accelerometers can 
be used to collect information about the amount, duration and intensity of 
upright activity. Uniaxial and triaxial ACs measure the acceleration in a number 
of directions and quantifies the amount of movement. Although triaxial ACs 
detect movement in three dimensions, uniaxial ACs are thought to provide more 
reliable data.114 The activPALTM professional (PAL Technologies Ltd, Glasgow, 
UK) is a monitor worn midline on the anterior aspect of the thigh which has been 
specifically developed to measure physical activity levels in a range of patients. 
It is able to discriminate between sitting/lying, stepping and standing allowing 
time spent in each activity to be measured. The activPALTM has been used in 
stroke research.115 116 112 In one study the primary outcome was the number of 
upright episodes (standing, transferring and walking). It is recognised that 
quantifying activity by counts does not describe the pattern of activity and may 
miss important factors such as the time spent in each upright or sedentary 
episode and the distribution of these events during the day. Information on 
these factors would provide a fuller picture of the patient’s pattern of activity 
and potentially inform the design and implementation of future rehabilitation 
interventions. 
As well as the amount of physical activity the schedule of activity may also be 
important i.e. how long should the rest periods be between mobilisation 
sessions.3 The impact of lying down for extending periods of time in stroke 
patients has been previously questioned.108 Research into sedentary behaviour, 
which is characterised by prolonged periods of sitting or lying, is growing.117 
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Large epidemiological studies have found a strong association between 
prolonged periods of sitting each day with negative physiological changes, 
increased risk of all-cause mortality and cardiovascular-disease.118 One study has 
shown that breaking up sedentary behaviour with short bursts of activity 
significantly reduced cardiovascular disease risk.119 This has resulted in an 
emerging interest in how sedentary behaviour is accumulated in stroke.120 
Activity-based rehabilitation interventions such as VEM aim to improve outcome 
for patients after stroke. However, to be able to assess the future 
implementation of effective activity-based interventions in clinical practice, a 
baseline i.e. what is currently happening with regards to activity needs to be 
investigated. Therefore, Chapter 3 now presents an observational study which 
aimed to establish pre-implementation physical activity levels in acute stroke 
patients. Prior to this study, no observational data for activity levels in acute 
stroke patients was available for a Scottish healthcare setting. It remains 
unknown if activity-based rehabilitation interventions do improve outcomes. To 
further develop the evidence base, the observational data will be used to assess 
the relationship between activity levels in the acute stages and functional 
outcome for patients at three and six months, adjusting the analysis for the 
factors identified to be predictive of outcome (Chapter 2).  
Aim 
This observational research aimed to quantify upright physical activity level and 
describe the pattern of upright activity and sedentary behaviour in acute stroke 
patients using accelerometry, complimented by process information elicited 
using a standard behavioural mapping technique (BMT).   
The objectives of this observational study were as follows: 
• To describe the level and pattern of upright physical activity and sedentary 
behaviour in acute patients in a Scottish healthcare setting using 
accelerometery and a behavioural mapping technique 
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• To investigate whether researcher observation can be predicted by 
accelerometery 
• To identify the patient and baseline stroke characteristics which determine 
levels of upright physical activity using regression analysis 
• To investigate whether the level of upright physical activity in the acute 
stages post-stroke is predictive of functional outcome at three and six 
months using regression analysis 
3.2 Methods 
A multicentre observational study design was used to establish the level and 
pattern of upright physical activity in acute stroke patients. Patients were 
recruited from three ASUs in the West of Scotland. Activity monitoring using 
researcher observation and accelerometry was conducted for each recruited 
patient, in the ASU for nine hours on one day between Monday to Friday. The BI 
was administered at three and six months by telephone interview.  
Patients over 18 years of age with a clinical diagnosis of first or recurring stroke 
admitted to an ASU with either a haemorrhage or infarct within the first 14 days 
of stroke onset were approached for inclusion. Only patients who, at the time of 
recruitment, were not planned for discharge were approached. All patients or 
their nearest relative provided informed written consent prior to enrolment. 
Patients were excluded if they had already been recruited to another 
rehabilitation intervention study as this may have influenced standard mobility 
practices. Patients for palliative care were excluded.  
Recruitment strategy 
The research nurses were informed of the study details and the 
inclusion/exclusion criteria. Oral presentations were provided locally; at hospital 
stroke research meeting groups and Managed Clinical Network Research and 
Development meeting groups to raise the profile of the research. The Scottish 
Research Network (SRN) nurse acted as the key contact for each of the hospital 
sites.  
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Contact was made daily with the research nurses in order to receive updates on 
new patients admitted to the ASUs and to assess their suitability for 
recruitment. All potential study patients were screened and if eligible, the 
patient or nearest relative was approached and provided with the study 
patient/relative information sheet (Appendix 7) 24 hours in advance of any 
decision to participate being made.  Potential participants and/or the nearest 
relative were also provided with verbal information about the study. The 
patient, where able, completed the consent form (Appendix 8). Where a patient 
was unable to complete the consent form fully and/or eligibly, a witness was 
sought to overview the recruitment process and verify the patient’s verbal 
consent. The SRN research nurses recruited patients when the researcher was 
unable to do so. 
3.2.1 Accelerometry 
The type of AC used was the activPAL™ professional (PAL Technologies, Glasgow, 
UK). The main features of the activPAL™ are that it is uniaxial, lightweight 
(weighs only 15mg), is slimline (only 7mm thick) and can collect and store data 
continuously for up to seven days. The activPAL™ was used to monitor physical 
activity between 08:00 and 17:00 for each recruited patient (to align with the 
monitoring timeframe used in the BMT protocol). The activPAL™ monitor was 
securely positioned onto the anterior aspect of the patient’s thigh using a 
PALstickie (double-sided hydrogel adhesive pad) at the start of monitoring. For 
hemiplegic patients there is some suggestion that ACs can be placed on either 
the non paretic or paretic side.121 To ensure consistency in this study the 
monitor was fixed to the patient’s unaffected thigh. The monitor was removed 
in the event of washing, bathing or showering or if the patient was attending a 
Magnetic Resonance Imaging (MRI). The time of monitor removal and re-
attachment was noted. The activPALTM  has been shown to be a valid and 
reliable device for measuring step number and cadence in a healthy adult 
population 122-124 and in patients with problems such as chronic low back pain.125  
A recent review suggests that ACs can produce valid and reliable data about the 
physical activity of patients with stroke.126  
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3.2.2 Researcher observation 
Intermittent researcher observation was conducted for each recruited patient 
between 08:00 and 17:00 in the ASU between Monday to Friday. The researcher 
employed a well-established BMT;127 to enable comparability of results with 
other studies. This technique involved structured observations, of approximately 
one minute duration, at 10 minute intervals throughout the day with four, 10 
minute, rest breaks scheduled. The monitoring timeframe adopted in previous 
studies has varied from one day to five days.128  
The BMT is designed to be unobtrusive, using distance observation where 
possible, and does not intrude on patients behind closed doors or curtains. 
Patients may become aware of the observer, but in this population it is unlikely 
that they will alter their behaviour in response to observation since many people 
newly diagnosed with stroke require physical assistance to move. 
The BMT procedure used was designed to provide a snapshot of routine activity 
of acute stroke patients. Due to the short length of patient stay in the ASUs the 
use of a longer monitoring timeframe observation period was considered 
impractical. Training in mapping procedure was provided by the author of the 
protocol.127 The type of motor activity, patient location and the people present 
were recorded on a paper case report form (CRF) at each time interval. Ten 
motor activity, 14 person present and five locations categories (bathroom, 
bedroom, hall, therapy area or off ward) were used (Table 3-1). Patient’s 
privacy was respected and activity behind closed curtains was not observed and 
patients were not followed off the ward. In such instances, information from 
periods where the patient could not be observed was determined by asking the 
patient or staff member as soon as they became available again and was noted 
as unobserved if unobtainable.  
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Table 3-1 Motor activity and person present classifications 
Motor activity Person present 
No active motor (supine or side-lying) Alone 
Sit support in bed Medic 
Sit support out of bed Nurse 1 
Hoist transfer Nurse 2 
Roll and sit up Nursing assistant 1 
Sit no support Nursing assistant 2 
Transfer feet on floor Physiotherapist 
Stand Occupational therapist 
Walk Speech and language therapist 
Stairs Family 
 Patient transport 
 Interpreter 
 Other members of multidisciplinary team 
 Other 
 
 
3.2.3 Data collection, processing and storage 
Information on patient demographics, stroke characteristics and the time of first 
mobilisation were collected prospectively from patient case notes. The findings 
from the systematic review and predictive modelling presented in Chapter 2 
informed the baseline factors that should be collected. The National Institutes of 
Health Stroke Scale (NIHSS) and modified Rankin Scale (mRS) assessments were 
conducted on the day before the observation or on the day of observation. Other 
baseline factors included level of consciousness; muscle power and gait (all using 
the sub-section of the SSS) were recorded. The treating physiotherapist assessed 
the patient’s functional mobility using the Mobility Scale for Acute Stroke (MSAS) 
on the day before the observation (+/- one day). Patients were followed up using 
the BI at three month and six months by telephone interview. Telephone 
assessment of function with the BI has been shown to be a reliable in comparison 
to a direct face-to-face assessment.129 
Contact information was collected from the patient, nearest relative or case 
notes for the purposes of follow-up. This contact information was kept 
separately from the CRFs and was treated as highly confidential in a locked area 
in an office at all times. On discharge, the patient’s general practitioner was 
advised in writing of the patient’s involvement in the study. The researcher 
contacted the person who provided consent for involvement to the study to 
arrange a convenient time to conduct the three month follow-up telephone 
interview. Patients recruited to the study were provided with a unique 
identification number (ID) which was used when completing the CRFs.  
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Completed observed motor activity CRFs were submitted via fax within one week 
of completion of the day of observation to a specialist centre in Melbourne for 
processing. The CRFs did not contain any patient identifiable information. The 
CRFs were converted and saved as a digital image using TeleformTM software, 
checked visually and uploaded to a database. The data underwent computer 
logic testing with data queries being sent via email by the centre’s 
administrator. The database was transferred electronically on completion of 
patient recruitment. Data from the activPAL™ monitors were downloaded to a 
password secured computer using the software package (activPAL™ Professional 
Research Edition, version 5.8.50). The CRF folder was stored locally in a locked 
cabinet and office. Data from baseline CRFs were inputted into a database on 
the day after monitoring. The CRFs containing the patients contact details were 
held in a separate folder and locked cabinet. Paper based data will be stored 
until June 2016, five years from study completion. 
3.2.4 Ethics and management approval 
The study was granted ethical approval from Scotland A Research Ethics 
Committee on 22nd July, 2010 and subsequent requests for management approval 
were granted by NHS Greater Glasgow and Clyde Research and Development on 
6th September, 2010 and NHS Lanarkshire Research and Development on 1st   
October, 2010. To allow access to the study sites honorary contracts with each 
of the health boards were applied for and granted on 1st October, 2010 and 29th 
November, 2010. An audit of this study was conducted by the sponsor, NHS 
Greater Glasgow and Clyde Research and Development, on 4th January, 2012.  
3.3 Statistical analysis 
3.3.1 Sample size 
The sample size calculation was based on a previous study which estimated time 
spent upright as measured by an AC as 8.3% (SD 8.5).112 The recruitment of 60 
patients was considered feasible and representative. The literature estimates 
(mean and standard deviation [SD]) showed that this sample size would provide 
an acceptable level of precision (95% confidence interval [CI], 6.1 to 10.5). The 
sample size was inflated by 10% to account for patient drop out or technology 
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failure resulting in loss of data. Therefore, the study aimed to recruit 66 
patients, a sample size considered clinically representative and feasible in 
relation to the study’s recruitment timeframe. Confidence intervals were 
calculated using CI Analysis software. 
3.3.2 Data management  
For the AC data the software package activPAL™ Professional Research Edition 
was used initially, to provide chart summaries of total time spent in sitting/lying 
(defined as sedentary behaviour), standing and walking (together defined as 
upright activity) for each patient. The charts were cross-checked with the BMT 
data to identify any periods that were known to be out of character for that 
patient (large amounts of stepping activity) or ward practices (such as high 
dependency patients having brief upright activity in the first hour of 
monitoring). As part of the activPAL™ Professional Research Edition package an 
Excel file was downloaded which provided summaries of total time spent in each 
activity classification for each hour as well as providing the time spent in 
sit/lying, standing and stepping every 15 seconds. For a more in-depth analysis 
the activPAL™ files generated by the activPAL™ Professional Research Edition 
software were imported into the Health and Social Care (HSC) PAL analysis 
software which has been developed by Professor Malcolm Granat’s research 
team at the School of Health and Social Care, Glasgow Caledonian University. 
This software provides more detailed data and allows time periods to be 
selected for individual patients. Individual patient activity data were extracted 
for the monitoring time excluding time points when it was known that the 
monitor had been removed (for the purpose of showering or MRI) or momentarily 
detached from the patient’s thigh. The more detailed data includes the number 
of upright, standing, walking, transitions and stepping events (Appendix 9 for 
full definitions). The BMT data were provided by the processing centre in an 
Excel spreadsheet. The data were manipulated in Excel to reformat prior to 
being transferred into the statistical software package for cleaning and analysis. 
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3.3.3 Data analysis  
Activity data (AC) 
The primary outcome was the proportion of time spent upright as measured by 
the AC. For each patient the amount of time spent upright as a proportion of the 
total recording time was calculated. The total upright time for each patient for 
each hour of the monitoring period was calculated with the group data for each 
hour reported as the median time. Additionally, the total upright time (sum of 
standing and stepping time) and total sedentary time was calculated for every 
hour of the monitoring period. Time did not have a normal distribution, 
therefore group data for each hour were summarised as medians with the 25th 
and 75th percentiles (interquartile range [IQR]) reported. The HSC PAL software 
provides the time at which a change in output category (i.e. a transition from 
sitting to standing) occurs and also the duration of each event (defined as 
continuous periods of one activity). This information was used to investigate the 
accumulation of events throughout the day. Each event was classified into one 
of the following time intervals which have been used previously (≤ 5 minutes, > 5 
to ≤ 10 minutes, > 10 to  ≤ 30 minutes, >30 to ≤ 60 minutes, > 60 minutes).130 
The amount of time spent in each of the time intervals as a proportion of total 
time spent upright/sedentary was calculated.  
This required decisions to be made regarding the appropriate extraction of data. 
In particular, whether or not to include events that crossed imposed start and 
end times. The HSC software is programmed to include the first event that 
crossed the start time so this may mean crediting a patient with a five minute 
duration event, when in fact it was 125 minutes long. Some researchers enforce 
rules (personal communication, 2011) that if the proportion of the overlapping 
event is more than 50% out with the monitoring time then it should be excluded. 
Whether or not to apply such a rule to these data was assessed by investigating 
the output for individual patients. Considering this potential underestimation it 
was decided that these events should be included. An example of an AC output 
is provided in Appendix 10. The same consideration was given to events that 
overlapped times when the monitor was removed or reattached. Again, using 
this case by case assessment approach the end of the event (monitor off) usually 
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inferred the beginning of a new event such as a transition from sedentary to 
upright in preparation for washing or a MRI scan, therefore events that 
overlapped were included. Subgroup analysis using categories of stroke severity 
measured on the day of observation (mild stroke: NIHSS ≤ 7; moderate and 
severe stroke: NIHSS ≥ 8) was conducted to investigate the association between 
severity and the activity outcome measures.  The number of patients with 
severe stroke (NIHSS >16) was too low (n = 5) to justify separate analysis. The 
NIHSS score that was extracted from medical notes on admission was used where 
the NIHSS had not been assessed on the day of monitoring.  
Other activity-related data (BMT) 
The activPALTM does not detect between lying and sitting so the BMT data were 
used to provide information of these types of sedentary behaviour. For example, 
a patient shown to have been consistently sedentary all day may have actually 
been hoisted from bed to chair. The activPALTM would have missed this 
important information. For the BMT data, the total number of observations for 
each type of motor activity was calculated. As more than one activity may have 
been observed in one observation period the highest level of activity obtained in 
each of the observations was used.  The motor activity categories were 
classified, again, into upright activity or sedentary behaviour. Sedentary 
behaviour was further classified as in-bed or out-of-bed (Table 3-2). 
 
Table 3-2 Classifications of motor activity categories from BMT 
Motor activity Type of behaviour 
No active motor (supine or side-lying) Sedentary (in-bed) Sit support in bed 
Sit support out of bed 
Sedentary (out-of-bed) Hoist transfer 
Sit no support 
Transfer feet on floor 
Upright activity Stand Walk 
Stairs 
 
To investigate relationships between upright activity and person present or 
location data from the BMT and AC were synchronised and combined. Firstly, to 
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summarise the person present data, the groups were collapsed into eight 
categories (Table 3-3) and the total number of observations was calculated for 
each person present and location categories. 
Table 3-3 Classifications of person present categories from BMT 
Original ‘person present’ category New ‘person present’ category 
Alone Alone 
Medic Medic 
Nurse 1 
Nurse Nurse 2 Nursing assistant 1 
Nursing assistant 2 
Physiotherapist Therapist Occupational therapist 
Speech and language therapist Speech and language therapist 
Family Family 
Patient transport Patient transport 
Interpreter 
Other∗ Other MD team 
Other 
∗ The ‘other’ category included ‘other MDT staff’ (pharmacists and dieticians), other hospital 
staff (phlebotomists, smoking cessation representatives, cleaning or catering staff) other 
patients or talking on mobile phone. 
 
Secondly, appropriate summary estimates for each time point were calculated. 
The amount of time spent upright as a proportion of the total recording time in 
each 10 minute time interval (i.e. 08:00 to 08:10) was calculated for each 
patient. This was summarised as the mean proportion of time spent upright. For 
each 10 minute time interval (08:00, 08:10 etc) the total number of nurses and 
therapists present as a proportion of the total number of observations was 
calculated. Likewise, the total number of patients observed in each location 
category as a proportion of the total number of observations was calculated. 
This required the assumption that the person present and location remained the 
same for each 10 minute interval.  
Different methods to monitor activity 
In order to assess the agreement between AC and BMT two comparable units of 
measurement were identified and calculated for each method. For the AC data 
the time spent upright in seconds as a proportion of the total monitoring time 
for each one minute time interval i.e. 08:00 to 08:01, 08:10 to 08:11 was 
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calculated. This was summarised as the mean proportion of time spent upright 
for each time interval and enabled the AC data to be time-matched with the 
BMT data. For the BMT data the number of times upright as a proportion of the 
total number of observations i.e. 08:00 to 08:01, 08:10 to 08:11 was calculated. 
These proportions were plotted against each other. Linear regression analysis 
was used to quantify the extent researcher observation can be predicted by 
accelerometry. 
Predictors of upright physical activity levels  
Multivariate linear regression was used to assess which baseline characteristics 
were significantly (p ≤ 0.05) predictive of upright physical activity. A logarithmic 
transformation was applied to the dependent variable, time spent upright. The 
variables that were entered into the regression model were as follows: stroke 
severity (NIHSS baseline), mobility (MSAS score), time in hours from stroke 
onset, previous stroke and family present (total number of times family were 
present as a proportion of the total number of observations for each patient).46  
Upright physical activity as a predictor of functional outcome 
Univariate analysis was undertaken to examine the association between 
potentially predictive baseline characteristics and functional outcome at three 
and six months. The factors identified as predictive of mobility at 30 days (refer 
to Chapter 2) were used here. These were as follows: age, stroke type (OCSP 
classification, coded as TACS = 1, no TACS = 0), living alone (coded as alone = 1, 
not alone = 0), level of disability (mRS ≥ 3 coded as high disability = 1, mRS < 2 
coded as 0), level of function (BI < 17, coded as dependent = 1, BI ≥ 18 coded as 
0) and stroke severity  (NIHSS ≤ 7, coded as mild stroke = 0,  NIHSS ≥ 8 coded as 
moderate and severe stroke).  Patient scores from the BI were dichotomised to 
create a binary outcome (BI ≥ 18 coded as independent = 1 or not independent = 
BI < 17). The variables that were statistically significant (p < 0.1) on univariate 
analysis were included in the multivariate model.72 Logistic regression was 
employed, using backward stepwise regression to drop the least significant 
variables (p < 0.1), to identify the variables which best predict function.  
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3.4 Results 
3.4.1 Stroke unit and patient characteristics  
The number of beds in the ASUs at each of the hospitals was 14 (hospital A), 18 
(hospital B) and 19 (hospital C) and the average length of stay based on local 
audits ranged from between seven to 14 days. Due to the re-design of stroke 
services in the local area, the stroke unit at hospital B expanded from one ward 
to two wards with a total of 37 beds. Staffing levels were in adherence with 
SIGN guidelines.2 Two hospitals delivered thrombolysis with each of the hospitals 
having a dedicated area and one additional bed prioritised for thrombolysed 
patients. The layout of the wards varied with a mixture of single rooms, four-
bedded rooms and open bays. Hospital A had five single rooms, hospital B had 
two and hospital C had three. Therapy rooms were present on the ward for two 
of the hospitals while for the hospital C it was off-ward but in close proximity to 
the stroke unit. There was a patient lounge, containing a television and chairs in 
one hospital and a dedicated relative’s room in another.  
Sixty-six patients were recruited between October 2010 and June 2011. Twenty- 
nine patients were recruited from hospital A, 26 from hospital B and 11 from 
hospital C. Consent was withdrawn by the relatives of one patient on the day of 
monitoring as the patient experienced neurological deterioration. Eight patients 
were discharged or transferred on the day of monitoring having completed 
between 37.8% and 90.7% of the total monitoring time. The data from these 
patients were included in the analysis. Discharge from physiotherapy and 
mobility function were factors considered to be associated both with hospital 
discharge and activity levels. When investigated no significant differences were 
detected for the factors (discharge from physiotherapy and mobility function) 
between the patients that had been discharged and those that had not been 
discharged (p = 0.72 and p = 0.42, respectively). Overall, five patients died, two 
patients were non contactable for at least one of the follow-up phone calls and 
one patient was lost at follow-up and therefore had no outcome data (Figure 3-
1).  
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Figure 3-1 Study recruitment flowchart 
1 drop out
Patient recruited                                
(n=66)
Followed up at 3 months                        
(n=63)                                                                     
Full Protocol                         
(n=65)                          
AC                      
(n=63)
BMT                  
(n=65)
3 died                                 
1 lost to follow up                    
* Patient later followed up at 6 months
3 technical failures      
Analysed (n=61) 
Follow up at 6 months                           
(n=63)                                        
2 died                             
2 lost to follow up*
 
3.4.2 Patient demographics 
The demographics of the 66 patients recruited from the three hospitals are 
shown in Table 3-4. The mean age of patients was 73.2 years (SD 9.8) and 
proportions of males and females were similar. The majority of patients were 
previously independent (56.1%), with 19.7% of patients having a history of atrial 
fibrillation and about 15% of patients having had a previous stroke. The median 
NIHSS score on admission was 5 (IQR 3 to 10) which reduced to 3 (IQR 2 to 5) on 
the day of observation. The median time from stroke onset to the day of 
observation was 5.5 days (IQR 4 to 9). The median NIHSS score of the 12 patients 
that received thrombolysis was 15 (IQR 6.5 to 19.0) on admission and 5 (IQR 3 to 
17) on the day of monitoring. Five patients had a haemorrhage. Two patients 
who had a clinical diagnosis of stroke at the time of recruitment were later 
confirmed negative for stroke. These patients remained in the analysis. At 
follow-up a further patient had subsequently been diagnosed with Guillain-Barre 
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syndrome, opposing the initial stroke diagnosis. The patient was being treated as 
per stroke protocol and under the care of the stroke unit during the day of 
observation so was included in the analysis.  
All patients had been either mobilised up to sit out of bed or stand/walk prior to 
monitoring. The first time to mobilisation was extracted from case notes for 21 
patients. This was not available for the remainder of patients. The median time 
from stroke onset to first mobilisation in these patients was 37.5 hours (IQR 26.5 
to 50.0) and the time from hospital admission to first mobilisation was 26.0 
hours (IQR 19.5 to 40.3). The first mobilisation was provided by two 
physiotherapists in the majority of occasions (51.5%) and one physiotherapist 
(36.4%), two nurses (10.6%) or one nurse (1.5%) for the remainder. Over a 
quarter of patients were independently mobile of which 75% were able to walk 
greater than five metres. Just over 10% of patients not able to mobilise 
independently were classified as ‘bedridden/wheelchair’ bound by the gait sub-
section of the SSS. Two patients with stroke also had dementia and three 
patients were considered to be agitated (stroke cause). 
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Table 3-4 Baseline demographics and clinical factors 
Factor All patients 
(n=66) 
Age (mean, SD) 73.2 (9.8) 
Female 28(42.2%) 
Living alone  25 (37.8%) 
Previous stroke  9(13.6%) 
Pre-morbid disability (mRS)  
  0 - No symptoms at all 48 (72.7%) 
  1 - No significant disability 13(19.7%) 
  2 - Slight disability 3(4.6%) 
  3 - Moderate disability 2(3.0%) 
Stroke risk factors  
  history of atrial fibrillation 13 (19.7%) 
Stroke severity (NIHSS)   
 on admission (median, IQR) 5 (3-10) 
  mild category 45(68.2%) 
  moderate/severe category 21(31.8%) 
Day of monitoring (median, IQR)∗ 3 (2-5) 
  mild category 52(78.8%) 
  moderate/severe category 14(21.2%) 
Stroke type (OCSP)  
  LACS 19(28.8%) 
  PACS 17(25.8%) 
  POCS 11(16.7%) 
  TACS 12(18.2%) 
  Haemorrhage 5(7.6%) 
  Uncertain 2(3.0%) 
Thrombolysis administered 12 (18.2%) 
Level of disability (mRS)  
  0 - No symptoms at all 2(3.0%) 
  1 - No significant disability 3(4.6%) 
  2 - Slight disability 12(18.2%) 
  3 - Moderate disability 19(28.8%) 
  4 - Moderate to severe disability 24(36.4%) 
  5 - Severe disability 6(9.1%) 
Conscious (SSS) 66(100.0%) 
Normal leg strength(SSS) 25(37.9%) 
Function (BI) (median, IQR) 60(30-85) 
Mobility function (MSAS) 27(19-29) 
Independently mobile (mRS) 17(25.8%) 
Days from stroke onset to day of monitoring (median, IQR) 5.5 (4-9) 
Entries are numbers (percentages), unless stated otherwise. 
∗Based on 53 patients 
mRS: Modified Rankin Scale; NIHSS: National Institute Health Stroke Scale; OCSP: Oxford 
Community Stroke Project Classification; LACS: Lacunar Circulation Syndrome; PACS: 
Partial Anterior Circulation Syndrome; POCS: Posterior Circulation Syndrome; TACS: Total 
Anterior Circulation Syndrome: SSS; Scandinavian Stroke Scale: BI; Barthel Index: MSAS; 
Mobility Scale for Acute Stroke 
 
Details of accelerometer data 
The total amount of excluded data was 5.1%. Eight patients were discharged or 
transferred on the day of monitoring which resulted in 30.4% missing data of the 
total possible recording time (72 hours). For the remaining 57 patients 513 hours 
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of monitoring was accumulated. Technical failure was the reason for excluding 
the majority of data from these 57 patients. Technical failures included a 
battery light turning on resulting in the monitor being removed and replaced by 
another, an electronic component failure and the monitor being fixed on upside 
down by staff member. This resulted in 18.7 hrs (73.3% of total missing) of data 
being excluded. As a result of technical failure two patients had no activity 
data, therefore including the patient that withdrew three patients in total had 
no AC data (Figure 3-6). In comparison, the proportion of data missing because 
the device had been taken off for showering, attending a MRI or due to 
inadvertent detachment was much lower (Table 3-5). The monitor detached 
briefly in one ‘agitated’ patient and one patient with dementia required an 
additional explanation before re-attaching after a shower. One patient asked for 
the monitor to be removed 54 minutes prior to the monitoring end time which 
was done.  
 
Table 3-5 Reasons for excluded accelerometer data  
Reason for excluded data No of events∗  Total time(hrs) 
Monitor accidently detached 3 0.4   (1.5%) 
Monitor deliberately removed∗∗ 12 7.4 (27.8%) 
Technical failure 4 18.7 (70.8%) 
Total excluded time 19 26.5   (5.1%) 
Total possible recording time  517 
∗    Based on 18 patients 
∗∗  For purposes of MRI/showering/patient preference 
 
Details of behavioural mapping data  
The potential number of BMT observations was 3,479 less 249 (7.0%) when the 
observer had a break. Twenty-five observations (0.8%) did not have information 
collected for any of the BMT items. Reasons for this missing information were 
that the patient was off ward for medical tests or the patient was not 
observable i.e. they were behind closed curtains, in therapy rooms or in the 
bathroom and the information was not obtained retrospectively. The majority of 
observations were conducted at hospitals A and B (Table 3-6).  
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Table 3-6 Researcher observations conducted by hospital site 
 
3.4.3 Activity outcomes  
Both the AC and BMT data were used in this section. Activity recorded using BMT 
is described in percentages of the observed nine hour day. Activity recorded 
with AC is described in minutes, events, steps or transitions over the same nine 
hour day. Patients spent a mean proportion of 8.2% (95% CI, 6.2 to 10.1) time in 
upright activity with an average standing time of 6.8% (95% CI, 5.2 to 8.5) and an 
average walking time of 1.3% (95% CI, 0.9 to 1.7). The proportion of time spent 
sedentary was 91.8% (95% CI, 89.9 to 93.8). The median time (minutes) spent 
upright was 31.91 minutes (IQR 11.20 to 59.85) and the median time spent 
sedentary was 491.41 minutes (IQR 436.68 to 526.55) over a nine hour day. 
There was variation between patients in the amount of time spent upright, three 
patients (one patient remained in bed, two patients were transferred up-to-sit) 
spent zero time upright, while one patient spent 34.3% of the time upright.  
Table 3-7 provides the time spent in each of these activities as well as the 
number of upright and sedentary events.  
 
Table 3-7 Summary of activity measure (AC data)  
Activity measure  
(time, minutes) 
Median (n=63) IQR 
Upright time 31.91 11.20-59.85 
Standing time  25.89 10.90-46.0 
Walking time  2.96 0.22-10.32 
Sedentary time 491.41  436.68-526.55 
Number standing events 32.00 8.0-70.0 
Number of walking events 17.00  1.0-49.0 
Number of sedentary events  12.00  7.0-25.0 
Number of transitions 24.00 14.0-51.0 
Number of steps 140.00  8.0-684.0 
Hospital ID  Number of patients Number of  
observations 
Not observed∗ 
A 29 1274 (42.6%) 189 (38.7%) 
B 26 1178 (39.4%) 234 (47.9%) 
C 11 538 (18.0%) 66 (13.5%) 
    
 Total 2990 (100%) 489 ( 100%) 
∗ Patient not observed or researcher on break  
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The pattern of time spent upright during the observational period is shown in 
Figure 3-2.  Median time spent upright was at its highest at 09:00 and 12:00 
(2.30 minutes [IQR 0 to 14.30] and 2.80 minutes [IQR 0 to 6.30], respectively) 
and lowest at 15:00 and 16:00 (0.2 minutes [IQR 0 to 5.6 and 0 to 4.5 minutes, 
respectively]).  The pattern of time spent sedentary shows the inverse pattern 
to upright activity with sedentary behaviour reduced at 09:00, 12:00 and 14:00. 
The largest amount of variation in time spent upright and in sedentary behaviour 
between patients occurred at 09:00 with time spent upright ranging from 
between zero minutes to 34.0 minutes upright. The pattern of upright activity 
and sedentary behaviour reflects the typical day of a patient in stroke unit care. 
At 09:00 patients are getting up out of bed and engaging in washing and 
dressing, at 10:00 to 11:00 they are sitting out of bed in a chair, at 12:00 moving 
about in preparation for lunch and at 13:00 return to bed after lunch. The peak 
at 14:00 reflects therapy time or patients getting back up to sit in preparation of 
family visiting (ranging from 14:30 to 16:00). The median time to the first 
upright event from 08:00 was 45.56 minutes (IQR 5.63 to 142.08). 
 
Figure 3-2 Median time spent upright by hour of day (AC data) 
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The BMT data revealed that the majority of time spent sedentary can be 
explained by patients sitting out-of-bed as opposed to in-bed (70.7% versus 
29.3%) Approximately the same amount of time was spent lying in bed as sitting 
in-bed (15.2% versus 14.1%). At most hours of the day, the majority of 
observations are of patients up sitting in a chair indicating that patients are 
spending prolonged periods in sitting. The level of out-of-bed behaviour was 
highest at 12:00 which was then reduced by 13:00, explained by patients 
returning to bed early in the afternoon (Figure 3-3). 
 
Figure 3-3 Pattern of sedentary behaviour by hour of day (BMT data) 
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When investigating how upright activity and sedentary behaviour were 
accumulated the greatest proportion (51.4%) of time spent upright was spent in 
epochs less than 5 minutes. The time spent upright in each epoch is as follows:  
> 5 to ≤10 minutes; 27.2%, > 10 to ≤ 30 minutes; 17.0%, > 30 to ≤ 60 minutes; 
4.3%. No upright time was accumulated in epochs of > 60 minutes. A reverse 
pattern was observed for sedentary events whereby the majority (58.7%) of 
Chapter 3 80 
sedentary time was accumulated by prolonged episodes of greater than 60 
minutes. The time spent sedentary in each epoch is as follows:  ≤ 5 minutes; 
3.3%, > 5 to ≤ 10 minutes; 4.6%, > 10 to ≤ 30 minutes; 14.4%, > 30 to ≤ 60 
minutes; 19.0% (Figure 3-4).  The majority of total sedentary time was 
accumulated by prolonged episodes of > 60 minutes sedentary behaviour. The U-
shaped pattern of accumulating upright and sedentary behaviour can be 
explained by the increasing amounts of time spent upright as the length of each 
time category increased.  
 
Figure 3-4 Total time upright and sedentary by length of event (AC data) 
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3.4.4 Activity outcomes by severity 
Both the BMT data and the AC data were used in this section. There were 52 
patients in the mild stroke group and 13 in the moderate/severe stroke group 
(excludes the patient that dropped out). The mean proportion of time spent 
upright over the day for patients with mild stroke was 9.8% compared to 2.1% for 
patients with moderate/severe stroke. The proportion of time spent standing 
was higher than walking for both mild and moderate/severe groups (8.2% versus 
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1.6% compared to 1.9% versus 0.2%). Patients with mild stroke spent 43.49 
minutes upright (IQR 13.24 to 76.83) and patients with moderate/severe stroke 
spent 9.50 minutes upright (IQR 1.76 to 15.59). Patients with mild stroke spent 
464.77 minutes sedentary (IQR 436.65 to 507.15) and patients with 
moderate/severe stroke spent 528.36 minutes sedentary (IQR 514.58 to 537.55).  
The median time spent upright for each hour by stroke severity is shown in 
Figure 3-5. Once again, upright activity was much lower in the moderate/severe 
stroke patients. Not only did the amount of time differ, pattern of activity also 
differed between groups. The pattern of upright activity differed between the 
two severity groups. The median time spent upright peaked in the morning for 
both groups, earlier for patients with mild stroke. Patients with mild stroke had 
a reduction in upright time from 14:00 while at the same time, peaked from 
patients with moderate/severe stroke. This was likely to be associated with 
patients being mobilised during therapy, returning to bed or getting up to sit for 
visiting.  Minimal upright activity occurred between 11:00 and 13:00 for 
moderate/severe patients and was lowest at 15:00 for patients with mild stroke 
(median 0.9 minutes [IQR 0.0 to 6.95]). Patients with moderate/severe stroke 
took longer to commence upright activity than patients with mild stroke. The 
median time to the first upright event from 08:00 was 35.22 minutes (IQR 3.75 
to 85.25) for patients with mild stroke and 149.39 minutes (IQR 98.67 to 177.57) 
for patients with moderate/severe stroke. 
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Figure 3-5  Median time spent upright over time by stroke severity (AC data) 
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Mild stroke = NIHSS ≤ 7, Moderate/severe stroke = NIHSS ≥ 8. The number of patients in the mild 
stroke category is 50 as AC data was not available for two patients with mild stroke. 
 
Patient in both severity groups spent similar amounts of sedentary time in-bed 
(12.0% and 13.5%, respectively) and the highest proportion of time out-of-bed 
sitting (58.6% and 53.0% respectively) (Figure 3-6).   
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Figure 3-6 Type of sedentary behaviour by stroke severity (BMT data)  
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For both groups most upright activity was accumulated in epochs of ≤ 5 minutes 
(mild = 51.1%, moderate/severe = 54.5%) (Figure 3-7). There were differences in 
how sedentary behaviour was distributed between the groups. For patients with 
moderate/severe stroke a higher proportion of sedentary behaviour was 
accumulated in epochs of > 60 minutes (92.5%) compared to patients with mild 
stroke (49.0%).   
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Figure 3-7 Time upright/sedentary by length of event and severity (AC data) 
 
3.4.5 Person present with patient 
Only the BMT data were used in this section. The patients were observed alone 
for the majority of time (60.1%). The professional group most frequently 
observed with the patient was nurses (9.5%) followed by physiotherapists (4.1%), 
occupational therapists (3.0%) and doctors (1.3%). Family were present 9.5% of 
the time. Patients were with doctors for a maximum of three consecutive 
observations, nurses a maximum of four observations, physiotherapists a 
maximum of six and occupational therapists a maximum of five consecutive 
observations. Table 3-8 shows data from observations with two or fewer people 
present. Most uni-disciplinary (two staff members from same professional 
discipline) interaction occurred between nurses and most multi-disciplinary 
interaction (two staff members from different professional disciplines) occurred 
between physiotherapists and occupational therapists. Nurses were observed 
most frequently with family members. 
For each hour the proportion of therapists and nursing staff present does not 
exceed 25%. The number of therapists did tend to vary across the day, more so 
than for nurses. The presence of therapists was highest at 11:20 (21.4% of 56 
Chapter 3 85 
observations) and, in the afternoon, at 14:00 and 14:10 (18.2% of 55 
observations). The presence of nursing staff was highest at 08:50 (19.3% of 57 
observations) and, in the afternoon at 12:40 (13.2%). The presence of therapists 
increases while that of the nurse decreases (Figure 3-8). Family were present 
between 14:30 and 16:00 which reflected visiting time.  
 
Figure 3-8 Scatter plot of person present by hour of day (BMT data) 
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Blue circles represent the proportion of total observations that a nurse was present in each 10 
minute epoch. Red squares represent the proportion of observations that a therapist was present in 
each 10 minute epoch. Green triangles represent the proportion of observations that family was 
present in each 10 minute epoch.  
  Table 3-8 Person type present with the patient (BMT data) 
 
 Person 2 type 
Person 1 type Doctor Nurse PT OT ST Family Porter Other Alone  Total (%) 
            
Doctor 6 5 0  0 0  0  0 0  28   45(1.3) 
Nurse  44  8 1  0  13 0  1  213   329(9.5) 
Physiotherapist (PT)   18  16  2  1  0  2 77   142(4.1) 
Occupational therapist (OT)    2  0  2  0  2  81   106(3.0) 
Speech & language therapist (ST)     1  5 0  0  31   40(1.1) 
Family       0  2  282   305(8.8) 
Porter        1  14   15(0.4) 
Other         118   126(3.6) 
Patient alone           2092(60.1) 
To be read across.  
Row numbers refer to the number of times the person 1-person 2 combination occurred not the total number of staff present.  
Column ‘total’ is the sum of the row (multiply by 2 where person1=person2) added to the column numbers i.e. total for nurses  = (44 x 2) + 8 + 1 + 13 + 1 + 213 + 5 
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3.4.6 Patient location  
Only the BMT data were used in this section. Patients were observed in the 
bedroom nearly 90% of the time. The proportion of total observations spent in 
the bedroom, therapy room, bathroom and hall were 89.9%, 2.5%, 2.1% and1.7% 
respectively. The time spent by patients off ward for medical tests was 3.7%. 
Patients were in the therapy room for between one (approximately 10 minutes) 
to five consecutive observations (approximately 50 minutes) and off the ward for 
between two (approximately 20 minutes) to 15 consecutive observations at any 
one time (approximately2.5 hours). Patients were most frequently observed in 
the bathroom between 08:00 and 09:50, reflected by the drop in patients 
observed in the bedroom at this time (Figure 3-9). Time spent in the hall showed 
little variation throughout the day. Most patients were observed in the therapy 
room at three points in the day; 09:50, 11:30 and 13:40. Most patients were off 
the ward at 11:40 and 15:20.  
Figure 3-9 Scatter plots of patient location by time of day (BMT data) 
 
The blue circles represent the proportion of observations the patient spent in that location 
measured by the BMT for each 10 minute epoch.  
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3.4.7 Upright activity, person present and location  
The BMT data and the AC data were used in this section. The proportion of 
observations in which a nurse was present was more consistent than that of 
therapists throughout the day. Nurses are usually stationary on the ward while 
therapists tend to visit the ward to provide therapy and have periods when they 
are off the ward such as at lunch time and towards the end of the day (Figure 3-
10 to Figure 3-12). Therapist presence is negligible before 08:50 and after 16:00. 
There are two peaks that reflect the provision of therapy, one in the morning 
and one in the afternoon correspond to a morning and afternoon treatment 
session. The highest proportion of nurses corresponded with a higher proportion 
of time spent upright, particularly between 08:00 to 09:30 during showering. 
The presence of therapists appears to be positively correlated with upright 
activity. At 09:40 the presence of therapists rises to 18.2% with patients 
spending 17.2% time upright and at 14:00 with therapists present 18.8% of the 
time and patients spending 13.6% time upright. Family tended to be present 
during visiting hours only and the reduction in time spent upright during 15:00 to 
16:00 indicates that family do not seem to influence the upright activity of the 
patient.  
Figure 3-10 Upright activity and nurses present (AC and BMT data)  
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Figure 3-11 Upright activity and therapists present (AC and BMT data) 
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Figure 3-12 Upright activity and therapists present (AC and BMT data)  
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Figure 3 -10 to Figure 3 -12: Blue circles represent mean proportion of time spent upright 
measured by AC for each 10 minute epoch. Red circles represent the proportion of observations 
that a nurse was present for each 10 minute epoch as measured by the BMT. Green circles 
represent the proportion of observations that a therapist was present for each 10 minute epoch as 
measured by the BMT. Purple circles represent the proportion of observations that family was 
present for each 10 minute epoch as measured by the BMT.
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As AC data does not provide information on the location of the patient during 
upright activity therefore the data from the two approaches were merged to 
quantify the amount of upright activity by location. The bathroom was the 
location with where most time was spent upright (34.1%) with similar levels of 
upright activity in the hall (32.7%) and the therapy area (32.3%). The least time 
spent upright was spent in the bedroom (6.5%) and during the time patients 
were observed to be off ward, predominately for tests (5.7%) (Figure 3-13). 
 
Figure 3-13  Time spent upright by location (AC and BMT data) 
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3.4.8 Predicting upright activity using accelerometry 
Linear regression showed that the method of AC was able to significantly predict 
upright activity as measured by the BMT (coefficient 0.86, 95% CI, 0.62 to 1.10); 
p < 0.01 R2 = 0.6). On visual inspection, accelerometry and the BMT showed 
similar measurements of upright activity throughout the monitoring period 
(Figure 3-14). However, there were times that the BMT measured a higher level 
of upright activity than the AC particularly at 08:40, between 10:30 and 11:10 
and between 13:00 and 14:00. These times were often points when the patient 
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was not observable such as in the bathroom or during therapy. This time spent 
upright may be a result of the BMT recordings being based on recall.   
 
Figure 3-14  Agreement of upright activity between AC and BMT 
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Upright as measured by the AC is the time spent upright in seconds as a proportion of the total 
monitoring time for each 60 second time interval i.e. 08:00:00-08:01:00, 08:10:00-08:11:00. Upright 
as measured by the BMT is the number of times upright as a proportion of the total number of 
observations at each BMT observation i.e. 08:00-08:01, 08:10-08:11.  
 
3.4.9 Predictors of upright activity  
Linear regression was used to identify which of the pre-specified patient and 
stroke characteristics were predictive of time spent upright. The variables 
predictive of activity included the NIHSS stroke severity score and the MSAS 
walking score. A reduction in activity is significantly associated with an increase 
in NIHSS score (higher severity).An increase in activity is significantly associated 
with an increase in MSAS score (higher function). A one point increase in NIHSS 
score resulted in 0.2% reduction in upright physical activity while an increase of 
one point of the MSAS score resulted in 0.1% increase in activity (Table 3-9). 
Chapter 3 
 
92 
Table 3-9 Predictive factors of time spent upright 
 Multivariate analysis 
 Coefficient p-value 95% CI 
Age (years) 0.00 0.94   0.03,   0.04 
Stroke severity (NIHSS score) -0.15 0.00      -0.22,  -0.09 
Mobility (MSAS score) 0.06 0.02 0.01,   0.12 
Time from stroke (days)  -0.09 0.10 -0.19,   0.02 
Family present -0.00 1.00 -0.05,   0.04 
Previous stroke 0.02 0.86 -1.06,   1.11 
 
3.4.10 Upright activity as a predictor of functional outcome 
The number of patients independent in ADL at three months was 27 (42.9%) and 
at six months was 30 (47.6%). Logistic regression was used to assess the 
independent effect of upright activity on independent function at three and six 
months. Baseline level of disability (mRS) was the only factor significantly 
associated with independence at both three and six months and was, therefore, 
included in the two final multivariate models (Tables 3-10 and 3-11). Stroke type 
was significantly associated with independence at six months on univariate 
analysis so was also included in the model for function at 6 months.  Upright 
activity did not have an independent association with independence at three 
months (OR 1.02, 95% CI 0.94 to 1.09) or six months (OR 1.02, 95% CI 0.95 to 
1.10). 
 
  
Table 3-10 Logistic regression models for function at 3 months 
 Univariate analysis Multivariate analysis 
 Coefficient p-value 95% CI Coefficient p-value 95% CI 
% upright activity  0.04 0.21 -0.02,   0.11 0.02 0.66 -0.10, 0.09 
Age  -0.03 0.22 -0.08,   0.02    
Stroke type (TACS) -0.36 0.84 -1.52,   1.24    
Living alone  -0.36 0.50 -1.40,   0.68    
Disability (high)∗ -1.45 0.02 -2.67,   0.23 -1.38 0.04 -2.68, -0.08 
Function (low) -0.90 0.14 -2.10,   0.29    
Severity (moderate/severe) 0.13   0.82 -0.94,   1.20    
∗ Entered into multivariate model 
TACS: Total Anterior Circulation Syndrome 
Disability (high) is defined as mRS score >3 
Function (low) is defined as BI score <18 
Severity (moderate/severe) as defined by NIHSS score ≥8 
Table 3-11 Logistic regression models for function at 6 months 
 Univariate analysis Multivariate analysis 
 Coefficient p-value 95% CI Coefficient p-value 95% CI 
% upright activity  0.05 0.19 -0.02,   0.11 0.02 0.55 -0.05, 0.10 
Age  -0.03 0.28 -0.08,   0.02    
Stroke type (TACS)  -0.40 0.60 -1.74,   1.01    
Living alone  -0.51 0.33 -1.53,   0.51    
Disability (high)∗ -1.32 0.03 -2.52,  -0.12 -1.21 0.06 -2.50, 0.06 
Function (low) -0.88 0.14 -2.10,   0.30    
Severity (moderate/severe) -0.01 0.98 -1.09,   1.06    
∗ Entered into multivariate model 
TACS: Total Anterior Circulation Syndrome 
Disability (high) is defined as mRS score >3 
Function (low) is defined as BI score <18 
Severity (moderate/severe) is defined as NIHSS score ≥8 
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3.5 Discussion  
Key findings: levels of physical activity  
A precise estimate of the time spent upright (standing or walking) was found to 
be 8.2% over a nine hour day. This was based on a sample of acute stroke 
patients from three Scottish hospitals. A study conducted by Lincoln et al (1996) 
16 years ago using a BMT estimated time spent standing as 2.3% over an eight 
hour day, nearly a third lower than that estimated in this research.105 Changes in 
practice over time and differences in study populations may explain this 
difference; the inclusion criteria used by Lincoln et al (1996) was more stringent 
excluding patients based on previous disability and those that required 
assistance of more than two nurses. A recent systematic review which pooled 
the findings from 15 studies that used a BMT reported that the median 
proportion of time spent inactive by patients was 48.1%.128 The median 
proportion of time spent in moderate to high physical activity was 21.0%. The 
data from this study were recategorised according to activity classifications used 
in the review. This comparison revealed that patients in this study spent less 
time inactive (26.0%) and less time in moderate to high (12.9%) physical activity 
than the patients included in the review. Patients spent more time in low 
activity in this study, that is sitting in a chair, than the pooled estimate (53.2% 
versus 27.5%). There was a large amount of variation between the studies 
included in the review in terms of study population, the research setting, 
classification of activities and management of non-observed periods. Intra-
patient variation (hour-to-hour differences within patients) was apparent across 
the day and most likely associated with the routine proceedings of the ward. 
Inter-patient variation (true differences between patients) is likely to explain 
the wide IQRs, especially at times when upright activity increased, presented for 
each hour of monitoring. There were significant differences in the level of 
upright activity between the sites after adjusting for baseline level of severity 
and level of mobility (see Chapter 5 for further discussion). 
The time spent sedentary (sitting or lying) was estimated as 91.8%. Patients 
spent the majority of sitting in a chair at the bedside with time spent sedentary 
accumulated through prolonged periods of time sitting greater than 60 minutes 
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at a time. Nearly all sedentary time for patients with moderate/severe stroke 
was accumulated in this way. A previous study of inpatients from a rehabilitation 
ward (n = 30) showed a similar pattern with regards to how time spent in 
sedentary behaviour was accumulated; the highest proportion of time spent 
sedentary was accumulated in epochs of greater than 60 minutes.130 This study 
was different: the population was not exclusively stroke, patients were not 
monitored in the acute stage and those that required substantial assistance with 
mobility were excluded. Staff working in the ASUs adhered to a local protocol of 
‘up-to-sit’, aiming to get patients mobilised, not only early after stroke, but as 
these results show, up sitting in a chair early on in the day, however, without 
much activity thereafter. The National Institute of Health and Clinical 
Excellence (NICE) Quality Stroke Standard Statement recommends that a 
minimum of 45 minutes of physiotherapy, occupational therapy and speech and 
language therapy is provided daily as required and as tolerated. The amount of 
time spent in therapy was not measured directly in this study. Time in the 
therapy room is not an accurate reflection of actual therapy time as therapy was 
often carried out at the bed side or in the hallway. Therefore, the presence of 
therapy staff could be used as a proxy to time spent in therapy. Other studies 
have shown that time spent in therapy in a rehabilitation centre is about one 
hour in the UK, which is almost half of that of other countries that have been 
studied.108 It has been reported that therapists overestimate the time patients 
spend in therapy;131 therefore time spent other than that in scheduled activities 
such as sitting time may be even harder to recall and may result in staff 
inaccurately measuring the time actually spent in one episode of sitting.   
Key findings: levels of interaction between patients and staff 
Multidisciplinary interaction between professional groups occurred most 
frequently between occupational therapists and physiotherapists and is likely to 
represent the occurrence of joint assessments or co-mobilisation of patients with 
complex mobility requirements. Nurses were the professional group most 
frequently observed with the patient either working with each other and the 
patient (usually two nursing assistants) or working individually with the patient 
in the presence of another nurse i.e. trained nurses prescribing medications at 
the bedside with a nursing assistant present performing a different task with the 
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patient. The BMT does not provide data on the interactions between staff that 
occurred outside that observed in the presence of the patient. The amount of 
times staff were observed with family was surprisingly low considering the value 
that staff working in ASUs place on patient/family education and involvement 
and recognition as one of the most important changes that has occurred in 
stroke care (based on the qualitative findings presented in Chapter 5). Increased 
levels of upright activity were associated with the presence of nurses or therapy 
staff and reduced levels of upright activity were associated with the patient 
being alone or with family.  
Key findings: the methods used to monitor activity 
Accelerometry was able to significantly predict upright activity as measured by 
the BMT. Synchronising the AC and the BMT data sets in relation to time spent 
upright at each observed time-point throughout the day showed a good level of 
agreement between the two methods. It has been speculated that the 
algorithms used in the activPAL™ may not detect stepping in patients without a 
defined heel strike or altered biomechanics, a feature common in an acute 
stroke patient’s gait. Upright activity was the primary outcome in this study so 
the detection of stepping was of less importance. The possibly of this unfounded 
shortcoming of the activPAL™ in explaining the low amount of time spent 
stepping presented in this study could not be ignored. An ad-hoc study to 
explore the sensitivity of the AC in detecting stepping was undertaken. It was 
noted that the type of researcher observation conducted in this study was not 
continuous; therefore no firm conclusions about the interchangeability of these 
two approaches in measuring activity could be drawn or assessed using a formal 
statistical analysis such as a Bland-Altman plots of agreement.132  
Firstly, the exploratory analysis revealed that accelerometry had good 
concurrent validity with MSAS scores (r = 0.6, p < 0.01) and BI scores (r = 0.8, p < 
0.01). The MSAS and BI are measurements of the patient’s mobility/function and 
capability as opposed to activity and reality. Therefore, in order to make more 
of a direct comparison between the two methods, the degree to which each BMT 
observation activity (used here as the criterion measure) was detected correctly 
by AC was investigated using data from patients with uninterrupted recordings 
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for the full monitoring period (n = 41). The BMT data was time-matched with AC 
data for each one minute observation and indicator variables were created to 
indicate the occurrence of sitting, standing and stepping for each of the two sets 
of data. This analysis showed high agreement between BMT and AC with 98.6% 
(i.e. sensitivity = 1673/1696) of observations being correctly classified as 
sitting/lying by the AC. Agreement was slightly lower for standing with 75.0% 
(i.e. sensitivity = 48/64) of observations being correctly classified by the AC. 
Agreement between the BMT and AC for stepping was low with the AC classifying 
only 35.7% (15/42) of observations. Times of disagreement were further 
explored and, in the case of stepping, could be explained by the differences in 
methodology and that this was not designed to be a validity study. Reasons for 
the ACs apparent lack of sensitivity in detecting 27 stepping events was the 
result of stepping recorded when it occurred within 15 seconds of the one 
minute observation and was immediately followed by a transition (i.e. step to 
stand). Also, the stop-watch used for the BMT was not regularly calibrated with 
the computer used to programme the AC.  
The need to investigate stepping, especially those with a slow gait needs to be 
further investigated. A study conducted in 2011 in Norway investigated the 
concurrent validity of activPAL™ against video observations as the criterion 
measure. This study showed the activPAL™ to be highly accurate in classifying 
lying, sitting and standing, however underestimated the step count during 
walking at slow speeds.133 Therefore, a larger validation study using direct 
researcher observation or video analysis to test the accuracy of the activPAL™ 
algorithms for use in the acute stroke population during gait-based activities and 
specifically for those patients with altered gait patterns is required.  
Key findings: factors associated with activity and functional outcome 
Generally, factors associated with decreased physical activity levels in older 
people have included increasing age, gender, obesity, disability, reduced 
education and social isolation.134 This study identified that a high level of stroke 
severity and reduced mobility function were significantly associated with 
reduced levels of upright activity. These findings, although in agreement with a 
previous study,46 should be considered cautiously as this study was not powered 
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to detect associations. A higher level of stroke severity at baseline and low level 
of walking have been associated with low levels of activity.46 It has been 
speculated that activity levels have the potential to be influenced by the 
physical layout of units such as the amount of space available to move in.  
Patient interaction in this study occurred between patients of similar ages and 
may well be facilitated or inhibited by the layout of the ward. It was difficult to 
conclude whether rooms with four beds or an open plan ward encouraged 
interaction between patients as this depended on further factors such as stroke 
impairments especially speech and age. A previous study has suggested the use 
of tables in the bedrooms to encourage interaction, which may also increase 
activity.108 This study has identified further patient factors that may have a role 
to play in the level of activity such as smoking status and certain personality 
traits. In this study it appeared that the patients that spent the most time 
upright were current smokers and frequented outside the hospital for a cigarette 
or patients that were considered ‘fidgety’ or to have a nervous/anxious 
disposition. 
This study has shown that time spent upright does not appear to be predictive of 
independent function at three months and at six months. The level of upright 
activity undertaken in the acute stages between those that were independent 
and those that were not independent at three months was not significantly 
different. A recent study has shown activity in the acute stages post-stroke to 
have a favourable effect on outcome in stroke.135 The sample was almost double 
the size of this study, consisted of more severely impaired patients, used BMT to 
measure activity and used the mRS scale as the outcome measure. These 
differences may account for these conflicting findings.   
Strengths and limitations  
The general inclusion criteria and the recruitment of patients from three ASUs 
provides the findings of this study with external validity. However, the number 
of patients recruited to the study with severe stroke impairment was low. The 
recruitment strategy aimed to be unselective, however recruitment of patients 
was not consecutive. The practicalities associated with one individual researcher 
recruiting patients across three sites may have resulted in patients, specifically 
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those that were considered on admission to be too unwell, being missed. For 
example, a patient who was reported as too unwell (and potentially more 
severely affected) and/or unsuitable to approach their relative so soon after 
diagnosis, required this patient or nearest relative to be followed-up at a later 
date. Yet, follow-up may not have been possible as recruitment may have 
occurred at another site or the patient may have been transferred onwards to a 
rehabilitation ward. Also, to ensure that patients were not burdened with 
invitations to participate in research studies it was agreed with the hospitals 
participating in the study that the patient after screening should only be 
approached for one research study. Although, it is unlikely that this specifically 
resulted in less patients with more severe stroke being recruited. Even with few 
eligibility criteria, recruitment can still be limited by the need to gain informed 
consent, especially for patients more severely affected.136 Measures of stroke 
severity do not always portray the level of disability. In this study, over 45% of 
patients with mild stroke had a baseline mRS score of four or five.  
Compliance with the study protocols was high. Patients frequently reported that 
they had “completely forgotten” that they were wearing the monitor, most 
likely due to its light-weight and non-invasive design. Technical failure did result 
in loss of data and is a limitation when using equipment to monitor physical 
activity. One patient, also the oldest, requested the activPAL™ be removed 
towards the end of the monitoring period and detachment occurred in one of the 
three agitated patients. The feasibility and adherence to ACs requires further 
research in these patient groups. The BMT data were used to identify and clarify 
any anomalies in the AC data that were ‘out-of-character’. As the BMT records 
data intermittently and incorporates breaks for the observer (the patient may 
have been unobserved for 20 minutes at a time) postural transitions may have 
been missed so cross-checking required assumptions and may have been the 
reason for the lack of congruence. The activPAL™ itself is not waterproof which 
could be problematic when monitoring in a busy environment where staff have 
competing priorities. There is potential for monitors to be put on upside down 
(as in this study and reported in others) or not at all. Having a researcher 
present during the monitoring period undoubtedly minimised such occurrences. 
If the activPAL™ monitor were to be used in routine acute stroke care such 
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practical issues alongside the financial implications need consideration. Advice 
to make the activPAL™ waterproof is now available including the use of a 
medical grade adhesive covering such as tegaderm, yet these applications are in 
early use. As the activPAL™ is uni-axial it does not distinguish between lying and 
sitting which may have important implications for this population. The activPAL™ 
would not detect transitions where stroke patients were transferred using a hoist 
from lying in bed to sitting in a chair i.e. the patient was not upright during the 
transition. This was the case for one patient in this study and without the BMT 
data then for this patient then he would have appeared to have been lying in 
bed all day. 
The BMT is designed to be as unobtrusive as possible, using distance observation 
and not intruding on patients behind closed doors or curtains. It is unlikely that 
patients altered their behaviour in response to being observed since the majority 
of patients who were able to walk required assistance to move, either with 
walking aids or the assistance of staff. Prior to commencing the study at each 
hospital it was explained to staff that the focus of the study was on how patients 
spend their time. It was also emphasised that there was no need for staff to 
change their way of working and that it was not their individual practice that 
was under evaluation. 
There is a lack of a standard classification system for physical activity in stroke 
patients. In the healthy population physical activity is categorised by intensity 
(i.e. light, moderate, hard) determined by energy expended (as measured by 
metabolic equivalent [METs]). However, in the stroke population less is known 
about energy expended during activity. An alternative method to determining 
activity classifications using energy expended is to develop physical activity 
intensity-related AC cut-points specific to stroke patients. The number of 
minutes spent above a pre-specified threshold could then be translated as a 
measure of intensity, for example, low, moderate or high physical activity. As 
well as different definitions for the term ‘physical activity’ exist different 
definitions for the term ‘sedentary’ also exist. In research, the term sedentary 
has recently been defined by the Sedentary Behaviour Research Network as 
spending ‘large amounts of time in behaviours that are of low energy 
expenditure (≤1.5 METs)’ while in exercise science sedentary refers to the 
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absence of a moderate-to-vigorous-intensity physical activity.137 However, 
applying this definition to the stroke population may not be reliable. The energy 
expenditure for a stroke patient whilst sitting may not satisfy the current 
definition of sedentary. Effort should be focused to explore the use of the term 
‘sedentary’ in this population. 
Implications for future monitoring and research 
This study is distinct from other research investigating activity in acute stroke in 
that it measures activity using accelerometry, a method considered in its infancy 
in this population. It is further strengthened by the novel integration of another 
data source (the BMT) to provide objective data on other items such as the 
location of activity. New technical developments which combine accelerometry 
with global position systems allow the location of the physical activity to be 
tracked without the need for researcher observation. Researcher observation has 
been of value in provided insight into explaining certain patterns which is 
important in the planning, designing and implementation of new acute 
rehabilitation interventions. This research provides novel data on current 
activity levels for patients very early after stroke and for a Scottish healthcare 
setting. This is of relevance considering the current focus on the delivery of 
rehabilitation interventions rapidly to acute stroke patients.  
The opportunity to measure physical activity in this population is not only 
important to identify associations between activity in these acute stages post-
stroke and outcome but to monitor trends over time and evaluate the 
effectiveness or implementation of new rehabilitation interventions such as VEM.  
For example, a study conducted in 1980, investigated treatment patterns, 
solitary and social behaviour over two years.103 The introduction of group 
exercise based therapy as opposed to that individually administered was 
illustrated by fewer peaks of treatment in year two. Information about the 
pattern of activity, therapeutic intensity of activities, person and location across 
the day provides a detailed picture of current practice. It offers a rich data 
source for a time-series evaluation to identify changes in practice or assess the 
longer term impact of new activity-based rehabilitation interventions. For 
example, the introduction of a longer working day may result in changes in 
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treatment patterns resulting in increased activity occurring later in the 
afternoon. With the development of new interventions or introduction of new 
practices it is important to embed rehabilitation-related process indicators into 
routine audits. This could provide opportunities for data linkage to assess, at a 
population level, the impact that the time of first mobilisation or the time spent 
in therapy in the acute stages has on (longer-term) outcome. 
Future applications of accelerometry 
Challenges exist with regards to selecting an appropriate monitor, how to 
manipulate, analyse and interpret AC data.138 A recent review of studies that 
had investigated the clinimetric properties of accelerometry in patients in stroke 
identified 25 studies in which a range of AC devices, research settings and stroke 
populations were studied. It is difficult to determine from this the most 
appropriate AC and it may be that key discussions with manufacturers and the 
research team’s budget influence choice. Presenting the median time spent 
upright for each hour to identify patterns of activity was considered sensitive to 
detect patterns over the day and to allow comparisons with other studies that 
have investigated activity over time.  
Currently there are no reporting standards for studies using AC so this study has 
adhered to the limited guidance available and reported on items such as the 
number of wearing interruptions and detailed the decisions made regarding data 
analysis. It has been speculated elsewhere that the relationship between 
physical activity and sedentary behaviour is independent each having distinct 
correlates and patterns. The value of each of these outcomes and the 
relationships between them in the stroke population needs further investigation. 
For example, an increase in the time spent upright or the number of upright 
events does not necessarily mean a reduction in the number of sedentary bouts 
greater than 60 minutes. In this study, there was a non-significant association 
between total time spent upright and the number of sedentary events lasting 
between 30 to 60 minutes and greater than 60 minutes. It could be speculated 
that the relationship between upright activity and the accumulating of sedentary 
time is independent. For example, an increase in total time spent upright may 
not be related with an increase in the number of events in prolonged periods of 
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sedentary behaviour. This is important in developing interventions aimed at 
affecting activity patterns. Would an intervention aimed at increasing the 
amount of physical activity reduce the prolonged periods of sedentary time 
behaviour or are independent strategies required?  
Accelerometry-based outcomes such as time spent upright could be used to 
measure the implementation (using process indicators) or effectiveness (using 
outcomes) of trial interventions aimed at increasing physical activity. A previous 
rehabilitation study aimed at doubling the amount of mobilisation practice to 
acute stroke patients resulted in a mean difference of 2.1% (95% CI -4.2 to 8.4) 
time spent upright measured by accelerometry between the control and 
intervention group. The mean difference does prompt discussion about defining 
and measuring clinically meaningful changes in upright activity which has 
implications for the monitoring of new rehabilitation interventions. Once 
determined, this expected mean difference could then be used to power future 
studies of interventions focused at increasing time spent upright. There is a need 
for further research to establish the clinimetric properties such as the predictive 
value and the responsiveness of AC-based measures in stroke before it can be 
considered gold standard in measuring activity in acute stroke patients or used 
as an outcome for change.126 For example, improved knowledge of whether AC-
based measures are able to predict outcomes such as disability is of value. These 
AC-based measures could then be recorded at baseline to assess a patient’s 
suitability for inclusion into a study or for an intervention. 
Future recommendations to increase activity levels in clinical practice 
If activity-based interventions such as VEM are shown to be effective the focus 
will be to increase levels of upright activity and reduce prolonged sitting times 
at this important stage of neurological recovery. Recommendations to increase 
physical activity could include encouraging and assisting patients to engage in 
purposeful tasks to break up periods when patients are likely to be inactive, 
targeting times when the patient is known to be alone and sedentary i.e. at 
11:00 and 13:30. Introducing a sense of ‘normality’ for patients such as the 
collection of their prescriptions from the nurse’s station, going to the newspaper 
trolley to choose a newspaper or to greet relatives at the front door at visiting 
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time. Indeed it is noted that maximising opportunities for increasing upright 
activity and minimising sedentary periods for patients that are more severely 
affected may be more of a challenge as these patients often require external 
assistance of staff and equipment to mobilise. A flexible approach to implement 
such recommendations or strategies is required and consideration given to time 
of the day; for example, the nursing station was observed as a busy place in the 
morning but quieter in the afternoon possibly shaping the collection of 
prescriptions by patients as an afternoon service only. The use of volunteers or 
family members (the presence of family was strongly associated with sedentary 
behaviour in this study) and the revival of dayrooms. Some UK health board 
areas are currently recruiting volunteer ward visitors to provide stimulation and 
non-clinical support to patients who may not have family members close by.  
There are perceived barriers to implementing strategies that involve family 
members and increasing activity levels such as HCPs’ concerns over patient 
safety and perceptions of patient fatigue and capability as well as the patient’s 
preference, motivation and ability. Education may be required to overcome 
these perceived barriers. The risks of prolonged sedentary behaviour should be 
included in patient and staff education sessions. Staff associated prolonged 
periods of time in one position with an adverse effect of muscle tone and 
believed that this should be interspersed with time in a lying position to stretch 
muscles.  
Technological advances in mobile phones, wireless and interactive technologies 
in promoting physical activity are currently being used. Pedometer applications 
are now available for download to mobile phones. Connecting mobile phones to 
an AC to provide real-time feedback to the user are just some of the recent 
advances being used in public health initiatives.139 The potential for the use of 
mobile phones is beginning to be recognised by HCPs to text reminder/feedback 
messages or also to monitoring and store activity data.  
Certainly, in this study it was evident that patients didn’t lose their connection 
with their mobile phones. They were often observed texting and talking on their 
mobile phone a number of times throughout the day. Mobile technology is 
primed to be the most powerful form of media to influence clinical practice in 
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the years to come. Using such wireless communication such as providing an opt-
in text messaging service to stroke patient may be an option. Such text messages 
could be used to alert the patient of availability of hospital services such as the 
arrival of the newspaper trolley to the hospital ward or the availability of 
medications for collection from the nursing station. This is used here only as an 
example to highlight the potential technology may have in paving the way for a 
more stimulating ward pattern and breaking the mould of sedentary behaviour 
which has dominated stroke rehabilitation wards. Whether or not it would 
incentivise patients to engage in more physical activity and break up the bouts 
of sedentary behaviour, given that self-practicing of exercises was rarely 
observed in this study, is questionable. Additionally, and of course, there are 
questions, especially regarding sedentary behaviour, that would need to be 
addressed before such technological investment could be considered to target 
the current pattern of physical inactivity and sedentary behaviour and to 
supplement the education, support and communication already provided to 
acute stroke patients by HCPs.  
3.6 Conclusion 
This Chapter includes research that addresses the development stage of the 
Medical Research Council complex intervention framework. This observational 
data provides a baseline measure of activity levels in acute stroke patients. This 
will assist the evaluation of the future implementation of effective activity-
based rehabilitation interventions such as very early mobilisation (VEM) in 
clinical practice. Appropriate methods of monitoring have been used and 
compared. Accelerometry-based measures such as time spent upright, time 
spent sedentary and how sedentary time is accumulated may prove to be valid 
process indicators to measure such implementation. The clinical problem of low 
levels of activity remains, however the prolonged periods of sedentary behaviour 
may be of more concern. Some strategies for use in clinical practice to increase 
activity levels have been suggested, however, it remains undetermined whether 
activity-based interventions such as VEM improve outcome. It is therefore 
important that the current evidence-base for VEM is investigated (Chapter 4). 
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4 Clinical impact of very early mobilisation  
4.1 Introduction 
Very early mobilisation is defined as mobilising patients up and out of bed (i.e. 
sitting out of bed, standing and walking) within 24 hours of stoke onset and 
continuing mobilisation at frequent intervals during the acute stage. Although 
early mobilisation of acute stroke patients is recommended in clinical 
guidelines,2 42 VEM remains controversial and specific recommendations cannot 
be made until further evidence to guide practice is available. Due to its complex 
nature, standardising VEM poses a challenge in that the intervention actually 
delivered to the patient differs according to patient capability.  
This issue of standardisation has important implications for approaches used in 
meta-analysis i.e. are the interventions comparable. Meta-analysis is defined as 
the “statistical analysis of a large collection of analysis results from individual 
studies for the purpose of integrating the findings.”140 Meta-analysis offers 
advantages for increasing statistical power and providing a more precise 
estimate of treatment effect than that of individual studies.2 This approach has 
been used to determine the effectiveness of stroke rehabilitation interventions 
where the individual trials are often small in size and therefore underpowered. 
Generally, meta-analysis of aggregate data is often limited by poor or selective 
reporting.  Additionally, as complex interventions are associated with issues of 
reproducibility, identifying and explaining clinical heterogeneity between 
studies using the ‘same’ intervention may pose further issues. Therefore, 
heterogeneity is considered a more pressing issue in the synthesis of complex 
interventions compared to that of drug interventions. Individual patient data 
meta-analysis may offer an alternative approach to identifying and explaining 
heterogeneity in complex intervention research. An IPD MA is defined as the 
collaborative collection of raw data from clinical trials that have addressed a 
common research question. To date, two phase II trials of VEM have already 
been conducted: the Australian AVERT phase II and the UK Very Early 
Rehabilitation or Intensive Telemetry after Stroke (VERITAS).45 141 In order to 
maximise these existing data sources an IPD MA approach was employed to study 
the clinical impact of VEM which allowed for the adjustment 
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of key patient characteristics, to identify sources of heterogeneity between the 
studies and to explore the response to VEM in predefined subgroups of patients.   
Chapter 3 highlighted that activity levels are low in acute stroke patients. 
Increasing activity levels in the acute stages post-stroke has been suggested to 
improve outcome. One activity-based rehabilitation intervention which aims to 
increase activity levels in the acute stages post-stroke is VEM. Very early 
mobilisation is under study in the ongoing AVERT phase III trial. As results from 
AVERT phase III are not available until 2013, this Chapter aims to explore the 
clinical impact of VEM using the best available evidence.  
Aim 
The aim of this IPD MA was to estimate the pooled effect of VEM in relation to 
pre-specified clinical outcomes. The primary outcome was independence at 
three months. In addition, the effect of VEM on stroke impairment, the risk of 
immobility-related complications and level of fatigue at one week post-stroke 
was investigated. Further secondary outcomes assessed at three months included 
the risk of immobility-related complications, death, discharge destination, ADL, 
mobility disability, health-related quality of life and resource use. The 
implementation of VEM was assessed using the following three process 
indicators; time to first mobilisation, total dose of mobilisation and mean time 
spent upright. 
4.2 Methods 
4.2.1 Trial selection 
The latest Cochrane review (2009) entitled ‘Very early versus delayed 
mobilisation after stroke’ was used to identify trials of early mobilisation in 
stroke.142 The aim of this previous systematic review was to establish the 
benefits and harm of VEM commenced within 48 hours of stroke onset in 
comparison with conventional mobilisation care. This review involved extensive 
searching of bibliographic databases, trial registers and hand searching of 
relevant journals. This review included “all randomised trials, with or without 
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blinding, of VEM within 48 hours of symptom onset compared with conventional 
care (that is, normal practice or no routine intervention.” The participants in 
the studies were required to have “deﬁnite clinical diagnosis of stroke (focal 
neurological deﬁcit of cerebrovascular origin) and could be mobilised within 48 
hours of stroke onset. There were no age restrictions.” The review identified 
three eligible trials, one completed; AVERT phase II and two that were currently 
underway at the time of the search; VERITAS and AVERT phase III. It should be 
noted that the VERITAS protocol had been intentionally matched to that of 
AVERT phase II in a number of key areas to ensure standardisation and in 
planning for this IPD MA. 
4.2.2 Data collection and management 
A prespecified analysis plan was provided to the researcher by the trialists in 
advance of collecting the individual patient data (IPD). This was used to 
establish the variables and outcome measures common to each dataset and to 
assess the data that could be combined (Table 4-1).   
 
Table 4-1 Shared outcomes used in AVERT phase II and VERITAS  
Shared outcome Outcome measure  
Week 1   
 VERITAS AVERT phase II 
Stroke severity National Institute Health Stroke 
Scale 
Scandinavian Stroke Scale 
Complications Measured as per protocol Measured as per protocol 
Level of fatigue Borg Perceived Exertion Scale Borg Perceived Exertion 
Scale 
Time to first 
mobilisation  
Measured as per protocol Measured as per protocol 
Dose of mobilisation∗ Time spent upright 
(accelerometry) 
Time spent in therapy  
(therapist report) 
Month 3   
Independence Modified Rankin Scale Modified Rankin Scale 
Discharge date Measured as per protocol Measured as per protocol 
Discharge destination Measured as per protocol Measured as per protocol 
Complications Measured as per protocol Measured as per protocol 
Activities of daily living Barthel Index Barthel Index 
Level of mobility Rivermead Mobility Index Rivermead Mobility Index 
Health-related quality of 
life 
Assessment of Quality of Life 
Questionnaire 
Assessment of Quality of Life 
Questionnaire 
Resource use∗ Measured as per protocol Measured as per protocol 
∗Data were not aggregated 
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Annonymised data for the relevant baseline factors and prespecified outcomes 
were extracted from the AVERT phase II data set and the sub-set sent, as an 
Excel file, via email to the researcher. The VERITAS data were sent, in its 
entirety, as a statistical package file via email to the researcher. The data were 
cleaned, re-coded as required and cross-checked with reports and publications. 
The trial protocols were used to provide information about the intervention 
provided and the outcome measures (and versions) used in each of the trials. 
Data queries were raised and managed in collaboration with the relevant trialist. 
Primary outcome and secondary outcomes at one week 
The choice of outcomes was based on those used in the previous Cochrane 
review.142 The primary outcome was independence at three months as measured 
by the Modified Rankin Score (mRS). The secondary outcomes measured at one 
week included stroke severity (National Institute Health Stroke Scale [NIHSS] or 
Scandinavian Stroke Scale [SSS]), complications of immobility in hospital and 
level of fatigue (Borg Exertion Scale [BORG]). The primary outcome was the 
proportion of patient’s independent at three months as defined by a mRS score 
of ≤ 2. The original rankin scale consisted of five categories based on ability to 
perform certain activities as well as taking account of the level of assistance 
required. The modified version as it is widely used today is considered to be a 
measure of global disability and consists of two additional categories – ‘no 
symptoms’ and ‘dead’, providing a seven point scale.  
The NIHSS is a 15 item neurological impairment scale with a maximum deficit 
score of 42 points.143 The key aspects that are measured are eye movement, 
motor and sensory impairment and level of consciousness.  The SSS is also a 
neurological impairment scale which incorporates an initial prognostic and long-
term functional score. The key aspects that are measured include consciousness, 
eye movement, motor power, speech and facial palsy. The level of impairment 
for a patient is measured as a value between 0 and 58, with lower scores 
indicating greater impairment.144 As stroke severity was measured using 
different outcome measures the SSS scores obtained for patients in AVERT phase 
II were converted to the NIHSS score using the following interconversion 
equation:145 NIHSS score = 22.99 – (0.39 x SSS score). Complications were defined 
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as stroke related, immobility related, co-morbidity related or any others. 
Complications of immobility included falls, pneumonia, chest infection, deep 
venous thrombosis, pulmonary embolism and pressure sores. Complications were 
collected from medical records by a blinded assessor. The BORG is a self-rating 
scale used to measure perceived exertion during physical activity; it ranges from 
6 to 20, where 6 equals “no exertion at all’ and 20 equals “maximal exertion”.146  
Excessive fatigue was defined as a score of >13 “somewhat hard”.  
Secondary outcomes at three months 
The further prespecified secondary outcomes measured at three months 
included mobility (Rivermead Mobility Index [RMI]), place of discharge, death, 
activities of daily living (BI), health-related quality of life (Assessment Quality of 
Life [AQoL)) and resource use. The Rivermead Mobility Item comprises of 14 
items with activities ranging from turning over to running.147 Each question is 
answered either yes (score = 1) or no (score = 0) with a maximum score of 14. A 
lower score indicates a greater mobility disability. Non-impaired mobility was 
defined as a RMI score of 10 to 13. Discharge destination was categorised as 
home, rehabilitation unit/ward, acute hospitalisation, sheltered housing or a 
nursing home. Return home was defined as patients who were previously living 
in private residence and had returned to this living arrangement by month three.  
The BI measures performance of ADL. It is a 10 item scale which ranges from 0 
to 100, where lower scores indicate greater dependency. This score is often re-
scaled from 0 to 20, with each item divided by five. Independence was defined 
as a BI score ≥ 18. Patients who had died were assigned a score of zero.  
The AQoL is a utility instrument which measures health-related quality of life 
(HRQoL)148 comprising of 15-items and five domains as follows; illness, 
independent living, social relationships, physical senses and psychological 
wellbeing. Responses to each of the AQoL items were summed to provide value 
profiles of illness, independent living, social relationships, physical senses and 
psychological wellbeing. Patients who died were assigned a score of zero. This 
coding created scores for each scale ranging from ‘0−9’, where ‘0’ represents 
‘normal’ or ‘good’ HRQoL and ‘9’ the worst possible HRQoL for each dimension. 
These scores were then summed to provide an overall unweighted HRQoL-index, 
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where overall AQoL scores ranged from ‘0−45’, where ‘0’ represents ‘normal’ or 
‘good’ HRQoL and ‘45’ the worst possible AQoL HRQoL-score. The AQoL score is 
then used to compute an overall utility score weighted by preference in order to 
calculate quality-adjusted life years (QALYs) for use in economic evaluation. The 
conversion of the unweighted HRQoL scores to utilities for use in economic 
evaluation is presented in Chapter 6. 
Resource use was determined by a blinded assessor during a face-to-face 
interview with the patient or nearest relative and by retrieving information 
about hospital re-admissions from medical records at three months post-stroke.  
The specific resource items varied between the trials; in both trials resource use 
information on initial acute hospital length of stay (LOS), hospital re-admission 
LOS and some aspects of care provided in the community were gathered. 
Generally, there is no consensus regarding the methods to pool multinational 
resource data or resource data from different hospitals for meta-analysis or 
economic evaluation. Resource use is highly variable between countries due to 
differences in healthcare systems. Combining resource data for a meta-analysis 
is controversial and may limit the generalisability of estimates of cost and by 
implication estimates of cost-effectiveness across settings.149 Considering this 
and the variation in resource use that existed between the two studies for the 
purpose of this IPD MA of resource use was not considered appropriate. 
Therefore, the summary data available from the published sources were 
extracted, tabulated and described. A planned economic evaluation alongside 
AVERT phase II has already been conducted and has since been published.150 
Process indicators are markers defined to assess the quality of care and 
benchmark the implementation of guidelines.151 Two process indicators were 
used in this analysis; time to first mobilisation after stroke onset and the amount 
of mobilisation activity. In order to measure time spent in mobilisation activity 
in AVERT phase II trial staff recorded time with a therapist doing mobilisation 
(VEM) and time spent in SC (control). This was measured for the intervention 
period of 14 days or earlier if the patient was discharged. In AVERT phase II the 
total dose of mobilisation for each treatment group (in minutes) across the 
length of stay was calculated. In VERITAS an AC was used to measure time (in 
minutes) spent in sitting/lying, standing and stepping for patients. This was 
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measured on days three, four and five with recordings on the first day 
considered most reliable due to the lower levels of missing data on that day. In 
VERITAS time spent upright, defined as the time spent standing or stepping, was 
calculated. As the methods of measuring mobilisation activity were different in 
each of the trials the data for this process indicator were not combined.  
4.2.3 Statistical analysis 
Analyses included all patients and used an intention to treat approach. Baseline 
patient characteristics were described for each trial and summarised in the two 
treatment groups.  Univariate analysis was used to compare patient 
characteristics at baseline and the time to first mobilisation between the two 
individual trials and between treatment groups in the IPD MA. Where data were 
not normally distributed (stroke severity scores, time to first mobilisation and 
length of stay), the Wilcoxon-Mann-Whitney test, a nonparametric equality of 
medians test was used.152 Time spent mobilising was compared between the 
treatment groups using summary data from the trials. The conventional level of 
significance (p ≤ 0.05) was used.  
The methods for meta-analysis for aggregate data are well-developed with a 
number of approaches available depending on the assumptions being made 
regarding a common treatment effect between the included studies. For IPD MA 
two main types of analysis are recognised; the one-stage analysis and the two-
stage analysis. The one-stage analysis combines all the IPD from the studies and 
models the treatment effect simultaneously. The alternative approach is the 
two-stage approach whereby a summary estimate is calculated for each 
individual trial and synthesised using traditional meta-analysis. For analysis in 
this Chapter the two-staged approach was used to assess the treatment effect. 
The outcomes were analysed for each of the trials and then these individual 
summaries were used to provide an overall measure of effect. A common 
treatment effect was assumed therefore it was appropriate to use a fixed effect 
model. Analyses were also run using a random effects model (DerSimonian and 
Laird, 1986153) to cross-examine the robustness of this assumption. The 
treatment effect was calculated using the Mantel-Haenszel method which 
combines on the log scale, ORs for each trial using a weighting scheme based on 
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the inverse of their variance. The random effects model, in assessing uncertainty 
incorporates an additional measure of between-study variation. For continuous 
factors (stroke severity and HRQoL scores) a weighted mean difference was 
calculated. For stroke severity, patients who died were excluded from the 
analysis. The amount of heterogeneity was assessed visually using forest plots 
and quantified using the I2 statistic, which describes the percentage of variation 
between studies due to heterogeneity rather than chance.154 An available guide 
for the approximate interpretation of the I2 statistic was used; low = 25%, 
moderate = 50% and 75% = high.154 
Multivariate logistic regression was used to assess the effect of VEM on 
independence at three months adjusting for patient and stroke characteristics 
known to effect outcome. The identity of each trial was upheld within the model 
so as to preserve clustering of patients within studies and allowed inferences to 
be based on the randomisation of patients within each trial.155 In multivariate 
analysis adjustments were made for known confounders including age, baseline 
stroke severity and pre-morbid disability. Age, baseline severity and the level of 
disability on admission have been identified as factors affecting recovery.156 157 
The effect of including additional factors, as informed by the univariate analysis 
(p < 0.10) was also explored in separate models. As the number of patients was 
small the most parsimonious model was selected. A similar method of univariate 
and multivariate analysis was carried out for the secondary outcomes.  
Similarly, the same approaches (either the one or two-stage) can be used to 
examine the effect of covariates. A two-staged approach was used in this 
analysis to conduct a subgroup analysis where patients within each trial were 
grouped into prespecified categories and the treatment effect was estimated 
across the trials for each of the subgroups. This subgroup analysis allowed the 
exploration of whether groups of patients with similar characteristics from two 
separate trials respond in the same manner to the intervention. Subgroup 
analysis was restricted to the primary outcome and based on prespecified groups 
that were identified in each trial as important patient characteristics for 
adjustment in the final analysis of outcome, these included age, stroke severity 
at baseline and pre-morbid disability. The patient groups were defined as (i) 
patients with a mild stroke (NIHSS ≤ 7) or moderate to severe stroke (NIHSS > 8), 
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(moderate and severe categories were collapsed due to the low number of 
events in the severe category), (ii) patients aged < 75years or ≥ 75years (iii) 
patients with no or mild previous symptoms (premorbid mRS, 0 - 1) or patients 
with moderate previous disability (premorbid mRS, 2 - 3). Subgroup interaction 
was tested between patient groups using the chi-squared statistic.149  
4.2.4 Ethical approval 
Each trial had separate protocols approved by National research ethics 
committees. Informed consent was gained from each patient or their next of kin.  
As the research questions of this IPD MA are addressing the same question as the 
original trials, ethical approval had already been sought. This IPD MA is 
potentially providing a more reliable answer to the question that the patient 
originally consented to when entering the trial, therefore the same consent 
applies. All data sent to the researcher by the trialist were de-identified. 
4.3 Results 
4.3.1 Trial characteristics 
The completed trial (AVERT phase II) and the (since completed) VERITAS trial as 
identified by the Cochrane review were included in the IPD MA. At the time of 
pooling these data AVERT phase III was ongoing. This IPD MA commenced on 
completion of the VERITAS trial and after both trial reports had been accepted 
for publication. A Very Early Rehabilitation Trial phase II and VERITAS were both 
designed to compare the feasibility and safety of a VEM protocol with usual 
stroke care mobilisation practices. A Very Early Rehabilitation Trial phase II was 
a multicentre randomised trial conducted at two hospital sites in Australia 
between 2004 and 2006. The Very Early Rehabilitation or Intensive Telemetry 
after Stroke trial was a single centre randomised trial conducted in Scotland 
between 2006 and 2007 and used 2 x 2 factorial design to investigate the 
combined effect of VEM and automated physiological monitoring. The key 
principles of the VEM intervention protocol used in AVERT phase II were adopted 
in VERITAS with respect to the timing, nature and frequency of the intervention. 
Both trials aimed to get patients up to sit, stand and walk within 24 hours or as 
soon after the point of recruitment as possible and continued mobilisation 
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throughout the day. The time to trial recruitment from onset of stroke symptoms 
was slightly shorter in AVERT phase II (< 24 hours) to that of VERITAS (< 36 
hours). Very Early Mobilisation was delivered for 14 days by a team of both 
nurses and therapists in AVERT phase II and was predominately nurse-led for 
seven days in VERITAS. Standard care at the hospital sites was similar in that 
patients were transferred to a stroke unit where staff with specialist skills in 
stroke and had regular MDT meetings. Routine physiological monitoring occurred 
ever four hours and mobilisation was provided by ward therapists and nurses.  
Patients recruited to VERITAS were randomised to one of four groups; SC, early 
mobilisation, automated physiological monitoring (AM) or AM and early 
mobilisation. Automated physiological monitoring involved the use of a 
commercial monitoring system and a well-developed protocol to continuously 
monitor patients and provide advice on managing irregularities in heart rate, 
blood pressure, temperature, oxygen saturation or blood glucose. This mode of 
monitoring was conducted for the first three days post-stroke, thereafter 
patients reverted to SC. Both trials used computer generated, blocked 
randomisation procedures and used opaque envelopes to conceal group 
allocation. In AVERT phase II, patients were stratified by stroke severity and 
hospital site. The inclusion and exclusion criteria were similar for both trials. In 
both trials patients aged over 18 years with a new or recurrent stroke were 
recruited and patients with severe pre-stroke disability or co-morbidities (severe 
heart failure, other progressive neurological disorder, acute coronary syndrome 
or confirmed/suspected lower limb fracture) were excluded. In AVERT phase II 
severe pre-stroke disability was defined as a pre-morbid mRS score >3 and in 
VERITAS it was defined as a pre-morbid mRS score > 2. There was no upper age 
limit in either trial.  Data were available for all recruited patients. Outcome 
assessment was conducted on day seven and 14 post-stroke then on month 
three, six and 12 months. In VERITAS outcome assessment was carried out on day 
five, at discharge and then at three months (Figure 4-1).  
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Figure 4-1 Trial pathways and assessment points 
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  Assessment Timepoint (AVERT phase II only)
AM   Automated Monitoring
SC   Standard Care
VEM   Very Early Mobilisation
AVERT PHASE II
  Early assessment timepoint
  Late assessment timepoint
Day 5 Day 7 Month 3
Month 6 Month 12Day 14
 
4.3.2 Patients characteristics 
All patients in AVERT phase II (n = 71) and VERITAS (n = 32) were included in the 
IPD MA. No patients were lost to follow-up at three months. AVERT phase II had 
33 patients in the SC group and 38 patients in the VEM group while VERITAS had 
eight patients in each of the four treatment group, 16 patients received early 
mobilisation and 16 patients received standard mobilisation practices. The 
pooled analysis showed the baseline characteristics of patients were comparable 
between treatment groups (Table 4-2). It is worth noting that VERITAS excluded 
patients with mRS > 2, therefore the number of patients in the mild to moderate 
disability category (premorbid mRS 2 - 3) was small.  Furthermore, there were 
some differences in the patient baseline characteristics between the two trials. 
VERITAS patients had a lower mean age than AVERT phase II patients (65.3 years 
versus 74.7 years). AVERT phase II had a higher proportion of patients with risk 
factors for stroke than VERITAS – hypertension (70.4% versus 37.5%), atrial 
fibrillation (31.0% versus 6.2%) and current smokers (40.6% versus 14.1%). More 
patients had moderate or severe stroke in AVERT phase II than VERITAS (57.8% 
versus 28.1%). The proportion of patients in AVERT phase II with TACS was higher 
than that of VERITAS (22.5% versus 9.4%). 
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 Table 4-2 Patient demographics and stroke characteristics by group 
 
 SC VEM p-value 
Number of patients 49 54  
Age (mean, SD)  72.0 (11.6) 71.6 (14.2) 0.86 
Female 27(55.1%) 22(40.7%) 0.15 
Stroke risk factors    
Hypertension 32(65.3%) 30(55.6%) 0.31 
Atrial fibrillation 12(24.5%) 12(22.2%) 0.79 
Coronary heart disease 18(36.7%) 11(20.4%) 0.07 
Diabetes 7 (14.3%) 13(24.1%) 0.21 
Current Smoker    
Yes 13(26.5%) 10(15.5%) 0.33 
No 36(73.5%) 44(81.5%)  
Premorbidity (mRS score)    
No or mild symptoms (0-1) 41(83.7%) 39(72.2%) 0.16 
Mild-moderate disability (2-3) 8(16.3%) 15(27.8%)  
Living arrangements on admission 
Home alone 17(34.7%) 11(20.4%) 0.24 
Home not alone  30(61.2%) 39(72.2%)  
Other 2(4.8%) 4(7.4%)  
Stroke history    
Previous stroke 7(14.3) 15(27.8) 0.10 
NIHSS score    
Total Score (median, IQR) 8(4-12) 6.5(3-13) 0.90 
     Mild (1–7)  24(49.0%) 29(53.7%)  
     Moderate/Severe (>8)  25(51.0%) 25(46.3%)  
Oxfordshire classification    
TACS 9(18.4%) 10(18.5%) 0.21 
PACS 17(34.7%) 17(31.5%)  
LACS 10(20.4%) 10(18.5%)  
POCS 5 (10.2%) 14(25.9%)  
ICH 6 (12.2%) 3 (5.6%)  
Unknown 2(4.1%) 0 (0%)  
Entries are n (%), unless stated otherwise.  
mRS; Modified Rankin Score, NIHSS; National Institute Health Stroke Scale. TACS - Total 
Anterior Circulation Syndrome; PACS - Partial Anterior Circulation Syndrome; LACS - Lacunar 
Circulation Syndrome; POCS - Posterior Circulation Syndrome; ICH - Intracerebral 
Haemorrhage.   
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4.3.3 Independence at three months 
The proportion of VEM patients who were independent at three months was 
higher than the SC group (61.4% versus 38.6%). Very early mobilisation was 
shown to have a favourable effect on independence at three months (unadjusted 
OR 2.02 (0.85 to 4.76; p = 0.10) (Figure 4-2). The estimates from the random 
effects model and the fixed effects model were similar indicating that the 
assumption that the individual trials were estimating the same treatment effect 
was robust. The level of statistical heterogeneity between the studies in 
estimating independence was negligible (I2 = 5.7%). After adjusting for baseline 
factors the effect size increased, with patients who underwent VEM were three 
times more likely to be independent at three months than SC patients (adjusted 
OR 3.11, 95% CI, 1.03 to 9.33; p = 0.04). Coronary heart disease was the only 
factor to be significant (p = 0.07) on univariate analysis. The model when further 
adjusted for this factor was unaltered (adjusted OR 3.10, 95% CI, 1.02 to 9.30; p 
= 0.05) therefore was not included in final multivariate model.  
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Figure 4-2 Forest plot for independence (mRS) at 3 months 
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The effect size of each of the trials is shown by the black circle. The grey coloured box represents 
the weight given to the individual study. The size of the box is proportional to the weight given to 
each of the individual studies. The diamonds and the broken red line represent the overall 
summary estimate. The top diamond is the overall summary estimate using a fixed effects model 
(Mantel-Haenszel method, “M-H Overall”). The bottom diamond is the overall summary estimate 
using a random effects model (DerSimonian and Laird, “D+L Overall”). The black vertical line 
represents the null value of 1.  
 
4.3.4 Secondary outcomes at one week 
Both groups showed a reduction in NIHSS score from baseline to that measured 
at one week; this reduction was significant in the VEM group (p = 0.01). Patients 
undergoing SC had a median score of 8 (IQR 4 to 12) at baseline which reduced 
to median score of 5.5 (IQR 3 to 10.6) one week later. Patients who received 
VEM had a median score of 6.5 (IQR 3 to 13) at baseline which reduced to a 
median score of 3.5 (IQR 1.6 to 11.5) one week later (Figure 4-3). For both of 
the trials severity scores were lower in the VEM group than the SC group at one 
week, resulting in a negative difference in means The effect of treatment, after 
adjusting for covariates was non-significant (adjusted coefficient -0.59, 95% CI, -
2.44 to 1.27; p = 0.53). 
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Figure 4-3 Boxplot of NIHSS scores by treatment group at 1 week  
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Number of patients = 97. The middle line in each of the boxes represents the median value. The 
bottom and top lines of each of the boxes represent the 25th and 75th percentiles. Values outside 
this are represented by the vertical bars. Extreme values (“outliers”) are represented by the circles. 
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A greater percentage of SC patients (51.0%) experienced at least one 
complication compared to VEM patients (35.2%) (Table 4-3).  
 
Table 4-3 Immobility-related complications at 1 week 
 SC (n=49) VEM (n=54) p-value 
No of complications    
1 12 9 
2 5 6 
3 5 2 
4 2 1 
5 1 1 
Stroke-related complications   0.20 
Death 1 4  
Progression 1 3  
Recurrent stroke 0 0  
Immobility-related complication   0.02 
Deep vein thrombosis/pulmonary embolism 1 0  
Falls 7 3  
Pneumonia/chest infection/aspiration 13 8  
Urinary tract infection 5 0  
Pressure sore 0 0  
Co-morbidity-related complication   0.34 
Myocardial infarction 0 1  
Other∗ 21 17 - 
Any immobility-related complication∗∗ 17 (68.0%) 7 (36.8%) 0.01 
Any complication 25 (51.0%) 19 (35.2%) 0.11 
∗   Other included a range of different conditions such as chest pain, dehydration and gout. 
∗∗ One patient may experience ≥1 complication  
 
 
Immobility-related complications accounted for 68.0% of complications in the SC 
group and 36.8% in the VEM group. The individual trials both showed a reduction 
in immobility-related complications at one week with an overall reduction of 
73% (p=0.01) (Figure 4-4). The level of statistical heterogeneity between the 
studies in estimating immobility-related complications was low (I2 = 13.9%). After 
adjusting for baseline factors, the risk of experiencing immobility-related 
complications at one week for VEM patients remained significantly lower than 
that of SC patients (adjusted OR 0.23, 95% CI 0.07 to 0.71; p = 0.01). 
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Figure 4-4 Forest plot for immobility-related complications at 1 week 
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Both trials show a reduction in immobility-related complications at 1 week. Despite being the 
smaller trial more weight is allocated to VERITAS due to this trial having a higher event rate than 
AVERT phase II. 
 
The number of patients that experienced excessive fatigue was similar in both 
groups (VEM = 16 [44.4%], SC = 17 [37.8%]) with this observation consistent 
between both the trials. No difference between groups was shown in VERITAS 
with a slight reduction in the odds of excessive fatigue shown in AVERT phase II 
(Figure 4-5). No statistical heterogeneity between the studies was detected. The 
odds of excessive fatigue were no higher for VEM patients than for SC after 
adjustment of baseline factors (adjusted OR 0.79, 95% CI, 0.27 to 2.31; p = 
0.67).  
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Figure 4-5 Forest plot for excessive fatigue at 1 week 
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A summary of outcomes at one week is provided in Table 4-4. The treatment 
effect remained unaffected when using a random effects model in all of the 
analyses. Overall, the levels of heterogeneity between the studies were low, 
ranging from between 5.7% and 13.9%. 
 
Table 4-4 Summary table of secondary outcomes at 1 week  
Outcome Adjusted 
(Yes/No) 
Summary statistic Summary estimate   
(95% CI) 
p-
value 
Stroke severity No Mean difference∗ -0.38 (-3.36,  2.53) 0.78 
 Yes Coefficient -0.59 (-2.44,  1.27) 0.53 
Immobility complications No Odd ratio 0.27 ( 0.09,  0.82) 0.01 
 Yes Odd ratio 0.23 ( 0.07,  0.71) 0.01 
Excessive fatigue No Odd ratio 1.01 ( 0.40,  2.54) 0.75 
 Yes Odd ratio 0.79 ( 0.27,  2.31) 0.67 
∗ Weighted mean difference 
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4.3.5 Secondary outcomes at three months 
At three months the number of patients in each group that had experienced at 
least one type of complication further to that experienced at one week after 
stroke were similar (SC = 61.2%, VEM = 59.4%) (Table 4-5). This observation was 
consistent between both trials (Figure 4-6) and the effect VEM has in reducing 
such complications, is reduced (refer back to Figure 4-4). No statistical 
heterogeneity between the studies was detected. 
 
Figure 4-6 Forest plot for immobility-related complications at 3 months  
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Immobility-related complications accounted for 66.7% of complications in the SC 
group and 50.0% in the VEM group. The risk of experiencing complications of 
immobility in VEM patients was not significantly lower than that of SC patients 
(adjusted OR 0.55, 95% CI, 0.23 to 1.32; p = 0.20). In summary, the total number 
(includes all complications at 1 week and 3 months) of patients that had 
experienced an immobility-related complication in the VEM group was 20 (37.0%) 
and 21(42.9%) in the SC group.
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Table 4-5 Immobility-related complications at 3 months 
 SC 
(n=49) 
VEM  
(n=54) 
p-value 
Number of patients 49 54  
No of complications   
1 13 17 
2 5 7 
3 4 4 
4 4 1 
5 0 0 
6 3 0 
7 1 1 
8 0 2 
Stroke-related complications   0.60 
Death 2 4  
Progression 2 0  
Recurrent stroke 0 1  
Immobility-related complication   0.94 
Deep vein thrombosis/pulmonary embolism 0 1  
Falls 21 23  
Pneumonia/chest infection/aspiration 2 2  
Urinary tract infection 10 7  
Pressure sore 1 1  
Co-morbidity-related complication   - 
Myocardial infarction 0 0 - 
Other∗ 38 31 - 
Any immobility-related complication∗∗ 20(66.7%) 16(50.0%) 0.23 
Any complication 30(61.2%) 32(59.3%) 0.84 
∗   Other - refer to Table 4-3 
∗∗ One patient may experience ≥1 complication 
 
At three months the SC and VEM groups had similar proportions of patients living 
in private residence, a rehabilitation unit, residential housing or a nursing home 
and are as follows:  67.4% versus 70.4%, 8.2% versus 1.9%, 6.1% versus 3.7%, 6.1% 
versus 3.6%, respectively. The number of patients that had previously lived in 
private residence, but at three months had not since returned home was 28.6% 
in SC group and 22.2% in VEM group. There was no strong evidence that VEM 
influenced the patients’ chances of returning home by three months (adjusted 
OR 1.40, 95% CI, 0.46 to 4.30; p = 0.55). The level of statistical heterogeneity 
between the studies in estimating the chances of returning home was low (I2 = 
27.2%). The VEM group had a greater but statistically non-significant number of 
deaths at three months than that of the SC group (SC = 4, VEM = 8, p = 0.32). 
The level of statistical heterogeneity between the studies for this outcome was 
low (I2 = 28.0%). On multivariate analysis there was no evidence to suggest that 
VEM resulted in a greater risk of death (adjusted OR 0.93, CI 95% 0.11 to 7.90; p 
= 0.95). The forests plots for discharge home and death are not shown.  
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Patients who had undergone VEM had a higher RMI score at three months than 
patients who had undergone SC practices (median score 6.5 [IQR 1 to 10] versus 
5 [IQR 0.5 to 8], respectively). A greater proportion of VEM patients had non-
impaired mobility than the SC group (56.0% versus 35.4%) with this observation 
and a positive effect present in both the trials (Figure 4-7). No statistical 
heterogeneity between the studies was detected. The pooled adjusted estimate 
showed that there was a much higher chance of a patient undergoing VEM having 
non-impaired mobility (adjusted OR 7.81, 95% CI, 1.70 to 35.0, p = 0.01). The 
wide CI indicates that there is a high degree of uncertainty associated with this 
estimate. 
  
Figure 4-7 Forest plot for non-impaired mobility at 3 months 
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Very early mobilisation patients had a higher level of ADL at three months than 
SC patients (median BI scores 20 (IQR 16.5 to 20) and 17 (IQR 12 to 20), 
respectively. Again, this effect was apparent in both the trials (Figure 4-8). No 
statistical heterogeneity between the studies was detected. Patients that 
received VEM were more likely to be independent in ADL at three months than 
SC patients (adjusted OR 4.20, 95% CI 1.34 to 13.5; p = 0.02). Scores were not 
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available for two patients; one patient was unable to complete the assessment 
and one patient was not contactable.  
 
Figure 4-8 Forest plot for independence (BI) at 3 months  
M-H Overall
AVERT phase II
D+L Overall
Trial
VERITAS
2.00 (0.91, 4.42)
1.54 (0.60, 3.96)
2.01 (0.89, 4.55)
OR (95% CI)
3.86 (0.86, 17.32)
100.00
%
79.90
(M-H)
20.10
Weight
Favours control  Favours intervention 
1.05 20
 
 
A complete set of HRQoL scores for five domains was available for 97(94.2%) 
patients. Four patients did not complete the questionnaire and two patients did 
not complete it fully. The median HRQoL score for VEM patients was lower than 
for SC patients suggesting VEM patients had a better HRQoL (12 [IQR 5.0 to 19.0] 
versus 14 [IQR 8.0 to 22.0], p = 0.09). To re-cap, scores for each domain range 
from ‘0 to 9’, where ‘0’ represents ‘normal’ or ‘good’ HRQoL and ‘9’ the worst 
possible HRQoL score. Differences in scores between VEM and SC patients for 
each of the five domains are as follows; Illness: 6.0 (IQR 3 to 7) versus 6.0 (IQR 5 
to 8), p = 0.14; independent living: 1.0 (IQR 0 to 5) versus 4.0 (IQR 0 to 8.0), p = 
0.22; social relationship 0.0 (IQR 0 to 2) versus 2.0 (IQR 0 to 3.0), p = 0.05; 
physical senses; 1.0 (IQR 0 to 2) versus 1.0 (IQR 0 to 2), p = 1.0; psychological 
wellbeing: 2.0 (IQR 0 to 3) versus 2.0 (1.0 to 4), p = 0.09 (Figure 4-9). Very early 
mobilisation appears to have the most influence on the social relationship 
domain, this score being significantly lower for VEM patients than SC patients.  
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Figure 4-9 Boxplot of AQoL scores for each domain by group at 3 months  
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Number of patient = 97. Assessment of Quality of Life scores for each domain range from ‘0 to 9’, 
where ‘0’ represents ‘normal’ or ‘good’ HRQoL and ‘9’ the worst possible HRQoL score. Apart from 
the social relationship profile, there is no or little difference in scores for each of the HRQoL 
domains between VEM and SC patients.  
 
For both of the trials HRQoL scores were lower in the VEM group than the SC 
group, resulting in negative difference in means (Figure 4-10). The effect of 
VEM, after adjusting for covariates was non-significant (adjusted coefficient -
3.63, 95% CI -7.30 to 0.13; p = 0.06). 
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Figure 4-10 Forest plot for HRQoL at 3 months 
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A summary of the secondary outcomes at three months is provided in Table 4-6. 
Again, reverting to a random effects model did not alter the estimates in any of 
the analyses. Overall, the level of heterogeneity between the studies was low, 
ranging from between 0% to 28.0%.  
 
Table 4-6 Summary table of secondary outcomes at 3 months 
Outcome Adjusted 
(Yes/No) 
Summary statistic Summary estimate 
(95% CI) 
p-
value 
Immobility complications  No Odd ratio 0.74 ( 0.32,   1.68) 0.47 
 Yes Odd ratio 0.55 ( 0.23,   1.32) 0.18 
Discharge home No Odd ratio 1.16 ( 0.50,   2.66) 0.73 
 Yes Odd ratio 1.40 ( 0.46,   4.30) 0.55 
Death No Odd ratio 1.81 ( 0.54,   6.09) 0.34 
 Yes Odd ratio 0.93 ( 1.11,   7.90) 0.95 
Non-impaired mobility No Odd ratio 2.57 ( 0.98,   6.76) 0.05 
 Yes Odd ratio 7.81 ( 1.70,   35.0) 0.01 
Independence in ADL∗ No Odd ratio 2.01 ( 0.89,   4.55) 0.07 
 Yes Odd ratio 4.20 ( 1.34,   13.5) 0.02 
Health-related QoL∗∗ No Coefficient -3.56 (-6.99,  -0.13) 0.05 
 Yes Coefficient -3.63 (-7.30,   0.13) 0.06 
∗   Activities of daily living 
∗∗ Quality of Life 
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Data on resource use during the intervention stage and at follow-up in each of 
the trials is shown in Table 4-7. The length and dose of VEM intervention 
provided to patients was not recorded in VERITAS. The acute length of 
hospitalisation in the VEM groups of both trials was lower; mean LOS 9.8 days (SD 
8.0 days) versus mean LOS 8.6 days (SD 9.4 days) in AVERT phase II and mean 
LOS 10.5 days (SD 4.5 days) versus mean LOS 8.5 days (SD 4.4 days) in VERITAS. 
Both trials showed that VEM patients had a lower mean bed stay for both the 
initial hospitalisation and re-admission than for SC patients. Rehabilitation 
provided to SC patients at home was double that provided to VEM patients in 
both of the studies. District nursing input for VEM patients was higher in AVERT 
phase II; it should be noted that resource use in this group was accumulated by 
one patient.  Data for the additional resource use items collected in AVERT 
phase II revealed that the level of resource use for VEM patients was less than 
that recorded for SC patients. In VERITAS the mean number of visits to the 
general practitioner was much the same in both groups while the mean number 
of visits from informal carers was substantially higher (p = 0.33) in the VEM 
group than the SC group.  
 
  
Table 4-7 Resource utilisation at 3 months by trial 
  AVERT phase II VERITAS  
 Resource item  SC  VEM  SC  VEM   
 
 
Mean (SD) Number of 
users (%) 
Mean (SD) Number of 
users (%) 
Mean (SD) Number of 
users (%) 
Mean (SD) Number of 
users (%) 
 
 VEM intervention, days 7.8 (4.9) 33 (100) 6.1 (4.3) 38(100) - - - -  
 Daily therapy time, min 17.3 (3.5) 30 (91) 40.3 (22.3) 37(97) - - - -  
 Acute-phase hospitalisation, bed days 9.8 (8.0) 33 (100) 8.6 (9.4) 38(100) 10.5 (4.5) 16 8.5 (4.4) 16  
 Re-hospitalisation, bed days 7.6 (7.9) 8 (24) 6.5 (7.3) 6(16) 0.9 (1.9) 5 (35.7) 0  0  
 Rehabilitation or therapy at home, n 
sessions 
17.8 (18.8) 18 (55) 7.3 (5.6) 7(18) 6.1 (8.7) 8 (50.0) 3 (5.3) 5 (31.3)  
 Royal district nursing service, visits 3.4 (1.8) 5 (15) 12.0 (0.0) 1(3) 0 0 0 0  
 Home help, visits 4.5 (3.5) 2 (6) 2.5 (2.1) 2(5) 1.6 (5.4) 3(18.8) 15.9 (57.6) 3 (18.7)  
 Interim care arrangement, bed days 24.0 (33.0) 2 (6) 20.0 (9.0) 3(8) - - - -  
 Inpatient rehabilitation, bed days 38.1 (24.4) 21 (64) 32.4 (18.0) 13(34) - - - -  
 Outpatient rehabilitation, n sessions 3.4 (1.9) 13 (39) 7.8 (5.0) 9(24) - - - -  
 Home modification, n 2.3 (1.3) 12 (36) 2.0 (1.3) 8(21) - - - -  
 Adaptive equipment, n 4.1(2.9) 17 (52) 2.3 (1.7) 11(29) - - - -  
 Delivered meals, n visits 35.0 (42.2) 2 (6) 46.0 (0.0) 1(3) - - - -  
 Personal care assistance, n visits 11.9 (10.2) 4 (12) 5 (0.0) 1(3) - - - -  
 Change in accommodation, n - 5 (15) - 3(8) - - - -  
 Respite care - in home or residential, n 20.7 (22.1) 3 (9) - 0 - - - -  
 Productivity loss, h/week 30.0 (10.0) 3 (9) - 0 - - - -  
 GP visited, n visits - - - - 2.2 ( 2.5) 7 (43.8) 2.3 ( 5.2) 12 (75.0)  
 Informal carer visited, n visits - - - - 6.4 (11.3) 7 (43.8) 69.1 (240.2) 4 (25.0)  
 Other visited, n visits - - - - 0.9 ( 2.6) 2(12.5) 0.2 ( 0.4) 3 (18.8)  
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In AVERT phase II the first time to mobilisation from stroke onset was 
significantly shorter for the VEM group (median 18.1 hours; IQR 12.8 hours to 
21.5 hours) compared to that of the SC group (30.8 hours; IQR 23.0 hours to 40.0 
hours; p < 0.01). Similarly, in VERITAS the time to mobilisation was also shorter 
for the VEM group (median 27.3 hours; IQR; 26.0 hours to 29.0 hours) compared 
to SC group (median 31.8 hours; IQR 23.0 hours to 46.8 hours); however, this was 
not significantly different (Figure 4-11). In AVERT phase II the total dose of 
mobilisation (defined as therapy time) in the intervention period for the VEM 
group was double that of SC group (VEM 167 minutes; IQR 62 minutes to 305 
minutes versus SC 69 minutes; IQR 31 minutes to 115 minutes; p < 0.01). Dose of 
mobilisation was defined as the mean time spent upright in VERITAS, 61.3 (SD 
53.6) minutes and 42.2 minutes (SD 56.7) were observed in the VEM and SC 
group, respectively. The pooled analysis showed that the time to first 
mobilisation from symptom onset was significantly shorter among VEM patients 
(median 21 hours; IQR 15.8 hours to 27.8 hours) compared with SC patients 
(median 31 hours; IQR 23.0 hours to 41.2 hours).  
 
Figure 4-11 Time to first mobilisation (hours) by treatment group  
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Figure 4-12 displays the stratum specific ORs for each of the predefined 
subgroups for the primary outcome. There is some indication that some groups 
of patients may respond differently to the intervention. Therefore, this 
exploratory analysis supports the need for subgroup analysis to be included in 
future studies. As with all subgroup analysis, this analysis should be interpreted 
with caution as it was not sufficiently powered to detect interactions between 
subgroups. Additionally, the cut-off points were dictated by the small number of 
events occurring in the pre-selected categories. Reducing information in this 
way may underestimate the extent of variation in outcome between groups.158   
There was no evidence (subgroup test for interaction: p = 0.59) that VEM was 
more or less effective for patients aged <75 years (OR 1.40, 95% CI 0.45 to 4.37) 
than those of >75 years (OR 2.70, 95% CI 0.79 to 9.21). Similarly, there was no 
evidence (subgroup test for interaction: p = 0.36) to suggest that VEM was more 
or less effective for patients with a lower pre-morbid mRS score (OR 3.06, 95% CI 
1.21 to 7.72) than those with a higher pre-morbid mRS score (OR 0.86, 95% CI 
0.08 to 9.74). The analysis by baseline severity indicated a subgroup interaction 
(subgroup test for interaction: p = 0.04) with a greater odds of independence 
(with VEM) in the mild stroke group (5.50, [1.56, 19.41]) but not in those with 
moderate/severe stroke (0.72 [0.17, 3.01]).  
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Figure 4-12 Predefined subgroup analysis for independence at 3 months  
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Caution must be drawn when interpreting this subgroup analysis (see text for details). Comparing 
whether the effect in one subgroup is significant whilst not in another subgroup is not the 
recommended approach to determine differences between subgroups. It is the overlap of the CIs 
which indicates statistical significance, but as in Figure 4-12, the CIs can overlap by a small 
amount yet still have a significant test of interaction.149  
 
4.4 Discussion 
Summary of key findings: primary outcome  
This analysis has shown a favourable effect of VEM in acute stroke patients on 
independence at three months. By increasing the statistical power and adjusting 
for confounders known to affect patient outcome in stroke, this analysis has 
provided a more reliable estimate of effect than previously reported in the 
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individual studies.6 7  The notion that beginning rehabilitation early after stroke 
improves outcome has been examined over recent years with one study showing 
that early rehabilitation is associated with greater improvement in ADL.159 A 
further study showed that earlier admission to rehabilitation is linked to greater 
functional gains despite functional levels at baseline.160 These studies compared 
rehabilitation delivered within a later time frame (within 15 days and within 30 
days) than this study which investigates a specific mobilisation intervention 
within a more acute time frame.  
In both AVERT phase II and VERITAS, VEM patients received earlier and more 
frequent mobility practice than that routinely provided. The treatment effect on 
the primary outcome in both trials was in favour of VEM suggesting, along with 
evidence for the use of a fixed effect model (Mantel-Haenszel method), that the 
individual studies were estimating the same treatment effect. Differences in the 
size of effect did exist with VERITAS, also the single-centre RCT, estimating a 
larger treatment size than AVERT phase II. A number of factors could explain 
this, differences in trial design, study populations and the context in which the 
intervention was delivered. The treatment effects from single-centre trials are 
often larger than those produced by multicentre trials.161 Single-centre trials are 
associated with having a large treatment effects in meta-analysis, more 
homogenous populations than multicentre trials and linked to teams highly 
skilled in the intervention. The single-centre trial in this IPD MA was indeed the 
smaller of the two studies so may well provide a valid explanation and an 
important issue to consider when interpreting the results of a meta-analysis.  
Summary of key findings: secondary outcomes at one week 
Each secondary outcome will be discussed in the same order as presented in the 
results section. The impact that VEM had on stroke severity at one week was 
statistically non-significant, suggesting the intervention is not influential in 
modifying stroke symptoms. Another study which compared mobilising patients 
out-of-bed at 52 hours with a delayed protocol of mobilisation over six days in 
acute ischaemic patients showed no significant difference in neurological deficit 
at day five.162 The more important implication here is that VEM does not appear 
to be associated with neurological progression. Patients in both trials who 
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underwent VEM appeared to have a lower rate of complications associated with 
immobility. Reduction in immobility-related complications is one of the proposed 
mechanisms by which VEM may improve outcome.9 A significant reduction in 
immobility-related complications was only apparent at one week and when 
subsequent episodes were considered at follow-up, the effect of VEM seemed to 
have somewhat diluted. There were some signs of statistical heterogeneity 
between the trials on estimating this effect. This could be due to differences in 
outcome ascertainment suggested by the much larger number and variety of 
complications recorded in AVERT phase II compared to VERITAS. Diserens et al 
(2012) found no increase in complications, especially severe complications (deep 
vein thrombosis, pulmonary embolism, pneumonia and acute coronary syndrome) 
with a protocol that compared mobilisation at 52 hours post-stroke with delayed 
mobilisation.162 Fatigue experienced by patients post-stroke is believed to be 
either alleviated or aggravated by activity. In this study patients who were 
undertaking VEM were no more likely to report excessive fatigue than SC 
patients. This has important connotations with respect to implementing VEM 
whereby HCPs’ perceptions of patient fatigue and patient reported fatigue may 
be a potential barrier to mobilisation.  
Summary of key findings: secondary outcomes at three months 
Very early mobilisation did not have a significant effect on discharge destination 
in this study contrasting with previous suggestions that discharge home within 6 
weeks is linked to starting mobilisation early in the ASU.47 The rationale 
supporting expedited discharge is that patients receiving VEM walk sooner after 
stroke therefore are more likely to be discharged directly home as opposed to 
being discharged to a rehabilitation unit.163 In relation to death, although the 
number of patients that died in the VEM group was higher, after adjustment for 
key factors the risk of death was not any higher for VEM patients compared to SC 
patients. The impact of VEM on death rates along with the other clinical 
outcomes investigated in this study can only be addressed by a definitive trial.  
Patients who underwent VEM were more likely to have non-impaired mobility 
and independence in ADL at month three. This has important implications 
considering that regaining independence in activities such as walking after 
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stroke is thought to be one of the most important rehabilitation goals for 
patients.11-13 The CIs around these estimates were wide indicating some degree 
of uncertainty. Health-related quality of life was higher for the VEM patients 
than for SC patients. Only four out of 21 studies included in a systematic review 
(as reported in Chapter 6) showed a significantly different rating of HRQoL in 
patients who had undergone the stroke rehabilitation intervention under 
examination than those that did not. Although the instruments used to measure 
HRQoL were different between the studies included in the review, the domain 
most affected by the intervention was that relating to physical functioning. In 
this study patients that had undergone VEM did report a better HRQoL for the 
most comparable domain - independent living. Scores for the social relationship 
domain were rated as normal suggesting that patients in the VEM group believed 
that their health did not impact on relationships nor result in a feeling of 
isolation. The mean resource use on follow-up tended to be lower for VEM 
patients than for SC patients and where it was higher the actual numbers of 
patients using the service was no more than in the SC group. Information about 
informal care provided to patients after discharge from hospital was collected in 
VERITAS. This was stated as outwith the scope of study in AVERT phase II. How 
best to identify and define, measure and value informal care is a challenging 
area and identified as a shortcoming in many economic evaluations of stroke 
rehabilitation interventions (as highlighted in Chapter 6).  
Summary of key findings: process indicators 
Although time to mobilisation was shorter for VEM patients in both trials this was 
not significant in VERITAS. This may be due to the difficulty in recruiting 
patients to VERITAS very early after stroke with delayed hospital admission being 
one potential contributing factor. Not being able to access patients early within 
a trial setting made mobilising patients more rapidly than usual, challenging. 
This was particularly relevant for patients most severely affected whereby 
gaining consent from the nearest relative had further time implications. It 
should also be noted that once the patient was recruited and randomised in 
VERITAS there was no delay to commencing the first mobilisation with the time 
between randomisation to first mobilisation significantly smaller for VEM 
patients than SC patients. Implementation of the VEM protocol in AVERT phase III 
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is monitored using data reported by trial investigators about the dose delivered 
to trial patients. The trial headquarters then assesses these reports against the 
target VEM dose, as based on the intervention protocol, for that individual 
patient. Feedback is then provided to the trial investigator to advise them of any 
shortfall in the intended dose. Albeit, this discussion relates to implementation 
within the trial setting, if VEM is shown to be effective then the real life 
implementation of such a policy for patients more severely affected may be 
compromised. Severe patients are believed to have longer delay in admission to 
rehabilitation than patients with mild stroke and have a perceived lack of 
readiness for rehabilitation in the acute stages. These barriers are speculative 
and may not be restricted to patients with severe stroke. Further exploration of 
such barriers specific to VEM is required (forthcoming in Chapter 5). Combining 
data on the dose of intervention delivered in each of the trials was limited by 
the different methods used to measure activity/therapy in each of the studies.  
There were differences in how the intervention was implemented in each of the 
studies. In VERITAS very early mobilisation was largely nurse-led and was 
provided for a maximum of seven days (the time period in AVERT phase II was 14 
days or until discharge, whichever was sooner). The variation in the providers of 
VEM and the actual dose delivered in each of the studies could also be used to 
reason the difference in effect estimated by each of the trials, however is more 
likely a consequence of the smaller number of patients in VERITAS than AVERT 
phase II. Also, the majority of patients in the VEM group in VERITAS had a length 
of stay less than 14 days and in AVERT phase II the VEM intervention was, on 
average, delivered for six days. A previous meta-analysis investigating different 
intensities of physiotherapy showed, using sensitivity analysis, that the 
organisational setting was a factor that influenced outcome and additionally, in 
support of the previous point, studies conducted in different settings resulted in 
a smaller treatment effect than those conducted in one setting.102 
Strengths and limitations 
Individual patient data meta-analysis is considered more reliable than a meta-
analysis of aggregate data in that it increases the number of participants and 
often includes more outcomes than that considered in the original analysis. The 
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exact difference between meta-analyses based on extracting data from the 
literature and that based on the collection and re-analysing of IPD is not clear. 
The authors of one study in which a head-to-head comparison of these two 
approaches was conducted concluded that the results of a meta-analysis based 
on the literature alone may be misleading.164 A two-stage approach was used in 
this analysis as this was considered a more readily interpretable method, 
providing forest plots to visually assess differences between the studies in terms 
of magnitude and direction of effect. A post-hoc analysis comparing the 
unadjusted estimates using the two-stage analysis approach and a fixed-effect 
regression model gave the same estimate. The use of logistic regression to 
examine the evidence for subgroup interaction is an alternative test of 
heterogeneity to that used in this study. The interpretation of subgroup 
interaction parameters in multivariate models is more complicated. Whether 
tests for heterogeneity using aggregate data (i.e. Chi2 test for subgroup 
interaction) are less revealing than that when using IPD has yet to be concluded. 
With limited guidance about the most reliable approach to test for 
heterogeneity between subgroups in an IPD MA, choice may be driven by that 
more widely adopted and recognised for ease of interpretation.  
One of the main limitations of this analysis is the small sample size. The size of 
the overall treatment effect can therefore only be indicative. Given the small 
sample size of the individual studies, this pooled analysis should only be 
considered as an illustration of the method, rather than allowing any confident 
deductions to be made regarding the effectiveness of VEM. The ongoing AVERT 
phase III trial will determine the impact of VEM practices using a larger sample. 
The study samples did vary between VERITAS and AVERT phase III. The patient 
sample for VERITAS could be viewed as the result of selective recruitment with a 
low mean age of 65.3 years (SD 11.6), few risk factors for stroke and the 
majority of patients having mild stroke. The inclusion criteria did not have an 
upper age limit or restriction on baseline NIHSS score. However, the patient 
characteristics in VERITAS are largely representative of the local population 
(registry data, Chapter 2) rather than the result of highly selective recruitment.   
Very early mobilisation has remained largely undefined in the literature and 
distinguishing VEM from SC could prove challenging for some HCPs and is 
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discussed in more depth in the forthcoming qualitative study (Chapter 5). The 
IPD MA process of planning, sharing and collaboration in conjunction with the 
statistical findings from each of the trials provides confidence that the current 
definition of VEM (and as used in the ongoing AVERT phase III study) is 
implementable and reproducible in different countries. The opportunity that IPD 
MA has for demonstrating the replication of an intervention in different settings 
has implications for the research of complex interventions which traditionally 
lack definition. The fidelity of complex interventions has received particular 
attention especially with respect to the flexibility permitted to achieve the 
desired treatment effect.28 This is relevant for multicentre trials of complex 
interventions where the delivering and receipt of the intervention may vary.30 
An IPD MA also offers the opportunity to conduct extensive data checking and 
the collection of a more comprehensive set of data on all relevant outcomes. 
Additionally, IPD MA allows for subgroup analysis that otherwise may be limited 
or not possible if solely based on published summary data from the individual 
trials. Obtaining and analysing IPD can be both costly and time consuming. In 
summary, if such practice were to be more widely adopted the process of 
synthesising the evidence would be more transparent and robust.14  
The exploratory analysis of specific patient groups provided an opportunity to 
explore hypotheses around which patients may be most receptive to a protocol 
of VEM. Knowing more about the patients that may benefit most will assist in the 
planning of services and the cost-effectiveness of stroke rehabilitation. Using 
aggregate data from each of the trials a differential treatment effect by stroke 
severity was observed. Although prespecified, as with all subgroup analyses the 
finding should be interpreted with caution. Subgroup analysis is not based on 
randomised comparisons so potentially misleading. The planning and conduct of 
subgroup analysis should adhere to guidelines.165 Results from such multiple 
analyses from studies with small sample sizes are more likely to be chance 
rather than be a true effect. The number of subgroups used in the analysis was 
kept to a minimum limiting subsequent false-positive findings (type 1 error) that 
could be caused by multiple testing. The time horizon available used in this IPD 
was only three months; recovery may well go beyond this with some patients 
reporting spontaneous improvements up to and beyond one year post-stroke. 
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Future use of IPD meta-analysis 
There is a current movement towards prospective meta-analysis which identifies 
studies before any results are released from the individual studies (unlike this, 
although planned, IPD MA). This approach could overcome some of the 
recognised biases associated with retrospective (IPD) meta-analyses by pre-
specifying research questions, an analysis plan and prospective application of 
selection criteria. This approach is also more likely to result in the collection of 
IPD and thus access to data for all patients and outcomes. Prospective meta-
analysis also provides the opportunity to ensure that the same outcome 
measures and definitions are used in each of the studies. The advantage of 
prospective meta-analysis over IPD MA may be more of a pragmatic one; offering 
more scope for flexibility in and local ownership of the protocol. This may assist 
management of the issues associated with intellectual property of protocols 
between trialists, research institutes and countries. 
4.5 Conclusion 
This Chapter includes research that addresses the evaluation stage of the 
Medical Research Council complex intervention framework. When considering 
the lack of knowledge about the exact components of acute stroke units that are 
associated with positive outcome, this study has contributed to the evidence-
base of one of these key components. It has studied the potential impact of very 
early mobilisation (VEM) in relation to a number of important clinical outcomes. 
This analysis approach used has highlighted the value of researcher collaboration 
with deliberate matching of protocol and outcome measures to allow data from 
two similar trials of methodological quality to be combined. The results support 
the need for an appropriately powered trial (the ongoing AVERT phase III) with 
attention to potential confounders. AVERT phase III aims to recruit over 2,000 
patients. The ongoing AVERT phase III follows patients for one year post-stroke 
and uses inclusion criteria which are generalisable with no restrictions on 
severity or age. Therefore, VEM can be tested across a spectrum of patient 
types. This will allow a better understanding of which patients may be most 
receptive to a VEM protocol.
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5 Barriers and facilitators to implementing very 
early mobilisation 
5.1 Introduction 
Complex interventions are difficult to implement and the science underpinning 
the implementation of a complex intervention is not well established.29 166-168 
Implementing new practices into complex health systems poses additional 
challenges as it may involve collaboration between disciplines or organisational 
change.169 For example, aspirin for ischaemic stroke is recommended in 
guidelines. Achieving this recommendation is multifaceted requiring input from 
other clinical services to ensure access to a CT scan to exclude haemorrhage, 
the completion of a swallow assessment and the prescription of the first dose of 
aspirin. Therefore, although the evidence to support aspirin is undeniable, this 
guideline requires a careful implementation plan with more than one system and 
professional group needing to effect a change.170   
Effective implementation ensures the intervention is workable and integrated in 
everyday healthcare practice.31 Embedding qualitative research methods and 
adopting a mixed method approach are MRC guidelines for the evaluation of 
complex interventions. A study conducted by Lewin et al (2009) of a sample of 
RCTs which included qualitative research revealed that the most common 
methodology, when reported, used ethnography or a grounded theory 
approach.171 Most of the qualitative studies were conducted before or during the 
trial, however there was little attempt to use and integrate the findings of the 
qualitative study with the results of the main evaluation. 
As introduced in Chapter 1 a process evaluation conducted in parallel to a 
clinical trial allows the opportunity to examine the way in which the 
intervention under study is implemented during the main evaluation and 
integrating process data with outcome data allows for better interpretation.5 30 A 
number of process evaluations exist in the literature and cover many aspects of 
implementation such as identifying the factors that may influence 
implementation, in particular the factors which inhibit the 
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implementation (barriers) and those which augment the process (facilitators).172 
Barriers can be behavioural, organisational or financial. A lack of time, limited 
knowledge of the evidence, an absence of institutional policies and inadequate 
support have all been used to explain poor implementation.173 174 Factors 
facilitating implementation have included highlighting the advantages to those 
involved in the change, encouraging staff to participate in the change process, 
the presence of a research champion and education for staff.175 Process 
evaluations have also aimed to establish levels of satisfaction from those 
receiving the intervention, to measure implementation fidelity and understand 
the views of those delivering the intervention.176 177 
With regards to early mobilisation three studies have previously been conducted 
to investigate healthcare professionals (HCPs’) views of early mobilisation in 
acute stroke patients. Arias and Smith (2007) conducted a questionnaire study in 
Scotland which aimed to examine HCPs’ views of and knowledge about early 
mobilisation.178 This study concluded that staff had a lack of understanding and 
agreement about the principles of early mobilisation. Skarin et al (2011) and 
Sjoholm et al (2011) used a nine-item questionnaire to explore HCPs opinions of 
the benefits and harms of VEM after stroke.179 180 The main finding was that 60% 
of HCPs had concerns about early mobilisation, in particular for those patients 
with haemorrhagic stroke. There were differences in opinion regarding the 
optimal time point to start mobilisation with 40% in support of mobilising 
patients within the first 24 hours post-stroke. It included the opinions of HCPs 
(54%) who worked in other areas other than ASUs. Therefore, the findings of this 
study may not be entirely representative of the opinions of HCPs currently 
dedicated to the mobilisation of patients in ASUs. Due to the questionnaire 
design of the studies the reason(s) why HCPs had concerns about the early 
mobilisation of acute stroke patients and the differences between professional 
disciplines could not be fully explored. 
The clinical effectiveness of VEM has been investigated in Chapter 4. It showed 
that VEM has the potential to improve patient outcome at one week and three 
months post-stroke. However, if the results of the ongoing AVERT phase III 
concludes VEM to be effective it remains unclear how it will be implemented 
into routine clinical practice. In the early stages of studying implementation it is 
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important to understand current practice (problem areas and good practice) and 
identify potential barriers and facilitators to implementation (evaluation stage 
of the MRC complex intervention framework, Figure 1-1).  
Aim 
The aim of this qualitative process evaluation was to identify the barriers and 
facilitators which may influence the future implementation of VEM into routine 
stroke care. The beliefs that HCPs hold towards VEM, some of which may act as 
a barrier or facilitator, were also explored. Beliefs have been defined as ‘mental 
representations of the state of the world’.181 The wide scope and uses of process 
evaluations has already been acknowledged. This process evaluation focused on 
the identification of barriers and facilitators and on gaining an understanding of 
the beliefs that HCPs have towards VEM. 
Objectives 
The objectives were as follows:  
1. To identify the barriers and facilitators to implementing very early 
mobilisation in real-life for each stage of the stroke pathway (from pre-
stroke diagnosis through to acute stroke unit stay)  
2. To identify healthcare professionals’ beliefs towards very early mobilisation 
of acute stroke patients 
5.2 Methods 
5.2.1 Sampling strategy 
Different types of sampling in qualitative research exist including purposive, 
theoretical, opportunistic and convenience sampling. Sampling in qualitative 
research is non probabilistic and does not aim to be statistically representative. 
Instead sampling the units i.e. hospitals and people are selected to reflect 
particular characteristics of the population with the chances of selection of each 
element unknown. Purposive sampling, the method of sampling used in this 
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study, is where the selection of sampling units such as participants or settings is 
criterion based.182 These sampling units are chosen because they have certain 
features which allow detailed exploration of the topic under study. Examples of 
these features include socio-demographic characteristics or may relate to 
specific experiences. Decisions around sampling should be based on how broad 
reaching or rich the data should be. For example, if the sampling is about 
comparing two main aspects such as male/female and experienced/non-
experienced, then it is about generating deep and rich data whilst if the 
sampling is about getting a range of peoples’ views, then it is about generating 
broad reaching data. The approach to sampling in this study aimed to create 
both broad reaching and deep data. This allowed the views from different 
professional groups working in different hospitals to be captured yet allowed for 
a more in-depth analysis to detect any differences between the HCPs with 
experience of delivering VEM and the HCPs with no experience of delivering 
VEM. Therefore, the sampling frame aimed to include a range of hospitals, with 
and without AVERT phase III experience, from different health board areas 
(Table 5-1). Only hospital sites in the West of Scotland were included and for 
practical reasons those outside a feasible commutable distance were excluded. 
Lewin et al (2009) outlined the advantages of conducting a qualitative study 
during a trial as having the opportunity to unpack processes of implementation 
and change and to explore the responses of those delivering the intervention. 
Given that the AVERT phase III study is ongoing the timing of this study was 
appropriate and close to the actual event of implementation. 
Table 5-1 Factors considered for site selection  
Hospital 
ID  
Health 
board ID 
Experience 
of AVERT 
Type of 
stroke unit* 
 
Feasible 
commutable 
distance 
Included 
1    HB1  A,C   
2     HB1  B   
3    HB1  C   
4     HB2  C   
5     HB2  C   
6     HB2  C   
7 HB3  C   
8    HB4  C   
9     HB4  C   
10   HB5  C   
11   HB6  C   
12   HB7  C   
* A: Hyper-acute; B: Acute / semi-intensive; C: Comprehensive  
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Doctors, nurses, physiotherapists and occupational therapists currently working 
in the ASUs of the included hospitals (hospital IDs 1-9) were invited to 
participate in the study. Nursing assistants and therapy assistants were also 
included. Initial contact was made with the respective manager of each 
professional group to discuss the research and the practicalities of conducting 
the interviews. These individuals provided NHS Management approvals for each 
health board. The nurse unit manager was considered the primary gatekeeper in 
terms of accessing, identifying and recruiting nursing staff to the study. 
Therapists and doctors considered more autonomous than nurses were 
approached directly. All potential participants were issued with an information 
and willingness to participate form to be returned with their contact details 
within ten days if they wished to participate. A consent form was signed at the 
beginning of each interview/focus group. A copy of the information and consent 
sheets are in Appendix 11 and Appendix 12, respectively. Potential participants 
had the opportunity to ask the researcher questions during the conduct of the 
observational study (Chapter 3). As potential participants were aware of the 
researcher’s previous involvement in AVERT phase III in the capacity as Trial 
Manager any concerns about this research being an attempt to covertly gain 
‘inside’ information on trial conduct were alleviated by explaining the purpose 
of this research. A student role was adopted which also aimed to prevent 
participants being guarded about their opinions about the trial intervention and 
to provide some distance between the participants and the researcher during 
the interviews. The researcher led all the focus groups and interviews. 
5.2.2 Data generation 
There are a number of ways in which qualitative data can be generated such as 
focus groups or individual/paired interviews. Focus groups are a valuable means 
of gaining insight into participants’ perceptions and experiences.183 Focus groups 
stimulate interaction and by guiding participants through a set of topics allows 
the opportunity to observe how issues are conceptualised, worked out and 
negotiated.184 185 It was anticipated that the implementation of this intervention 
would be associated with processes that people do collectively therefore focus 
groups would provide a means to unravel these activities. Examples of such 
processes include shared decision making regarding a patient’s potential for 
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mobilisation or staff working together to assist a patient to mobilise for the first 
time. As VEM is likely to involve a number of different members of the stroke 
team, each focus group, where possible, consisted of a mix of nurses, therapists 
and doctors, to capitalise on peoples’ different views within a group setting. The 
group size recommended for a successful focus group ranges from four to 12 
individuals to eight to 12 individuals. This study aimed to have focus groups 
consisting of between six to eight individuals to allow ample speaking time. 
However, due to the difficulty in releasing staff from the ward to participate in 
the research, the number of participants in each focus group was actually 
between three and four. Similarly, difficulties in releasing nursing staff from 
ward responsibilities to attend a focus group at some hospitals resulted in paired 
interviews with therapy staff being conducted. Paired interviews proved 
beneficial in providing more space for thinking and allowing the participants to 
complement each other’s responses and stories. 
As a result of the sampling strategy the focus groups/paired interviews consisted 
of pre-existing groups/pairs which are seen as advantageous in setting a more 
comfortable scene allowing participants more freedom and confidence to raise 
sensitive issues or opposing opinions. On the other hand this may also limit 
groups or individuals who disagree in the workplace with respect to feeling 
inhibited in the group discussion. 
Each consenting participant was provided with written confirmation of the date 
and location of the focus groups. A reminder letter was sent to the participant 
by mail or email seven days prior to the focus group. A one page demographic 
questionnaire was enclosed to be completed prior to attendance. Participants 
were also provided with a scenario questionnaire which required staff to rate 
the appropriateness in turn of three different mobilisation strategies for both 
haemorrhagic and ischaemic stroke. This approach is based on a consensus 
method known as the ‘appropriateness criteria’ where different scenarios known 
to affect decision making around implementing a certain technology are 
presented. The expected time of completion of these two activities was 15 
minutes. It was planned that participants would be provided time at the 
beginning of the session to complete these questionnaires if need be. This 
occurred in the majority of cases, with the participants forgetting or having a 
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“lack of time” to complete the questionnaires. The questionnaire proved to be 
difficult for HCPs to complete as a stand-alone exercise prior to attending the 
focus group. Instead, the questionnaire was used as a tool for discussion during 
the focus groups. 
It has often been viewed that involving professionals from different disciplines 
may potentially inhibit those that are in the company of more dominant 
professions. Whilst based on the stroke units for the observational study it 
became obvious that there were differences in practices and opinions between 
professional disciplines. Additionally, it is recognised that doctors are not 
actually involved in the conduct of mobilisation, so may have different beliefs 
from those staff that mobilised patients on a daily basis. Therefore, to ensure 
professionals felt comfortable during their participation in the study semi-
structured interviews were held with doctors as opposed to inviting them to the 
focus group. There was an opportunity to have informal discussions with nursing 
assistants about participating in the focus groups. Nursing assistants decided 
against participation, believing that they would not have anything to offer and 
that they would feel “uncomfortable” in the presence of trained staff. Due to 
time-constraints it was not an option to hold separate focus groups for nursing 
assistants. Nursing assistants were still encouraged to take part and it was 
emphasised to the nurse manager that these staff members were not excluded 
from taking part.  
An interview schedule was used to ensure that topics were covered in a 
consistent manner yet flexibility was still allowed. The interview schedule 
previously used in the Stroke Care Outcomes: Providing Effective Services study 
was used to inform the questions in this schedule.186 The interview schedule 
(Appendix 13) included three main sections: 
1. Current stroke service to capture information about the organisation and 
context of the ward 
2. Mobilisation practices to gauge perceptions of very early mobilisation in 
relation to associated benefits, risks and value 
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3. Changes that have occurred in stroke care to assess the factors that may 
influence the implementation of very early mobilisation 
A pilot study consisting of one focus group (one nurse and two physiotherapists) 
was conducted on the 8th October 2010. This hospital (ID 7), was later excluded 
from the main study. The fluency of the interview schedule was tested, 
ambiguous questions were identified and the quality of recording equipment was 
checked. The interview was transcribed verbatim and the responses examined to 
ensure that the data collected during the pilot met the research aims. The pilot 
study did not highlight any major concerns regarding the conduct of the 
interview. Changes were made to the ordering and the wording of some of the 
questions and the addition of the following question: “Imagine that next week in 
the unit you had to start mobilising nearly every patient within 24 hours post-
stroke what would you need to do this?” 
Focus groups were conducted with nurses and therapists between December 
2010 and May 2011, in a pre-booked room within or near to the ASU at the staff 
member’s place of work to maximise attendance and situate the participants 
with familiar and convenient settings. The focus groups were recorded using a 
digital recorder. An introduction was provided at the beginning of each group 
detailing the background, purpose and confidentiality of the research. The aim 
of the study was explained to participants and that this was an opportunity for 
them to discuss the process of care offered within their units in particular their 
mobilisation practices. Discussion was facilitated to encourage involvement from 
all the participants and to probe any responses where appropriate. The focus 
groups lasted for one and half hours. 
Semi-structured interviews were conducted with doctors between December 
2010 and May 2011. Interviews were conducted using the same schedule as the 
focus groups and were semi-structured in nature so as to remain open to 
discussion beyond the specific interview questions yet maintain focus on the 
topic.  
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5.2.3 Data analysis 
There are a number of methods that exist to analyse qualitative data such as 
content and grounded theory which are based on the epistemological (nature of 
knowledge and how it can be acquired) approach used to address the research 
question. Content analysis examines both the content and context of data with 
themes being linked to external factors such as age and gender.187 Grounded 
theory develops analytical categories and identifies relationships between them 
with this process continuing until categories and relationships are ‘saturated’, 
and new data no longer contributes to theory under development.188 Thematic 
analysis, the choice of analysis in this study, “is a method for identifying, 
analysing, and reporting patterns (themes) within data”.189 Thematic analysis 
was seen as an appropriate method to both reflect current stroke practices yet 
unpack ‘the surface of reality’.189 Framework analysis is a matrix based analysis 
which allows transparent data management to ensure that all the stages of data 
development can be systematically constructed.190 
Immersion in the data was achieved by listening to the interview recordings and 
by reading the full set of transcripts in entirety and repeatedly. The first three 
focus groups were transcribed verbatim with the remainder of the recordings 
being professionally transcribed verbatim. Transcribing provided the opportunity 
to take an early analytical mind to the data, improve interview style in terms of 
fluency, to seek definitions and ensure the effective use of prompts in future 
interviews. Transcripts were checked against the original audio recordings for 
accuracy. Separate field notes were made throughout the coding process about 
recurring themes, impressions of the data and questions to follow-up on. Where 
participants used a particular tone or placed emphasis, annotations were 
inserted in the transcripts.   
Codes were used to categorise similar text together. Thematic coding is a multi-
step procedure. Concepts or codes were assigned to the empirical data codes 
and were initially formulated as close to the text as possible and then became 
increasingly more abstract.191 The codes were than categorised into generic 
concepts and relationships between the categories were developed.191 There 
were no restrictions to the number of times that the extracts were coded. The 
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second coder (NB) read and coded a subset of transcripts. The coding was 
discussed to define and identify any overlap of codes using the initial version of 
the coding framework. Thereafter, a second version of the coding framework 
was devised whereby NB applied this to a different subset of transcripts to test 
the interpretation of the codes. Barriers and facilitators were identified both 
directly from the relevant sections of the transcripts i.e. participants responses 
to question 7 of the interview schedule, and by adopting a more implicit 
approach. For example, staff when discussing current stroke processes (in 
response to question 1 of the interview schedule), highlighted how delays in 
discharge plans impacted on bed availability and thus admission of new patients 
to the ASU, this was then implicitly coded as a barrier to VEM (‘delayed 
admission to the ASU’). Prevalence data to gauge the importance of each of the 
barriers and facilitators were not provided (see discussion).  
Themes were subsequently developed from patterns in the data such as 
“conversation topics, vocabulary, recurring activities, meanings, feelings, or folk 
sayings and proverbs”.192 The transcripts were initially read through to identify 
emerging and recurring themes. This was an iterative process of arranging codes 
into broader interpretations, discussing emerging themes and writing up of 
ideas. Analysis moved from the specific (detailed analysis of each transcript) to 
the more general (comparing patterns across all the transcripts). The barriers 
and facilitators that had been identified and coded were interrelated (a 
facilitator was often the reverse of a barrier) and were more general contextual 
factors. Therefore, the barriers and facilitators were interpreted together and 
more broadly within the themes. To represent the keyness of a theme the 
following terms were used: ‘the majority of staff’, ‘many staff’, or ‘a number of 
staff’. The analysis, as well as identifying the themes, also detected differences 
between professional groups and experiences of delivering the intervention 
within a trial setting.  
The focus groups were analysed in the same way as the interviews, and with 
particular attention given to the additional aspects that need to be considered 
when analysing data from group discussion as opposed to individual interviews. 
These aspects include group dynamics, interactions and the influence of other 
views.190 Group dynamics is describing how certain events may affect the way in 
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which the topic of interest is discussed such as what and how it is said. 
Interactions are exchanges that occur between group participants to affirm or 
disagree. The influence of other views is where participants have the 
opportunity to listen and engage in different viewpoints from others. This 
allowed the identification of challenges or consensus between participants.  
The literature was interspersed with the findings to provide background and to 
develop theories about the data. The final themes derived from the data were 
linked together using three headings (specification of the intervention, 
organisational characteristics and provider characteristics) to achieve a coherent 
and detailed narrative based on the experiences of the participants. Themes 
were described under the relevant heading with extracts which best illustrate 
the theme provided. Descriptors for each extract are provided in parentheses. 
These include participant ID, profession and experience of VEM (‘non-VEM’ refers 
to participants with no experience of delivering the trial intervention and ‘VEM’ 
refers to participants with experience of delivering the trial intervention). The 
‘experience of VEM’ descriptor was not applicable for quotes from doctors or 
from specialist nurses. Where extracts were conversations from paired 
interviews or focus groups the interview ID (as featured in Table 5-2) was 
provided under the quote. The term ‘staff’ is used interchangeably with ‘HCPs’ 
and includes all participants. The term ‘therapist’ refers to physiotherapists and 
occupational therapists. Nvivo software (version 9) was used to code the data. 
5.2.4 Ethics and management approval 
Ethical approval was granted by the West of Scotland Research Committee on 8th 
October, 2010. Research and Development Management approvals were granted 
on 21st October 2010, 17th January 2011, and 28th January 2011 for each of the 
three health board areas. Two substantial amendments were subsequently 
approved; the first amendment was to approve the changes of the interview 
schedule after the pilot study and the second to approve the use of semi-
structured and paired interviews in the study design.
Chapter 5 
 
153 
5.3 Findings 
5.3.1 Participants demographics 
Thirty-one HCPs from seven different hospitals and across three health board 
areas participated in the study. Four of the hospitals had been previously or 
were currently involved in AVERT phase III. Several attempts were made to 
arrange interviews with staff from the other included hospital, however these 
were unsuccessful. In total, six focus groups and seven semi-structured 
interviews, three of which were paired, were conducted. All of the focus groups 
comprised of a mix of nurses and therapists. Two out of the three paired 
interviews conducted were with two therapists with the remaining paired 
interview conducted with one nurse and one physiotherapist. The composition of 
these groups is provided in Table 5-2 along with a full list of participants with 
focus group/interview ID professional group and VEM experience. 
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Table 5-2 Characteristics of participants 
 
 
 
 
 
 
Focus group/interview ID∗ ID∗∗ Profession VEM experience∗∗∗ 
F1 1 Physiotherapist VEM 
F1 2 Stroke Specialist Nurse NA 
F1 3 Nurse VEM 
F1 4 Physiotherapist VEM 
F2 5 Stroke Specialist Nurse NA 
F2 6 Physiotherapist Non-VEM 
F2 7 Occupational Therapist Non-VEM 
F2 8 Occupational Therapist Non-VEM 
Interview 9 Doctor NA 
Interview 10 Doctor NA 
Interview 11 Doctor NA 
F3 12 Physiotherapist VEM 
F3 13 Nurse VEM 
F3 14 Nurse VEM 
F4 15 Occupational Therapist Non-VEM 
F4 16 Occupational Therapist Non-VEM 
F4 17 Occupational Therapist Non-VEM 
F4 18 Nurse VEM 
F5 19 Physiotherapist VEM 
F5 20 Nurse VEM 
F5 21 Nurse VEM 
Interview 22 Doctor NA 
PI 1 23 Physiotherapist Non-VEM 
PI 1 24 Nurse Non-VEM 
PI 2 25 Occupational Therapist Non-VEM 
PI 2 26 Physiotherapist Non-VEM 
PI 3 27 Physiotherapist VEM 
PI 3 28 Physiotherapist VEM 
F6 29 Physiotherapist Non-VEM 
F6 30 Nurse Non-VEM 
F6 31 Occupational Therapist Non-VEM 
∗      “F” refers to focus group, “PI” refers to paired interview 
∗∗     “ID” refers to participants individual identification number 
∗∗∗  “VEM” refers to experience of delivering very early mobilisation within trial setting. “Non-
VEM” refers to no experience of delivering very early mobilisation. 
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The highest proportion of HCPs were female and were aged between 31-50 years 
(Table 5-3). The therapist group (54.9%) comprised of physiotherapists (35.5%) 
and occupational therapists (19.4%). Two of the 10 nurses were stroke specialist 
nurses. No nursing or therapy assistants participated in the study. Most HCPs had 
worked in their current position for less than six years and had worked with 
stroke patients for greater than 10 years. 
 
Table 5-3 Demographics of participants 
Characteristic Number (%) 
Age (years)  
≤30 5 (16.1%) 
31-50 22 (71.0%) 
≥51 4 (12.9%) 
Gender  
Male 4 (12.9%) 
Female 27 (87.1%) 
Profession  
Doctor 4(12.9 %) 
Nurse  10(32.2 %) 
Occupational Therapist   6(19.4 %) 
Physiotherapist 11(35.5 %) 
Length of time in present position (years)  
<6 18 (58.3 %) 
6-10 9 (29.0 %) 
>10 4 (12.9 %) 
Length of time worked with stroke patients (years)  
<6 10 (32.3 %) 
6-10 7 (22.6 %) 
>10  14 (45.1 %) 
Accredited education/training specific to stroke  
No  11 (35.5 %) 
Yes 20 (64.5 %) 
Experience of VEM  
No  13 (41.9%) 
Yes 12 (38.7%) 
NA∗ 6 (19.4%) 
∗ Includes all doctors and 2 stroke specialist nurses not expected to deliver VEM. Two 
doctors and one stroke specialist nurse worked at hospitals involved in AVERT phase III. 
 
Specification of the intervention 
The themes in this category focus on the definition of VEM and if and how it can 
be distinguished from current mobilisation practices.  
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The themes that are covered are as follows:  
• Defining the intervention 
• Accessing patients within 24 hours 
• Mobilising patients more frequently 
The demands that VEM may have on current stroke processes were explored and 
the associated barriers and facilitators identified. This allowed the assessment 
of how congruent the intervention is with current stroke practices.  
5.3.2 Defining the intervention  
Staff defined their current practice as early mobilisation, believing that they 
already mobilise patients early after stroke; “I don't think it's [VEM] something 
that we don't do at the moment” was the immediate response from the majority 
of participants. The key identifiers used to differentiate VEM from other 
mobilisation practices were the 24 hour timeframe of the first mobilisation and 
the increased frequency of mobilisation practice. Differentiating between 
current mobilisation practice and VEM was not always straightforward for staff. 
Staff from hospitals not participating in AVERT phase III interpreted the 
timeframe as 24 hours from hospital admission to the stroke unit not from the 
onset of stroke symptoms. In addition, the reliability of determining this 
timeframe underpinning the intervention was questioned.  
“…if you try to qualify that then it is a very rare person that you can 
actually get a true time of onset…its a very very small proportion and a lot 
of people wake up with strokes…so who knows?...” 
(ID 5, Stroke Specialist Nurse) 
The exact reason for adopting this current practice of early mobilisation was not 
clear, yet, appeared to have been developed via clinical experience and the 
opinions of clinical leaders, with staff giving the impression that this is just what 
we do. A recent questionnaire survey revealed that most stroke professionals did 
not require high-level evidence to justify the need for certain practices such as 
VEM.180  
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“I know when I was an SHO [Senior House Officer] people did seem to sit 
around a lot longer, but I’m not sure what their thinking was or there just 
was no thinking about it. I don’t, I don’t know.” 
(ID 11, Doctor) 
Occasionally the terms ‘mobilisation’ and ‘therapy’ were used interchangeably 
with staff often correcting themselves as illustrated in the following extract. 
“I say therapy but actually it’s mobility, it’s different.  Because therapy is 
the therapist, mobilities, everyone, so what I mean is they should be 
mobilised as much as we can all do with them.”  
(ID 10, Doctor) 
Nurses and doctors were the only professional groups that openly questioned 
what was meant by mobilisation in relation to the intervention: 
“What are the mobilisations? if it's a…somebody who is walking with one, 
you walk to the nurses station and back again, doing that twice a day, then 
yes, we could do that without additional nursing staff.”  
(ID 18, Nurse, VEM) 
 Or whatever mobilisation is, um, as soon as possible.” 
(ID 22, Doctor)  
5.3.3 Accessing patients within 24 hours 
Gaining access to patients within 24 hours of stroke onset was the main barrier 
to delivering VEM identified by participants. Patients were not routinely in the 
ASU within this timeframe, due both to delayed patient presentation to hospital 
and delayed diagnosis of stroke (and so a delay in transfer to the stroke unit). 
The success of the stroke referral pathway was dependent on the individuals 
operating the system. Adherence to stroke referral protocols and being able to 
make a rapid stroke diagnosis was heavily reliant on the level of experience the 
admission staff had in managing stroke patients. Stroke consultants, liaison 
nurses and managed clinical networks had invested effort, with some success, 
into making stroke protocols visible and to train front door staff and bed 
managers about the importance of getting patients with a diagnosis of stroke 
into a dedicated stroke unit. The system was still prone to delays in diagnosis, 
inappropriate referrals and break-downs in communication resulting in delayed 
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admission to the stroke unit.  
“I think our problem arises more when we actually can't get them into the 
unit within the 24 hours.”  
(ID 19, Physiotherapist, VEM) 
Delayed patient presentation to hospital was experienced by all of the hospitals 
and viewed as out of the control of HCPs expected to deliver VEM. Staff from 
three hospitals experienced delays in admitting patients to the ASU, often due 
to the lack of bed availability as a consequence of delays in discharge. Nurse 
unit managers and doctors negotiated with bed managers, often transferring a 
patient out of the ASU to make a bed available for a new patient. Staff with 
experience of VEM overcame this challenge by conducting the first mobilisation 
for trial patients outside the unit, however, they highlighted that this was for 
the purposes of a trial protocol. Therefore, this approach would require ward 
staff to work outside the ASU and therefore could not be easily implemented 
beyond the trial and into everyday practice.  
Even a rapid diagnosis of stroke followed by immediate admission to the ASU 
may not guarantee mobilisation within 24 hours of the stroke event as it further 
depended on the patient’s time of arrival to the ASU and staff availability. 
Subsequently the majority of staff questioned the workablility of VEM in routine 
practice. Some discussion was given to the feasibility of educating staff outside 
the ASU specifically in VEM, yet there was an appreciation that these non-stroke 
specialist staff already had a range of medical conditions to manage and related 
protocols to implement.  
ID 21: “…if you are educating staff down there in the ARU but stroke is not 
their priority.   
ID 20: They’ve got a lot to do. 
ID 21: They have so many priorities down there…” 
Focus Group 5 (ID 19 – Physiotherapist; VEM, ID 20 – Nurse, VEM; ID 21 - 
Nurse, VEM) 
Interestingly, out-sourcing the task of first mobilisation was considered to 
potentially dilute stroke care as a speciality. 
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“…whereas you know the physio or whoever it is in that ward is not a 
specialist in stroke, may not be confident, you know, to, you know, to 
assess and then to get that patient up, erm, so training issues and, you 
know, do we want them doing that because then is it taking away from our 
speciality, erm, you know, if they can do it well why do we need to come 
here, erm, so I guess if we can get them here ASAP, but I don’t know.” 
(ID 29, Physiotherapist, non-VEM) 
Alternatively, a doctor suggested that if patients were not getting to the unit in 
time then an outreach facility to provide specialist stroke input to medical 
receiving units could overcome these difficulties. 
“…um, or, outreach to the receiving units and do more there, um, because 
at the moment, a large chunk of our patients are still in the receiving unit 
within that 24 hours – you know, if the guidelines said it had to be within 
24 hours, then we would have to raise our game a little bit from that 
perspective.”  
(ID 22, Doctor)  
Opinions of staff were dependent on the organisation of stroke care within each 
of the hospitals in which they worked. For one particular unit seeing patients 
within 24 hours of stroke onset was atypical which made it difficult for staff to 
even speculate about mobilising patients within this more acute time frame. 
R: “I think going back to what you said really the 24 hours we probably 
don’t get that many people…we do get some but not many so really our 
answers are a bit flawed…I think we cant really honestly answer. 
I: But if you could access patients within 24 hours…  
R:…but you would need to know what there are like in that 24hours and I 
don’t know if the experience is there to know that possibly….do you know 
what I mean?” 
(ID 5, Stroke Nurse Specialist) 
5.3.4 Mobilising patients more frequently  
Most staff believed that increasing the level of mobilisation undertaken by 
patients would be challenging. Once admitted to the ASU accessing the stroke 
patient in between the routine proceedings of the ward such as ward rounds and 
protected meal times was considered to be an obstacle to direct patient contact 
and provision of therapy as practice stands now, let alone increasing 
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mobilisations. Patients were frequently away from the ward for tests, often staff 
not knowing exactly what test they were away for and when they were expected 
to return.  
“I find the patients’ days a pretty well…they’re absolutely packed full of 
stuff because, you know, you can’t, you can’t go near them when they’re 
eating their meals now…”.  
(ID 11, Doctor) 
This resulted in failed attempts to access patients throughout the day. In these 
cases accessing patients was considered to be opportunistic rather than planned, 
often in parallel with other staff waiting to see the same patient (this is further 
explored in the “unpredictability and planning” theme).  
“…and probably more often than not therapists want to see them at the 
same time as well, so, you know, it’s just trying to fit in your timetable 
with patients as best as possible”.  
(ID 30, Occupational Therapist, Non-VEM) 
Organisational characteristics 
The themes within this category describe how characteristics of stroke units may 
affect the operationalisation of VEM. The themes that are covered are as 
follows: 
• Environment 
• Unpredictability and planning  
• Teamwork 
• Resources 
• Time 
• Evidence-based practice 
• Organisation norms to change 
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Staff perceived a need for additional resources to support VEM and that the 
collective contribution from the MDT and the enrolment of key players such as 
hospital managers for the successful implementation of VEM. The usefulness and 
effectiveness of implementation strategies such as champions are discussed and 
illustrated using other acute stroke interventions recently introduced to the 
hospitals. 
5.3.5 Environment 
Participants described the ambience of the units in a positive manner, with staff 
taking pride in what they do and the staffing structure frequently referred to as 
non-hierarchical; as one HCP noted “everyone speaks to everyone”.  
“I think that most staff are positive about their jobs on the unit. Obviously 
I can only speak for myself but I enjoy coming to work and when you come 
in it’s a friendly atmosphere and I get the impression that everyone else 
actually enjoys being here and working because everyone puts in maximum 
effort.” 
(ID 6, Physiotherapist, non-VEM) 
The atmosphere in the stroke units was distinguishable from that of other 
specialities mainly due to the noticeable respect that staff had for each other’s 
roles, MDT working and the shared decision making. Participants believed that 
everyone’s opinion was valued unlike other departments where, for example, 
occupational therapy was viewed as a tick box exercise. 
“Because you see a different respect for the medical staff as well and 
they, they very much respect everybody in the team here, it's not the case 
that I'm God, what I say goes, it's not like that.  We respect everybody’s 
opinions and I think that's a big, big thing.” 
(ID 21, Nurse, VEM) 
The physical layout of wards was not seen to be conducive to patient 
mobilisation. The general design of hospital wards and in some cases 
unattractive facilities did little to encourage patients to mobilise beyond the 
bedside or from the ward to other areas such as dayrooms.   
 “It's too far to walk to the toilet, so actually they, they’ve got no 
opportunity to do any additional mobilisation”. 
Chapter 5 
 
162 
(ID 19, Physiotherapist, VEM) 
Lack of space was a big issue especially in terms of therapy and areas around the 
bed space making it cumbersome and time consuming to assist a patient out-of-
bed. Staff competing for space with other members of the team and using 
spaces not intended for therapy was a frequent occurrence. A lack of quiet areas 
and privacy was a feature common to many of the wards. Dedicated therapy 
staff having offices and therapy rooms located near to or on the stroke unit was 
viewed favourably in terms of being able to communicate easily across 
disciplines. 
“So yes, I think obviously as a team that works quite well, probably 
because, like you’re saying as well, that we are kind of close in vicinities 
to one another; it’s not like we’re in another part of the building, so 
you’re having to try and trace us down to find things out. That works quite 
well, it works well in every unit where everyone’s based.” 
(ID 30, Occupational Therapist, non-VEM) 
5.3.6 Unpredictability and planning 
The medical condition of a stroke patient was viewed by staff as unpredictable 
with improvements or deterioration evolving quickly and unexpectedly requiring 
staff to take immediate action and taking precedence over what they were 
currently doing or planning to do. Constant assessment by the individual HCP and 
the team was as an aspect of care that staff frequently referred to, ensuring any 
changes were detected early and acted upon. As already noted, issues such as 
not knowing when a porter was going to arrive to take a patient off ward to 
attend a medical test contributed to this unpredictable environment. This 
required nurses and therapists to have a flexible approach to change their plans.  
“You might have a plan in your head as to where you want to go but then 
that day it might not be appropriate you know to take them up to the 
kitchen or something because they are not well enough, they have had a 
bad night or something or it really varies you have to be quite flexible to 
change your plan quite quickly depending on the outcome of the meeting 
in the morning or during the day how the patients are.” 
(ID 8, Occupational Therapist, non-VEM) 
In addition to this unpredictability, HCPs had to contend with the variable 
nature of stroke. Most staff emphasised that the effects of stroke differ 
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markedly between patients in relation to the level of impairments and 
disabilities, rehabilitation requirements and responses to treatment. Therefore, 
to assess the appropriateness of VEM these patient factors would need to be 
assessed on an individual basis. This made it difficult to provide opinions about 
the general appropriateness of getting patients up earlier and more frequently. 
The recovery pathway for patients post-stroke was viewed as uncertain, often 
ambiguous with differences in opinion existing, in particular around the 
maximum time horizon for recovery. Nurses believed doctors focused on a three 
month time point while they, along with therapists, believed that the timescale 
for recovery was closer to one year. Staff also accepted that stroke patients may 
well have unexpected outcomes. 
“We've had people that we just didn't think would do at all [well] 
and...Aye, [it may end-up that patients unexpectedly] walk out. Maybe 
with a Zimmer right enough…” 
(ID 12, Nurse, VEM) 
A ward timetable, prepared one day in advance, was used at one of the hospitals 
to provide structure to the daily organisation of the ward. The timetable allowed 
the medical tests, therapy or dressing practices that the patient was scheduled 
for that day to be highlighted. This informed ward staff when the patient was 
likely to be off the ward providing an opportunity for staff to plan and time 
manage more effectively. It did not prove popular with staff from hospitals not 
currently employing such a system, believing that the unpredictable nature of 
the ASU would make it difficult to apply such a timetable. 
“In acute, when they’re moving as quick and it’s really hard to then kind 
of make a timetable up even for the day, because things can often change 
pretty much all the time in your day as well, so there’s a lot of things 
going on.” 
(ID 31, Occupational Therapist, non-VEM) 
One doctor believed planning between physiotherapists and nurses was pivotal 
to integrating more mobilisations into the patient’s day. This doctor was new to 
the working of this particular stroke unit and may not have been fully aware of 
the detailed daily communications about the plans for the patient’s day that 
were frequently mentioned by some nurses and therapists at this same hospital. 
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Nurses and therapists communicated routinely in the morning as a way of 
receiving an update on new patients, any changes in a patient’s condition and to 
be informed of, or co-ordinate the patient’s schedule for the day. This resulted 
in more effective use of time, for example organising the transfer of a patient 
who was scheduled for a medical test that day. 
ID 3: “The other thing that influences it is what investigations they are 
undertaking….obviously they have just been admitted and they have come 
in the last few days and they have a lot of investigations to get done and 
sometimes ‘Mrs so and so is going for a scan and she will be going in a 
trolley so lets not get her upright now lets wait till she has been for a scan 
and get her up later’ 
ID 4: Or we will get her up and put her back to bed.” 
Focus group 1 (ID 3: Nurse, VEM; 1D 4: Physiotherapist, VEM) 
5.3.7 Teamwork 
Getting the patient out of bed for the first time involved a team approach to 
assess the patient’s suitability for mobilisation, delegate the appropriate 
professional expertise and to risk assess. Staff stated that the MDT was a key 
aspect of stroke care. Although not specifically asked to define MDT working it 
included references to role definition, shared decision making, joint assessments 
and communication between different professional disciplines and patients. 
There was trust and respect for each professional group’s experience, 
competencies and perspective. 
“I would probably get a patient to the edge of the bed, but I wouldn’t try 
and stand them, but I would do that if I was wanting to see what their 
balance and things was like, but obviously you probably, you know, liaise 
with the physios as well, just about what, you know, from a therapy point 
of view where we’re at should be similar but different perspectives 
really”.  
(ID 31, Occupational Therapist, non-VEM) 
Staff acknowledged that although they were quite often on ‘the same page’ it 
was the ironing out of disagreements to achieve a consensus which demonstrated 
the strength of MDT working. One example frequently used to illustrate MDT 
working in practice was discharge planning. 
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“No, I think we do kind of all come and ask each other before we send, 
maybe bar some people… but people home and things too; you know, we 
go round everybody rather than… it’s not one person’s decision, it’s 
definitely a team decision.” 
(ID 30, Nurse, non-VEM) 
Methods of communicating a patient’s level of mobility amongst the stroke team 
included MDT meetings, written patient notes, bedside mobility charts and 
morning meetings. All units had at least one main MDT meeting a week where 
information about patients was exchanged and despite daily communications, 
were still viewed to be the place where key decisions were made. Nurses viewed 
these meetings as a landmark in the week in terms of getting information in 
place before the meeting and ensuring they had a good grasp of the patient’s 
medical history and expected care pathway.  
“…or we have a plan, as you say, and sort of say, ‘Well, I'm going to take 
them on stairs today.’  And then the OT is saying, ‘Well, I'm going to do 
access visits’, so you're kind of ahead of the case conferences.  They're 
(the doctors) wanting answers at the case conference, not a, not a big 
debate, do you know.  They want answers about, do you know, can they 
go, are they going with [care packages]...what is it they're going home 
with?” 
(ID 12, Physiotherapist, VEM) 
Daily communication amongst the members of the MDT was an integral part of 
stroke care and often starting with mini-MDT exchanges first thing in the 
morning (between nurses, therapists and, depending on the hospital, medical 
staff), during ward rounds (nurses and medical staff) and after ward rounds 
(nurse and therapists). Morning mini-MDT meetings in the majority of units had 
evolved over time whilst other units had deliberately introduced them. With 
immediate updates about new patients or changes in medical or mobility status 
they were seen to have several advantages such as mobilising new patients 
quicker or expediting discharge. 
“…I think the HP staff come in and out a bit, and I think there is a…quite a 
lot of changing over because…to cover leave, so it’s more I think just so 
everyone gets a chance to know who’s about and what’s going on, to flag 
up problems, perhaps to try and move discharges on a bit quicker, perhaps 
to try and get people mobilised a bit quicker. didn’t always have medical 
input at this which was OK for some patients but not for others.” 
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(ID 11, Doctor) 
Communication was not always seamless and a break-down in communication 
between nurses and therapists, as a result of MDT meetings often having no 
representation from nursing staff, caused particular tensions in the atmosphere 
and ward standard practices not being adhered to. 
I: “So sometimes you'll go and the patient's already dressed? 
R: Sometimes, 90 percent of the time, other than sticking a flashing neon 
light on the poor patient's head to say for ‘dressing practice’, I don't know 
how we're ever going to overcome it. I've been in this ward for eight years 
and I still can't get dressing practices.” 
(ID 25, Occupational Therapist, non-VEM) 
Joint assessments between physiotherapists and occupational therapists were 
beneficial in avoiding duplication in assessments, prevent patient fatigue and to 
assist mobilisation of a more severely affected patient.  
“…we might want to do joint work together, because we’re doing some 
similar things, but the patient may not be able to kind of, erm, tolerate 
two different sessions, so again it’s like kind of communicating that way.” 
(ID 31, Occupational Therapist, non-VEM) 
5.3.8 Resources  
Staff agreed a static base of HCPs trained specifically in stroke care was one of 
the strengths of their units. Most staff believed current staffing levels were 
adequate enough, yet, operated on a fine balance with staff deployment to 
other areas, illness or leave having an immediate and obvious impact on the 
ward. Participants, regardless of their experience in AVERT phase III, when 
asked what they would need in order to implement VEM in real-life, most 
frequently stated that they needed an increase in the number of ward staff. The 
majority of nurses and therapists did not routinely see patients within the first 
24 hours of stroke onset so limited by experience hypothesised that higher levels 
of dependency in this acute timeframe would require more staff to assist in the 
first mobilisation. There was agreement from all HCPs that to deliver an 
increased daily level of mobilisations to patients would certainly require more 
staff.  
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“Also the early stages that you are probably talking about more staff 
again, if the person is more dependent at that stage then so, and you’re 
doing that maybe throughout the day which could be four, four times or so 
during the day if they’re able, so, you know, that staffing you literally 
would have to have staff there in, in those units to be able to, to do that, 
that are specially trained to do it.” 
(ID 31, Occupational Therapist, non-VEM) 
There were uncertainties associated with this requirement. Firstly, it was 
unclear what form these additional resources would take. Respondents found it 
difficult to speculate what type of worker would be required and how many 
additional staff members would be required to support VEM.  
“Yes, yes, if you, if you’ve got quite a lot of dependent patients and 
you’ve needed two therapists per patient, or not even therapists, maybe 
even like assistant staff for technical instructor staff, and then you could 
potentially need another kind of one to two of each discipline” 
(ID 29, Physiotherapist, non-VEM) 
Secondly, how these additional resources would be allocated and utilised. The 
changeability of the types of patients in the unit at any one time in relation to 
dependency levels and the number of patients for VEM may pose problems.  
 “So you can’t actually, there’s no point in having an extra member of 
staff on, because……it might, it might be two weeks before you need them 
the next time.” 
(ID 22, Doctor) 
This need for additional staff to support the implementation of VEM was 
compared to the staff requirements required to deliver another acute stroke 
intervention (thrombolysis). As opposed to requiring an increase in nursing 
levels, staff revealed that thrombolysis was achieved within the current staffing 
compliment.  
“You can’t have that kind of resource fail, so it’s just done within the 
complement, but most of the time, that doesn’t seem to be too much of a 
problem, and the staff have been very good actually, because, for 
instance, if somebody gets thrombolysed late evening, and there aren’t 
enough staff over the night shift to cover, the day staff stay on.” 
(ID 22, Doctor) 
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The current focus regarding staffing for nurses was more about reinstating 
reduced staffing levels to their previous compliment rather than increasing them 
for the purpose of mobilisation, putting recent financial cuts to staffing budgets 
into perspective. 
“We’re already at the kind of, we’ve… our numbers have dropped even 
further, so we’re at the point just now where we’re trying to push it back 
up to where we were before.  Erm, I still don’t know that that would 
follow all that… again, maybe with therapists in at the weekend, that 
would help us slightly, maybe; I don’t know.” 
(ID 30, Nurse, non-VEM) 
Staff were aware that while increasing staffing levels would facilitate the 
delivery of more frequent mobility in the current economic climate of limited 
resources felt that this was unlikely to happen. Alternatively a more flexible 
shift pattern for therapists without necessarily increasing staff numbers was 
suggested. For example, having a back shift to extend the therapy working day 
would provide a means to support the mobilisations of patients later on in the 
day. 
“Erm, you know, if they’ve got up in the morning, done well, gone back to 
their beds again, there’s no reason why they couldn’t be getting up 
again...So, again, staff working twelve to eight as well...”  
(ID 27, Physiotherapist, VEM) 
This would provide therapists with a broader perspective about the patient’s 
mobility and function across the day. The nursing perspective of how a patient 
was mobilising can be quite different from what the therapy staff may see at 
selected points in the day i.e. transferring patients back to bed in the evening 
can be quite different from getting them out of bed in the morning. The 
majority of staff felt that VEM would require more equipment including 
specialist stroke chairs, hoists and hoist slings. In some instances when a 
particular type of chair was not available a flexible approach to alternating 
seating so as not to prevent the opportunity to get a patient up sitting out-of-
bed.  
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“Er hoists. There's only one hoist on our ward at the moment [voices 
overlap] so we would need more maybe handling equipment.”  
(ID 17, Physiotherapist, non-VEM) 
At one hospital, one participant believed that it was the lack of equipment that 
could pose problems, however another participant viewed a lack of storage as 
the problem. The data from this focus group is presented below and highlights 
the strength of the focus group data to provide the opportunity for participants 
to disagree or provide an alternative viewpoint. 
ID 7: “Sometimes we have an issue about appropriate seating in the 
ward…well not often….but on occasion you don’t have enough stroke chairs 
or enough chairs that might be ideal for the patient so  we work round 
that and modify that and swap seating about and things…but there an 
abundance of that… 
ID 5: I would qualify that by saying that we have actually had the chance 
to a lot more equipment but our problem is that we have no where to 
store it and following the health inspectorate we even had to move stuff 
that we had stored…” 
(Focus group 2, ID 5: Stroke specialist nurse; ID 7: Occupational therapist; 
non-VEM) 
Providing therapy cover at weekends was a recurring theme raised by all 
professional groups, although this did not meet with much enthusiasm from 
therapy staff. Therapy cover was seen as a facilitator to VEM but also had other 
advantages by reducing the pressure on the nurses at the weekends and 
preventing the backlog of new patients to be assessed at the beginning of the 
week.  
“You would think the ward was quiet at the weekend but it's busier 
because the patients aren't getting any of the OTs or physios so they are, 
there are more, they need us more. So we don't get as much time at the 
weekend as we would do during the week to maybe mobilise them as 
well.”  
(ID 13, Nurse, VEM) 
Therapy input at weekends is traditionally provided to patients considered to be 
at risk of respiratory problems or requiring input prior to discharge. For one unit 
the physiotherapists had recently secured a priority system for patients to be 
seen on public holidays. This was an isolated case and an evidence-base for VEM 
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was seen as one way in which stroke patients would be prioritised for such a 
service. Staff were uncertain how this would be funded.  
“…if anyone in our ward had a respiratory problem that we wanted 
weekend cover for that (respiratory care) would be fine, erm, but not for, 
not for mobilisation, not for any kind of rehab issues, erm, but as you say, 
orthopaedics do, and that comes out of orthopaedics budget, erm, so I 
don’t know if that would be, you know, whether it would come out of 
stroke budget erm, in, in the future that's how they would get.” 
(ID 29, Physiotherapist, non-VEM) 
Employing a more flexible approach to therapy working hours may accumulate to 
a six or seven day working week for therapists. Reducing working hours for 
therapists Monday to Friday could create scope for therapy weekend cover 
without having to increase the number of staff. 
ID 28: “Yeah, but they could take a wee hour off every day, you’re working 
Monday to Friday to… make a wee shift on Saturday… and Sunday. 
ID 27: I think even a six day service would be good... 
ID 27:…because I think everybody does need a rest, but it could be a 
staggered, somebody gets their rest on a Wednesday.” 
Paired interview ID 3 (ID 27 - Physiotherapist, VEM; ID 28 - Physiotherapist, 
VEM) 
5.3.9 Time 
Lack of time, competing demands on time and the length of time that it took to 
do certain tasks was frequently mentioned by nurses and therapists. Nurses and 
therapists valued being able to spend their time equally amongst patients on the 
ward. Time could easily be absorbed by one patient i.e. a patient with 
dementia, a particular task or by a patient unexpectedly scheduled for discharge 
that day.  
“…between my home visit and my home visit report, ordering equipment 
and organising things, that's pretty much one patient has taken a big chunk 
of my day, you know, so then you’ve got to prioritise the other patients 
for therapy as well and the new patients, like you’re saying that's been in, 
that need assessed, so there’s a lot of kind of flexible planning within 
that.” 
(ID 31, Occupational Therapist, non-VEM) 
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Therapy sessions for stroke patients were viewed to be more time consuming 
than that of other patients with one physiotherapist explaining the length of 
time to prepare a patient for the core therapy session. 
“And the length of time of taking the patient from the ward, through 
getting them transferred onto the plinth, doing your therapy and getting 
them transferred back and taken through to the ward and back in that, 
you know, a half hour session doesn’t warrant for all those things, so 
sometimes you have to expand your length of session; but as you say, [that 
could impact on] other patients that you’re seeing.” 
(ID 27, Physiotherapist, VEM) 
Such experiences may have resulted in the nurses and therapists belief that a 
lack of time would impact on the potential to increase the frequency of 
mobilisation being provided to patients. Most staff with experience of VEM 
explained the challenge to deliver the extra mobilisations to patients.  
“And then there's lots of other things going on, do you know, they've gone 
for a shower, they've gone for a CT, they've gone to OT, they've gone...do 
you know.  So actually then physically it's very hard for us because there's 
not enough time in the day to keep going back to them, and then when you 
go and if you can't get into that one then you think, sugar!  So...and it's 
staffing.  We've just had an AVERT patient and it's been a challenge.” 
(ID 12, Physiotherapist, VEM) 
Very early mobilisation was clearly associated with an increase in workload. One 
physiotherapist believed the decision to participate in AVERT phase III was 
reliant on staff preferences for and attitudes towards the intervention and that 
this association with an increase in work was invalid. 
“Erm, you know, and I think that kind of sums it up, I just don’t think they 
[referring to the nurses] wanted to do it, I think..... they just saw it as 
work...... and they didn’t get the fact that actually they weren’t doing 
that much work and it was a massive opportunity.”  
(ID 27, Physiotherapist, VEM) 
Nurses believed that changes over time that have occurred in care now impacts 
on the time that they can spend directly engaging face-to-face with patients. 
Therapists prioritised the use of their time, aiming to see more independent 
patients or patients with low exercise tolerance early on in the day and new 
patients before morning MDT meetings.  
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“Yeah I mean we do negotiate, people have got poor exercise tolerance 
and if we know that [name of Physiotherapist]  like bringing them in here 
at half past ten in the morning…And we know that if we get them up at 
eight o'clock in the morning, by the time she comes to them, they're going 
to be fast asleep, then no, we're good at negotiating that and we'll say oh 
that's fine, we'll keep them in bed and [name of Physiotherapist] will then 
just get them up and bring them straight through in here.” 
(ID 18, Nurse, VEM) 
Whilst most stroke units operated a ‘blanket referral’ system for 
physiotherapists, nurses would also highlight patients to physiotherapists 
especially about patients they were keen to see mobilised sooner rather than 
later. For example, this often led to a new patient having priority before a 
morning MDT so that the physiotherapist after their assessment could feedback 
at the meeting with regards to patients’ levels of mobility. In some cases this 
facilitated discharge planning. The length of time since stroke onset was not a 
factor that staff considered when deciding whether or not to mobilise a patient. 
Staff did not express a need to know an optimal time to mobilisation from stroke 
onset. Staff revealed no hesitancy in mobilising a patient very early on after 
stroke as long as they were “medically stable”.  
5.3.10 Evidence-based practice 
Staff considered early mobilisation as an important aspect of stroke care and 
were aware of its presence in stroke guidelines. Positive results from AVERT 
phase III could promote the profile of VEM practices within hospitals and capture 
the attention of hospital managers. 
“... and say this has been proven, this can get your patients better results, 
it can maybe get them faster results but generally better quality of life 
because I mean it’s, I suppose you’re thinking about recurrent admissions 
as well, your decrease in that so I think it would give an awful lot of clout 
to be able to say money needs to be spent on, or directed [laughing]...into 
providing… staff to provide that, eh, the early mobilisation, because I 
think just now it’s very hard to go and say, yeah, we think early 
mobilisation works but they’re looking for the hard facts, so... we are kind 
of keeping our fingers...crossed for AVERT.” 
(ID 27, Physiotherapist, VEM) 
A protocol was seen as one way to facilitate an evidence-based approach to VEM 
into real life clinical practice. There were a few throwbacks associated with 
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protocols including the pressure on staff to gravitate away from clinical 
judgement and as well as providing a reason to do something protocols may also 
provide a reason for not doing something. 
“I think I do worry that, you know, it will eventually get to the stage 
where we are taking away people’s own clinical judgement around things, 
you know, if we start saying well, you know, you’ll have to do, you do 20 
minutes, three times a day and that will make them better and I suppose 
if they’ve got good evidence to prove it then…you would need, you know, 
if we were working as an evidence based service and whatever then, you 
would need to do something about” 
(ID 19, Physiotherapist, VEM) 
In the following extract, albeit within the context of AVERT phase III, a 
physiotherapist illustrates that clinical decision may well take precedence over 
adherence to a protocol. 
 “Do you know, you always have to sort of stand back and think, right, if 
they weren't in the trial, would I do this at this point?  And do you know, if 
the answer's no, then it's like, right, well, we'll come back at some other 
time.” 
(ID 12, Physiotherapist, VEM) 
One doctor had a more frank opinion to offer: 
 “…to be honest, we all, as consultants we break all the rules anyway.” 
(ID 22, Doctor) 
Nurses were more likely to support an increased frequency of mobilisations for 
patients if each mobilisation had a functional or meaningful purpose. This 
concept is illustrated by a nurse involved in AVERT phase III who referred to 
some mobilisations as a ‘tick’ box exercise to fulfil a protocol. This may indicate 
that the rationale behind VEM is not explicit to some staff. 
“…then you were going to them (number) times a day over and above what 
was standard care to say ‘right, well come on, we'll just stand you up.  
Why?  Well, I just want to give you a wee stand up and a walk to the 
toilet.’” 
(ID 18, Nurse, VEM) 
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5.3.11 Organisation norms to change 
A number of changes had occurred in stroke care. The organisation of stroke 
care was regarded as the most valuable change with the establishment of stroke 
units and provision of a quicker and more streamline service. Other important 
changes included the introduction of new medical interventions such as 
thrombolysis, new protocols for stroke referral and end of life care, improved 
patient education and a move towards early rehabilitation. Competing priorities 
would often determine the organisation’s decision to implement a new 
intervention. The implications for service and staff outside of stroke care were 
also raised when discussing changes in stroke care. 
“ Erm, took a long time, but it did (adherence to stroke protocol) 
eventually come along, medical receiving took it on, but it, it can be hard 
work sometimes for medical receiving and I, I can see their point of view 
because they’ve got loads of different things coming in and things.” 
(ID 30, Nurse, non-VEM) 
The approaches that staff described to introduce change differed. A risk-adverse 
approach to implementation was displayed by some hospitals, preferring to 
observe other hospitals’ experiences of implementation first. A gradual and 
unplanned approach was adopted:  
“…creeping services where they just, kind of, started doing it, and then 
it’s got gradually bigger.” 
(ID 22, Doctor) 
Other hospitals opted for a more systematic and protocol driven approach. The 
later often involved rolling out the change from an established centre to a non-
participating site. Advantages of this approach included being able to tailor 
existing protocols to local needs, to diffuse enthusiasm amongst staff and to 
impart operational knowledge to those that were soon to be undertaking the 
change. Communicating the details of the change to the staff involved was 
integral in the planning stage of change. It was frequently mentioned that if 
staff felt included in the decision to implement and plan for the change they 
were more likely to come onboard and support it.  
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“I think the communication aspect of it I think having experienced change 
elsewhere before as well is like if you don’t have everybody on board with 
the change, and people don’t understand why the changes are happening, 
or what, what the changes are going to, erm, what value the changes are 
going to have, erm, that doesn’t work.” 
(ID 30, Occupational Therapist, non-VEM) 
There was acceptance that change took time and needed to be managed in 
parallel with the dynamic nature of healthcare systems making the process even 
more convoluted. 
“…it was kind of shelved for a period of time and whatever, but then 
obviously other things have happened since then as well like, you know, 
kind of more even like government wise there’s other things happen in the 
wider picture, which I think has obviously impacted as well on that and can 
take it further, but I don’t know where it’s at” 
(ID 30, Occupational Therapist, non-VEM) 
In some cases the emergence of research evidence had an immediate impact on 
stroke care. Two physiotherapists recall the day when the results from the ‘Clots 
in legs or stockings after stroke study’ where published. 
ID 27: …“erm, clots was published we were all just, there was a buzz in 
the ward, erm, it was quite a...” 
ID 28: It was literally... 
ID 27: strange thing... 
ID 28: it was literally the day, wasn’t it? 
ID 27: stockings off… [laughing] 
ID 28: Erm, it started with one consultant saying… and then we had to wait 
the next day for the other consultant to come in.... and he was like no, 
I’m happy as well.” 
Paired interview ID 3 (ID 27- Physiotherapist, VEM; ID 28 - Physiotherapist, 
VEM) 
The preference that physiotherapists stated for not using anti-thrombotic 
stockings was fitting with patient’s low compliance to wearing the stockings. It 
may be that the implementation of an intervention depends on the level of 
congruence between the opinion of the individual HCP and the preference of the 
patient. It should be noted that this extract is an example of discontinuing an 
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intervention as opposed to implementing a new intervention or changing the way 
in which an intervention is delivered. This issue of patient preference has 
bearing for the implementation of VEM. Staff explained that there were times 
when patients preferred to remain sedentary as opposed to engaging in therapy 
or go for a walk. The most common reasons for this is that they were too tired, 
had a busy day of investigations or it was late in the day and would prefer to be 
seen in the morning.  
“I’m sure most patients would, um, you know, the majority of patients 
would like more therapy and would benefit from it, but there’ll be some 
that don’t want any therapy. [Laughs].That’s a different story.” 
(ID 13, Nurse, VEM) 
The methods that were discussed to monitor the implementation of certain 
policies included audit, internal process meetings (quality circles), champions, 
hospital governance groups and regional forums. Some nurses and therapists did 
not view themselves actively involved in audit regarding this as the responsibility 
of the organisation. Process meetings were less commonly used than champions 
with both approaches used by one site during involvement with AVERT phase III. 
I: “In terms of Very Early Mobilisation do you think either of these 
approaches [use of a champion and quality circles] would be required and 
if so work?  
R: because of the AVERT study both approaches have been used you know 
particularly discussions about how to make it better but certainly that 
requires someone to take a hold of it and they did.”  
(ID 9, Doctor) 
Forum meetings were used more as a platform for information and exchange to 
enable staff to compare and reflect on the practices of other units. Staff defined 
a champion as an individual who had a genuine interest in the change and was 
naturally enthusiastic in driving it forward and had responsibility for cascading 
new information. The profession of the champion was less important with more 
emphasis on the individual’s qualities and level of interest as this extract reveals 
when discussing a VEM champion. This contrasts to the theory that change is 
usually owned and operated by the discipline most associated with the new 
intervention as presented i.e. doctors with acute medical interventions  
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“I don’t know. I think it could be a physiotherapist, it could be a medic, it 
could be a nurse. If it’s someone who’s enthusiastic and, you know, and 
quite charismatic really, that’s what makes a difference just to put the 
point across.” 
(ID 10, Doctor) 
The champion was seen to have a role in solving problems and maintaining 
enthusiasm in order to sustain the change. Having one dedicated person 
overseeing and co-ordinating the process may become onerous or result in the 
rest of the team developing evasive attitudes towards the change.  
“If somebody (a patient) came in, right (name of staff) will get them 
tomorrow. Tomorrow's not good enough, we want them in today.  So I 
think sometimes with champions, it can work in some instances, but in 
others you're making it a very one person dependent system, and if that 
person's not there, nobody else steps up in their place.”  
(ID 18, Nurse, VEM) 
Therefore, success of the champion approach is reliant on having the 
organisation onboard and staff having a sense of responsibility. 
“…says well it’s their responsibility, but it’s everybody’s responsibility, so 
that’s the, you know, the only negative thing.” 
(ID 30, Occupational Therapist, non-VEM) 
The champion role was not solely viewed as an adjunct to one staff member’s 
role but may emerge by staff collectively sharing experiences.  Members of one 
stroke team visited another unit abroad, renowned for embedding VEM routinely 
in care, and on return to their own unit felt enthused and empowered to 
imparted new knowledge and principles of what they had experience elsewhere. 
This was believed to be the driver towards adopting early mobilisation in their 
practice. The following list of implementation strategies based on the current 
literature was presented to the HCPs to enquire about the specific use in the 
implementation of VEM; educational materials, small group education, audit and 
feedback, support tools i.e. decision making trees, reminders, financial 
incentives, revision of professional roles, local opinion leaders. There was no 
clear consensus regarding the most appropriate for use in the implementation of 
VEM. Education and revision of professional roles were met with most 
enthusiasm. Reservations were attached to feedback unless it was delivered in 
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an unthreatening manner and financial incentivises were believed to be 
unnecessary and unrealistic. 
Provider characteristics 
The themes within this category describe who is involved in mobilising the 
patient for the first time after stroke and providing subsequent mobilisation 
practice. The themes that are covered are as follows: 
• Defining the providers  
• Decision making 
• Confidence and experience in stroke care  
• Perceived risks and benefits 
• Training and knowledge requirements 
• Individuals’ attitudes to change 
The factors that influence the provider’s decision making are identified. The 
provider’s perceived benefits of VEM and the value of these benefits to patients 
are outlined. The levels of enthusiasm for VEM were assessed including the steps 
that individual staff members take to appraise the impact a new set of practices 
has on their role. 
5.3.12 Defining the providers 
The professional groups that were involved in the mobilisation of patients were 
physiotherapists, occupational therapists and nurses with a sizeable contribution 
from nursing assistants. Doctors, although not routinely involved in providing 
mobilisation, still viewed themselves as having a role in decision making. 
“You’d need some weekend provision. And that might not just be the AHP 
[Allied Health Professional] side, it might also be medical staff saying oh 
that’s okay occasionally.” 
(ID 11, Doctor) 
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“...[patients] deemed medically stable by us then we would encourage 
people to get up.” 
(ID 9, Doctor) 
Physiotherapists when going to assess new patients frequently found that the 
patient had already been mobilised either by a nurse or independently. 
“Even, even during the week it's often...because they (the nurses) might 
wash them and then just get them up in the chair.  It's not always us (the 
physiotherapists) that's going to initiate it, do you know what I mean, um, 
particularly for the...you know, most patients, a lot of them are up out of 
bed before I've gone into them.” 
(ID 12, Physiotherapist, VEM) 
There was a divide in opinion between physiotherapists regarding the role of 
nurses in getting patients up for the first time. One opinion, coming mostly from 
those working at AVERT phase III sites, being that “nurses are more than 
qualified to be able to make a clinical judgement about somebody” (ID 012, 
Physiotherapist) with the opposing view detailed in the following extract: 
 “I do take onboard they see the patients a lot more and they are able to 
decide whether they are struggling to help them with that transfer or not 
but for the initial assessment I do sometimes think that they have made a 
judgement and its not quite right.”  
(ID 6, Physiotherapist, non-VEM) 
This issue of professional boundaries was a recurring theme throughout 
discussions. Some participants believed if these boundaries were relaxed and the 
sharing of traditional roles more customary this had the potential to increase the 
amount of mobilisation practice being delivered to patients.  
 “…already we are seeing the blurring and I think given more of a blurring 
of the roles, you know…so if there was a quiet moment why you know two 
nurses could do …say walking a patient up the ward….why has it always got 
to be [a therapist]…if I take a gentleman that’s in at the moment…I am 
just thinking why couldn’t  say an auxiliary nurse that free…that 5 minute 
walk done 3 times a day not necessarily by the physio might be the 
difference in getting that man home.”  
(ID 2, Stroke Specialist Nurse) 
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5.3.13 Decision making  
Prior to mobilising a patient for the first time all the respondents stated that the 
patient would have to be “medically stable”. Staff defined medical stability as 
blood pressure, heart rate and oxygen saturation levels being within the normal 
ranges. A need for cardiovascular stability has been regarded by HCPs in other 
studies as a key consideration when mobilising patients for the first time.178 179 
“… and I think, um, general not wellness has always been a factor as well, 
so, um, physiologically, we’re told always that if saturations are low or if 
they’re tachycardic, or blood pressure’s too high or low, then they don’t 
get mobilised.”  
(ID 22, Doctor) 
Other terms such as “medically unfit” and “medically unwell” were also used. It 
is unclear if these terms were used in addition to “medically stable” and had 
different meanings or used interchangeably. Other factors such as level of 
consciousness, headaches and temperature were also included in the definition 
of “medically unfit”. It may be that “medically stable” relates to cardiovascular 
stability while “medically fit” relates to the patient’s general health status.  
“Other reasons for not getting people up?  Pain, not that common with 
strokes I suppose, headaches and things you get with it. Headaches and 
drowsiness but, I suppose, that’s a medically unfit patient with a headache 
or drowsiness. They probably need to just take things more slowly.” 
(ID 10, Doctor) 
Signs of medical instability were monitored during the first mobilisation using 
either physiological monitoring equipment or subjective assessment. The need 
for medical stability appeared to be a communally approved criterion evolved 
from clinical opinions; “we’re told always” rather than evidence-based. This 
prerequisite for medical stability was only challenged by doctors.  
“ Well, I don’t, I don’t, um, it’s not that I don’t believe it, nobody can 
give me any evidence [voices overlap] to say that it’s a harmful thing to-to 
mobilise somebody with those issues. Um, and I suppose at the moment, 
nobody can give me a lot of evidence that only mobilisation…definitely, 
definitely, definitely is the right thing to do either.”  
(ID 22, Doctor) 
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Doctors viewed the patient’s ability to achieve sitting balance as an important 
factor in the decision making process in mobilisation a patient for the first time. 
This agrees with the existing theory that concerns are related to the area of 
non-expertise i.e. doctors towards the physical aspect of mobilisation.178 
“I guess the key thing would be that the physio would decide if the patient 
had enough sitting balance to get up to a chair would be the first step and 
if they didn’t they couldn’t and if they did you know they would be got 
up”. 
(ID 9, Doctor)  
In contrast when posed to nurses and therapists in later interviews sitting 
balance was not considered as a determinant to mobilising patients. 
I: “Sure, if they've got enough sitting balance? 
R: Well, he hasn’t got any, but he's safe enough in...we've got an 
appropriate chair for him.” 
(ID 30, Nurse, non-VEM) 
Unlike therapists, the level of weakness the patient had seemed to be more of a 
deciding factor in whether a nurse would mobilise the patient for the first time. 
This depended on “what nurse was on [shift]” with some nurses going ahead and 
mobilising patients regardless the degree of weakness: “especially if they look 
like they have got a dense weakness there, we would normally just hoist them 
anyway regardless”. Nurses believed they take the lead from physiotherapists 
with regards to mobilisation, especially of patients with more complex needs, 
but it could be that nurses underestimated the extent of their role in the 
mobilisation of patients. One strength of the focus group data is that the 
participants can choose whether to agree or disagree with the other 
participants’ impressions or opinions. In the conversation below, the nurse 
explains that she usually relies on physiotherapists however the physiotherapist 
present in the same focus group quickly interjects the nurse to correct her 
colleagues perceived role in mobilisation.  
ID 014: “It's taking the lead really from you. 
ID 012: Well, it's not always the case, because yous are often... 
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ID 014: Aye, no, at the weekend, at the weekend, uh huh. 
ID 012: You'll always get people up. 
ID 014: Aye, we still do.  Unless they're going to be a huge mobility risk 
and then we would say, do you know, it's not really advisable for us, we 
need to wait for physios or other therapists to come in and assess them.”  
Focus group 3 (012 – Physiotherapist, VEM; 014 – Nurse, VEM) 
Other factors including the patient’s risk of complications, level of consciousness 
or fatigue played a role in influencing the HCP’s decision to mobilise a patient 
for the first time.  
“I mean, he was medically kind of stable enough, though, to kind of get 
him up, but he had gurgle chest, so getting him up to sit in the chair is 
much better than, than being in the bed anyway”  
(ID 30, Nurse, non-VEM) 
Low levels of consciousness did not discourage the mobilisation of a patient; 
therapists reiterated the need for a “dynamic risk assessment” to detect any 
changes in the patient’s medical status in response to being upright. The 
following extract from a physiotherapist provides a step-by-step commentary of 
the typical decision making process when mobilising a patient for the first time. 
“…then actually if they are medically stable regardless of their GCS 
[Glasgow Coma Scale] we would probably get them up but not necessarily 
out of bed but we would assess them sitting over the edge of the bed to 
see what their arousal state is like and see if they are actually waking up 
to any stimulation and then from there check monitor their cardiac, blood 
pressure stability and if we feel that it is appropriate we will get them out 
of bed with the appropriate means…but of you feel it is still a wee bit too 
early then we would get them back to bed and go back the next day…GCS 
3…mmmm…maybe just put them back to bed depending if there are 98 
[years of age] or whatever but yeah if they’re starting to come round we 
would probably push them.” 
(ID 4, Physiotherapist, VEM) 
There was some agreement between nurses and physiotherapists that nurses 
were more tentative than physiotherapists when deciding to mobilise a patient 
for the first time. Furthermore, some nurses were critical of nursing colleagues 
for their overly zealous approach to mobilisation while it was physiotherapists 
that considered themselves to be the pro-active group in having a more 
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“aggressive” approach to mobilising patients than nurses. This was not always 
the case with one nurse posing the following question; 
“And sometimes we take a risk even when they are not medically stable 
don’t we?” 
(ID 3, Nurse, VEM) 
The majority of nurses and therapists regarded fatigue as a direct consequence 
of stroke which may have resulted in a more cautious or protective approach to 
mobilising patients had it been related to some other cause such as disturbed 
sleep patterns or associations with a result of low mood. 
“I’m a bit of a stickler for people sitting out [of bed] and I, I sometimes 
get this chat about they’ve not been sat out cos they were too sleepy. But 
I mean it’s all relative, and yeah, some people occasionally are too 
drowsy…even to sit out, and certainly people can be too drowsy to have 
physiotherapy, but, yeah, I’d just…occasionally I’ve thought perhaps just 
needed to be slightly more…”  
(ID 11, Doctor) 
Relatives/carers placed value in knowing their relative had been up sitting in a 
chair, often asking if “they been up to sit today?” when they phoned in the 
morning. The meaning of mobilisation to relatives did require special 
consideration. Although not usually reported as a reason for not getting someone 
up early after stroke, mobilisation may provide relatives/carers with false hope 
which was particularly relevant for patients with poor rehabilitation potential or 
prognosis where patients may appear to look a lot better when sitting upright. 
“…maybe they are not for resus but they are still for active treatment 
then to sit someone out that may give their relatives the wrong impression 
so we have to take that into consideration as well so again kind of 
weighing up the individual and thinking well is it appropriate that they sit 
out” 
(ID 3, Nurse, VEM) 
5.3.14 Confidence and experience in stroke care 
The confidence and experience of staff working with acute stroke patients was 
considered to be an influencing factor in initiating and providing mobilisation to 
patients. It would often take a more confident nurse to make the decision to 
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mobilise patients for the first time. It was unclear if these confidence issues 
were related to a lack of skills to assess how patients’ impairments may affect 
mobilisation, experience in transferring stroke patients or knowledge of the 
most appropriate method of transfer or seating. At one hospital, two 
physiotherapists agreed that NIHSS training for nurses was linked with improved 
confidence. This subsequently led to a more pro-active approach to mobilising 
patients for the first time.  
ID 27: “…maybe it’s [NIHSS training], you know, giving them a bit of 
confidence that they’re actually having to look at somebody’s, you know, 
leg strength and then think…”.  
ID 28: And sensation, and...  
ID 28: ... you know, actually maybe you can get them up.”  
(Paired Interview 3, ID 27 – Physiotherapist, VEM; ID 28 – Physiotherapist, 
VEM) 
In cases of uncertainty nurses preferred to wait for the physiotherapist to seek 
advice on mobilising the patient for the first time. 
“Sometimes if you are not sure how to transfer them (the patient) you 
would wait until we (the physiotherapists) came...Or you weren't sure 
what chair you wanted them in or whatever then they would wait until we 
came in normally then.” 
(ID 19, Physiotherapist, VEM) 
The focus groups gave participants the opportunity to compare their approach, 
at a professional level, to mobilising patients for the first time. In one group two 
nurses explaining their approach as individual, based on clinical judgement and 
has its limits i.e. not mobilising a patient considered to be medically stable. The 
physiotherapist in this same focus group uses this as an opportunity to express 
her opinion that physiotherapists take more of a risk with these types of patients 
than nurses, which was agreed by the nurses. 
ID 21: “And you know the ones that you can try. 
ID 20: You know the one you can get. 
ID 21: Try, you know the ones you just can't. 
I: Okay so what you are saying there about fit, I guess you are saying 
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medically fit...? 
ID 21: Was she medically fit aye. 
ID 20: Medically if there is somebody then really in the red, we put off till 
the next day… 
ID 19: I think sometimes we maybe risk take more than you do. 
ID 21: Aye definitely, definitely.” 
Focus group 5 (ID 19 – Physiotherapist; VEM, ID 20 – Nurse, VEM; ID 21 - 
Nurse, VEM) 
Being familiar with how others work and being able to draw on each other 
experiences was regarded with much importance. Therapists who worked 
together with patients referred to this joint working as intuitive with “non-
verbal communication” making mobilising patients more natural and efficient. 
This intuitive working is also represented by the way in which therapists often 
interacted with each another during discussions, particularly during the paired 
interviews. The following extract from a conversation during a paired interview 
between two physiotherapists about the rehabilitation environment. It provides 
a snapshot of how the two physiotherapists were at ease with one another, 
talking over one another and at times finishing off each other’s sentences. This 
indicates the close bond that has developed between two colleagues working 
together.  
ID 027: “…rehab’s a much better environment for them because they feel 
they’re actually... 
ID 028: …getting more therapy and getting somewhere rather than... 
ID 027:..at rehab to accommodate, erm, trips out and things even that, 
which... 
R 028 :…they’ve got no chance of getting in the acute stroke unit. 
R 027:…Even getting outside into the... 
R 028:…they’ve got nice grounds and they can get, it’s on the ground floor 
so they can get taken outside...” 
(Paired Interview 3, ID 27 – Physiotherapist, VEM; ID 28 – Physiotherapist, 
VEM) 
As well as length of time working in stroke care it was important that staff also 
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had recent work experience in stroke rehabilitation to account for the changes 
that had occurred in recent years. 
“You see I think that it’s quite old school – to think that someone has a 
chest infection, spiking a temperature, on oxygen you are probably more 
likely to want to keep them in bed than wanting to get them out of bed…” 
(ID 4, Physiotherapist, VEM) 
5.3.15 Perceived risks and benefits  
Therapists and nurses associated mobilising patients within 24 hours and at a 
higher intensity with the risk of doing “too much too soon” (ID 019, 
Physiotherapist) and an increase in patient falls as opposed to more direct 
medical risks. The majority of staff that mentioned medical risks such as 
changes in blood pressure were nurses and doctors.  
“…probably most blood pressure flux [fluctuation] would be the thing that 
would intuitively concern us if people lost their blood pressure responses 
and if they stand up and their blood pressure falls then it may extend any 
deficit and that sort of thing.”  
(ID 9, Doctor) 
A few nurses believed that if a patient was going to deteriorate, this would 
happen regardless of them receiving VEM or not. Increased fatigue, “if that 
counts as risk” (ID 010, Doctor), was linked with an increase in mobilisation of 
patients. Staff at one hospital had been involved in a study investigating the 
effects of augmented therapy recalled the recurring fatigue patients allocated 
to the intervention group experienced.  
“…and that was just physio, but they were also timetabled to have OT and 
if appropriate still having speech therapy. So some of them were actually 
physically tired.” 
(ID 26, Physiotherapist, non-VEM) 
Therapists aimed for a balance between rest and activity for patients which may 
partly explain this concept of “too much too soon”. Rest was seen to have an 
important role in patient rehabilitation. Increasing the intensity of mobilisation 
may influence this balance and result in patient exhaustion or “knock the 
patient back”. Staff did not specify an optimal length of time for mobilisations 
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such as the sitting in a chair seeing it more dependent on the preference of the 
individual patient. It was acknowledged that the impact of remaining in one 
posture for prolonged periods of time may begin to counter any positive effects 
that being upright may have as the scenario in the following extract explains. 
“I know he wants to be sitting but actually it's working against him just 
now because, because he was so busy fixing everything, when you tried to 
stand him up he couldn't, he just kept, he was half bent over and whatever 
so it was around sort of saying to the girls I know he is saying that he 
wants to be sitting up all the time but actually he needs to go and lie 
down for a wee while because he needs to get stretched out.” 
(ID 19, Physiotherapist, VEM) 
On the other hand, risks associated with bed rest were more readily identified 
by staff and included higher risk of medical complications, a poorer recovery, 
increased length of acute stay and reducing the patient’s rehabilitation 
potential.   
“I think that any rehab potential would be just significantly decreased – its 
just means that they would have progressed in the way that they would 
have done and if they had not had that earlier input”.  
(ID 1, Physiotherapist, VEM) 
Again doctors were the only professional group to question this way of thinking 
believing that it lacked hard evidence.  
“Yeah I guess there would be…in the longer term there would be a risk of 
less mobility and…ehm…contractures and things went on that long but you 
would suspect that there would be an increased risk of chest infections or 
DVTs if people well less mobilised yet that is not convincingly proven.”  
(ID 9, Doctor) 
One team shared their experience of a patient who had a stroke whilst on 
holiday abroad and had not been mobilised during his acute hospital stay. When 
the patient was transferred back to Scotland stroke unit staff were horrified that 
bed rest was still in practice: 
“And he found that really stressful, he wanted to get up and do 
something.  So I just thought that was really interesting, we can't believe 
somebody being kept in bed for two whole weeks post-stroke.” 
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(ID 12, Physiotherapist, VEM) 
Patient safety was high on the agenda for staff when discussing the mobilisation 
of acute stroke patients in particular those patients with perceptual or cognitive 
issues or were agitated. An increase in the number of staff injuries were also 
connected with increased patient mobilisation if it was not performed correctly. 
ID 3: “…there are the ones that are so unsafe to be…you they would be 
better out of bed but maybe its just not possible…and they try to get up 
and walk. 
ID 4:…because of their perceptual difficulties…we would still get them up, 
get them out and moving…but it may be getting them up to sit and back to 
bed because they are safer in bed than in a chair.” 
Focus group 1 (ID3 – Nurse, VEM; ID4 – Physiotherapist, VEM) 
Two previous studies have revealed conflicting evidence regarding opinions of 
early mobilisation and stroke type. One study revealed that HCPs had more 
concern over mobilising patients with a haemorrhage than patients with 
ischemic stroke,179 while the other showed that HCP opinion to mobilise early 
was not influenced by stroke type.178 The immediate reaction of staff in this 
study was that their opinion of the VEM would remain the same regardless of 
stroke type. Nurses and therapists stated that stroke type was often not known 
at the time they currently mobilise the patient anyway. On further probing staff 
did go on to state a “little” concern for mobilising haemorrhagic strokes within 
24 hours with a potential of further bleed. This didn’t necessarily equate to staff 
excluding VEM but adopting a more cautious approach to mobilising these 
patients for the first time; haemorrhagic stroke patients were viewed to have a 
more variable clinical presentation than ischaemic strokes and likely to require 
extra monitoring.  
R: “I would say we are still a little more cautious with haemorrhages but 
um we obviously monitor everybody um, keep an eye but I do think um we 
are more, more aware. 
I: And why do you think that is?  
R: I don't know just in case there is a further um, a further haemorrhage, 
in case anything…gets worse.” 
(ID 23, Physiotherapist, non-VEM) 
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There was strong agreement that if VEM were shown to be effective for a 
subgroup of patients this would compromise the care of other patients not 
receiving VEM. The following two extracts shows that this consensus was evident 
within focus groups (FG5, first extract) and across focus groups (FG 4, second 
extract) and interviews (PI1, third extract). 
 
ID 19: “I think it's hard to, you know, what we’ve said and what I’ve sort of 
reported back er to my managers and whatever is that if we, you know, if 
we use AVERT as a, as an example, if we have a patient in the 
interventions group on AVERT then the other patients suffer as a result of 
that, you know, especially if they are in the higher level groups, you know, 
because tell all you to deliver what you need to deliver for the trial then 
somebody else... 
ID 20: Is not going to get their session. 
ID 19:...you know, gets their session shorter or they just don't get seen 
that day or whatever um, you know…” 
Focus group 5 (ID 19 – Physiotherapist; VEM, ID 20 – Nurse, VEM; ID 21 - 
Nurse, VEM) 
“So if you then feel that you're concentrating more on a certain patient or 
a certain group of patients, something else has got to give, because you're 
going to have to drop something else to do that.  So at what cost is that 
going to be?”  
(ID 17, Physiotherapist, non-VEM) 
“I was very much how would people feel lying across from somebody that's 
getting loads of attention and like support and things whereas you got it 
once a day, do you know what I mean, you’d be a bit like mmm”.  
(ID 24, Nurse, non-VEM) 
 
The flipside to this argument was that an evidence-base for VEM may actually 
strengthen the campaign to get patients onto the stroke pathway more quickly. 
The focus for staff was to deliver good stroke care whether the patient received 
VEM or not.  
“Um, it’s meant that in general terms, we’re getting people imaged 
quicker than we would have otherwise, even if they’ve not, um, even if 
they’re not getting thrombolysis, um, we’re getting people to the stroke 
Chapter 5 
 
190 
units quicker than we did as well, so, so, it’s, probably is a side benefit – 
all the patients that aren’t getting thrombolysis or even, aren’t even 
getting assessed with thrombolysis, are getting a better deal.” 
(ID 22, Doctor) 
Staff highly valued early rehabilitation and believed that it provided benefits to 
patients. The same benefits, yet with additive effect, were seen for VEM.  
“Ehmm...I guess the quicker they start the quicker they back on their feet 
which should translate to better functional outcome, shorter hospital stay 
and less risk of early complications would be the guess.” 
(ID 9, Doctor) 
This additive effect of VEM may only be observed in subgroups of patient.  
“…there are some patients that would very much benefit from it and 
there’s others that, you know, might not make a huge difference in the 
overall outcome.” 
(ID 30, Occupational Therapist, non-VEM) 
One of the most frequently mentioned benefits of VEM was the improvement of 
the patient’s mood. Staff believed getting patients up provided them with the 
stimulation of the ward environment and a sense of ‘normality’. It allowed them 
to engage in their surroundings and if they were sitting up or mobilising more 
frequently around the ward that would give them more opportunity to interact 
with other patients. The risks and benefits of VEM as identified by staff are 
summarised in Table 5-4. 
Table 5-4 Perceived risks and benefits of VEM 
Perceived benefits of VEM Perceived risk of VEM Perceived risks of bed-rest 
• Improve patient mood 
• Improve patient confidence 
• Improve patient motivation  
• Increase interaction 
between patients  
 
• Stroke extension 
• Fluctuation in blood 
pressure  
• Increase in patient falls  
• Increase in staff injury 
• Impact on service i.e. other 
patients  
• Unrealistic perceptions for 
patient 
• False impression of 
recovery for families 
• Increase risk of immobility 
related complications; 
pressures sores, deep 
venous thrombosis, chest 
infections, subluxations, 
contractures, muscle 
wasting, reduced range of 
movement 
• Reduce mobility 
• Increase length of acute 
hospital stay 
• Reduce rehabilitation 
potential 
• Reduce long term recovery 
Ranked in order of frequency i.e. improve patient mood was the most frequently reported 
benefit of VEM   
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5.3.16 Training and knowledge requirements 
By and large, technical training of existing ward staff was not viewed as a 
prerequisite to implementing VEM. Providing training in, for example, moving 
and handling was given little regard with the issue of “performance”, that is 
actually employing the skill in real-life, taking precedence.  Educating staff in 
the theoretical principles of VEM was seen to offer more benefit by incentivising 
staff to adopt and sustain the intervention in clinical practice. 
“The education, the skill sets there, that's more say 
performance…performance management.  So I think it's more the 
education about why early mobilisation and what benefit it's going to be, 
rather than how to actually do it.” 
(ID 18, Nurse, VEM) 
“The nursing staff on this ward are so good there stroke specific trained so 
they know how to mobilise patients.” 
(ID 8, Nurse, non-VEM) 
At one hospital, the training of nursing staff to encourage them to be more 
involved in the mobilisation of patients especially at the weekend proved 
unsuccessful in changing behaviour. There was a sense that physiotherapists felt 
nurses did not see this as integral to their role while the nurses were more likely 
to reason this with a lack of time and competing ward priorities. 
“And I mean they have access to the chairs, so if somebody has got denser 
and needs a more supportive armchair then they're in the dayroom and I 
have over the years spent numerous sessions showing people how to use 
them correctly. So they (the nurses) should know why they would use it 
and they have access to them.” 
(ID 25, Occupational Therapist, non-VEM)  
Assessing mobility and the act of mobilising a patient was considered to be a 
complex task requiring specialised input as this physiotherapist explained:  
“I think with that they would have to do a full neuro assessment because 
everything that you do with that neuro assessment helps then you decide 
how that patient is going to manage its not…I mean there are some 
mobility assessments that you don’t need a trained therapist you know to 
carry out…however there are so many different aspects that can affect the 
way a patient is mobilising or transferring”.  
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(ID 6, Physiotherapist, non-VEM) 
5.3.17 Individuals’ attitudes to change 
Nurses recognised that although change may appear a ‘simple process’ on paper 
there was fear; believing that if they got it wrong there are huge consequences 
for the patient. Nurses using thrombolysis as an example did reveal that when 
the change was put into practice fears were often alleviated and the practice 
became “normal”. 
“But it's like, it's like a new job. So once you've got the process up here, 
and you know what's going to happen as soon as that patient comes in, it's 
a process you get...it's like doing your job every day. There are a lot of 
things now that you used to have to think carefully about, now you 
don't...you just know that that's what you've to do next, so you get on wi' 
it.” 
(ID 13, Nurse, VEM) 
Doctors were more confident when discussing change, most likely due to them 
being the professional group most likely to lead or be heavily involved in the 
implementation of an intervention, while nurses and therapists were more 
tentative towards change. A number of therapy staff felt that they were up-to -
date with stroke guidelines but it was more an issue of resource that prevented 
implementation. Staff appeared to be aware of current policy and research and 
viewed the emergence of clinical guidelines and NHS performance standards 
such as Health Improvement, Efficiency, Access and Treatment targets as the 
main drivers of change. Policy often resulted in the re-design of stroke services, 
for example, the working time directive resulted in less medical cover being 
provided to off-site units which impacted on how care was organised and the 
role of staff. Staff showed signs of appraising their actions: 
“We have been caught out a couple of times and we recognise that 
ourselves and its something that we are sort of actively trying to, to make 
better I think.” 
(ID 19, Physiotherapist, VEM) 
Staff appreciated that an intervention implemented in real-life may not have the 
same effect as when it was under study in a trial. There was a sense of 
disappointment that the results didn’t meet expectations. 
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 “It [thrombolysis] doesn’t appear as successful as the statistics would 
have you suggest.” 
(ID 27, Physiotherapist, VEM) 
5.3.18 Summary of barriers and facilitators 
Barriers to mobilising patients within 24 hours included lack of staff stroke 
experience, delays in diagnosis and patient presentation to hospital, break-
downs in the referral process, lack of bed availability in the ASU, patient 
“medically unstable”, perceived risks of mobilisation, time of admission to 
stroke unit, individual patient requirements, staff lack of 
confidence/experience, staff clinical decision making and the belief by staff 
that ‘we already mobilise early’. Barriers to increasing the frequency of 
mobilisation patient had been mobilised for the first time, included a lack of 
resources, unpredictability of stroke care, lack of evidence-base, patient 
fatigue, lack of and competing demands on time and the physical layout of 
ward.   
Facilitators to mobilising patients within 24 hours included the provision of 
stroke specific training for hospital admission staff, a protocol for early 
mobilisation, support from hospital managers and the education of non-specialist 
staff working in general medical units in the principles of VEM. A structured 
therapy referral system, perceived benefits of mobilisation, early team 
communication, earlier admission to the stroke unit, planning the patient day, 
daily team communication, therapy cover at weekends and an increase in 
resources, were the facilitators identified to mobilising a patient more 
frequently within the ASU. These barriers and facilitators are summarised for 
each stage of the stroke pathway in Figure 5-1. 
  
 
Figure 5-1 Barriers and facilitators by stage of the stroke pathway 
BARRIERS
Patient medically unstable
Percieved risks of mobilisation Lack of resources
Time of admission to stroke unit Unpredictability of stroke care
Individual patient requirements Lack of evidence base
Lack of staff stroke experience Staff lack of confidence/experience Patient fatigue
Delay in diagnosis Break-down in referral process Staff clinical decision-making Lack of and effective use of time
Delay in patient presentation Bed availability in ASU Belief ‘we already mobilse early' Physical layout of ward
Stroke diagnosis Admission to ASU First Mobilisation Mobilisation
FACILITATORS
Ongoing training for admission staff Protocol for early mobilisation Structured therapy referral system Planning patient day
Support of hospital managers Perceived benefits of mobilisation Daily team communication
Educate non-specialist staff in VEM Early team communication Therapy cover at weekends
Earlier admission to stroke unit
Beliefs against bed rest 
Increase in resources
Patient pathway Patient pathwayPatient pathway Patient pathway
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5.4 Discussion 
This study has provided rich narratives about HCPs’ experiences of working 
within an ASU. Barriers and facilitators to implementing VEM have been 
identified and a set of beliefs that HCPs hold towards VEM has been formulated.  
Summary of key findings: barriers and facilitators identified 
As previously explained, information about barriers and facilitators is 
particularly salient for a complex intervention such as VEM. Factors that may 
promote or inhibit the embedding of VEM in routine practice were identified for 
each stage of the stroke pathway. Accessing the patient during the acute stage, 
with the patient being off ward for tests was viewed as problematic by staff. 
Interestingly, the observational data estimated that the time spent off the ward 
by patients was only 3.7% which illustrates that potentially, there is 
incongruence between perceived barriers and real-life (Appendix 14). The need 
for more staff was an automatic and recurring response when the participants 
were asked what would be required to facilitate VEM in routine clinical practice. 
Few participants were able to provide details of the form that this required 
additional resource may take and fewer (two participants at the same hospital) 
challenged that the focus should be more on how best to use current staffing 
resources. 
At a site level, the same barriers and facilitators to VEM were raised regardless 
whether they had experience of the trial or not. Staff currently involved in 
AVERT phase III were more forthcoming in identifying requirements for the 
delivery of a rapid mobilisation service to patients such as an outreach service to 
wards outside the ASU. Making comparisons between sites is important to 
identify the factors that may predict implementation. For example, staff from 
all but one of the sites believed that communication between nurses and 
therapists was cohesive, fluid and responsive. At the other site, also a non-
AVERT site, there were signs of tension between staff which impacted on the 
opportunity for mobility practice. Comparing sites is useful to identify the 
absence of key processes or components of care. This example highlights that 
communication is pivotal to patient mobilisation and that targeted strategies are 
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required to prepare such sites prior to implementation of VEM.  
Barriers and facilitators are often classified into environmental or organisational, 
however this requires knowledge about the cause of the barriers and facilitators. 
For example, lack of resources may be an individual’s perception of the 
organisation rather than the organisation not providing enough staff to organise 
the system. Bed availability may be due to the break-down in operating the 
system, not the actual system put in place by the organisation.  
Summary of key findings: healthcare professionals’ beliefs 
The main beliefs about VEM were centred around the perceived impact on the 
patient’s outcome and the HCPs routine practices. More specifically, it was 
believed that VEM: 
• is already being conducted  
• relies on the time of symptom onset being available 
• is beneficial to patients but may have some risks 
• is associated with an increased workload 
• is a shared task between therapists and nurses 
• requires tailoring to meet individual patient requirements 
• is appropriate only for patients who are medically stable 
Each of these beliefs will be discussed briefly in turn. All of the participants 
were aware of the current Scottish Intercollegiate Guideline Network which 
states that “stroke patients should be mobilised as early as possible after 
stroke”.2 Therefore, HCPs may have been eager to portray themselves as 
adhering to the current guideline about early mobilisation. This may explain 
their immediate response that they are already practising VEM when first asked. 
When the definition of VEM was reiterated and participants were asked to 
compare the VEM principles with their current practice and processes, it 
emerged that staff were actually mobilising patients for the first time as early 
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after stroke as they believed was possible. Indeed, the observational data 
(Chapter 3) did indicate that the time of first mobilisation was either more than 
24 hours or unknown, conflicting with HCPs beliefs of what happens (Appendix 
15). Integrating the qualitative and quantitative data in this way (triangulation) 
raises an interesting question about how behaviour can be perceived to be 
different to that which actually occurs. The more general question that is raised 
here is - how best to define VEM so that it is distinguishable from current 
practice? This is a common issue associated with complex interventions. Current 
mobilisation practice appeared to be highly variable (patient and context 
dependent), implicit (‘just something that we do’) and largely undefined as a 
specific intervention in acute stroke care. As the time from symptom onset to 
hospital arrival is the factor determining eligibility for many acute stroke 
interventions this does pose challenges in being able to ascertain this 
information and subsequently deliver the intervention within an acute 
timeframe.193 The belief that VEM is beneficial was based on the understanding 
that bed-rest can result in immobility-related complications.  
The association of VEM with an increase in workload was a prevalent topic 
discussed amongst all therapists and nurses, particularly therapists. 
Interestingly, for HCPs working at non-AVERT sites and with no experience of 
VEM this perception had been shaped through conversations with other local 
HCPs who were working at AVERT phase III sites and delivering the intervention. 
Some HCPs did believe that perceptions of increased workload could be 
alleviated once experience of delivering the intervention was gained. This raises 
once again the issue of contamination of complex interventions, initially 
presented in Chapter 1. The AVERT phase III intervention protocol prohibits 
communication between trial and non-trial staff. Contamination in the form of 
current behaviour inadvertently being changed due to attempts to adopt the 
intervention under study, does not appear to be the issue here. More 
disconcerting are the negative preconceptions around VEM as a result of 
communication between trial and non-trial staff. 
Staff regularly stated that their current workload was busy enough. Although, 
there was a sense (when comparing findings in Chapter 3) that staff tended to 
over-estimate and make assumptions about the length of time a patient was 
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inaccessible during the day. Perceptions about the patient’s accessibility and 
readiness for therapy/mobilisation resulting in missed opportunities. It may be 
that staff need to realise that they may not be using time as efficiently as they 
believe. The Productive Ward: Releasing time to careTM programme by the NHS 
Institute for Innovation and Improvement provides an example of how this 
realisation could be provoked in real-life. This initiative aims “to empower ward 
teams to identify areas for improvement by giving staff the information, skills 
and time they need to improve the way they work and the care they provide”.194  
Staff are video-recorded during routine practice (referred to as an ‘activity 
follow’) and then these recordings are fed back directly to the staff included. 
Exposing staff to their own actual data separated their beliefs about goings on 
and reasons for things occurring with reality. The video recordings from these 
‘activity follows’ provided a sense of revived individual responsibility amongst 
HCPs and reactive engagement to collectively identify problem areas and 
provide simple solutions.  
The majority of participants viewed the first mobilisation as a shared task whilst 
in a previous study the majority of nurses and therapists believed that each 
professional group had independent responsibility.178 Staff worked together to 
deliver mobilisation to patients and were cognisant that the success of this 
depended not only on their individual skill-set but also understanding and having 
confidence in the skills of their colleagues. At the sites where this was not the 
case (evidence at two sites) there was an obvious and historical divide between 
the nurses and therapists where roles appeared to be based on traditional 
models. There were occasions where the physiotherapists believed that the 
nurses had made the incorrect judgement. At one AVERT phase III site the 
physiotherapists were unclear as to who actually delivered the first mobilisation 
for intervention trial patients. This illustrates that there is some evidence that 
the division of labour may not always be explicit and this can differ markedly 
between sites depending on the skills and experience of staff.   
There were a number of patient level factors that contributed to the decision 
whether to mobilise a patient for the first time. Many patients have 
comorbidities which may determine the level of physical activity that they are 
able to engage in. The factors were not only multiple, varied by individual 
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patient but were also considered simultaneously making it challenging to 
identify the key factor(s) driving decision making. For example, HCPs commonly 
used trade-offs when deciding to mobilise a patient up-to-sit in a chair for the 
first time: 
• increasing fatigue levels versus creating a more stimulating environment  
• reduced consciousness level versus reducing risk of chest complication 
This decision making was an intuitive process for most staff when mobilising a 
patient for the first time and it was believed that the same principles would 
apply to VEM. Reliance on subjective evaluations of patient progress based on 
intuition or clinical experience is recognised elsewhere.195 Medical stability was 
the most pressing issue for professionals, which is in line with a previous study 
whereby along with the level of consciousness, medical stability was considered 
one of the most important factor in deciding whether or not to mobilise a 
patient.178 There is a need for the term “medical stability” to be clearly defined 
and for more evidence around the mobilisation of patients considered to be 
“medically unstable”. The patient’s level of consciousness was a key factor in 
deciding whether or not to mobilise a patient both for the first time and when 
continuing mobilisation practice. Defining consciousness was difficult due to the 
number of terms used and an acceptable level of consciousness was not agreed; 
it was clear that if patients were almost asleep staff questioned the worth of 
getting them sitting up in a chair.  
Strengths and limitations 
The findings are based on a relevant sample of HCPs and provides multiple and 
diverse perspectives. One limitation in the study was that no nursing assistants 
participated. Nursing assistants are considered to be the group who deliver a 
large proportion of patient care and are involved in the day-to-day mobilisation 
of patients.  
The findings from triangulation of data (using the observational data and the 
qualitative data) presented at points through this discussion have proved useful 
in highlighting discrepancies between what staff believe they do and what they 
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actually do. This emphasises the importance of sharing the findings of clinical 
effectiveness activities with staff. Having being involved in AVERT phase III in 
the capacity of Trial Manager it could be argued that participants may have been 
less reluctant to highlight any problems or provide critical responses, portraying 
an overly-optimistic picture of implementing the trial intervention. The frank 
nature of the data presented in this Chapter does provide some support against 
this argument. Developing relationships with participants during the conduct of 
qualitative research is an essential part of the process and it is believed that 
having a pre-existing relationship with the majority of participants enhanced 
discussions and facilitated open and honest answers about topics that they 
understood the interviewer to have an appreciation for.  
As previously noted, one of the shortcomings identified by Lewin et al (2009) 
was that qualitative findings are not often integrated with the outcome data of 
the evaluation.171 The findings of this process evaluation could be integrated 
with the outcome data from AVERT phase III. Process data could be used to 
explain any variability in the effect size of VEM. For example, staff frequently 
highlighted that rehabilitation had to be tailored to meet the needs of individual 
patients. This may result in staff being unable to deliver VEM in a standardised 
way and explain variation in outcome.   
Chapter 3 revealed significant differences in the level of upright activity 
between the sites. Adjusting the analysis for baseline level of severity and level 
of mobility did not explain much of this variation. Therefore, it could be 
speculated that other factors such as differences in current practices and ward-
layout (as informed by data from researcher observation and interviews) may 
explain this. The hospital that had the highest level of upright activity also had 
more open-planned bed bays, more formal MDT meetings per week and a higher 
presence of therapists on the ward throughout the day. 
Prevalence data to gauge the importance of each of the barriers and facilitators 
were not provided. Alternatively it could have been counted in relation to the 
number of participants who raised it across the entire data set. However, this 
could be potentially misleading as a barrier that had a high prevalence could 
have been the result of just one person repeatedly saying this.  
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This study is limited in providing details on the relative importance of barriers 
and prioritising of the barriers. This may have particular relevance in the area of 
implementation science whereby the relative importance of each of the barriers 
and facilitators may be required to guide investment decisions around 
implementation strategies. The use of discrete choice experiments (DCEs) to 
investigate preferences may be of value in implementation science. Discrete 
choice experiments present people with a range of choices requiring them to 
state a preference for a given scenario. Each choice consists of one or more 
hypothetical options and for each choice people are asked which one they would 
choose. It works on the assumption that decisions are based on multi-criteria 
and not just one factor (attributes). Forcing people to make choices and trade-
offs (between barriers and facilitators) could ensure that implementation 
strategies are tailored to the specific preferences and trade-offs of those who 
will actually be delivering the intervention. The barriers and facilitators 
identified here could be used to inform the basis of a DCE. The analysis of 
relative importance of each of the attributes may reveal that the decision to 
mobilise is strongly influenced by the need for the patient to be medically 
stable. Thus, indicating that the greatest effort in developing implementation 
strategies should be invested into defining the term ‘medically unstable’ and, as 
required, alleviating HCPs’ concerns of mobilising patients confirmed or 
perceived to be medically unstable. 
It has been recommended that implementation science could be significantly 
improved by taking a more systematic approach in using theory to study 
healthcare implementation. The main limitation of this qualitative analysis is the 
lack of use of a theoretical framework. This is important to increase the 
accessibility and usability of the knowledge that has been generated. The use of 
an implementation or behavioural change theory may have assisted in identifying 
the determinants of change and if those determinants are modifiable. One 
sociological model called the Normalisation Process Model is specifically 
designed to study complex interventions and enquire what people do to make a 
complex intervention workable in real clinical practice.196 The model proposes 
that the success of a complex intervention should be interpreted in relation to 
the workability and integration of it in practice. This model has since been 
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developed and reoffered as the Normalisation Process Theory (NPT). In 2005, the 
UK House of Commons Health Committee emphasised the need for an improved 
understanding of the implementation process and NPT may offer the conceptual 
tools to satisfy this requirement.31 Further models and theories of 
implementation and behavioural change are described in Section 7.5.2. 
A flexible seven day working week would mark a significant turning point for 
therapists and certainly, although not met with much enthusiasm here, signs of 
this are already evident in some parts of the UK. The Chartered Society for 
Physiotherapy guidance has already made stipulations for such services in that 
they should be adequately funded and piloted prior to implementation. The 
cost-effectiveness of such a service in stroke care needs to be determined. One 
of the ten points for action outlined in the national stroke strategy is for 
intensive rehabilitation “operating across the seven day week”.17 
As noted in Chapter 1, the uptake of a complex intervention depends on the 
responsiveness of those receiving it. Very early mobilisation requires patient 
participation and possible self-practicing which has implications for compliance. 
This study did not interview patients to gauge their perceptions of the 
intervention. Staff often raised patient preference as a factor to consider before 
and during mobilisation as was the response of relatives. A previous study 
reported that the majority of nurses (71.8%) and physiotherapists (57.1%) were 
prepared to mobilise a patient whatever the families/patients view.178 Staff 
were observed on the wards (Chapter 3) using motivational and negotiation 
techniques with patients initially unenthusiastic to mobilise. Staff believed that 
the patient’s response to VEM would be varied; with some patients in favour of 
undertaking more mobilisation while others were not. This concept could be 
explored by conducting interviews with either stroke survivors or patients that 
have taken part in AVERT phase III. If trial patients are to be interviewed it may 
only be feasible to do this on completion of their involvement in the trial. 
However, recall may pose a challenge. If the blinding to group allocation of the 
interviewer and patients could be guaranteed and that interviewing patients 
would not pose any biases to the trial (assume that any response to being 
interviewed is the same between the SC and VEM groups), interviewing ongoing 
trial patients about their experience of acute stroke care (which will include 
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mobilisation) after the intervention period may be a possibility. Collaboration 
between the developers, the providers and the intended population of VEM is an 
important consideration for the future. 
Lessons can be learnt from hospitals that have and have not implemented other 
acute interventions successfully. Healthcare professionals’ views and 
experiences of change were explored; however the detail that could be divulged 
was limited due to time-constraints. A closer evaluation of the real-life 
workability of thrombolysis could provide transferable information for the 
implementation of VEM. How tasks are allocated and how the flexible staffing 
structure (as raised when discussing thrombolysis in this study) is initiated and 
operated when a patient eligible for thrombolysis arrives on the ward are 
aspects which could be studied.  
Developing implementation strategies 
Better, more broad implementation and uptake leads to better outcomes.41 The 
transfer of effective programs into the real world is challenging and is 
considered to comprise of four phases including “how well information about a 
program’s existence and value is supplied to communities (dissemination), 
whether the local community decides to try the new guideline (adoption), how 
well the programme is conducted during the trial (implementation) and whether 
the programme can be maintained (sustainability).” 41 There is a need for 
implementation strategies that are evidence-based to facilitate each of these 
phases. Although, the development of implementation strategies usually occurs 
in the later stages of the implementation process36 some preliminary 
recommendations for the implementation of VEM for each of these four phases 
are provided. Each stage is broadly defined and preceded by key findings from 
this qualitative study to illustrate that an evidence-based approach to 
generating these recommendations has been used. 
Dissemination  
Dissemination refers to how well information about an intervention’s existence 
and its value reaches its users. This process is defined as the spread of new ideas 
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and technologies. They must be marketed effectively so that the target 
audience learn about its existence and potential benefit.197 
Key findings relating to the dissemination stage: 
• Healthcare professionals have concerns about the feasibility of implementing 
very early mobilisation in real-life 
• Healthcare professionals believed that very early mobilisation may result in 
care being compromised for certain groups of patients 
• Pre-existing contextual factors may facilitate the implementation of very 
early mobilisation; regular and early team communication, planning the 
patient’s day, collaboration as characterised by non-hierarchical relationships 
amongst participants, mutual trust and open communication, shared 
responsibilities for completing tasks and efforts to reach consensus when 
opinions are conflicting 
Recommendations for the dissemination stage:  
• Initiate priming activities to highlight the need for and to trigger change such 
as provide feedback to staff on findings from local behavioural mapping 
studies studying context and current practices 
• Provision of a guideline with clear statement to define and provide a set of 
actions to distinguish very early mobilisation from standard practice 
• Provide a statement to address concerns about equity of care. The use of 
negative recommendations may be required to reinforce and reason why 
certain groups of patients may not benefit i.e. ‘the use of very early 
mobilisation is not indicated for patients with…’  
• Appoint trouble-shooters and scientists specialising in behavioural change to 
work with hospital staff at all levels to identify potential problems and 
provide solutions at this early stage 
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Adoption 
This refers to whether the user decides to try the new intervention. For any 
practice to be adopted in clinical practice there is a need for those that are 
providing it to be convinced that the work is worth the effort. Individuals need 
to believe that the benefit of changing practice is ‘worth’ the energy and 
resources to make the change. Facilitation is emerging as a way in which to 
encourage evidence uptake in healthcare and successful implementation is 
dependent on the quality of the facilitation.198 Facilitation is a technique by 
which one person makes things easier for others.199 Facilitators play an 
important role in assisting individuals and teams with identifying what needs to 
change and how to embed these changes into real life. The existence of a 
facilitator has been recognised as a valuable resource to encouraging new ways 
of working and thinking.41 Facilitator appears to be the new buzzword for 
champion, no attempt has been found in the literature to distinguish between 
these terms so they are used interchangeably here.   
Key findings relating to the adoption stage: 
• Healthcare professionals often relied on success stories (using thrombolysis as 
an example) from colleagues working at other hospitals or research findings 
• Change needs to be planned in advance, introduced in stages with everyone 
on-board at an early stage 
• Healthcare professionals were more likely to engage in the change if it had 
‘appeal’ i.e. there was a sense that ‘everyone is talking about it’, offered 
new responsibilities or had visible and immediate effects on patients 
• Some hospitals were more cautious in adopting change, preferring to see how 
other hospitals got on first before trying it themselves 
There were differences in how professional groups responded and approached 
change. There was a sense that doctors, with more experience of being the 
leaders in change, were more proactive whilst therapists and nurses were more 
tentative about how they may overcome barriers (Appendix 16). Generally, the 
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use of a champion was seen to have advantages and disadvantages. Given the 
multidisciplinary nature of VEM this may not be the most appropriate approach 
to getting everyone on-board. A champion was seen to have a role to play in 
solving problems and maintaining enthusiasm in order to sustain the change. 
Having one dedicated person overseeing and co-ordinating the process may 
become onerous for the champion and result in the rest of the team becoming 
evasive. Therefore, the success of this approach lies in having the organisation 
onboard and everyone receptive to change.  
Recommendations for the adoption stage:  
• Efforts to break negative preconceptions about the intervention i.e. 
perceived workload may be more attributed to participation in a study 
requiring more time than delivering the intervention in real-life due to the 
study administration and additional measurements that may need to be 
taken. The trial protocol may differ from the final product recommended for 
use in real-life. 
• The risks and benefits of very early mobilisation are explicitly stated with 
easily interpretable scientific findings 
• The appointment of a leader with dedicated time to encourage ‘buy-in’ may 
be just as effective as the use of an individual as a champion. This should be 
at the discretion of each hospital. 
Implementation 
Implementation refers to how well the intervention was conducted during the 
trial and if evaluates positively, how well it will be implemented in real-life post 
evaluation. Early monitoring of implementation during and post-trial can identify 
problems in application that can be corrected. Early monitoring of 
implementation followed by retraining has doubled fidelity of implementation to 
over 85% for providers who were having initial difficulties.200 Adaption of an 
intervention prior to and during its implementation is a controversial issue.28 
Some believe that it is acceptable to adapt the intervention, determining to 
what extent original core program components can be changed, whether new 
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aspects are added and what they are, or whether parts of the intended 
intervention are omitted.  
Key findings relating to the implementation stage: 
• Healthcare professionals previous experience of the intervention within the 
trial and changes in practice that they have been involved in may be an 
important predictor to successful implementation  
• The process of normalisation was a concept that many staff related to 
whereby new practices became routine and cumulative experiences of the 
new intervention or change alleviated fears associated with the introduction 
of the intervention  
Healthcare professionals did not routinely discuss as a team the process of 
implementation to identify problem areas or solutions. When asked about the 
use of process evaluation meetings this was well received with staff seeing 
benefits in ironing out any issues, identifying any slippage and having time 
within the working day to discuss as a team problem areas and solutions. 
Meetings would also provide a platform to support, put anxieties into 
perspective and learn from each other.  
Recommendations for the implementation stage:  
• Provide example models for local delivery which may be based on current 
and future development of staff skill-base and structures such as the 
availability of equipment 
• Education packages underlining the benefit and risks of very early 
mobilisation. Those that recognise the need for the intervention, the 
potential benefits, have self-efficacy and skill proficiency are more likely to 
implement a program with higher levels of adherence 
• Systems to actively identify eligible patients. This is an important practice 
which will involve organisational collaboration as well as individual ownership  
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• Protocol or decision flowchart should consist of a task checklist of which 
some may relate to contextual issues– Has this been verbally communicated 
to the nurse? If applicable, has the bed-side mobility chart been updated?  
• Risk management strategies which target pre-existing beliefs such as the 
need for patient medical stability prior to mobilisation 
• Early morning team communication to plan and structure the patient’s day 
• Embed ‘mini’ process evaluations in team meetings. Formally referred to as 
quality circles these are more readily used in industry than healthcare. 
Quality circles are defined by voluntary participation, collaborative decision 
making and contribution from employees.201 
• Generally, implementation strategies should reflect the acute and busy 
environment of ASUs and take on-board the factors that are likely to 
influence behavioural change in HCPs (such as preconceptions around patient 
eligibility, the benefit of the intervention to the patient, the effort required 
by the individual to make the change). 
Sustainability 
Sustainability refers to whether the intervention can be maintained in the long-
term. It has been shown that few interventions are sustained over time, 
regardless of the success achieved during the trial. Sites may adopt the practice 
but it is also vital to monitor how these are being sustained in the long-term. 
Healthcare is delivered in dynamic systems with changes in the workface, high 
turnover of staff, new interventions and changes in the population therefore 
there is a need to monitor the implementation of these contextual factors and a 
mixture of observational techniques and interviews should be integral to the 
longer term monitoring plan. Strong leadership and the day-to-day presence of 
the leader are key, with time dedicated within portfolios to allow staff 
performance to be monitored and developed.  
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Key finding relating to sustainability: 
• Feedback sometimes resulted in staff feeling threatened by the need to 
respond to performance criteria. Feedback itself may not explain why things 
are not being achieved. For example, recording information about actions 
that did or did not happen does not explain the clinical context in which this 
did or did not occur. 
Recommendations for the sustainability stage:  
• Include process indicators related to very early mobilisation in quality 
assurance activities 
• Engage and involve staff in the monitoring process which may involve a 
general change in the way audits are conducted. Healthcare professionals 
need to view actual practice data about their performance and context. 
Video recording would provide the ideal data.  
• Engage with professional councils to support and campaign for the continued 
development of seven-day working (extended day and shift system) for 
therapists 
5.5 Conclusion 
This Chapter includes research that addresses the evaluation stage of the 
Medical Research Council complex intervention framework. This study has 
provided data on current stroke processes, pre-existing context and the factors 
that may influence the future implementation of very early mobilisation (VEM). 
It has also provided rich data about the complex array of individual, intervention 
specific and environmental elements that influence change. A set of beliefs has 
been formulated based on the viewpoints of a range of healthcare professionals 
with and without experience of implementing VEM within a trial setting. Barriers 
were complex, multifunctional and affected the system at a number of levels; 
the individual healthcare professional, patient, social, organisational, political 
and economic. Access to the patient within 24 hours and medical instability 
were the barriers most frequently mentioned. The hospital organisational 
Chapter 5 
 
210 
structure often impacted on the speed of patient diagnosis and subsequent 
pathway to the acute stroke unit. The intervention’s association with increased 
staff workload was a constant theme throughout discussions. This study has 
highlighted the need for a well-designed implementation plan and strategies 
which aim to have staff ‘on-board’ and one that breeds a supportive 
management climate to ensure the successful implementation of VEM.
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6 Economic impact of very early mobilisation 
6.1 Introduction 
Much of the onus of stroke care lies with the rehabilitation service and since 
stroke rehabilitation is highly resource-intensive, it is important for policy 
makers to consider the potential trade-offs between all relevant costs and 
benefits. Chapter 4 estimated the clinical impact of VEM showing that it has the 
potential to improve outcomes after stroke. However, the cost-effectiveness of 
VEM has not yet been estimated or the economic impact explored. Therefore, 
this Chapter aims to estimate the cost-effectiveness of VEM.  
A number of systematic reviews to identify the economic evidence in stroke 
research have been conducted;202-205 however only one was dedicated to 
rehabilitation services. The studies included in these reviews were appraised 
based on good practice guidelines for economic evaluation alongside clinical 
trials and economic modelling.206 207 The authors of these reviews made several 
general suggestions to improve the undertaking of economic evaluation in 
stroke, although these are not specific to complex rehabilitation interventions. 
These include: the comparison of all relevant interventions, taking account of all 
available sources to ensure the reliability of effectiveness and cost data and 
examining the uncertainty of the results.  
The clinical evaluation of a complex intervention such as stroke rehabilitation 
service is widely recognised as more complicated (Chapter 1) than that of, say, 
pharmacological interventions. It is therefore not unreasonable to state that the 
economic evaluation of a complex intervention may be more challenging; the 
context dependent and variable nature of complex interventions is a 
complicated arena for researchers undertaking economic evaluations and one 
that deserves attention. Therefore, this Chapter begins with a systematic review 
aimed to identify approaches used to evaluate the cost-effectiveness of stroke 
rehabilitation. The findings from this review will then be used to inform the 
economic evaluation of VEM. The resource use items and the health-related 
quality of life data reported in Chapter 4 will now be used in this economic 
evaluation. The qualitative evidence from Chapter 5 with regards to the
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suggested implementation strategies for VEM will also be considered to identify 
costs not traditionally associated with the implementation of complex 
interventions. 
6.1.1  Types of economic evaluation 
An economic evaluation must compare two or more alternatives, examining both 
the costs and consequences.208 A number of different types of economic 
evaluations can be used to evaluate health interventions depending on the aim 
of evaluation and in some cases the data available. As these will be referred to 
and used throughout this Chapter the various types of economic evaluations, 
along with the health economics terminology used, will now be introduced and 
briefly explained.  
The types of economic evaluations that will be referred to in this Chapter are as 
follows: cost-minimisation analysis (CMA), cost-consequence analysis (CCA), 
cost-effectiveness analysis (CEA) and cost-utility analysis (CUA) (Table 6-1). The 
other type of economic evaluation is a cost-benefit analysis (CBA) which will not 
be referred to throughout this Chapter. A CMA is conducted when there is no 
difference in effect therefore only costs are of interest. A CCA is a balance sheet 
approach where all costs and all consequences are tabulated but not combined. 
A CEA synthesises cost and effect data in the form of an incremental cost-
effectiveness ratio (ICER) which identifies the additional costs associated with 
the intervention per additional unit of outcome produced by the intervention in 
comparison to the alternative. A CUA is sub-type of a CEA and is used where 
there is no single outcome of interest. A CBA is where all inputs (i.e. healthcare 
resources and costs) and outputs (health outcomes) are expressed in money 
terms.
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 Table 6-1 Types of economic evaluation 
 
The measure of effectiveness in a CEA is specific to the intervention in terms of 
the intervention’s natural units. Therefore, it does not allow a comparison of 
cost-effectiveness to be made between different interventions in other areas. To 
allow such comparisons to be made by decision makers a generic measure of 
effectiveness is required. A QALY is one that is commonly used in the economic 
evaluation of health interventions, this is also the preferred measure by NICE.209 
A QALY is a measure of combined length of life and health-related quality of life 
(valued on an index where 1 represents perfect health and 0 represents death) 
in a single outcome. Quality-adjusted life years adjust each remaining year of a 
person’s life by the expected health-related quality of life for those years. For 
example, a patient aged 60 years of age may be expected to live for another 20 
years, however, having had a stroke their HRQoL is expected to be half the 
quality of life prior to stroke for the remainder of their life. Therefore, at the 
patient’s current age of 60 years, this patient has 10 QALYs remaining (20 years 
x 0.5 QALY/years). Within a trial setting the patient’s actual HRQoL can be 
collected at intervals during the trial and at follow-up. The HRQoL data can then 
be used to estimate HRQoL beyond the observed time frame of the trial i.e. for 
ten years or a life-time.  
Study type Key feature(s) Measurement of 
effectiveness 
Cost-
outcome 
comparison 
Cost-minimisation 
analysis  
• Presents costs and 
resource 
• Conducted when there is 
no difference in effect 
• Benefits are equivalent • None 
Cost-consequence 
analysis  
 
• Tabulates all costs and all 
consequences separately 
i.e. a ‘balance sheet’ 
approach 
• Benefits are multiple • None 
Cost-effectiveness 
analysis  
• Combines the costs with 
primary natural unit of 
interest 
• Natural units  
(e.g. death, falls, life-years 
gained) 
• Cost per 
outcome 
unit 
Cost-utility  
analysis  
• Combines the costs with 
a measure of utility 
• Healthy years  
(e.g. quality adjusted life 
years) 
• Cost per 
QALY 
Cost-benefit 
analysis 
• Both inputs and outputs 
are expressed in 
monetary terms 
• Monetary benefits • Net 
monetary 
benefit 
Adapted from Drummond and Jefferson, British Medical Journal206 
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In the UK, the standard threshold set by NICE to assess whether or not an 
intervention is cost-effective is based on the value that society places on a 
QALY. These values are in the region of £20,000 to £30,000.210  
Aim 
The aim of this Chapter was to use an evidence synthesis approach to model the 
economic impact of VEM using the findings of a systematic review and the IPD 
from VERITAS and AVERT phase II to inform the model.  
6.2 Systematic review of economic evaluations  
6.2.1 Methods  
A systematic review was undertaken prior to the economic evaluation to review 
the methodological approaches and assess the quality of economic evaluations in 
stroke rehabilitation. As the findings of the systematic review will inform the 
methods of the economic evaluation the methods and findings of the systematic 
review are presented before the economic evaluation. 
Inclusion and exclusion criteria 
Studies that reported on economic evaluations of rehabilitation interventions 
targeted at stroke patients were included. A stroke rehabilitation intervention 
was defined as either a service (acute/community rehabilitation or early-
supported discharge) or a specific intervention aimed at improving the patients 
activity such as walking and participation in, for example, leisure activities and 
employment after stroke. Economic evaluations were defined as studies that 
compared two or more alternative stroke rehabilitation interventions or services 
with the costs and outcomes being examined for each alternative. Studies that 
were methodological or discursive, reviews of economic evaluations, 
efficacy/effectiveness evaluations, studies that presented resource use only 
without unit costs, cost studies where no consequences/benefits were reported 
or evaluated the burden of disease were excluded. Rehabilitation interventions 
that included a drug or medical device, or interventions or services targeted at 
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carers and/or HCPs were also excluded. 
Search strategy and data extraction 
The following electronic databases were searched from inception to September 
2011: EMBASE, MEDLINE In-Process and NHS Economic Evaluation Database (NHS 
EED). No restrictions were applied to language. In order to identify relevant 
studies, search strategies specific to each database were developed using a 
combination of MeSH and free text words (Appendix 17). A citation search of 
Web of Science and reviewing the references lists of key papers was undertaken 
to ensure an efficient and comprehensive coverage. The titles and abstracts of 
retrieved references from the search were screened by the author only to 
exclude irrelevant studies. The full-text articles of studies that satisfied the 
inclusion criteria were reviewed in full and data extracted. Decisions were then 
cross-checked with a Health Economist. Data extraction included key study and 
methodological characteristics:  
• The intervention or service and the comparator(s) used 
• The perspective and time horizon of the evaluation 
• The source of effectiveness and cost data  
• The measure of benefits (such as natural units, utility based measures or 
monetary benefits)  
• The measure of cost-effectiveness (such as incremental cost per QALY or 
incremental cost per life year gained) 
• Reported analysis of uncertainty 
The quality of each of the studies was assessed using a well-defined checklist for 
the conduct and reporting of economic evaluations.206 The findings from this 
quality assessment were summarised using the following three headings; study 
design, validity of data and analysis and interpretation of results.  
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6.2.2 Results  
The total number of studies identified by the search was 2,061. Following 
screening of titles and abstracts the full-text articles of 35 studies were assessed 
in detail (Appendix 18).  Overall, 21 studies met the selection criteria, and were 
included in the review (Appendix 19).211-231  The results from the quality 
assessment are shown in Appendix 20 to Appendix 22. 
Study design 
Overall, nine studies used a CCA type approach, six studies conducted a CEA and 
the remaining six were classified as a cost-minimisation analysis (CMA). None of 
studies conducted a CUA or developed an economic model i.e. to extrapolate 
beyond the timeframe of the trial. There was variation between the studies that 
adopted a CCA approach in relation to the planning, design and conduct of the 
evaluation as well as the reporting of all costs and all consequences. None of the 
studies provided a rationale for adopting this cost-consequence approach and 
this was not explicitly stated as the type of economic evaluation in any of the 
studies. All possible consequences of the intervention were not identified and/or 
tabulated alongside all possible costs, with the reader often being referred 
elsewhere for the effectiveness results of the study. One of these studies was a 
health technology assessment where data from the individual studies were 
extracted and synthesised.220 Cost-minimisation analyses were conducted where 
it was inappropriate to synthesis the costs and benefits as there had been no 
difference in effect.  
Overall, the perspective, when reported, was that of the healthcare provider. 
Two studies adopted a societal approach whereby productivity costs were 
included.225 229 All studies followed patients for either six months or one year 
with the time horizon for the economic evaluation rarely stated explicitly. 
Validity of data 
In eighteen studies, clinical effectiveness data were from RCTs in which between 
59 and 331 stroke patients were recruited. The majority of studies investigated a 
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stroke rehabilitation service including early supported discharge service, 
community or home-based rehabilitation. One study evaluated a specific stroke 
rehabilitation intervention.225 The comparator was always current practice 
within the particular setting. All studies provided some description of the 
intervention under study; however, the level of detail with respect to the 
staffing structure, content and quantity of rehabilitation sessions provided 
varied. 
The number and type of patient-related outcomes reported in the studies 
reflects the multidimensional nature of stroke rehabilitation in its aim to affect 
the level of impairments such as lost motor function, activity limitations and 
participation restriction.20 All studies reported more than one patient-related 
outcome, four studies211 212 217 231 reported carer-related outcomes such as carer 
stress and five studies211 212 215 216 228 reported either patient or carer satisfaction 
with the health care that they had received.  With respect to HRQoL, the 
measure used to derive QALYs for use in economic evaluations, the majority of 
studies reported an overall non-significant effect. One study showed significant 
differences in the overall HRQoL score 224 while three other studies reported 
improvements for specific domains (most commonly the physical component) of 
the HRQoL assessment.217 226 228 
Costing was limited to the delivery of the intervention in two studies 213 230 and 
did not include non hospital resource use such as community services provided. 
In one study assumptions regarding intervention delivery and/or resource use 
were made as opposed to being solely informed by data from the individual 
patients included in the study. It was explicitly stated in two studies that an 
average cost was applied where patients that had no or incomplete information 
about resource use. 211 213 The resource use items associated with the service or 
intervention under evaluation were described in detail, but in nine studies 
resource quantities were not always given separately.214 215 217 218 223 224 226-228 The 
sources used to determine resource use varied and all studies included 
specifically designed study questionnaires/interviews or hospital departmental 
records. In all cases the method of costing included the use of data from hospital 
expenditure or the application of national unit costs. Only one study considered 
the costs of implementation which included those associated with establishing 
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new links with other agencies and increased administration.221 Overall, costs to 
the patient i.e. ‘out-of-pocket’ expenses such as home adaption’s or equipment 
purchased were not identified in the majority of studies (n=17) whilst costs to 
informal carers were identified as potential costs in three studies but this rarely 
measured. Authors of one study stated that they had attempted to incorporate 
costs to the informal carer but questioned the quality of their data.212   
Analysis and interpretation of results 
Where an ICER was calculated the measure of effectiveness was in natural units 
such as cost per good outcome,150 cost per disability averted 224 or cost per mean 
point improvement in balance.218 The impact of variations in resource use or unit 
costs, on the final results, was analysed in seven studies. Sensitivity analysis 
tested assumptions around average per-day costs,211 length of stay,212 therapy 
workload,222 provision of a home-based rehabilitation team,211 222 224 ambulance 
costs222 and day hospital.222 One study used probabilistic sensitivity analysis to 
examine the uncertainty of ICER calculated.225 One study explored the 
opportunity costs that an early discharge team may have on increasing inpatient 
bed-capacity.212  
Summary of limitations  
Assessing the quality of the studies against the generic quality checklist 
identified some general methodological shortcomings in the economic 
evaluations, such as not routinely conducting uncertainty analysis or not 
justifying the design of the study. There were other shortcomings that are of 
particular relevance to the evaluation of complex interventions, with regards to 
the context and patient dependent nature of such interventions. These will now 
be identified and explained below:  
The perspective of the evaluation was not explicitly stated - this makes it 
difficult to assess if all the appropriate costs and outcomes have been identified, 
measured and valued. Where it was stated, the majority of studies adopted a 
healthcare perspective, therefore did not routinely measure and value costs 
associated with a loss of productivity and informal care. This has particular 
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relevance in the study of complex interventions where the aim is often to 
rehabilitate the person to return home or return to work. Therefore, a broader 
societal perspective, which considers a range of costs and effects is 
recommended over a narrower perspective i.e. health service. 
A protocol-driven approach to costing intervention implementation - this 
requires assumptions about what resources were actually used and that the 
intervention was delivered as intended. This may not be true as complex 
interventions involve different resources to tailor the intervention to the needs 
of individual patients.  
Inadequate attempts to synthesis the cost and effectiveness data - where 
studies did not aggregate costs and effects in the form of an ICER few authors 
used narrative synthesis to provide a statement about the cost-effectiveness of 
the intervention or systematically tabulate all costs and consequences. Out of 
the studies that did present cost-effectiveness in the form of an ICER, three 
studies reported an ICER for all clinical outcomes.  
Cost-utility analysis was not an approach used in any of the studies - none of 
the studies attempted to value the HRQoL data, either because this was not 
collected during the trial or the intervention had no effect on quality of life. As 
a CUA is the preferred type of analysis by decision makers this will limit the 
comparisons that can be drawn between interventions from other disease areas. 
It has been argued that QALYs do not capture all the broader benefits (including 
non-health benefits) that are associated with complex interventions232, although 
this argument was not used to justify the approach used in any of the studies.  
6.3 Economic evaluation of very early mobilisation 
6.3.1 Methods 
Study design and perspective 
As the potential outcomes of stroke rehabilitation are likely to be wide-reaching 
with implications for patients, carers and society, and as supported by the 
findings of the systematic review, the perspective of the economic evaluation 
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was societal. Very early mobilisation was the intervention and the comparator 
was SC. A CCA was conducted in the first instance where all costs and 
consequences of the intervention were tabulated. The use of a CCA is 
advantageous when the rehabilitation intervention is known to have multiple 
health and non-health benefits and one composite measure is justifiably 
inappropriate. The costs and consequences of VEM were identified using the 
findings from the systematic review, the IPD MA (Chapter 4) and the qualitative 
process evaluation (Chapter 5). As previously indicated in the IPD meta-analysis, 
VEM may have more specific health benefits such as increased odds of 
independence other than those captured by measuring general HRQoL. With this 
in mind (and as supported by the findings from the systematic review) CEAs using 
independence and immobility-related complications as the natural measures of 
effectiveness were conducted so as to fully explore all possible 
benefits/outcomes of VEM in comparison to SC. Cost-utility analysis is the 
preferred type of economic analysis by NICE who are the UK decision makers 
with regards to health technologies. Therefore, a complimentary CUA was 
conducted. The primary outcome for the CUA was the incremental cost per 
additional QALY gained. The calculation of QALYs was estimated using trial data.  
Measurement and valuation of effectiveness  
The primary effectiveness outcome for the CEA was the incremental cost per 
additional case of independence gained. The secondary effectiveness outcome 
for the CEA was the incremental cost per additional immobility-related 
complication prevented. All effectiveness data were based on the IPD meta-
analysis. The HRQoL data as collected using the AQoL instrument was previously 
summed to provide an overall unweighted HRQoL-index (Chapter 4). The AQoL 
score was then used to compute an overall utility score weighted by preference 
(using a widely available algorithm233) in order to calculate QALYs for use in the 
CUA. To calculate a within trial QALY requires HRQoL data to be collected at 
baseline and at one or more follow-up points.234 Health-related quality of life 
data was not collected at baseline, therefore, QALYs were calculated based on 
the three month and 12 month HRQoL data from AVERT phase II using a standard 
approach.234 Values were not assigned to the natural units of effect. 
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Measurement and valuation of costs  
Costs and resource use are likely to vary between countries due to differences in 
unit costs and the different combinations of resource use that are required to 
deliver the intervention within a given setting.235 Therefore, it was considered 
inappropriate to combine the UK and Australian resource data, so for this reason 
the CEA was based on the VERITAS resource use data.  Resource use was 
classified into one of the following three sectors; health care, personal or 
societal. Health care resource use included NHS resources and those consumed 
in the community, as well as immobility-related complications (adverse events 
considered to be related to the intervention). Data about implementing the 
intervention (such as staff time) were not collected in the VERITAS study. 
Therefore, it was assumed that the implementation of the intervention was per 
protocol which aimed at doubling current therapy time. Current therapy time as 
provided in the UK has been estimated to be approximately 45 minutes.106 236 
Loss of productivity was not measured in VERITAS, therefore it was estimated 
based on that measured in AVERT phase II. The mean loss of productivity was 30 
hours per week for SC patients with no loss of productivity for patients in the 
VEM group at three months.150 
The costs were calculated by applying a unit cost to each of the resource items. 
The reference year for costing was 2010 (£UK). Unit costs were based on UK 
National Health Service reference costs.237 It is not appropriate to divide total 
health care expenditure by the number of patients as it does not account for 
individual patient differences (case-mix). Reference costs use case-mix adjusted 
measures and in the UK these are called health care resource groups. These 
groups are “defined by clinicians and reflect clinical practice in the UK, 
providing standard groupings or similar treatments that use similar resources.” 
238 Where reference costs were not available, Personal Social Services Research 
Unit costs were applied.239 The Personal Social Services Research Unit costs were 
used to cost staff time, community visits made by a home help and GP visits. 
Staff time (based on cost per hour for an Agenda for Change Grade 5 
Physiotherapist) was used to cost the implementation of VEM per protocol and 
SC. Individual patient costs were summed and the difference in mean costs 
between the VEM and SC groups was calculated as recommended.240 The mean 
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number of visits made by informal carers was measured in VERITAS. 
Informal care (time of informal carers) was valued on the equivalent hourly rate 
of a local authority home care worker. Each visit by the informal carer was 
assumed to last one hour. Productivity costs were presented separately and 
valued according to UK earnings from the National Office of Statistics. Excluding 
overtime, median hourly earnings of full-time employees on adult rates of pay 
were £12.50 per hour in April 2010.241 The mean loss in productivity for the SC 
group was calculated as follows: 30 hours multiplied by £12.50 multiplied by 12 
weeks.  
Data analysis  
All costs and consequences were tabulated. Costs were listed according to 
perspective (health care, personal or societal). For the CEA and the CUA the cost 
and effectiveness data were used to calculate an ICER (ICER = incremental cost 
divided by the incremental unit of outcome). In health economics, dominance is 
the term used to describe a situation where an option is both more costly and 
less effective than the alternative intervention.242 For example, on comparing 
two interventions, if intervention A is less costly and more effective than 
intervention B, intervention B is said to be dominated by intervention A. Where 
dominance is found no ICER is reported, the outcome is dominance. 
Sensitivity analysis 
One-way sensitivity analyses were performed on key unit costs by varying one 
measure at a time. As this was intended as a small scale evaluation the 
sensitivity analysis was limited to costs and to the CEA using independence as 
the main outcome as per the IPD. The unit costs that were varied included the 
hourly rate of a physiotherapist, home carer and informal carer which were 
increased by 50% then by 75%. As actual resource use associated with the 
intervention was measured in AVERT phase II (time spent in therapy) and the 
methods to costs informal carers time vary 243, additional sensitivity analyses 
were undertaken to assess the impact on cost-effectiveness outcomes. These 
included; i) costing physiotherapist time based on the actual mean time spent in 
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therapy for the SC and VEM groups (17.3 minutes and 40.3 minutes, 
respectively150) ii) costing the intervention based on nurse time iii) costing the 
need for an informal carer equivalent to admission to a local authority care 
home. 
6.3.2 Results 
Results of cost-consequence analysis 
The costs (health sector, personal and societal) are shown in Table 6-2 (for 
resource quantities refer back to Chapter 4).  When only costs associated with 
healthcare are included the mean cost for a patient in the VEM group was higher 
than for a patient in the SC group (£4248 versus £3803). The two key resource 
items which contribute to this difference in cost between the two groups are the 
implementation of the intervention and resource use associated with deep 
venous thrombosis. When the costs associated with the loss of productivity are 
included the mean cost for a patient in the VEM group was lower than for a 
patient in the SC group (£5975 versus £8444). 
In addition to the resource use items listed, there are likely to be costs 
associated with implementation strategies used to embed VEM into routine 
practice. Although there was not a consensus from staff regarding the most 
appropriate implementation strategy for VEM most staff viewed the provision of 
educational sessions as a key facilitator to implementing VEM by HCPs. 
Therefore, costs identified with the provision of such sessions; including 
educational materials (printing and/or videos), personnel (expert speakers and a 
facilitator) and the opportunity costs of staff attending the sessions (and 
learning time) should be considered.  
  
Table 6-2 Costs of very early mobilisation 
Costs of very early mobilisation in comparison to standard care 
 
Resource item  Unit Unit cost Unit cost source SC (n=16)  
(mean cost) 
VEM (n=16) 
(mean cost) 
Data source1 
Health care sector       
Implementation of intervention  Hour £40 PSSRU  £189 (47) £360 ( 96) VERITAS 
Acute-phase hospitalisation National los £2793 NHS Reference cost £2793 £2793 VERITAS 
Immobility-related complications (baseline-day 5)      VERITAS 
• chest infection Event £1028 NHS Reference cost £514 (650) £129 (351) VERITAS 
• urinary tract infection Event £1380 NHS Reference cost  £259 (556) £0 (0) VERITAS 
• deep venous thrombosis Event £1376 NHS Reference cost  £86 (344) £0 (0) VERITAS 
Immobility-related complications (day 5-month 3)      VERITAS 
• chest infection Event £1028  £0 (0) £64 (257) VERITAS 
• urinary tract infection Event £1380  £173 (471) £172 (471) VERITAS 
• deep venous thrombosis Event £1376  £0 (0) £86 (344) VERITAS 
District nurse visit Visit £36 NHS Reference cost £0 (0) £0 (0) VERITAS 
GP visit Visit £36 PSSRU £84 (186) £79 (  88) VERITAS 
Physiotherapy visit Visit £99 NHS Reference cost  £304 (647) £185 (386) VERITAS 
OT visit Visit £99 NHS Reference cost  £304 (540) £111 (345) VERITAS 
Social services      VERITAS 
Home help visit Hour £25 PSSRU £40 (135) £397(1440) VERITAS 
Mean cost per patient (healthcare costs only)    £3803 (930) £4248 (1587) - 
 
   
  
 
Personal costs      VERITAS 
Informal carer visited Hour £25 PSSRU £161 (283) £1727(6006) VERITAS 
Mean cost per patient (healthcare and personal costs)    £3944 (938) £5975( 6883) - 
 
   
  
 
Societal costs       
Productivity loss Hour £12.50 ONS £4500 £0 (0) AVERT phase II 
Estimated mean cost per patient (with productivity cost)    £8444 £5975 - 
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The health-related consequences for the patient (both short and long term) and 
carer are shown in Table 6-3 and have been discussed more fully in Chapter 4. At 
one week the risk of experiencing immobility-related complications for VEM 
patients remained significantly lower than that of SC patients. At three months 
patients who underwent VEM were three times more likely to be independent, 
had a increased chance of non-impaired mobility and significant improvement in 
ADL than SC patients.  
The systematic review highlighted that stroke rehabilitation may not only have 
health benefits but also non-health benefits and these may include: 
• Promoting the patient’s return to work (improved productivity of the 
workforce; reduced use of government benefit schemes) 
• Increased satisfaction with aspects of the delivery of health care  
• Increased knowledge; acute rehabilitation interventions may provide pressure 
for more public health campaigns aimed at increasing the general public’s 
recognition of the symptoms of stroke
  
Table 6-3 Consequences of very early mobilisation 
 
 
Consequences of very early mobilisation in comparison to standard care 
 
Health-related  Effect  Estimate (95%CI)  p-value Data source∗ 
 Patient outcomes (day 5-7)     
 Stroke severity  Non-significant reduction -0.59 (-2.44,   1.27) 0.53 IPD MA 
 Immobility-related complications Significant reduction 0.23 ( 0.07,   0.71) 0.01 IPD MA 
 Excessive fatigue Non-significant reduction 0.79 ( 0.27,   2.31) 0.67 IPD MA 
 Patient outcomes (month 3)     
 Level of independence Significant improvement 3.11 ( 1.03,   9.33) 0.04  
 Immobility-related complications Non-significant reduction 0.55 ( 0.23,   1.32) 0.42 IPD MA 
 Discharge home Non-significant increase 1.40 ( 0.46,   4.30) 0.60 IPD MA 
 Non-impaired mobility Significant increase 7.81 ( 1.70, 35.00) 0.01 IPD MA 
 Death Non-significant reduction 0.93 ( 1.11,   7.90) 0.95 IPD MA 
 Independence in activities of daily living Significant improvement 4.20 ( 1.34, 13.50) 0.01 IPD MA 
 Health-related quality of life Non-significant increase -3.63 (-7.30,   0.13) 0.06 IPD MA 
 Carer outcomes     
 Carer strain Non-significant reduction215 - 0.17 SR 
∗ IPD MA = Individual patient data meta-analysis, Chapter 4; SR = Systematic review (data extracted from the review is not specific to very early mobilisation), 
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Results of cost-effectiveness analyses 
Details of the mean costs, effectiveness and cost-effectiveness expressed as an 
ICER are provided in Table 6-4. From a societal perspective, as VEM was less 
costly and more effective, it was found to dominate SC, therefore no ICER was 
reported.  When excluding societal costs to consider healthcare and personal 
costs only, the VEM intervention resulted in an additional 10 patients achieving 
independence at an additional cost of £2031. Therefore, the ICER associated 
with VEM in comparison to SC was an additional £203 per additional patient 
achieving independence. As the incremental outcome is the same for immobility-
related complications as for independence, the ICER associated with VEM in 
comparison to SC remained the same. These ICERs suggest that VEM is 
potentially cost-effective when considering the NICE threshold of £20,000 to 
£30,000.  
 
Table 6-4 Results for cost-effectiveness analysis 
Societal perspective  
 Mean cost  EA ICER  EB ICER  
SC £8444 17 - 17 - 
VEM £5975 27 Dominates∗ 7 Dominates 
Healthcare perspective   
 Mean cost  EA ICER  EB ICER  
SC £3944  17 - 17 - 
VEM £5975  27 £203  7 £203  
EA = effectiveness outcome is independence 
EB = effectiveness outcome is immobility-related complications  
∗ The term ‘dominates’ refers to the treatment strategy that is less costly and more effective. 
In this case SC is dominated by VEM. 
ICER; Incremental cost-effectiveness ratio 
 
Cost-effectiveness outcomes were not sensitive to varying unit costs for the 
implementation of the intervention, home help or informal carer time (Table 6-
5). Cost-effectiveness outcomes were not affected when different estimates 
were used to cost the intervention. Outcomes were sensitive on costing informal 
care equivalent to a local authority sheltered housing weekly rate. 
  
Table 6-5 Sensitivity analyses for costs 
Resource category SC  
Mean cost (SD) 
VEM 
Mean cost (SD) 
Difference in cost 
(95% CI) 
p-value ICER  
 
Baseline analysis £3944 (939) £5975 ( 6883) £2031 (-1515, 5578) 0.25 203 
Sensitivity analysis      
Implementation intervention costs at 50% of baseline £4039 (  950) £6155  (  6863) £2116  (-1420, 5654) 0.23 212 
Implementation intervention costs at 75% of baseline £4086 (  955) £6245  (  6853) £2159  (-1374, 5692) 0.22 216 
Home help unit costs at 50% of baseline £3963 (  967) £6173  (  7020) £2211  (-1407, 5829) 0.22 221 
Home help unit costs at 75% of baseline £3972 (  983) £6273  (  7116) £2301  (-1367, 5968) 0.21 230 
Informal carer unit costs at 50% of baseline £4042 (1015) £7139  (  9990) £3094  (-2033, 8220) 0.23 309 
Informal carer unit costs at 75% of baseline £4078 (1037) £7568 (11452) £3490  (-2381, 9361) 0.23 349 
Implementation intervention costs based on AVERT phase II £3827 (  925) £5777  (  6906) £1949  (-1608, 5506) 0.27 195 
Implementation intervention based on nurse time∗ £4001 (  945) £6083  (  6871) £2082  (-1459, 5623) 0.24 208 
Informal carer costs equivalent to local authority sheltered home∗∗ £5342 (2190) £5127  (  2936) £-214  (-2084, 1656) 0.82 Dominates∗∗∗ 
Unit costs;  
∗     Nurse hourly rate = £52 
∗∗   Expected total costs of local authority home care for older people = £293/week 
∗∗∗  The term ‘dominates’ refers to the treatment strategy that is less costly and more effective. In this case SC is dominated by VEM. 
Primary effectiveness outcome was used (independence at 3 months) 
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Result of cost-utility analysis 
Details of the mean costs, effectiveness and cost-effectiveness expressed as an 
ICER are provided in Table 6-6.  From a societal perspective, the ICER associated 
with VEM in comparison to SC was an additional £256,900 per additional QALY. 
The ICERs suggest that VEM is potentially not cost-effective when considering 
the NICE threshold of £20,000 to £30,000. When excluding societal costs to 
consider healthcare and personal costs only, VEM was associated with a higher 
cost and lower effectiveness than SC, so it is therefore said to be dominated by 
SC. 
 
Table 6-6 Results for cost-utility analysis 
Societal perspective  
 Mean cost  EA ICER  
SC £8444 0.51 (0.42) - 
VEM £5975 0.50 (0.50) £246,900 
Healthcare perspective 
 Mean cost  EA ICER  
SC £3944  0.51 (0.42) Dominates∗ 
VEM £5975  0.50 (0.50) - 
EA = effectiveness outcome is independence 
∗ The term ‘dominates’ refers to the treatment strategy that is less costly and more 
effective. In this case SC is dominated by VEM. 
ICER; Incremental cost-effectiveness ratio 
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6.4 Discussion 
Summary of key findings: systematic review 
This systematic review included 21 studies that had conducted an economic 
evaluation of a stroke rehabilitation service or specific intervention in 
comparison to current care. The findings from the quality assessment highlighted 
some general methodological shortcomings of economic evaluations conducted 
in this area. These included not reporting resource quantities and costs 
separately or examining uncertainty. Further limitations, that may have more 
implications for the economic evaluation of stroke rehabilitation, were also 
identified such as the perspective of the evaluation was not explicitly stated and 
inadequate attempts to synthesise the cost and effectiveness data.  
As the majority of studies did not present the costs and benefits in an aggregate 
form it was difficult to identify the primary outcome used in some of the 
studies. This was appraised on the appropriateness of the outcome in relation to 
the type of evaluation conducted. It may be that the generic nature of the 
checklist was limited in representing some of the issues relating to the study of 
complex interventions such as the multiple outcomes and scope to justify why 
costs and benefits were not aggregated. That said, the majority of these studies 
were inadequate in identifying, measuring and valuing all costs and benefits 
pertinent to the complexity of stroke rehabilitation. There was little 
consideration given to the wider effects of stroke rehabilitation such as 
productivity costs, patient education and the impact on carers.  
Summary of key findings: economic evaluation 
As recommended by the MRC complex intervention framework this economic 
evaluation is an early stage and explorative analysis, not a comprehensive 
economic evaluation.  The use of a CCA to identify potential costs and 
consequences of the intervention provided a comprehensive overview of the 
potential impact of VEM. This type of analysis provides an itemised account of 
the intervention’s impact for decision makers to then appraise the components 
relevant to their perspective. Presenting costs by perspective will facilitate the 
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assessment of any shift in costs and allow decision makers to make their own 
judgements. The CCA also enabled resource use items associated with 
implementation strategies relevant to VEM such as educational sessions (as 
highlighted in Chapter 5) to be identified. Resource use items, although 
uncosted, could be used in future economic evaluations of implementation 
strategies. 
When using the primary outcome, independence, the results of the CEA showed 
that VEM is potentially cost-effective from both healthcare and societal 
perspectives. Very early mobilisation may result in a faster and/or enhanced 
recovery therefore facilitating the return to work and/or minimising the loss of 
productivity. As in the CCA, an ICER was calculated from both healthcare and 
societal perspectives. A resource intensive intervention delivered in the acute 
stages after stroke may not be cost-effective from the perspective of the 
healthcare provider but by minimising loss of productivity may actually be cost-
effective from a societal perspective.  
The costs relating to informal care may be higher in the VEM group than the SC 
group. Very early mobilisation has been associated with an earlier and an 
increased chance of discharge home which could shift care from the healthcare 
provider to informal carers. This is an important issue in stroke rehabilitation 
considering the increasing number of stroke patients being discharged directly 
home. The CEA outcomes were sensitive to the method of costing informal care 
(as shown in Table 6-5). This finding is likely to be the result of small patient 
numbers and is not surprising considering the actual number of patients in the SC 
group who received input from informal carers was higher than in the VEM group 
(43.8% versus 25.0%).  
Strengths and limitations 
The main limitation of the systematic review is that multiple definitions and 
different forms of stroke rehabilitation exist and this may have resulted in 
studies not being identified by the search strategy. Existing guidance for the 
systematic review of complex interventions244 were incorporated and a scoping 
exercise to encompass relevant subject headings to inform the search strategy 
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was conducted. Hand searching was also included to increase the sensitivity of 
the search.  
A  CCA does not explicitly compare the costs of an intervention with its outcome 
therefore has been considered not to be an economic evaluation in the strictest 
sense.245 It does, however, provide a comprehensive and itemised account of the 
intervention’s impact for decision makers to then appraise the components 
relevant to their perspective and to identify the most appropriate outcome for 
use in a future trial. Furthermore, a CCA simply presents all cost and 
effectiveness outcomes separately, it can include quality of life and health 
utility outcomes. Therefore, an ICER could still be calculated and compared 
across different interventions, allowing cost-effectiveness threshold based 
decisions to be made. The CCA also has appeal for the clinician. It allows for a 
collaborative approach to decision making, involving clinicians and incorporating 
factors relevant to routine clinical decision making. This approach also provides 
a transparent and easy to interpret framework for the clinician.  
The planned use of a CEA as well as CUA provided the opportunity to synthesis 
the cost and effect data. As demonstrated here, presenting an ICER for the 
primary outcome measure and a secondary health outcome such as the reduction 
of immobility-related complications ensures that all available evidence is 
synthesised and presented appropriately. 
There are a few limitations with the QALY estimates used in this economic 
evaluation. Firstly, the calculation of QALYs was limited to the duration of 
AVERT phase II which required the assumption that there is no lifelong effect of 
VEM. This analysis was not intended to be a comprehensive analysis, but to 
provide some indication of the economic impact of VEM. Therefore, future 
analysis should include formal modelling techniques so as to determine the 
longer term effect of VEM on length and quality of life. Secondly, within trial 
QALYs were calculated based on HRQoL data collected at three months and 12 
months and this data may not be equivalent to the first three months post-stroke 
(the time horizon for this CEA).  
The sensitivity analysis conducted only varied one factor at a time which may 
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underestimate the uncertainty as the components of an evaluation do not vary in 
isolation, however varying two or more factors at a time makes results difficult 
to interpret.246 Probabilistic sensitivity analysis is a technique used to provide a 
level of confidence in the results to the decision maker. Each parameter in the 
model (for example the probability of independence) is assigned a distribution 
and using computer software a large number of simulations are run. The results 
of each of these simulations are recorded and used to present the variation in 
results. Undertaking probabilistic sensitivity analysis was outwith the scope of 
this exploratory economic evaluation, however incorporating probabilistic 
sensitivity analysis would strengthen and highlight areas of uncertainty for future 
trials.   
Recommendations for economic evaluation of stroke rehabilitation 
The findings from the systematic review and the economic evaluation together 
support the development of specific guidelines for conducting economic 
evaluations of stroke rehabilitation using the generic Drummond et al checklist 
as the basis for these recommendations. Davis et al247 have provided guidelines 
in a similar way for conducting and reporting economic evaluation for fall 
prevention strategies. This could be used to guide the development of similar 
guidelines specific to stroke rehabilitation. Such recommendations may include 
the following: 
• Conduct of an economic evaluation alongside a clinical trial to ensure an 
individual patient data approach to costing data. Details about the 
implementation of the rehabilitation intervention can then be measured and 
recorded so that reliable costs can be calculated. Details about the staff 
member(s) involved in delivering each episode of the intervention and the 
length of time (dose) of each episode of intervention are examples of 
resource use that could be collected for rehabilitation-based interventions.  
• As there are challenges associated with measuring and valuing all costs and 
consequences within a single evaluation, an attempt should be made to 
primarily identify these, as illustrated here, using a cost-consequence 
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analysis. Other data sources should be used to estimate the value of the costs 
and consequences where they cannot be measured within the single study.  
• The use of multiple ICERs using justifiable secondary clinical outcomes may 
be appropriate.  
Multi-criteria decision analysis for complex interventions 
While cost-effectiveness is the key consideration, it is acknowledged that other 
factors are relevant and are already being taken into account by policy makers. 
With respect to NICE, these factors have been explicitly stated and include 
severity of the underlying illness and end of life treatments. The development of 
multi-criteria decision analysis (MCDA) has the potential to add transparency to 
the decision making process.248 Multi-criteria decision making has been defined 
as “a set of methods and approaches to aid decision making, where decisions are 
based on more than one criterion, which make explicit the impact on the 
decision of all the criteria applied and the relative importance attached to 
them.” 249  
There is little known about the weight that is attached to these factors and any 
others that may come under the judgement bracket. Also, the trade-offs that 
are made between the cost per QALY and these other factors is not explicit. The 
MCDA frameworks offers the decision making process a more reliable (different 
committees provide the same decision) and transparent approach, by rating 
decision makers preferences for an intervention with respect to these extra 
criteria such as the quality of evidence, disease impact and ethics.250 Some 
MCDA tools involve sophisticated mathematical algorithms to suggest 
appropriate choices while others aim to structure the process. In the context of 
complex interventions there is an extra emphasis on describing the intervention 
and the comparator(s) used in studies in enough detail to allow decision makers, 
clinicians and researchers to relate these to their own local area. Whether the 
amount of information provided in the studies included in this systematic review 
would allow a valid assessment of local applicability is debatable. Thus, 
‘generalisability’ is an example criterion that may be of particular relevance for 
inclusion in a MCDM framework for complex interventions (Table 6-7). 
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Table 6-7 Example criteria for multiple-criteria decision making 
Criterion Definition(s)∗ Prompt(s) for decision makers∗∗ 
Generalisabilty “the extent to which the results 
of a study, as they apply 
to a particular patient 
population and/or a specific 
context, hold true for another 
population and/or 
in a different context.”251 
• Do the results apply to the populations 
and settings under question? 
Implementability 
 
 
 
“how well the program is 
conducted during a trial 
period”41  
 
 
• What are the barriers and facilitators to 
implementing the intervention? 
• What are the costs of implementing the 
intervention and implementation 
strategies beyond the trial? 
Coherence “defining the components of a 
practice, and its differences 
from other – already 
established”252 
• Are the components of the intervention 
defined?  
• Is the intervention as a whole readily 
distinguishable from that of usual care? 
Sustainability “whether the program is 
maintained over time”41 
• What is the best decision for longer-
term investment i.e. invest in the new 
treatment or invest in better 
implementation of available 
interventions?  
∗   Literature based definitions  
∗∗ Informed by qualitative findings in Chapter 5 
 
This could easily be viewed as adding to an already considerable number of 
factors. Alternatively, it could be viewed as a tool to facilitate decision making, 
not as a tick box exercise. It is important that researchers are aware of the 
supplementary information that may need to be collected to address these 
‘prompts’ (as outlined in Table 6-7) to inform decision makers. Also, the way in 
which this information is presented to decision makers to ensure decisions can 
be made in the allocated time and without being seeing to remove judgements.  
For example, a process evaluation would elicit information about the barriers 
and facilitators of the intervention, however, once this information is made 
available, the challenge may be how best to present this qualitative research to 
decision makers in an easily interpretable and cohesive manner so as not to 
delay the decision making process. One suggestion here is for the use of an 
existing qualitative framework, NPT (as described in Chapter 5), which has been 
specially designed to assess the implementation of complex interventions. The 
attractive feature of this framework is that it translates qualitative findings 
under purposefully developed and defined constructs in a user-friendly way.   
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6.5 Conclusion 
This Chapter includes research that addresses the evaluation stage of the 
Medical Research Council complex intervention framework. An evidence 
synthesis approach was used to model the economic impact of very early 
mobilisation (VEM). The findings from the individual patient data meta-analysis 
(Chapter 4), the qualitative study (Chapter 5) and the systematic review 
(Chapter 6) were used. The findings from the systematic review have highlighted 
the importance of adopting a wider cost and benefit perspective and that a 
single generic outcome measure has limited used in the economic evaluation of 
complex interventions such as stroke rehabilitation. The economic evaluation 
conducted using existing data showed that VEM is potentially cost-effective from 
a societal perspective. However, the sample size used to model the impact of 
VEM was too small for any definitive conclusions to be drawn from this analysis. 
The evaluation did, however, show the value of conducting a cost-consequence 
analysis to identify the possible costs and consequences pertaining to the 
intervention and conducting cost-effectiveness analyses alongside a cost-utility 
analysis for interventions with wide-reaching effects. This Chapter has 
highlighted the need to evaluate the cost-effectiveness of implementation 
strategies and suggested the development of multi-criteria decision frameworks 
in complex intervention research.
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7 Conclusions 
This Chapter summarises and concludes on the results presented in Chapter 2 to 
Chapter 6. This thesis is a series of qualitative and quantatative studies which, 
by converging research findings, contributes to the evidence-base of one of the 
proposed most important aspects of stroke unit care. New and novel quantitative 
and qualitative data were generated whilst making use of the best available 
evidence in order to address the research questions. Whilst, this thesis did not 
set out to confirm the clinical effectiveness of VEM, it does substantiate the 
current evidence-base for VEM in terms of favourable outcome and supports the 
need for AVERT phase III. This thesis has provided vital information required for 
the early stage of implementation and which can be used to inform the next 
stages of implementation.  
Overall, the main advantage of conducting this extensive body of research has 
been the opportunity to use a combination of methods to allow the linking, 
merging and triangulation of data both between and within the studies. Linking 
data between the studies, for example using the information about predictable 
variations in outcome to inform the design of the observational study, has 
illustrated a systematic approach to developing and using new evidence. Merging 
data within studies, for example the accelerometer data and BMT data, provided 
a more comprehensive dataset about activity levels and environmental factors 
had the datasets been analysed seperately. Triangulating data between studies, 
for example the observational data and the qualitative data, identified 
important tensions and incongruences in clinical practice. Other advantages 
included the generation of novel and rich data and the chance to cut across 
different disciplines.  However, the main drawback of conducting this research 
has been the use of resource intensive methods, such as the systematic reviews 
of complex interventions and the conduct of the BMT.  
This Chapter also details the literature that has emerged recently with regards 
to early mobilisation in stroke, the next stages of implementation if VEM is 
shown to be effective and finally some suggestions for quality measures that may 
be appropriate to monitor VEM in the future. Finally, the Chapter suggests 
specific implementation activities that could be conducted to study the 
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implementation of a complex intervention and highlights important issues raised 
in this thesis that could be applied more generally to implementation science.   
7.1 Summary of key findings 
7.1.1 Chapter 2 
Baseline factors predictive of mobility after stroke 
There is a dearth of studies that aimed to identify factors predictive of or 
associated with mobility within 30 days post-stroke in comparison to the number 
of studies investigating the predictors of function or disability in the longer-
term. The systematic review identified baseline factors that may have value in 
predicting mobility, more specifically independent walking, within 30 days post-
stroke. The systematic review showed that age, the severity of paresis, reduced 
leg power, presence of hemianopia, size of brain lesion and type of stroke were 
all predictive of or associated with walking within 30 days post-stroke. The 
potential overlap in meaning between the two factors - severity of paresis and 
reduced leg power is noted, however, due to the limited reporting of the 
definitions and methods to measure these factors it was considered appropriate 
to present these two factors separately. All of the factors identified in this 
review have been previously reported in individual studies investigating 
predictive factors of function or disability. The presence of hemianopia and the 
size of brain lesion appear to be less researched and most controversial.253  The 
size of brain lesion is not routinely available in clinical documentation and may 
be one reason for this factor not being included in predictive studies. The 
findings of this review are based on a limited number of studies. On assessing 
the quality of these studies using best practice principles for conducting 
predictive research revealed limitations. In an attempt to overcome these 
methodological shortcomings two new predictive models were subsequently 
developed using registry data; Model 1 used the factors identified by the 
systematic review and Model 2 used the factors identified by clinical opinion and 
univariate analysis. The factors identified by the systematic review were shown 
to be predictors of walking and constituted Model 1. In addition, to age and 
stroke type, Model 2 also included living arrangements on admission, baseline 
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level of stroke severity, level of disability and level of ADL as predictors.   
The immediate application of these findings was to inform the factors to be 
collected at baseline in the observational study that may be important when 
investigating patient activity levels. The factors were used to adjust for patient 
case-mix in the analysis investigating the association between activity in the 
acute stages after stroke and function at three and six months. There is an 
obvious limitation in this planned for systematic approach. Chapter 3 aimed to 
investigate the association between activity in the acute stages after stroke and 
function at three and six months, not mobility.  
Whilst predictive models can reveal differences in the recovery profiles of 
subgroups of patients these do not take individual patient responses to 
rehabilitation interventions into account. The level of stroke severity was shown 
to be the strongest predictor in the final model. Chapter 4 provided the 
opportunity to explore (with caution) responses to a rehabilitation intervention 
in patients with different groups of severity.  
7.1.2 Chapter 3 
Baseline levels of activity in acute stroke patients 
The most obvious finding to emerge in Chapter 3 was to confirm the low levels 
of upright activity in acute stroke patients; however, the prolonged periods of 
time spent in sedentary events may be more cause for concern. Chapter 3 has 
provided a precise estimate of the time spent upright and time spent sedentary 
in a sample of acute stroke patients from three Scottish hospitals using 
accelerometry. Patients spent the majority of time sitting in a chair at the 
bedside. The majority of total upright time was the result of short episodes of 
less than 10 minutes. The opposite pattern was observed for sedentary 
behaviour whereby the majority of total sedentary time was accumulated by 
prolonged episodes of greater than 60 minutes sedentary behaviour. Nearly all 
sedentary time for patients with moderate/severe stroke was accumulated in 
this way. 
Chapter 7 
 
240 
This baseline measure of activity could be used to inform the design and 
implementation of future activity-based rehabilitation interventions in acute 
stroke care. Measuring patterns of activity is important in order to develop 
interventions. It can assist in understanding relationships between activity and 
routine ward processes and inform delivery of the day-to-day implementation of 
such activities such as the time of day the intervention should be delivered. 
Accelerometer-based measures are important process indicators or outcome 
measures that could be included in future observational and interventional 
studies.  
7.1.3 Chapter 4 
Clinical impact of very early mobilisation 
Chapter 4 provided a more precise estimate of effect for VEM in relation to 
independence at three months post-stroke than that previously reported. In both 
AVERT phase II and VERITAS, VEM patients received earlier and more frequent 
mobility practice than that routinely provided. The treatment effect on the 
primary outcome in both trials was in favour of VEM suggesting, along with 
evidence for the use of a fixed effect model, that the individual studies were 
estimating the same treatment effect. Very early mobilisation had a favourable 
impact on the secondary outcomes. This varied by effect size and the level of 
significance. The relevance of VEM in reducing immobility-related complications 
at one week (significant reduction) and at three months (non-significant 
reduction) after stroke is supported by the findings in Chapter 4. Levels of 
mobility and levels of independence in ADL were significantly better for VEM 
patients than SC patients at three months. The only outcome that VEM had little 
effect on was the chances of death. Some may consider this unsurprising as 
reducing the odds of death may not be seen as an obvious outcome for a 
rehabilitation intervention. The primary outcome used in the ongoing AVERT 
phase III is death and disability with mobility as a secondary outcome. This 
choice of primary outcome allows for the findings of this trial to be compared 
with other acute stroke interventions and to be interpreted in the context of the 
estimated effect size of ASUs.  
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Very early mobilisation had the largest and most significant effect on mobility 
with a patient undergoing VEM seven times more likely to have non-impaired 
mobility than a SC patient. This analysis indicates that VEM has the potential to 
influence the early recovery of general mobility and ability to walk. This is 
important considering the ability to walk is a determinant of longer term 
functional recovery. Both studies are limited by small sample sizes supporting 
the need for larger trials to determine the effectiveness of VEM. Therefore, at 
this point in time it would be inappropriate to make recommendations on the 
use of VEM in stroke. Early mobilisation features in a number of guidelines 
throughout the world, but specific recommendations cannot be made until 
robust evidence to guide the practice has emerged from the AVERT phase III, 
after which time there will be greater clarity about the harms and benefits of 
VEM.  
7.1.4 Chapter 5 
Barriers, facilitators and beliefs of very early mobilisation 
Chapter 5 has provided data on current stroke processes, pre-existing context 
and the factors that may influence the future implementation of VEM. It has also 
provided rich data about the complex array of individual, intervention specific 
and environmental elements that influence change. Staff questioned the 
workability and integration of VEM into routine practice if shown to be effective. 
The AVERT phase III is multinational and guidelines are frequently being set by 
international committees. Therefore, Chapter 5 supports the need for a global 
statement about the implementation of VEM. Suggestions for the next stages of 
implementation are covered in Section 7.3.2. 
The findings from the qualitative study were interpreted in parallel with the 
researcher observations conducted in Chapter 3. These researcher observations 
could be viewed as a context evaluation as it studied “naturally occurring events 
and influences in the setting or environment of the intervention that might act 
to contribute to or impede intervention success”.37 There was congruence 
between what was observed and what was said. Incongruence was also 
identified. These are essential observations to highlight when considering 
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behavioural change. Capturing information about the pre-existing context is 
important to assess the compatibility of the intervention with the local context. 
It is helpful in generating hypotheses about the hospitals that may have 
difficulty in implementing the intervention. For example, it could be 
hypothesised that the uptake and sustainability of VEM may be unstable in sites 
without a history of successful change or strong collaboration between therapists 
and nurses. The implementation of VEM could be seen to have an auxiliary role 
in forging new collaborations between departments and by strengthening 
relationships between groups of ward staff with increased opportunity for 
interaction, shared working and patient goal-setting.  
Chapter 5 forms the basis and justification for a multicentre qualitative study to 
further explore and validate the identified barriers and facilitators in other 
countries. The generalisability of these factors could be assessed and the 
potential requirement for country specific implementation strategies could be 
addressed. This is imperative if the findings of the trial are going to reach and 
inform practices across the globe. Furthermore, the contextual factors identified 
in Chapter 5 may not be transferable to hospitals outside of Scotland, therefore 
there is a need for local study which will contribute to the building of theory 
around the process of implementation. All staff involved in this study were 
aware of VEM, either currently involved in delivering the intervention or were 
aware of the trial via colleagues or conference attendance. It would be of 
interest to capture the views from staff working in countries that are not 
involved in AVERT phase III in an attempt to minimise this contamination. 
Different issues may be raised for the implementation of VEM at these ‘clean-
sheet’ hospitals. Further evaluations should involve experts in behavioural 
change and adopt a theory-driven approach to ensure that VEM has and is 
associated with a clear and cost-effective implementation strategy. 
A quantitative process evaluation that aimed to monitor the activity levels of 
trial patients using accelerometry would allow implementation fidelity to be 
assessed objectively i.e. the degree to which the intervention is actually 
implemented. Data about the actual single dose duration, frequency and 
schedule of activity undertaken by VEM patients would have allowed the 
development of reliable and objective indicators. For example, actual time 
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spent in upright activity would be measured and distinguished from time spent 
with the patient (currently recorded in AVERT phase III). Such objective 
indicators could then be used to assess the implementation of VEM in real-life. 
Until recently, the process data currently collected in AVERT phase III does not 
provide a continuous measure of activity or information about self-mobilisation 
(outside that recorded by trial staff) that may be a consequence to the 
intervention. A substudy (AVERTcog)254 of AVERT phase III is now underway which 
monitors the activity level of AVERT phase III trial patients using an AC 
(SenseWear). Using the data from AVERTcog, the pattern of activity between the 
SC and VEM groups could be compared and expected activity profiles for patients 
receiving VEM derived. Whether SC and VEM patients respond in a similar manner 
to monitoring, as too with staff delivering the intervention to either group, is an 
interesting area and should be explored. The therapy dose delivered to patients 
recruited to AVERTcog with those recruited to only AVERT phase III could be 
compared. The findings of AVERTcog may allow the investigators to state, that it 
supports, along with routine monitoring of intervention implementation (as 
discussed in Chapter 4) that the intervention was delivered as intended. 
Otherwise, if the findings are not favourable it could be speculated that this was 
due to implementation failure as opposed to the inherent failure of the 
intervention. 
7.1.5 Chapter 6 
Economic impact of very early mobilisation 
The systematic review showed that most of the economic evaluations compared 
conventional rehabilitation with an early supported discharge team either using 
a CMA or CCA type approach. A CUA, which uses QALYs to infer health benefits, 
is the economic analysis preferred by decision makers such as NICE. When the 
findings from this review were considered within this decision making context, 
the use of such a single outcome could be viewed as inappropriate and limited in 
representing the multiple health benefits of stroke rehabilitation. Indeed, VEM 
did not appear to affect HRQoL and was not associated with a gain in QALYs. It 
may well be that there is no theoretical basis to support the notion that VEM 
affects quality of life. It has been stated elsewhere that interventions targeted 
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at older people are unlikely to generate any additional QALYs.255 In any case 
using a single outcome offers little scope to consider the wider and non-health 
effects of stroke rehabilitation such as productivity costs, patient education and 
the impact on carers. The limitations of the use of QALYs have been raised 
elsewhere and the findings from this review support a move away from 
traditional decision making based purely on cost-effectiveness, towards MCDM 
for stroke rehabilitation, where a broader perspective is adopted and a range of 
criteria are assessed by policy makers. 
The ICERs associated with the effectiveness outcomes suggest that VEM is 
potentially cost-effective when considering the NICE threshold of £20,000-
£30,000. For example, the ICER associated with VEM in comparison to SC was 
approximately an additional £200 per additional patient achieving 
independence. These estimates are based on a very small number of patients 
and the cost-effectiveness of VEM will be better estimated using the findings 
from the AVERT phase III study. The findings from the systematic review and the 
economic evaluation together support the development of comprehensive 
guidelines for conducting CEA in stroke rehabilitation using the generic 
Drummond et al checklist as the basis for these recommendations.206 Davis et al 
have provided guidelines in a similar way for conducting and reporting economic 
evaluation for fall prevention strategies.247 This should be used to guide the 
development of similar guidelines specific to stroke rehabilitation. 
7.2 Critique of methods 
Overall, a systematic approach, guided by the MRC complex intervention 
framework has been used. A combination of methods was of value to generate 
new data and analyse existing data in order to address the aim of this research. 
These included evidence synthesis, observational and qualitative research 
methods. Areas of health research, including health services research and health 
technology assessment have emerged as a result of political and economic 
pressures. These research fields aim to bring together clinicians, social scientists 
and statisticians to clinically and economically evaluate interventions. This 
thesis provides an example of health service research as it stands today.  
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Evidence synthesis approach 
The systematic reviews conducted in this thesis have been carried out according 
to the principles set out in the Preferred Reporting Items for Systematic Review 
and Meta-Analysis guidance. Assessing the methodological quality of the included 
studies in the systematic reviews (Chapter 2 and Chapter 6) allowed 
recommendations to be made, some of which were subsequently utilised in the 
development of the predictive models and the economic evaluation. The 
predictive modelling in Chapter 2 used a systematic method to selecting the 
factors to develop the model and tested the performance of the models. The 
findings from the review highlighted these as common methodological 
shortcomings. The final development of the predictive models was not without 
limitations, for example: the selection of factors was based on the opinions of 
only two clinical experts. A Delphi-method where a panel of experts are used to 
provide consensus would provide a more robust approach. Additionally, the 
model was not externally validated. The data set generated for Chapter 3 would 
not have provided sufficient statistical power to validate the predictive models. 
Similarly, the economic evaluation in Chapter 6 makes use of the 
recommendations from the review by conducting a CEA to synthesis the cost and 
effect data.  
The IPD MA conducted in Chapter 4 should be viewed as an illustration of 
applying this method to complex intervention research. Undertaking a meta-
analysis can increase statistical power, and especially with regards to complex 
interventions, IPD MA offers advantages over meta-analysis of aggregate data. 
Individual patient data meta-analysis is deemed time consuming, and although in 
this IPD MA there were only two studies, the greatest amount of time was 
invested in data manipulation to re-code and re-format data to ensure it could 
be combined. Future protocols for IPD MA should provide guidance to trialists 
about the expected format of the data to be included in the meta-analysis. One 
of the main advantages in conducting an IPD MA is the opportunity to study 
potential confounders and effect modifiers for future regression analysis. Again, 
numbers were small in each of the pre-determined subgroups so no firm 
conclusions can be drawn. This IPD MA should, therefore, be viewed as a 
hypothesis generating exercise, particularly for the groups of patients that may 
Chapter 7 
 
246 
respond differently to rehabilitation interventions. It could also support the need 
for and inform subgroup analysis of larger future trials and IPD MA investigating 
intensive therapy regimes. Combining individual patient data in this way has 
emphasised the importance of sharing protocols and agreeing outcomes to 
reduce variations between trials and ensure comparability of trials of complex 
intervention.  
An evidence synthesis approach was used to estimate the economic impact of 
VEM. The findings from Chapter 4 (IPD MA), Chapter 5 (qualitative study) and 
Chapter 6 (systematic review) were used. The analyses conducted illustrated the 
value of a CCA to identify potential cost and consequences of the intervention 
and to inform the outcomes for use in a CEA. The sample size of the study was 
small, yet, satisfies the recommendations provided in the MRC framework which 
encourages the use of small scale analysis in the early evaluation of complex 
interventions. 
Predictive modelling 
Generally, such predictive models have use in both research and clinical 
practice. For the purposes of research it is important to be able to classify 
patients into balanced prognosis groups.59 Stratifying patients based on 
predictive outcome has been used in comparative audits to evaluate the efficacy 
of care in different hospitals.256 Forty percent of stroke patients have been said 
to need active rehabilitation.257 Therefore, having accurate estimates of the 
likelihood and timing of mobility recovery would help to determine the 
appropriate placement and timing of rehabilitative efforts in different groups of 
patients who have this activity limitation. This need to inform the efficient 
allocation of resources has supported the development of such models. 
Predicting patient’s mobility status post-stroke, such as the likelihood of 
ambulation, is of great clinical relevance, providing vital information to HCPs, 
patients and their families.57 77 258  
The application of predictive models relies on having strong evidence that the 
recovery profile of patients can be robustly determined by such predictions. 
Furthermore, these models must be used routinely in clinical practice. To 
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increase the uptake of predictive models it is important to improve a clinician’s 
confidence in the tools and to confirm that the model predictions compare 
favourably with clinician predictions. The current use or avoidance of prediction 
tools in clinical practice needs to be addressed. It is important that before a tool 
is used clinically it is evaluated in a RCT to compare outcomes for patients 
managed using the model with patients who were not managed with the model. 
Evaluating the cost-effectiveness of predictive models are not usually 
conducted. This would allow the full impact of predictive tools to be assessed in 
terms of the cost implications and consequences for the patient and family 
where accurate or inaccurate information is provided. 
Technology used in the observational study 
Novel and established methods for monitoring activity were used in Chapter 3, 
explored and compared. The method used to integrate the AC data with the BMT 
data to provide objective data on location and stroke processes offers a model 
for analysis of similar data sets. Chapter 3 highlights the need for further 
investigations into the use of ACs in patients with altered biomechanics and 
reduced heel strike. Despite synchronising the AC data with the observational 
data, no firm conclusions can be drawn about the accuracy of the activPAL™ in 
detecting stepping as this study was not a validity study. A validation study 
conducted in an ASU with patients stratified according to existing gait 
classifications into homogenous groups259 needs to be conducted. The activPAL™ 
does not distinguish lying or sitting therefore the establishment of algorithms to 
detect sitting from lying or the use of the activPAL™ system as a two-sensor unit 
are areas of further work. The activPAL™ does not have a start/stop button so 
does pose challenges for use in an acute hospital environment in the absence of 
a study co-ordinator.  
Further technological advancements could be enhanced with greater 
collaboration between manufacturers and researchers. Guidance for the use of 
ACs in stroke i.e. choice of device and decisions around the analysis of data such 
as how to manage missing data are required. The potential for accelerometry to 
provide feedback to patients and clinicians on performance should be 
investigated in the future. Behavioural mapping makes the findings directly 
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comparable with that of other completed and ongoing mapping studies. 
Discussion regarding a future IPD MA using multinational BMT data has been 
initiated (personal communication, 2012). Any differences in activity levels 
between countries could be identified and explained using rich comparable data.  
Qualitative methods 
The findings are based on a relevant sample of HCPs and provides multiple and 
diverse perspectives. However, no nursing assistants participated in the study 
and considering they deliver a large proportion of patient care and are involved 
in the day-to-day mobilisation of patients, this is a shortcoming. One of the 
strengths of this analysis was to be able to triangulate two new sets of data (the 
observational data and the qualitative data). This provided an opportunity to 
highlight discrepancies between what staff believe they do and what they 
actually do.  
Chapter 5 is limited in providing details on the relative importance of barriers. 
This may have particular relevance in the area of implementation science 
whereby the relative importance of each of the barriers and facilitators may be 
required to guide investment decisions around implementation strategies. The 
use of DCEs to investigate preferences was discussed as a method to overcome 
this limitation.  
7.3 The future study of very early mobilisation 
7.3.1 Emerging literature on early mobilisation 
The IPD MA (Chapter 4) was informed by a Cochrane review based on a search 
conducted in April 2008. Due to the growing interest in VEM and since the 
release of this Cochrane review several studies have been published 
investigating the effects of early mobilisation. Although, the more recent studies 
identified do not meet the criteria of the Cochrane review (due to the definition 
of VEM) it is still important to be aware of the evidence base of early 
mobilisation and current mobilisation practices across the globe. Most recently, 
Sundseth et al (2012) conducted a RCT to investigate the effect mobilisation 
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within 24 hours after admission (versus mobilisation after 48 hours) had on 
mortality or disability three months post-stroke.260 This study found that patients 
in the control group had more favourable outcomes. This finding was not 
statistically significant before or after adjustment and the sample size was small 
(n = 56). Canavero et al (2012) used patient admission data (n = 9787) to 
examine the impact of early mobilisation (within 48 hours) on within hospital 
mortality and medical/neurological complications.261 Early mobilisation was 
significantly associated with better survival at discharge, yet was associated 
with a significantly higher chance of in-hospital cardiovascular complications and 
falls. The authors concluded that there would need to be attention to 
monitoring during this procedure. A study conducted in Japan by Matui et al 
(2010) explored the association between very early rehabilitation and outcome 
for patients using a retrospective cohort study design. Very early rehabilitation 
commenced within three days of stroke rehabilitation was significantly 
associated with less disability at discharge.262   
7.3.2 Future implementation of very early mobilisation 
The AVERT phase III trial, being sufficiently powered and pragmatically 
designed, is well placed to provide reliable evidence about the effectiveness of 
VEM. If shown to be effective, the trialists can make recommendations about the 
‘form’ of VEM and the real-life implementation can begin. If shown to be no 
more effective than SC, the trialists can still make recommendations about 
mobilisation practices based on SC.  
At face value, HCPs believed that VEM is similar to the early mobilisation 
practices that they currently practice. Therefore, the act of implementation in 
this case is likely to be even more challenging in that it will involve the 
replacement of an intervention with another that has similar properties. Whilst 
implementation usually involves the end or changing of current behaviours and 
the introduction of new behaviours, changing current practice is likely to prove 
most challenging in the future implementation of VEM.   
Interventions shown to be effective, but are never implemented provide no 
benefit to patients. This thesis has provided vital information required for the 
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early stage of implementation as described in Grol and Wensing’s (2006) ‘Model 
for Effective Implementation’ (Chapter 1). Current practice and relevant 
practice issues (problems or best practice) have been identified. 
Recommendations for developing evidence-based implementation strategies 
have been provided. This early stage implementation research supports the need 
for a clear implementation plan for VEM which may require the input of a 
behavioural change scientist to work with staff to alleviate concerns towards 
change (Chapter 5, Section 5.3.17) and design appropriate implementation 
strategies (Chapter 5, Section 5.3.11). 
The next stage of implementation should further investigate current practice 
and the context where change will take place at other hospitals outside 
Scotland. It is also important that the individuals responsible for implementing a 
complex intervention know the context in which the intervention was evaluated. 
This provides the opportunity to consider any differences between the context 
of evaluation and the context for implementation.  
Operational change objectives need to be set and the implementation strategies 
outlined in Chapter 5 should be further developed and tested. Multidisciplinary 
communication in the form of brief daily morning meetings was identified as a 
facilitator for VEM. Therefore, an example of an operational change objective 
could be to embed such meetings into daily ward practice for those sites that do 
not currently employ these meetings. The final stage of implementation would 
be to put the implementation plan i.e. who does what, and when into action and 
to conduct a comprehensive evaluation of process and outcome.  
7.3.3 Quality measures for very early mobilisation 
Measures will need to be developed and put in place to monitor any future 
implementation, only then can the true success of VEM be assessed. The NICE 
quality statement introduced in Chapter 3 regarding the amount of therapy time 
that should be provided to acute stroke patients is underpinned by a set of 
quality measures to assess the implementation of this statement. For example, 
the quality measure for ‘structure’, (as introduced in Chapter 1), is the evidence 
that local arrangements are in place for the provision of a minimum of 45 
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minutes of each active therapy for a minimum of five days a week. Similarly, 
quality measures to assess the success of implementation of VEM should be 
defined. Quality measures could aim to address the following questions:  
• What education is available to new or existing staff about very early 
mobilisation? 
• Is very early mobilisation discussed and recorded during multidisciplinary 
meetings? 
• Do any members of staff have implementing the policy of very early 
mobilisation embedded within their job description? 
• Has the way in which mobilisation provided, changed? 
• Have any new systems been introduced as a result of very early mobilisation 
i.e. a referral system, use of visual mobilisation charts by the patient’s 
bedside, ward timetables for patients? 
• Is the very early mobilisation policy integrated into organisations or local 
agency strategy documents? 
• Is or was there any funding allocated for the implementation and 
sustainability of very early mobilisation and if so what is the source of this 
funding?  
Very early mobilisation is multidimensional and consists of various variable 
components i.e. timing, amount, frequency and type of mobilisation. Therefore, 
identifying and defining valid quality measures may be challenging or even 
inappropriate for an intervention such as VEM. 
7.4 The future study of implementing complex 
interventions 
7.4.1 Specific implementation activities  
As Chapter 1 underlined there has been more attention given to the 
implementation of complex interventions in the most recent MRC guidance 
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document. Researchers are asked to think about the impact of results in terms 
of whether they are accessible to decision makers and recommendations are 
detailed and explicit. Considering implementation early on in the research of 
complex interventions is essential to assess how easily the intervention can be 
implemented into real-life. An intervention may have little chance of real-life 
implementation therefore should be discarded on these grounds as opposed to 
embarking on a full scale and costly evaluation investing finite resources.263 
Attracting funding for these smaller scale developmental activities is more 
challenging. 
It is recommended that implementation related-activities are extended to 
consider the following:  
• The use of process data monitoring committees as well as outcome data 
monitoring committees during the main evaluation stage  
• Integrating the findings of process evaluations whilst the intervention is 
under evaluation. This takes time especially for investigators to consider 
reports and make decisions whether or not to act upon these.264 
• Further methods to study context and the wider use of existing theoretical 
frameworks such as the normalisation process theory specifically developed 
for studying the implementation of complex interventions  
• Complexity of the intervention lies just as much in context as in the 
components of the intervention. More time needs to be invested into the 
study of context. The use of in-house ethnographers may have more to offer 
than developing sophisticated causal models to disentangle the infamous 
“black box”. 
• The longevity of implementation strategies should be evaluated to assess how 
effective they are in sustaining the intervention beyond the dissemination, 
adoption and implementation stages 
Furthermore, the impact that the research itself has on the intervention is an 
interesting area. The media coverage, involvement of opinion leaders and 
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ground-level staff in clinical trials may impact on implementation both during 
the trial phase and later into real-life, by shaping HCPs and the public’s view of 
the intervention. Recruitment to large trials of complex interventions take years 
and changes in the clinical, research, economic and political landscapes may 
impact on the design of the study and intervention and the findings (practice 
creep). 
7.4.2 Recommendations for implementation science 
This thesis does raise some important issues relating to theory, research, policy 
and long-term monitoring that can be applied more generally to implementation 
science.   
Models and theories for use in implementation research 
There appears to be a lack of simple yet theoretically driven approaches to 
understanding HCPs’ beliefs and organisational change. This limits the ability to 
assess the applicability of implementation strategies in different circumstances. 
Models and theories that aim to explain change and how it can be influenced are 
likely to be of most benefit in implementation research. There are a number of 
models and theories that exist which explain implementation and behavioural 
change and include the theory of planned behaviour, the diffusion of innovations 
and the PRECEED/PROCEED Model. 265-267.   
The theory of planned behaviour has considerable evidence around its use and 
provides a list of behavioural influences known to affect the use of guidelines. It 
has been used to explain associations between beliefs, attitudes, social 
influences (social norms), and perceived abilities to perform the behaviour.265 
The diffusion of innovations aims to explain how interventions are taken up in a 
population and differs to other theories of changes in that it focuses more on 
how the intervention evolves to meet the demands of the population and not 
how people change.266 This theory also classifies people into groups ranging from 
the ‘innovators’ (those that are motivated by new ideas) to the ‘Laggards’ 
(those that resist change). The PRECEDE/PROCEED model can be used to plan 
and explain change in patient care with the initial stages of the model aimed at 
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identifying the factors (those that are predisposing, enabling and reinforcing) 
that influence change.267  The later stages of the model focus on developing the 
best approach and incorporate an evaluation of process, impact and effect. 
The ‘Model for Effective Implementation’ referred to in this thesis focuses more 
on planning change and takes the perspective of both the ‘implementer’ (the 
person/organisation instigating change) and the ‘target’ group (the 
team/individual that needs to go through the change).36 It offers an attractive 
stepwise and pragmatic approach with the initial stages involving the 
identification of current practice then describing operational change objectives 
and finally developing implementation strategies.  
Clinical considerations and research methods 
This thesis has highlighted the importance of treatment differentiation at a 
clinical and research level, conducting an evaluation of pre-existing context and 
collaboration between the developers, the providers and the intended 
population of the intervention. Healthcare professionals have high regard for 
clinical judgement so more guidance is required about how to develop and 
implement protocols/guidelines without compromising clinical judgement. Due 
to the patient dependent nature of complex interventions this is an important 
balance to strike. Previous studies in the area of implementation science have 
provided an array of barriers and facilitators 268-270 but most of these, as with the 
qualitative study (Chapter 5) are limited to providing quantitative detail around 
the relative importance of barriers. The value of applying DCE methodology in 
implementation science should be explored to provide quantitative data in this 
complex study of barriers and facilitators. 
Whilst conducting this research and engaging with experts in complex 
intervention research (personal communication, 2010) there also appeared to be 
a lack of evidence-based approaches stated in the literature which could be used 
in the dissemination stage of implementation. Intervention dissemination groups 
should be formed to conduct priming activities to motivate the target audience 
to being open to future change with efforts to ensure the intervention has a 
marketable ‘buy-in’. Guidance of the timing of such activities is needed. 
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Policy 
To ensure that findings are translated into policy, it is important that they are 
made available using methods that are in an interpretable format and convincing 
to decision makers. Some of the recommendations made in this thesis have 
direct implications for policy. In Chapter 6, the suggestion is for the use of NPT 
to translate findings from qualitative research (such as barriers to 
implementation) into a format policy makers are accustomed to. Additionally, 
Chapter 6 highlighted the development of multi-criteria decision analysis where 
a broader range of criteria relevant to complex interventions be assessed by 
policy makers. Such frameworks would allow the consideration of factors other 
than just cost-effectiveness when considering whether or not to adopt a certain 
intervention. This is important when considering the wide-reaching impact of 
complex interventions.  
Long-term monitoring 
Experimental studies rarely provide comprehensive information on the longer-
term effectiveness and generalisability of the intervention. Trials are not usually 
powered to detect rare adverse events and even adopting a wide inclusion 
criteria has limitations such as selection bias. Therefore, it is important to 
monitor the effects of the intervention in the long-term especially considering 
that effects are likely to be reduced and unanticipated consequences of the 
intervention may begin to emerge.29 New ways of routinely embedding long-term 
surveillance of new interventions was raised by the UK government a few years 
ago.271 
 “We recommend that the Department should seek to introduce a national 
system for reviewing and tracking the implementation of new devices over 
a number of years to ensure patient safety and efficacy issues are closely 
monitored. Currently there is no clear system for determining safety and 
efficacy beyond the clinical trials and evidence-based model of the Health 
Technology Assessment (HTA) programme” House of Commons Health 
Committee, 2005 
This requires re-thinking and investment (is it doubtful that current IT systems 
are comprehensive enough to support such monitoring) into how the cycle of 
audit and feedback is currently conducted in healthcare.  
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7.5 Conclusion 
This thesis has adhered to current guidance provided by the Medical Research 
Council to develop and evaluate VEM. The clinical effectiveness and cost-
effectiveness of VEM were investigated revealing that VEM may have the 
potential to improve patient outcome and be cost-effective. Barriers and 
facilitators to implementing VEM in routine stroke care were identified. The 
AVERT phase III trial will provide definitive evidence about the cost-
effectiveness taking into account the wider implications of VEM. Only after this, 
can recommendations be made about the use of VEM in acute stroke care and 
the real-life implementation and monitoring of VEM commence. This research 
has provided the support and the foundations for the development of a clear 
implementation strategy for VEM. 
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Appendices 
Appendix 1 Search strategies for databases (Chapter 2) 
 
Medical Literature Analysis and Retrieval System Online (Medline) 
1. Epidemiologic studies/ 
2. exp case control studies/ 
3. exp cohort studies/ 
4. Case control.tw. 
5. (cohort adj1 (study or studies)).two. 
6. Cohort analy*.tw. 
7. (Follow up adj1 (study or studies)).tw. 
8. (observational adj (study or studies)).tw. 
9. Longitudinal.tw. 
10. Retrospective.tw. 
11. Cross sectional.tw. 
12. Cross-sectional studies/ 
13. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 
14. exp cerebrovascular disorders/ or exp basal ganglia cerebrovascular disease/ 
or exp basal ganglia hemorrhage/ or exp brain ischemia/ or exp brain 
infarction/ or exp brain stem infarctions/ or exp cerebral infarction/ or exp 
infarction, anterior cerebral artery/ or exp infarction, middle cerebral 
artery/ or exp infarction, posterior cerebral artery/ or exp hypoxia-ischemia, 
brain/ or exp "intracranial embolism and thrombosis"/ or exp intracranial 
hemorrhages/ or exp cerebral hemorrhage/ or exp subarachnoid 
hemorrhage/ or stroke/ 
258 
 
15. ((cerebral* or cerebellar or brainstem or vertebrobasilar or stroke) adj5 
(infarct* or ischaemi* or ischemi* or thrombo* or emboli* or apoplexy)).tw. 
16. hemiplegia/ or exp paresis/ 
17. (hemipleg* or hemipar* or paresis or paretic).tw. 
18. (stroke or poststroke or post-stroke or cva* or cerebral vascular accident* or 
cerebrovascular accident*).tw. 
19. ((cerebral or brain or subarachnoid) adj5 (haemorrhage* or hemorrhage* or 
haematoma* or hematoma* or bleed*)).tw. 
20. 18 or 19 or 16 or 15 or 17 or 14 
21. "Infant"/ 
22. "Infant, Newborn"/ 
23. "Child"/ 
24. "Child, Preschool"/ 
25. "Infant, Premature, Diseases"/ 
26. (infan* or child or childhood or children).tw. 
27. or/21-26 
28. exp locomotion/ or exp walking/ or exp Gait/ or exp Movement/ or exp 
Motor Skills/ or exp Motor Activity/ or exp mobility limitation/ 
29. (mobil* or motor* or sit* or stand* or walk* or stair* or ambulant* or ambulat* 
or gait or step* or balanc* or function* or daily living or disabilit* or physical* 
or movement or activit* or locomot*).tw. 
30. (recover* or outcome* or milestone*).tw. 
31. exp "recovery of function"/ 
32. 28 or 29 
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33. 30 or 31 
34. exp Prognosis/ 
35. (predict* or prognos*).tw. 
36. 35 or 34 
37. ((indicat* or determin* or factor*) adj5 (mobil* or motor* or sit* or stand* or 
walk* or stair* or ambulant* or ambulat* or gait or step* or balanc* or 
function* or daily living or disabilit* or physical* or movement or activit* or 
locomot*)).tw. 
38. 37 and 36 and 13 and 20 
39. 34 and 28 and 13 and 20 
40. 38 or 39 
41. ((recover* or outcome* or milestone*) adj5 (indicat* or determin* or 
factor*)).tw. 
42. 36 and 13 and 41 and 29 and 20 
43. ((predict* or prognos*) adj5 (recover* or outcome* or milestone*)).tw. 
44. 13 and 44 and 29 and 20 
45. 45 or 42 or 40 
46. 45 not 27 
Excerpta Medica Database (Embase) 
1. Clinical study/ 
2. case control study/ 
3. Family study/ 
4. Longitudinal study/ 
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5. Retrospective study/ 
6. Prospective study/ 
7. Randomized controlled trials/ 
8. 6 not 7 
9. Cohort analysis/ 
10. (Cohort adj (study or studies)).mp. 
11. (Case control adj (study or studies)).tw. 
12. (follow up adj (study or studies)).tw. 
13. (observational adj (study or studies)).tw. 
14. (epidemiologic$ adj (study or studies)).tw. 
15. (cross sectional adj (study or studies)).tw. 
16. or/1-5,8-15 
17. exp cerebrovascular disease/ or exp basal ganglia hemorrhage/ or exp brain 
ischemia/ or exp brain infarction/ or exp brain hematoma/ or exp brain stem 
infarctions/ or exp brain hemorrhage/ or exp cerebral artery disease/ or exp 
brain embolism/ or exp subarachnoid hemorrhage/ or exp stroke/ 
18. ((cerebral* or cerebellar or brainstem or vertebrobasilar or stroke) adj5 
(infarct* or ischaemi* or ischemi* or thrombo* or emboli* or apoplexy)).tw. 
19. exp hemiplegia/ or exp paresis/ 
20. (hemipleg* or hemipar* or paresis or paretic).tw. 
21. (stroke or poststroke or post-stroke or cva* or cerebral vascular accident* or 
cerebrovascular accident*).tw. 
22. ((cerebral or brain or subarachnoid) adj5 (haemorrhage* or hemorrhage* or 
haematoma* or hematoma* or bleed*)).tw. 
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23. or/17-22 
24. exp child/ 
25. exp infant/ 
26. (infan* or child or childhood or children).tw. 
27. or/24-26 
28. exp locomotion/ or exp walking/ or exp Gait/or exp body movement/ or exp 
patient mobility/ or exp physical mobility/ or exp motor performance/ or exp 
motor activity/ or exp walking difficulty/ 
29. (mobil* or motor* or sit* or stand* or walk* or stair* or ambulant* or ambulat* 
or gait or step* or balanc* or function* or daily living or disabilit* or physical* 
or movement or activit* or locomot*).tw. 
30. (recover* or outcome* or milestone*).tw. 
31. 28 or 29 
32. exp prognosis/ 
33. (predict* or prognos*).tw. 
34. 32 or 33 
35. ((indicat* or determin* or factor*) adj5 (mobil* or motor* or sit* or stand* or 
walk* or stair* or ambulant* or ambulat* or gait or step* or balanc* or 
function* or daily living or disabilit* or physical* or movement or activit* or 
locomot*)).tw 
36. 16 and 23 and 35 and 34 
37. 16 and 23 and 32 and 28 
38. 36 or 37 
39. ((recover* or outcome* or milestone*) adj5 (indicat* or determin* or 
factor*)).tw. 
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40. 16 and 23 and 34 and 39 and 29 
41. ((predict* or prognos*) adj5 (recover* or outcome* or milestone*)).tw 
42. 16 and 23 and 41 and 28 
43. 16 and 23 and 30 and 34 and 31 
44. 38 or 40 or 42 or 43 
45. 44 not 27 
Allied and alternative medicine database (AMED) 
1. exp prospective studies/ 
2. exp case control studies/ 
3. exp longitudinal studies/ 
4. exp cohort studies/ 
5. exp retrospective studies/ 
6. (observational adj (study or studies)).tw. 
7. (follow up adj (study or studies)).tw. 
8. (epidemiologic$ adj (study or studies)).tw. 
9. (cross sectional adj (study or studies)).tw. 
10. or/1-9 
11. exp cerebrovascular disorders/ 
12. ((cerebral* or cerebellar or brainstem or vertebrobasilar or stroke) adj5 
(infarct* or ischaemi* or ischemi* or thrombo* or emboli* or apoplexy)).tw. 
13. exp hemiplegia/ 
14. (hemipleg* or hemipar* or paresis or paretic).tw. 
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15. (stroke or poststroke or post-stroke or cva* or cerebral vascular accident* or 
cerebrovascular accident*).tw. 
16. ((cerebral or brain or subarachnoid) adj5 (haemorrhage* or hemorrhage* or 
haematoma* or hematoma* or bleed*)).tw. 
17. or/11-16 
18. exp child/ 
19. exp infant/ 
20. (infan* or child or childhood or children).tw. 
21. or/18-20 
22. exp locomotion/ or exp Walking/ or exp Gait/ or exp movement/ or exp 
Motor activity/ or exp motor skills/ 
23. (mobil* or motor* or sit* or stand* or walk* or stair* or ambulant* or ambulat* 
or gait or step* or balanc* or function* or daily living or disabilit* or physical* 
or movement or activit* or locomot*).tw. 
24. (recover* or outcome* or milestone*) 
25. 23 or 24 
26. exp Prognosis/ 
27. (predict* or prognos*).tw. 
28. 26 or 27 
29. ((indicat* or determin* or factor*) adj5 (mobil* or motor* or sit* or stand* or 
walk* or stair* or ambulant* or ambulat* or gait or step* or balanc* or 
function* or daily living or disabilit* or physical* or movement or activit* or 
locomot*)).tw. 
30. 10 and 17 and 29 and 28 
31. 10 and 17 and 22 and 26 
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32. 30 or 31 
33. ((recover* or outcome* or milestone*) adj5 (indicat* or determin* or 
factor*)).tw. 
34. 10 and 17 and 28 and 23 and 33 
35. ((predict* or prognos*) adj5 (recover* or outcome* or milestone*)).tw. 
36. 10 and 17 and 35 and 23 
37. 10 and 17 and 25 and 28 and 24 
38. 32 or 34 or 36 or 37 
39. 38 not 21 
Cumulative Index to Nursing and Allied Health Literature (CINHAL) 
1. ("Prognosis") or (MH "Prognosis+") or (MH "Outcomes (Health Care)") 
2. (MH "Stroke") or ("stroke" or "poststroke" or "post-stroke" or "cva*" or "cerebral 
vascular accident*") 
3. (MH "Physical Mobility") or (MH "Motor Activity") or (MH "Physical Activity") or 
(MH "Functional Status") 
Web of Science (WoS) 
1. TS=("Physical Mobility" or "Motor Activity" or "Physical Activity" or "Functional 
Recovery" or "Motor Recovery" or "Physical Disabilit*" or "walk*" or "sit to 
stand" or "step*") 
2. TS=(Prognosis or predict* or prognos*) 
3. TS=(stroke or cva or "cerebral vascular" or cerebrovascular) 
System for Information on Grey Literature in Europe (SIGLE)  
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1. (stroke OR poststroke OR "post-stroke" OR cva OR cerebrovasc* OR cerebral* 
OR intracerebral OR apoplexy OR hemipleg* OR hemipar* OR subarachnoid)  
AND (mobilit* or function*) AND (predict* or prognos*) 
Latin American and Caribbean Health Sciences Literature (LILACS)  
1. ( ( "STROKE" ) or "CEREBROVASCULARDISEASE" ) or "CEREBROVASCULAR" or 
"CVA" [Words] and ( ( ( ( ( "MOBILITY" ) ) or "FUNCTION" ) ) or "PHYSICAL 
REHABILITATION" ) or "PHYSICALTHERAPY"  
Electronic Table of Contents (ZETOC)  
1. Stroke and mobility
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Appendix 2 Search flow inception to July 2010  
  Search Output 
 
(n = 11,120) 
  
   
 
 
 
 
 
 
 
 Duplicates 
 
(n = 2,830) 
Hand searching 
 
(n = 2) 
 References to be 
screened 
 
(n = 8,292) 
 
  
   
 
 
 
 Excluded 
(n = 8,227) 
 
Irrelevant 7,879 
Population 65 
Outcome 227  
Study Type 56 
   
   References retrieved 
 
(n = 65) 
  
    Excluded 
(n = 60) 
 
Irrelevant outcome 24 
Population 2 
Duplicate paper  5 
Irrelevant 2 
Assessment timescales 27 
 
 
  Included studies 
 
(n = 5) 
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Appendix 3 Search flow updated  
 
  Search Output 
 
(n = 3,049) 
  
   
 
 
 
 
 
 
 
 Duplicates 
 
(n = 363) 
  References to be 
screened 
 
(n = 2,686) 
  
   
 
 
 
 Excluded 
(n = 2,662) 
 
Irrelevant 2,369 
Population 65 
Outcome 153 
Study Type 75 
   
   References retrieved 
 
(n = 24) 
  
 
 
   Excluded  
(n = 24) 
 
Irrelevant outcome 5 
Assessment timescales 19 
 
 
 
 
 
  Included studies 
 
( n = 0) 
  
 
 
 
  
Appendix 4 Quality assessment of included studies  
 Frideman 1990 Matsunga 1997 Baer & Smith2001 Jorgensen 1995 Smith 1999 
External validity      
Community-based cohort Yes Yes Yes Yes Yes 
Included patients with TIA or SAH No No No No No 
Major exclusion criteria No No No No No 
Description of cohort provided Yes∗ Yes Yes Yes Yes 
Internal validity      
Inception cohort established Yes Yes Yes Yes Yes 
Adequate sample size No Yes Yes Yes Yes 
Baseline data collected prospectively Yes Yes Yes Yes No 
Outcomes valid and reliable No No No Yes Yes 
Fixed assessment time-point Yes Yes No No No 
Important predictors missed in the model No No NA NA NA 
Predictive variables clearly defined Yes No Yes Yes Yes 
Statistical validity      
The sample size adequate (EPV>10) Yes Yes Yes Yes Yes 
Stepwise regression was used      Yes∗∗ No∗∗∗ NA NA NA 
Evaluation of the model      
The final model was internally validated No No NA NA NA 
The final model was externally validated No No NA NA NA 
Model predictions are better than clinical judgement No No NA NA NA 
The effect of the model assessed in clinical practice No No NA NA NA 
Practicality of the model      
The predictors are readily collected in practice No Yes Yes Yes Yes 
The coding of predictor variables was explained No Yes NA NA NA 
CIs were provided for the predictions No No NA NA NA 
TIA: Transient ischemic attack; SAH: Subarachnoid Haemorrhage; EPV: Events Per Variable 
∗    The reporting of baseline demographics was stratified into mobile and non-mobile 
∗∗   Backward selection; it was unclear the level of significance used 
∗∗∗ Multivariate analysis 
  
Appendix 5 Factors selected by clinical opinion for model inclusion   
Variable 
label  
Description Include  Exclusion∗ Variable coding 
(as provided in data set) 
Re-naming & coding  
(as entered in to model) 
age Age (years) Y - Continuous  Continuous 
gender Gender Y - 1 = male, 2 =female 0 = female, 1 = male 
doad Date of hospital admission N 2 - - 
recfloor Ward number first admitted N 2 - - 
timesyma Time symptoms onset to admission (hrs) Y - continuous 0 = ≤3.4 hours 1= >3.5 hours 
housing Living arrangements prior to admission Y - 1 = private address alone, 2 = private address 
not alone, 3 = sheltered housing, 4 = 
residential care, 5 = PNH, 6 = NHS, 7 = other 
Alone, 0 = no, 1 = yes 
psr Level of disability prior to admission N  3 - - 
psdepend Level of dependency prior to admission Y - 1 =  yes (RS 3 - 5), 2  = no (RS 0 - 2) Independent pre-stroke,  0 = no, 1 = yes 
hbp History of hypertension Y - 0 = no, 1 = yes, 9 = not known 0 = no, 1 = yes (9 recoded no) 
af History of atrial fibrillation Y - 0 = no, 1 = yes, 9 = not known 0 = no, 1 = yes (9 recoded no) 
miihdcf History of myocardial infarction, ischemic 
heart disease or cardiac failure 
Y - 0 = no, 1 = yes, 9 = not known 0 = no, 1 = yes (9 recoded no) 
dm History of diabetes Y - 0 = no, 1 = yes, 9 = not known 0 = no, 1 = yes (9 recoded no) 
pastcva History of previous stroke Y - 0 = no, 1 = yes, 9 = not known 0 = no, 1 = yes (9 recoded no) 
pasttia History of previous TIA Y - 0 = no, 1 = yes, 9 = not known 0 = no, 1 = yes (9 recoded no) 
smoker Smoking status Y - 0 = not, 1 = current, 2 = ex-smoker, 9 = not 
known 
Current smoker, 0 = no, 1 = yes 
alcohol Level of alcohol intake per week N 1 - - 
antihbp Current user antihypertensive medication  Y - 0 = no, 1 = yes, 9 = not known 0 = no, 1 = yes (9 recoded no) 
antiplat Current user of antiplatlet medication N 2 - - 
diuretic Loop diuretic N 2 - - 
anticoag Current user of anticoagulant medication Y - 0 = no, 1 = yes, 9 = not known 0 = no, 1 = yes (9 recoded no) 
diabmed Current user of oral hypoglycaemic / insulin N 3 - - 
∗ Reason for exclusion: 1: missing data; 2: irrelevant; 3: better measure available 
 
  
Variable 
label  
Description Include  Exclusion∗ Variable coding 
(as provided in data set) 
Re-naming & coding  
(as entered in to model) 
othermed Current using of ‘other medication’ N 1 - - 
sbpad Systolic blood pressure on admission Y - continuous ≤160mmH = 0, >160mmH = 1 
dbpad Diastolic blood pressure on admission N 3 - - 
dysphag Presence of dysphagia Y - 0 = no, 1 = yes 0 = no, 1 = yes 
lesion Side of lesion Y - 0 = not classifiable (n=35), 1 = left, 2 = right 3 
= posterior 
Left, 0 = no, 1 = yes 
      
revocsp Clinical classification of stroke type (OCSP) Y - 0  = not classifiable, 1 = TACS, 2 = PACS, 3 = 
LACS, 4 = POCS 
TACS, 0 = no, 1 = yes 
ctlesion Stroke type based on CT results Y - 0 = no scan, 1 = no appropriate lesion visible, 
2 = infarction, 3 = PICH, 4 = other 
Haemorrhage, 0 = no, 1 = yes 
daysct Time to CT scan (days) N 2   
consc0 Level of consciousness N 4   
armpow0 Level of arm motor power N 4   
hndpow0 Level of hand motor power N 4   
legpow0 Level of leg motor power N 4   
speech0 Level of speech N 4   
palsy0 Level of facial palsy N 4 - - 
urea0 Level of urea on admission N 2 - - 
creat0 Level of creatinine on admission N 2 - - 
gluc0 Level of glucose on admission N 1 - - 
hb0 Level of haemoglobin on admission N 1 - - 
wcc0 Level of white cell count on admission N 1 - - 
floor The location after ward admission N 1 - - 
protocol Use of stroke protocol N 1 - - 
destday3 Hospital location of patient at day 3 N 1 - - 
maxtd12 Maximum temperature day 1 or 2 N 3   
maxsbp12 Maximum systolic BP day 1 or 2 Y - continuous ≤160mmH = 0, >160mmH = 1 
minsbp12 minimum systolic BP day 1 or 2 Y - continuous ≤160mmH = 0, >160mmH = 1 
maxdbp12 Maximum diastolic BP day 1 or 2 N 3 - - 
  
Variable 
label  
Description Include  Exclusion∗ Variable coding 
(as provided in data set) 
Re-naming & coding  
(as entered in to model) 
mindbp12 Minimum diastolic BP day 1 or 2 N 3 - - 
o2day12 Minimum oxygen saturation day 1 or 2 N 2 - - 
na0_3 Maximum Na measured day 0 to 3 N 2 - - 
urea0_3 Max urea measured day 0 to 3 N 3 - - 
maxgl0_3 Max glucose measured day0-3 N 3 - - 
saline0 IV saline administered day 0 N 2 - - 
saline1 IV saline administered day 1 N 2 - - 
saline2 IV saline administered day 2 N 2 - - 
dext0 IV dextrose administered day 0 N 2 - - 
dext1 IV dextrose administered day 1 N 2 - - 
dext2 Iv dextrose administered day 2 N 2 - - 
para0_2 Doses of paracetamol provided day 0 to 2 N 2 - - 
antipla3 Antiplatelet administered on day 3 N 2 - - 
antibio3 Antibiotics administered on day 3 N 2 - - 
insulin3 Insulin administered on day 3 N 2 - - 
oxygen3 Oxygen saturation on day 3 N 2 - - 
advev Adverse events recorded N 3 - - 
modadve Refined version of adverse events Y - - - 
patpos3 Best level of mobility achieved by day 3 Y - 1 = lying, 2 = sitting in bed, 3 = sit in chair, 4  
=walking with help  5 = walking unaided 
Walking 0 = no, 1 = yes 
physio Date of first assessment by physiotherapist N 1 - - 
occther Date of first assessment by occupational 
therapy 
N 1 - - 
salt Date of first assessment by speech and 
language 
N 1 - - 
dateass3 Date of blinded assessment N 2 - - 
patpos Best level of mobility achieved by day 3 N 3 - - 
rankin3 Level of disability day 3 Y - 0 = well, no symptoms, 1 =minor symptoms, 2 
= minor handicap, 3 = moderate handicap, 4 = 
a lot of help, 5 = constant attention, 6 = death 
Mild (3-6=0, 0-3=1) Moderate (0-3 & 
6=0, 4=1) Severe (0-4 & 6=0, 5=1) 
  
Variable 
label  
Description Include  Exclusion∗ Variable coding 
(as provided in data set) 
Re-naming & coding  
(as entered in to model) 
consc3 Level of consciousness day 3 N 4 - - 
eyemvm3 Level of eye movements day 3 N 4 - - 
armpwr3 Level of arm motor power day 3 N 4 - - 
hndpwr3 Level of hand motor power day 3 N 4 - - 
legpwr3 Level of leg motor power day 3 N 4 - - 
orient3 Level of orientation day 3 N 4 - - 
speech3 Level of speech day 3 N 4 - - 
fapalsy3 Level of facial palsy day 3 N 4 - - 
gait3 Level of gait day 3 N 4 - - 
SSS3 Level of stroke severity (SSS) day 3 Y - continuous Mild (0-42=0, 43-58=1) Moderate ( 0-
26=0 & 41-58=0, 26-42=1) Severe (25-
58=0, 0-25=1) 
sssabre0 Level of stroke severity (level of 
consciousness, arm power, leg power, 
speech) day 0  
N 3 - - 
sssabre3 Level of stroke severity (level of 
consciousness, arm power, leg power, 
speech) day 3 
N 3 - - 
cathetr3 Use of catheter day 3 N 3 - - 
bowel3 Level of bowel function day 3 N 3 - - 
bladder3 Level of bladder function day 3 N 3 - - 
groom3 Level of grooming function day 3 N 3 - - 
toilet3 Level of toilet use day 3 N 3 - - 
feed3 Level of feeding day 3 N 3 - - 
transf3 Level of transfer day 3 N 3 - - 
walk3 Level of walking day 3 N 3 - - 
dress3 Level of dressing function day 3 N 3 - - 
stairs3 Level of stair climbing day 3 N 3 - - 
bath3 Level of bathing day 3 N 3 - - 
      
  
Variable 
label  
Description Include  Exclusion∗ Variable coding 
(as provided in data set) 
Re-naming & coding  
(as entered in to model) 
bartot3 Level of activities of daily living (BI) day 3 Y continuous Mild (0-10 = 0, 10-20=1) Moderate (0-3 
& 9-20 = 0, 3-9 = 1) Severe (3-20 = 0, 
0-2=1)  
ulf3 Upper limb function affect day 3 N 3 - - 
knf3 Use of knife and fork day 3 N 3 - - 
mug3 Ability to drink from mug day 3 N 3 - - 
comb3 Ability to comb hair day 3 N 3 - - 
card3 Ability to put on cardigan/jacket day 3 N 3 - - 
butn3 Ability to fasten buttons day 3 N 3 - - 
writ3 Ability to write name day 3 N 3 - - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Appendix 6 Factors included in the multivariate models 
 
 
 
Method of selection: Systematic review (Model 1) Clinical opinion (Model 2) Univariate Analysis (Model 3) 
Factors entered in 
model: 
 
 
Age, Stroke type, Consciousness level, Leg 
power 
Age, Gender, Housing arrangements, Pre-
stroke dependency, Risk factors, History of 
stroke/transient ischemic attack, Smoking 
status, Antihypertensive medication, 
Presence of dysphagia, Side of lesion, Type 
of stroke, CT lesion, Maximum systolic blood 
pressure (day 1-2), Adverse events, 
Patient’s best level of mobility (day 3), 
Stroke severity, Disability, Activities of daily 
living, Time from symptom onset to 
admission, Anticoagulant medication, 
Systolic blood pressure, Minimum systolic 
BP (day 1-2) 
 
Age, Gender, Living alone, Pre-stroke 
dependency, Atrial fibrillation, History of 
stroke, Smoking status, Antihypertensive 
medication, Presence of dysphagia, Side of 
lesion, Type of stroke, CT lesion, Maximum 
diastolic blood pressure (day 1-2), Adverse 
events, Patient’s best level of mobility (day 
3), Stroke severity, Disability, Activities of 
daily living, Alcohol intake, Diabetic 
medication, Antiplatlets use prior to stroke 
(day 0), Maximum level of urea (day 0-3), 
Antiplatlets administered (day 3), Maximum 
systolic blood pressure (day 1 or 2), 
Maximum temperature (day 1 or 2), 
Minimum oxygen saturation (day 1 or 2), 
Maximum sodium level (day 3), Mean level 
of saline/dextrose administered (day 0-2), 
Mean level of dextrose administered (day 0-
2), Antibodies administered (day 3), Insulin 
administered (day 3), Oxygen administered 
(day 3) 
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Appendix 7 Patient information sheet 
 
The participant information sheet is 4 pages long. Please make sure you have all the pages. 
 
Invitation paragraph 
We would like to invite you to take part in a research study. Before you decide you need to 
understand why the research is being done and what it would involve for you. Please take time to 
read the following information carefully. Please talk to others about the study if you wish and ask if 
there is anything that is not clear or if you would like more information. Please take time to decide 
whether or not you wish to take part. 
 
What is the purpose of the study?  
The purpose of this study is to collect information about the amount of physical activity people who 
have had a stroke undertake during their acute hospital stay. Physical activity refers to bodily 
movement which uses up energy. The information from this study will be used to understand more 
about physical activity levels in stroke patients and how to monitor activity levels effectively.  
 
Why have I been invited? 
You are invited to participate in this research project because you have been diagnosed with a 
stroke within the last 14 days and are currently in a stroke ward. We are keen to include as many 
appropriate people as possible so that our results reflect normal care in a stroke ward. 
 
Do I have to take part? 
It is entirely up to you to decide whether or not you should take part.  If you decide to take part, you 
will be asked to sign a consent form. You will be given copies of this information sheet and the 
consent form to retain. If you do decided to take part the researcher will write to your GP to let 
them know your involvement in the study. You will still be free to withdraw from the study at any 
time and without giving a reason.  A decision to withdraw at any time, or a decision not to take part, 
will not affect in any way the standard of care you will receive. 
Participant Information Sheet 
Study Title:   Physical activity levels after stroke 
Researcher Name:  Louise Craig 
Researcher’s contact details: University of Glasgow 
Public Health and Health Policy 
1 Lilybank gardens,  
Glasgow G12 8RZ 
Phone: 0141 330 7172 Mobile: 07810515504 
Email: l.craig@clinmed.gla.ac.uk 
Protocol Version Version 2 
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What will happen to me if I take part? 
Your physical activity levels will be monitored for one day only during your stay in the stroke 
ward. A researcher will observe your activity throughout the day from 8.00am till 5.00pm. This will 
take place on the ward and the researcher will observe you for one minute every 10 minutes of the 
day. Information about who helped you with the activity and where the activity occurred will be 
recorded on a paper assessment sheet.  There will be no audio or videotape record of your activity. 
The researcher will not come behind closed curtains or doors, however, the researcher may ask you 
or a staff member to tell them the nature of any activity not directly observed. 
 
We will also use a small monitor to measure the time in minutes that you spend in activities such as 
sitting, standing and walking. The monitor is the size of a credit card and it will be attached on your 
thigh under your clothes using a specially designed sticky pad. This should not cause any 
discomfort or irritation. If it does, the monitor will be removed. 
 
The same researcher who you meet in hospital will contact you by phone three months and six 
months after your stroke. You will be asked a few questions over the phone about how you are 
managing with certain activities since you have had your stroke. This will last about 20 minutes and 
will be done at a time which is convenient for you. 
 
What will I have to do? 
You will have nothing extra to do, apart from what has been explained above. You are not required 
to change your behaviour in any way on the day your activity is monitored.  It is important that 
staff, family members and patients continue routine activities throughout this time.   
 
What are the alternatives for diagnosis or treatment? 
In this project we are not changing your treatment but collecting information about the care that you 
are currently receiving. If you choose not participate in this study, you will receive the current 
standard care for your medical condition. 
 
What are the possible disadvantages and risks of taking part? 
There is minimal risk in participating in this study. Should you find that you feel uncomfortable 
about being observed, you are free to talk to the study team or a member of the hospital and 
withdraw from the observation part of the study. If you find that wearing the monitor is 
uncomfortable you can ask a member of staff for this to be removed. Your hospital care will not be 
affected in any way whatsoever. 
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What are the possible benefits of taking part? 
There are no direct benefits to you as a result of your participation in this study however your 
participation will help us understand more about how to monitor activity in stroke patients. This 
will allow any future changes in clinical practice which aim to affect activity levels in stroke 
patients to be detected. 
 
What if new information becomes available? 
Sometimes we get new information about the treatment being studied. If this happens, your doctor 
will tell you and discuss whether you should continue in the study. If you decide not to carry on, 
your doctor will make arrangements for your care to continue. If you decide to continue in the study 
they may ask you to sign an updated consent form. If the study is stopped for any other reason, we 
will tell you and arrange your continuing care. 
 
What happens when the research study stops? 
This will make no difference to your treatment. 
 
What if there is a problem? 
The study is indemnified by the local hospital National Health Service (NHS) board, through whom 
you may be entitled to seek compensation. If you are harmed by taking part in this research project, 
there are no special compensation arrangements. If you are harmed due to someone’s negligence, 
then you have grounds for a legal action but you may have to pay for it. Regardless of this if you 
wish to complain about any aspect of the way you have been treated during the course of this study 
the NHS normal complaints mechanism may be available to you. 
 
Will my taking part in the study be kept confidential? 
All information which is collected about you during the course of the research will be kept strictly 
confidential.  Any information about you which leaves the hospital will have your name and 
address removed.  You will be provided with a study identification number. 
 
What will happen if I don’t want to carry on with the study? 
You can withdraw from the study at any point. Information collected about you may still be used.  
 
What will happen to the results of the research study? 
The results of this study will be presented.  The results may also be presented at conferences and 
written up in professional journals. You will not be identified in any report/publication. You will be 
provided with a copy of the study results if you wish.  
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Who is organising and funding the research? 
Louise Craig is conducting this study and it is funded by a charity organisation called the Stroke 
Association.   
 
Who has reviewed the study? 
All research in the NHS is looked at by independent group of people, called a Research Ethics 
Committee to protect your safety, rights, wellbeing and dignity. This study has been reviewed and 
given favourable opinion by the Scotland A Research Ethics Committee.  
 
Contact details of the researcher 
 
Louise Craig 
Stroke Association Research Fellow 
University of Glasgow 
Public Health and Health Policy 
1 Lilybank gardens,  
Glasgow   G12 8RZ 
Phone: 0141 330 7172 
Mobile: 07810515504 
Email: l.craig@clinmed.gla.ac.uk 
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Appendix 8 Patient consent sheet 
 
 
 
Please place your initials in every box 
 
1. I confirm that I have read and understand the information sheet 21st July 2010 for the 
above study. I have had the opportunity to consider the information, ask questions and 
have had these answered satisfactorily.  
 
2. I understand that my participation is voluntary and that I am free to withdraw at any time 
without giving any reason, without my medical care or legal rights being affected.  
 
3. I understand that relevant sections of my medical notes and data collected during the 
study, may be looked at by a researcher from the University of Glasgow, from regulatory 
authorities or from the NHS Board, where it is relevant to my taking part in this research. 
I give permission for these individuals to have access to my records.  
 
4. I agree to my GP being informed of my participation in the study. 
 
5. I agree to take part in the above study. 
__________________________   ____________   ________________________ 
Name of Patient Date    Signature  
__________________________   ____________   ________________________ 
Name of Person taking consent     Date Signature 
(if different from researcher) 
_________________________   ____________   ________________________  
Researcher                                       Date Signature 
Patient Consent Form 
Study Title:   Physical activity levels after stroke 
Researcher Name:  Louise Craig 
Researcher’s contact details: University of Glasgow, Public Health and Health Policy 
1 Lilybank gardens, Glasgow G12 8RZ 
Phone: 0141 330 7172 Mobile: 07810515504 
Email: l.craig@clinmed.gla.ac.uk 
Protocol Version Version 2 
     
Appendix 9 Definitions of summary accelerometer measures 
Type of 
behaviour 
Activity measure Definition 
 
Upright activity Time spent upright  
 
The proportion of time spent upright for each patient was calculated as follows: the total length of time spent in 
upright events (continuous periods of standing or walking)/total monitoring time x 100.   
A mean proportion was calculated to summarise group data. Times are presented as medians.  
 Standing time  The total length of time spent in a standing posture. 
 Walking time  The total length of time spent in a walking posture. 
 Number of upright events The total number of upright events.  
 Number of standing events The total number of standing event.  
 Number of walking events The total number of walking events. 
 Number of transitions The total number of changes between an upright and a sedentary posture (sit-to-stand plus stand-to-sit). 
Sedentary Time spent sedentary The proportion of time spent sedentary for each patient was calculated as follows: the total length of time spent in 
sedentary events (continuous periods of lying or sitting)/total monitoring time x 100.   
A mean proportion was calculated to summarise group data. Times are presented as medians. 
 Number of sedentary 
events 
The total number of sedentary (continuous periods of lying or sitting) events in the period analysed. Summary 
estimate used was median time. 
Upright activity 
and sedentary 
Accumulation of upright and 
sedentary episodes  
Each sedentary event and upright event were classified into one of the following time intervals: < 5 minutes, 5 to 
10 minutes, 10 to 30 minutes, 30 to 60 minutes, > 60 minutes).  
The percentage of total time spent upright and sedentary for each time interval was then calculated. 
All times are in minutes 
     
Appendix 10 Example accelerometer output 
 
In the example above the first event overlaps the start time. The amount of time spent in this event 
after 08:00 was 9% (75.2 minutes) of the total event time. Using the decision rule to exclude events 
that were spent more than 50% of time outside the monitoring period would result in 13.9% of the 
data being excluding for this patient and would result in an underestimation of time spent. Yellow 
colour represents sitting/lying. Green colour represents standing. An event is defined as a 
continuous period of activity.
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Appendix 11 Participant information sheet  
 
The participant information sheet is 3 pages long. Please make sure you have all the pages. 
 
Invitation paragraph 
We would like to invite you to take part in a research study. Before you decide you need to 
understand why the research is being done and what it would involve for you. Please take time to 
read the following information carefully and talk to others about the study if you wish. Ask the 
researcher if there is anything that is not clear or if you would like more information. Take your 
time to decide whether or not you wish to take part. Louise Craig is a Research Fellow based at the 
University of Glasgow and will be conducting this study in part fulfilment of a research degree.  
 
What is the purpose of the study?  
The purpose of this study is to understand more about the current process of care in an acute stroke 
unit such as early rehabilitation and also to hear your views on how new guidelines are introduced 
into your units. This will add to our understanding about how research findings can be implemented 
into real clinical practice more smoothly. In order to hear your views multidisciplinary discussion 
groups known as focus groups will be conducted.  
 
Why have I been invited to participate in the study? 
You are invited to participate in this research project because you are currently working in an acute 
stroke unit in Scotland and delivering care to acute stroke patients. We are keen to include as many 
healthcare professionals and assistants so that our findings are representative of National Health 
Service staff working in acute stroke units in Scotland. Also, the more people who take part the 
better, as the information collected and the findings from the research can be used with more 
confidence. 
 
Do I have to take part? 
It is entirely up to you to decide whether or not you should take part.  If you decide to take part, you 
will be asked to sign a consent form and provide your contact details so that the researcher can be in 
touch with you. You will be given copies of this information sheet and the consent form to retain. 
You will still be free to withdraw from the study at any time and without giving a reason.   
 
Participant Information Sheet 
 
 
Study Title:   Exploring the Implementation of Very Early Mobilisation in 
Acute Stroke Care 
Researcher Name:  Louise Craig 
Protocol Version Version 2 
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What will happen to me if I take part? 
If you do decide to take part the researcher will write to you to confirm a date, time and location 
which you have pre-specified as convenient to you. You will only have to attend one of the eight 
focus groups being set up which is likely to be the one held in your place of work. There will be up 
to eight participants in each of the groups. During the focus group the researcher will ask a number 
of questions which you will discuss as a group. You will be encouraged to talk freely and listen to 
other participants in the group. You will be reminded that there are no right or wrong answers to the 
questions. The expected length of the focus group is one and a half hours. All group discussions 
will be recorded using a dictaphone so that what you say can be recorded accurately and can be 
typed up at a later date. A few weeks after you have participated in the focus group you will be sent 
a copy of the transcript to ensure that you are happy that it is a true interpretation of what was 
discussed. No information that could lead to your personal identification will be released, reported 
or published. Statements from the focus groups that illustrate particular themes or issues may be 
included in published outputs. You will be asked to indicate any of your sections on the proof 
transcript that you would not want include in any of these outputs. The sections you indicate will 
remain confidential. 
 
What are the possible disadvantages and risks of taking part? 
There is minimal risk in participating in this study. Should you feel uncomfortable at any point 
during the focus group, you are free to withdraw from the study. Your contribution in the focus 
group will be included in the final focus group data analysis. 
 
What are the possible benefits of taking part? 
There are no direct benefits to you as a result of your participation in this study however your 
participation will help us understand more about the processes of care such as early rehabilitation 
for acute stroke patients and will improve our understanding about how new guidelines and 
procedures can be more easily implemented into acute stroke units.  
 
What if there is a problem? 
The study is indemnified by the local hospital National Health Service (NHS) board, through whom 
you may be entitled to seek compensation. If you are harmed by taking part in this research project, 
there are no special compensation arrangements. If you are harmed due to someone’s negligence, 
then you have grounds for a legal action but you may have to pay for it. Regardless of this if you 
wish to complain about any aspect of the way you have been treated during the course of this study 
the NHS normal complaints mechanism may be available to you. 
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Will my taking part in the study be kept confidential? 
All information which is collected about you during the course of the research will be kept strictly 
confidential. No names will be used in reports or publications. You will be provided with a study 
identification number. The audio recordings made during this research will be used only for 
analysis and for illustration in publications. No other use will be made of them without your written 
permission, and no one outside the project will be allowed access to the original recordings.   
 
What will happen if I don’t want to carry on with the study? 
You can withdraw from the study at any point. Information collected about you may still be used.  
 
What will happen to the results of the research study? 
The results may be presented at conferences and written up as a report and in professional journals. 
You will not be identified in any report/publication. You will be provided with a copy of the study 
results if you wish.  
 
Who is organising and funding the research? 
Louise Craig is conducting this study and it is funded by a charity organisation called the Stroke 
Association.   
 
Who has reviewed the study? 
All research in the NHS is looked at by independent group of people, called a Research Ethics 
Committee to protect your safety, rights, wellbeing and dignity. This study has been reviewed and 
given favourable opinion by West of Scotland Research Ethics Committee. 
 
Contact details of the researcher 
Louise Craig 
Stroke Association Research Fellow 
University of Glasgow 
Public Health and Health Policy 
1 Lilybank gardens,  
Glasgow   G12 8RZ 
Phone: 0141 330 7172  
Mobile: 07810515504  
Email: Louise.Craig@glasgow.ac.uk
 Participant Consent Sheet Version 2 29/09/10    
 
 
Appendix 12 Participant consent sheet  
 
 
Please place your initials in every box 
 
1. I confirm that I have read and understand the information sheet 29th September 2010 for the 
above study. I have had the opportunity to consider the information, ask questions and have 
had these answered satisfactorily.  
 
2. I understand that my participation is voluntary and that I am free to withdraw at any time 
without giving any reason 
 
3. I understand that the focus groups will be audio-taped and that the data collected and held 
about me will be confidential and stored securely 
 
4. I agree to the use of anonymised quotes from the group discussion illustrating particular themes 
or issues being included in published outputs. I understand that the proof transcript that I 
receive will ask me to indicate any of the sections that I do not want included in any of these 
outputs. These sections which I indicate will remain confidential.  
 
5. I agree to take part in the above study 
 
__________________________   ____________   ________________________ 
Name of Participant   Date    Signature 
  
 
 
__________________________   ____________   ________________________ 
Name of Researcher                            Date    Signature 
 
 
 
 
 
  
 
Participant Consent Sheet 
 
Study Title:   Exploring the Implementation of Very Early Mobilisation in Acute 
Stroke Care 
Researcher Name:  Louise Craig 
Protocol Version Version 2 
  
Appendix 13 Interview schedule 
Focus Group Schedule (version with prompts) 
 
1. Can you tell me what happens to a stroke patient from hospital arrival to their 
admission to the stroke unit? What is the referral process? Who is involved in this referral process? What criteria are used to decide whether or not a patient is to be cared for in an acute stroke unit? Are all stroke cases admitted to the stroke unit? If not, do you see any reason for this? How well do you think the referral pathways works? Can you suggest any improvements in this referral process? 
2. What do you think is good about what you do in the stroke unit? What is good about how care is organised on your unit? (Communication, MDT working, 
discharge planning…..) What are the strengths of the staffing arrangements for the stroke service in this hospital?  In what ways do you think the stroke service in this hospital could be improved? 
3. At what point after admission to the stroke unit do you decide to get a patient out of 
bed for the first time? What influences your decision to mobilise a patient for the first time? Who usually gets the patient out of bed for the first time?  -why do you think it is this particular profession/individual that carries this out? Does this vary depending on the time of day the patient is admitted to hospital or if it is at the weekend? Do you see any issues with the current practice around mobilising the patient for the first time? 
4.  After this first mobilisation, how do you go about mobilising the patient for the 
rest of their stay? How often in a day would the patient be mobilised by staff? - do you think this is enough? Who is involved in the mobilisation of patients? -how do you communicate the patient’s mobility within the team? Do you see any issues with mobilising patients in the unit? 
5. What do you think would happen if a patient was not mobilised during their time in 
the stroke unit? How do you think this would impact on the patient’s recovery? -how do you think the patient would view this?  What effect do you think this would have on the unit? 
Very Early Mobilisation is a topical area at the moment. By very early mobilisation I mean 
mobilising patients within 24 hours of stroke onset and continuing mobilisation at an increased 
frequency throughout their time in the stroke unit.  
6. What do you think about mobilising patients within 24 hours after their stroke? Do you think it is beneficial for patients? If so, what do you think the benefits are? Do you think there any risks? If so, what do you think these risks are? What you think about mobilising patients more frequently than they currently are? 
I am also interested in what you think about very early mobilisation and other mobilisation 
strategies for different types of patients. I provided a list of scenarios that you rated in terms of 
appropriateness before you came to the group and now I would like to discuss these ratings. 
7. Imagine that next week in the unit you had to start mobilising patients within 
24 hours of stroke onset what would you need to do this? What would help this process? -who would you need involved? What do you see as the barriers to implementing mobilising patients within 24 hours of stroke onset? And as for mobilising patients more frequently what would you need to do this? 
  
Focus Group Schedule (version with prompts) 
 What do you see as the barriers to implementing mobilising patients within 24 hours of stroke onset? -what do you think the patient would think of this? 
Research into stroke care is going on all the time. I am interested in hearing about how some of 
these may have changed your practice. 
8. Have there been any changes in stroke practice that you think have been particularly 
good? (specific example headings may include organisation and staff structure and positions, education, methods of communication, referral systems, protocols, decision management) Can you explain how this change came about? How did it impact on how you would normally do things? Who was involved in this change? Did anything help you/the unit to make this change? -new equipment/staff What do you think were the barriers to change? -do you think other members of the team felt the same? Did you see this change benefit patients? 
9. There are a number of different approaches being used in healthcare to assist with 
changing practice.  I am going to describe two of these and would like your views on 
both. i)Having a local champion that is someone in the organisation who knows how things work and is passionate about the change? -have you heard or used this strategy been used before? -how well do you think that this would work in your unit/local area Do you think such an approach would benefit the implementation of very early mobilisation, given it was shown to be effective? ii) Using quality circles that is meeting as a group to discuss current problem areas, successes and failures? -have you heard or used this strategy been used before? -how well do you think that this would work in your unit/local area - do you think such an approach would benefit the implementation of very early mobilisation, given it was shown to be effective? 
10. What do you consider to be the three most important key aspects to stroke care in 
your unit? 
11. Have I missed anything that you would like to add? 
  
Appendix 14 Incongruence between perceived and actual behaviour (1) 
“I don't think it's [very early mobilisation] 
something that we don't do at the moment. ”(ID 
017, Physiotherapist)
Data source: focus group Reasoning
Staff did not readily distinguish very early 
mobilisation from standard mobilisation 
practices; the 24 hour time frame and the 
term 'mobilisation' had multiple 
interpretations.  
Question raised
How best to define very early 
mobilisation so that it is 
distinguishable from current 
practice?
Supporting data extracts and data source  Exploring the finding
Finding
Discrepencies between staff  
reports of current mobilisation 
practice and that measured in 
the observational study.
Incongruence between percieved and actual behaviour regarding very early mobilisation
Median time to first mobilisation after stroke 
onset was greater than 24 hours
Patients spent majority of sedentary time in 
prolonged periods of greater than 60 minutes
Data source: observational study
 
  
Appendix 15 Incongruence between perceived and actual behaviour (2) 
“there's lots of other things going on, they've 
gone for a shower, they've gone for a CT, they've 
gone to OT, they've gone....  So actually then 
physically it's very hard for us because there's 
not enough time in the day to keep going back to 
them." (ID 012, Physiotherapist)
Data source: focus group Reasoning
Easier to attribute reason for not doing 
something to external factors out-with- 
control of the individual: unpredictability of 
stroke care (environment) and increased 
administrative (orgainisation)
Question raised
Is realisation the key to changing 
behaviour in healthcare? If so, 
how is realisation achieved?
Supporting data extracts and data source  Exploring the finding
Finding
Discrepencies between what 
staff percieve to be barriers to 
what may actually occur in real-
life
Incongruence between percieved and actual behaviour regarding frequency of mobilisation
Patients spent only 3.7% time off the ward having 
medical tests
Data source: observational study
 
  
Appendix 16 Differences in attitude between professional groups  
“…at the moment, a large chunk of our patients 
are still in the receiving unit within that 24 hours 
– you know, if the guidelines said it had to be 
within 24 hours, then we would have to raise our 
game a little bit from that perspective .” (ID 022, 
Doctor) 
Data source: semi-structure interview
“we can only do what we’re doing here, and if 
they’re not here within the twenty-four hours 
then it’s not, it’s going to be outwith… out of 
control, isn’t it .”  (ID 014, Nurse) 
Data source: focus group
Reasoning
Pre-existing beliefs held by current providers 
of mobilisation.
Doctors viewed as the leaders in previous 
changes that have occurred in the acute 
stroke units.
Question raised
Do changes in healthcare have 
to 'operated and owned' by the 
discipline most closely 
associated with the change?
Supporting data extracts and data source  Exploring the finding
Finding
Differences in attitute towards 
implementing a future policy of 
very early mobilisation between 
professional groups.
Differences in attitudes towards change
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Appendix 17 Search strategies for databases (Chapter 6) 
Medical Literature Analysis and Retrieval System Online (Medline) 
1. exp cerebrovascular disorders/ or exp basal ganglia cerebrovascular disease/ 
or exp basal ganglia hemorrhage/ or exp brain ischemia/ or exp brain 
infarction/ or exp brain stem infarctions/ or exp cerebral infarction/ or exp 
infarction, anterior cerebral artery/ or exp infarction, middle cerebral 
artery/ or exp infarction, posterior cerebral artery/ or exp hypoxia-ischemia, 
brain/ or exp "intracranial embolism and thrombosis"/ or exp intracranial 
hemorrhages/ or exp cerebral hemorrhage/ or exp subarachnoid 
hemorrhage/ or stroke/ 
2.  ((cerebral* or cerebellar or brainstem or vertebrobasilar or stroke) adj5 
(infarct* or ischaemi* or ischemi* or thrombo* or emboli* or apoplexy)).tw. 
3. hemiplegia/ or exp paresis/ 
4. (hemipleg* or hemipar* or paresis or paretic).tw. 
5.  (stroke or cva* or cerebral vascular accident* or cerebrovascular 
accident*).tw. 
6.  ((cerebral or brain or subarachnoid) adj5 (haemorrhage* or hemorrhage* or 
haematoma* or hematoma* or bleed*)).tw. 
7. Economics/ or "costs and cost analysis"/ 
8. Cost allocation/ or Cost-benefit analysis/ 
9. Cost control/ or Cost savings/ 
10. Cost of illness/ or Cost sharing/ 
11. "deductibles and coinsurance"/ or Medical savings accounts/ 
12. Health care costs/ or Direct service costs/ 
13. Employer health costs/ 
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14. Hospital costs/ or Health expenditures/ 
15. Capital expenditures/ or Value of life/ 
16. exp economics, hospital/ or exp economics, medical/ 
17. Economics, nursing/ or Economics, pharmaceutical/ 
18. exp "fees and charges"/ or exp budgets/ 
19. (low adj cost).mp. 
20. (high adj cost).mp. 
21. (health?care adj cost$).mp. 
22. (fiscal or funding or financial or finance).tw. 
23. (cost adj estimate$).mp. 
24. (cost adj variable).mp. 
25. (unit adj cost$).mp. 
26. (economic$ or pharmacoeconomic$ or price$ or pricing).tw. 
27. 1 or 2 or 3 or 4 or 5 or 6 
28. 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 
21 or 22 or 23 or 24 or 25 or 26 
29. 27 and 28 
30. rehabilitation/ or occupational therapy/ or physical therapy techniques/ 
31. "Physical Therapy (Speciality)"/ or exercise therapy/ or exercise movement 
techniques/ or exercise/ 
32. early ambulation/ or " Physical Education and Training"/ or Physical Fitness/ 
or "Recovery of Function"/ 
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33. Rehabilitation Nursing/ or "Activities of Daily Living"/ or "Physical Education 
and Training"/ or Physical Fitness/ 
34. (rehabilitat$ or exercise$ or physiotherap$).tw. 
35. (Physical adj3 (therp$ or education or activit$ or function)).tw. 
36. (Physical adj3 (therap$ or education or activit$ or function)).tw. 
37. (improve$ adj3 (function or mobil$ or recover$)).tw. 
38. 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 
39. 29 and 38 
Embase Search Strategy 
1. exp cerebrovascular disease/ or exp basal ganglia hemorrhage/ or exp brain 
ischemia/ or exp brain infarction/ or exp brain hematoma/ or exp brain stem 
infarctions/ or exp brain hemorrhage/ or exp cerebral artery disease/ or exp 
brain embolism/ or exp subarachnoid hemorrhage/ or exp stroke/ 
2. ((cerebral* or cerebellar or brainstem or vertebrobasilar or stroke) adj5 
(infarct* or ischaemi* or ischemi* or thrombo* or emboli* or apoplexy)).tw. 
3. exp hemiplegia/ or exp paresis/ 
4. (hemipleg* or hemipar* or paresis or paretic).tw. 
5. (stroke or poststroke or post-stroke or cva* or cerebral vascular accident* or 
cerebrovascular accident*).tw. 
6. ((cerebral or brain or subarachnoid) adj5 (haemorrhage* or hemorrhage* or 
haematoma* or hematoma* or bleed*)).tw. 
7. Socioeconomics/ 
8. Cost benefit analysis/ 
9. Cost effectiveness analysis/ 
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10. Cost of illness/ 
11. Cost control/ 
12. Economic aspect/ 
13. Financial management/ 
14. Health care cost/ 
15. Health care financing/ 
16. Health economics/ 
17. Hospital cost/ 
18. (fiscal or financial or finance or funding).tw. 
19. Cost minimization analysis/ 
20. (cost adj estimate$).mp. 
21. (cost adj variable$).mp. 
22. (unit adj cost$).mp. 
23. 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 
21 or 22 
24. 1 or 2 or 3 or 4 or 5 or 6 
25. 23 and 24 
26. rehabilitation care/ or rehabilitation nursing/ or rehabilitation/ or 
rehabilitation patient/ or community based rehabilitation/ or rehabilitation 
medicine/ 
27. physiotherapy/ 
28. occupational therapy/ 
29. exercise recovery/ or movement therapy/ 
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30. (rehabilitat$ or exercise$ or physiotherap$).tw. 
31. (Physical adj3 (therap$ or education or activit$ or function)).tw. 
32. (improve$ adj3 (function or mobil$ or recover$)).tw. 
33. 26 or 27 or 28 or 29 or 30 or 31 or 32 
34. 25 and 33 
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Appendix 18 Search flow inception to September 2011  
  Search Output 
 
(n = 2,061) 
  
   
 
 
 
 
 
 
 
 Duplicates 
 
(n = 439) 
Hand searching  
 
(n = 1) 
 References to be 
screened 
 
(n = 1,623) 
  
   
 
 
 
  
 
 
 
 
 
 
   
   References retrieved 
 
(n = 35) 
  
 
 
   Excluded 
 
(n=14) 
 
Design 8 
No comparator 3 
Population 1 
Intervention 1 
Duplicate study 1 
 
  Included studies 
 
(n = 21) 
  
  
Appendix 19 Table of evidence of included studies (Chapter 6) 
Author 
(location) 
Study 
type 
Comparison  
 
Perspective Source of 
effectiveness 
data 
Source/method of costing  Uncertainty 
 
Measures of 
benefit∗ 
Synthesis of 
costs & 
benefits 
Anderson et al 
2000 
New Zealand 
 
 
CMA  ESD service versus 
home-based 
rehabilitation 
 
Health service 
& carers 
Single RCT 
study 
n=86 
6 months 
 
Health service: individual 
resource use from study 
(where not possible average 
costs were applied), costs 
from hospital finance 
(included overheads), national 
unit costs  
Caregivers: study 
questionnaire 
Yes Clinical outcomes: 
HRQoL (SF-36), 
general health, 
physical function, 
social activities, 
family dynamics, 
emotional state, 
the Caregiver 
Strain Index were 
administered to 
caregivers. Use of 
community 
services, 
readmissions to 
hospital, history of 
falls, place of 
residence, and 
patient and 
caregiver 
satisfaction with 
their medical care, 
rehabilitation and 
recovery  
NA 
  
Author 
(location) 
Study 
type 
Comparison  
 
Perspective Source of 
effectiveness 
data 
Source/method of costing  Uncertainty 
 
Measures of 
benefit∗ 
Synthesis of 
costs & 
benefits 
Beech et al 
1999  
UK 
 
CMA Community based 
care versus standard 
inpatient 
 
Not explicitly 
reported (health 
service & social 
care assumed) 
Single RCT 
study 
n=331 
12 months 
Health service: individual 
resource use from study (38 
patients only), costs from 
hospital finance 
Social services: study 
questionnaire, costs based on 
PSSRU 
Yes Clinical outcomes: 
Impairment, 
disability, general 
health, caregiver 
stress and patient 
and caregiver 
satisfaction. 
NA 
Bjorkdahl et al 
2006  
Sweden 
CCA 
 
Home rehabilitation 
versus outpatient 
rehabilitation 
 
Not explicitly 
reported (health 
service 
assumed) 
Single RCT 
study 
n=59  
12 months 
Health service: costs of 
delivering the intervention 
(assumed treatment length, 
therapy salary & travel), cost 
based on therapy salary, 
hospital finance & authorities 
No Clinical outcomes: 
Motor and 
process skills, 
functional 
independence 
measure and 
dependence in 
activities of daily 
living.  
NA 
Chen et al 
2006 
China 
 
CEA Three-stage 
rehabilitation program 
with no rehabilitation 
training 
Societal Single RCT 
study 
n=70 
6 months 
Health service: direct medical 
costs (method of costing not 
reported) 
Indirect expenses (transport, 
special diet, carer costs 
patients and loss of 
productivity). 
 
No Clinical outcomes: 
motor (FMA), ADL 
(BI), function 
(FCA) , cognition 
(CFS) and 
neurological 
deficit (NDS) 
 
All outcomes were 
used in the 
economic 
analysis. 
 
ICER (cost 
per score 
increase on 
each of the 
outcomes) 
  
Author 
(location) 
Study 
type 
Comparison  
 
Perspective Source of 
effectiveness 
data 
Source/method of costing  Uncertainty 
 
Measures of 
benefit∗ 
Synthesis of 
costs & 
benefits 
Donnelly et al 
2004  
UK 
CCA 
 
Community stroke 
team with hospital 
rehabilitation 
 
Health service Single RCT 
study 
n=113 
12 months 
Health service: individual 
patient resource use (38 
patients only), costs based on 
hospital finance 
Social care: individual patient 
resource use, costs based on 
PSSRU 
No Clinical outcomes: 
HRQoL (SF-36), 
activities of daily 
living, patient and 
carer satisfaction. 
NA 
Gladman et al 
1994 
UK 
 
CMA Community-based 
rehabilitation versus 
hospital based 
rehabilitation 
Health service Single RCT 
study 
n=327 
6months 
Health service: total 
intervention (therapists salary 
& travel) & hospital 
admissions, costs based on 
hospital finance & ambulance 
service 
No Clinical outcome: 
HRQoL 
(Nottingham 
Health Profile), 
activities of daily 
living, carer 
satisfaction and 
life engagement  
NA 
Harrington et 
al 
2010 
UK 
 
CMA 
 
Community-based 
exercise and 
education scheme  
 
Health service, 
social services 
& carers 
Single RCT 
study 
n=243 
12 months  
Health service: individual 
patient resource use, costs 
based on national unit costs, 
BNF 
Social care: individual patient 
resource use, costs based on 
PSSRU 
Personal: individual patient 
resource use, costs self-
reported & AA schedule 
No Clinical outcome: 
HRQoL 
(WHOQoL-Bref), 
social and 
physical outcome, 
mobility, activities 
of daily living, 
carer strain, 
functional reach 
and mobility and 
depression 
NA 
  
Author 
(location) 
Study 
type 
Comparison  
 
Perspective Source of 
effectiveness 
data 
Source/method of costing  Uncertainty 
 
Measures of 
benefit∗ 
Synthesis of 
costs & 
benefits 
Huijbregts et 
al 
2008 
Canada 
CEA Self-management 
program with land & 
water exercise versus 
a standard education 
program 
 
Health service  Single non-
randomised 
trial  
n=30 
3 months 
Health service: individual 
patient resource use, costs 
based on personnel costs 
Personal: charge of program 
to individual & carer 
No Clinical outcomes: 
balance (ABC), 
re-integration into 
normal living 
scale (RNL) , 
function, 
depression, 
physical 
performance 
 
The cost per 
mean point 
improvement 
on the ABC 
scale & RNL 
index  
Keith et al 
1995  
USA 
CEA 
 
Acute rehabilitation 
versus sub-acute 
rehabilitation facility 
 
Not reported 
(health service 
assumed) 
Single 
retrospective 
cohort 
 n=428 
discharge 
Health service costs: charge 
data for a stay was used as a 
proxy 
No Clinical outcomes: 
successful 
discharge and 
functional gain 
 
 
The average 
cost per 
successful 
case for 
patients 
returned to the 
community 
and the cost 
of functional 
gain  
Larson et al  
2006 
Denmark 
CCA ESD service versus 
conventional 
rehabilitation 
Not reported 
(health service 
assumed) 
 
Systematic 
review and 
meta-analysis  
Costing data was based on 
the individual economic 
analyses. The average 
number of visits in the trials 
multiplied by assumed time. 
Unit costs: international unit 
standard 
No Odds of poor 
outcome and the 
number of 
patients need-to-
treat 
No 
  
Author 
(location) 
Study 
type 
Comparison  
 
Perspective Source of 
effectiveness 
data 
Source/method of costing  Uncertainty 
 
Measures of 
benefit∗ 
Synthesis of 
costs & 
benefits 
McNamee et al 
1998 
UK 
CCA ESD service versus 
conventional care 
Healthcare 
service 
Single RCT 
study 
n=92 
6 months 
Health service costs: 
individual patient resource use 
Social care costs: medical 
records 
Yes Clinical outcomes: 
ADL, depression, 
general health 
No 
Roderick et al 
2001 
UK 
 
 
CCA 
 
Community-based 
rehabilitation versus 
geriatric hospital 
 
Health service 
and social 
service 
Single RCT 
study 
n=140 
6 months 
Health service costs: 
individual patient resource 
use, costs based on hospital 
trust financial returns, national 
unit costs, ambulance service 
Social care costs: PSSRU 
Yes Clinical outcomes: 
HRQoL (SF-36), 
functional gain, 
mobility, mental 
state and social 
activity.  
NA 
Rodgers et al 
2003 
UK 
 
CMA Increased-intensity 
interdisciplinary upper 
limb programme 
versus standard care 
 
Health service 
and social 
services 
Single RCT 
study 
n=123 
6 months 
 
Health service costs: 
individual patient resource 
use, costs based on national 
unit costs 
Social care costs: national unit 
costs 
No Clinical outcomes: 
impairment, upper 
limb function, 
disability and 
upper limb pain. 
NA 
Sritipsukho 
2010 
CEA Home rehabilitation 
program versus 
conventional care 
Health service Single RCT 
study 
n=60 
12 months  
Health service costs: 
individual patient resource 
use, costs based on 
reimbursement rate 
 
Yes Clinical outcomes: 
HRQoL (EQ-5D) 
and disability 
 
 
 
ICER 
(disability 
averted as 
measure of 
effect) 
Tay-Teo et al 
2008 
Australia 
 
CEA  Very early mobilisation 
versus standard care 
 
Societal Single RCT 
study 
n=71 
3 months 
Health service costs: 
individual patient resource 
use, costs based on national 
unit costs 
Social services: individual 
patient resource use, an 
annuity in arrears was applied 
Yes Clinical outcomes: 
death, serious 
adverse events, 
stroke 
deterioration and 
perceived exertion 
 
ICER (cost 
per good 
outcome used 
as measure of 
effect) 
  
Author 
(location) 
Study 
type 
Comparison  
 
Perspective Source of 
effectiveness 
data 
Source/method of costing  Uncertainty 
 
Measures of 
benefit∗ 
Synthesis of 
costs & 
benefits 
to estimate costs for 5 year 
usage of modifications & 
equipment 
Productivity costs: human 
capital approach 
 
 
 
Teng et al 
2003 
Canada 
CCA ESD versus standard 
care 
 
Health service Single RCT 
study 
n=114 
3 months 
 
Health service costs: 
individual patient resource 
use, costs based on hospital 
finance (included overheads) 
Social services: individual 
patient resource use, costs 
based on local community 
finance records 
Yes Clinical outcomes: 
HRQoL (SF-36), 
impairment, 
activities of daily 
living, mobility, 
reintegration into 
normal life and 
community living 
NA 
Von Koch et al 
2001 
Sweden  
 
CCA ESD versus standard 
care 
 
Not explicitly 
reported  
(health service 
assumed) 
Single RCT 
study 
n=83 
12 months 
 
Health service: individual 
patient resource use, costs 
based on council and national 
social insurance board 
No Clinical outcomes: 
mortality, motor 
capacity, 
dysphasia, 
activities of daily 
living, social 
activities, 
perceived 
dysfunction and 
self-reported falls. 
NA 
Widen 
Holmqvist et 
al   
1996 
Sweden 
CCA ESD versus hospital 
 
Health service 
& carers 
Single non-
randomised 
trial 
n=27 
12months 
 
Health service: individual 
patient resource use, costs 
based on council registers, 
market prices of equipment 
Social care: individual patient 
resource use, costs based on 
No Clinical outcomes: 
HRQoL (Sickness 
Impact Profile), 
patient 
satisfaction and 
dependency in 
NA 
  
Author 
(location) 
Study 
type 
Comparison  
 
Perspective Source of 
effectiveness 
data 
Source/method of costing  Uncertainty 
 
Measures of 
benefit∗ 
Synthesis of 
costs & 
benefits 
 market prices of equipment, 
salary of home-helps 
Carers: individual patient 
resource use, costs based on 
home-help equivalent 
activities in daily 
living 
Xiao 
2004 
CEA Comprehensive 
rehabilitation group 
versus a conventional 
rehabilitation group 
 
Societal Single 
randomised 
trial 
n=116 
2 weeks 
Health service: total hospital 
charge 
Patient and carers: loss of 
productivity  
No Clinical outcomes: 
ADL and 
neurological 
deficit (NDS) 
 
ICER (ADL 
and 
neurological 
deficit scores) 
Yagura et al 
2005  
Japan 
CCA Stroke rehabilitation 
unit compared with a 
general rehabilitation 
ward 
 
Health service  Single RCT 
study 
n=178 
3 months 
 
Health service: individual 
patient resource use, source 
of costs not explicitly stated 
No  Clinical outcomes: 
disability, 
neurological 
impairment and 
discharge 
disposition. 
NA 
Young and 
Forster 
1993 
UK 
CMA Day hospital care and 
home physiotherapy 
Health service, 
social services 
carer 
Single RCT 
study 
n=124 
6 months 
Health service: individual 
patient resource use 
Social care: individual patient 
resource use 
No Clinical outcomes: 
HRQoL 
(Nottingham 
health profile), 
ADL, motor 
impairment, carer 
stress  
NA 
∗ Outcomes that are in italic refer to those that were used in the economic evaluation 
ESD: Early Supported Discharge; RCT: Randomised Controlled Trial; HRQoL: Health Related Quality of Life; SF-36: Short-Form 36 Health Survey: PSSRU; Personal Social 
Services Research Unit; FMA: Fugl-Meyer Motor Assessment; ADL: Activities of Daily Living; BI: Barthel Index; FCA: Function Comprehensive Assessment; CFS; Cognitive 
Function Score; NDS: Neurological Deficits Scores; BNF: British National Formulary; AA: Automobile Association; ABC: Activities-Specific Balance Scale; RNL; Reintegration 
to Normal Living Index: EQ-5D: Euroqol-5D; ICER: Incremental Cost-Effectiveness Ratio 
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Appendix 20 Quality assessment – study design  
0% 20% 40% 60% 80% 100%
A1
A2
A3
A4
A5
A6
A7
C
he
ck
lis
t i
te
m
Percentage of studies
Yes No Unclear NA
 
 
 
 
 
 
 
 
 
 
 
 
Checklist item Quality statement 
A1 The research question is stated. 
A2 The economic importance of the research question is stated. 
A3 The viewpoint(s) of the analysis are clearly stated and justified. 
A4 The rationale for choosing alternative programmes or interventions 
compared is stated. 
A5 The alternatives being compared are clearly described. 
A6 The form of economic evaluation used is stated. 
A7 The choice of form of economic evaluation is justified. 
Key findings (n=21): 
• The viewpoint of the analysis was stated in 13 studies 
• The form of the economic evaluation was stated in 9 studies 
• The choice of the type of economic evaluation was justified in 13 studies 
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Appendix 21 Quality assessment – data collection  
0% 20% 40% 60% 80% 100%
B8
B9
B10
B11
B12
B13
B14
B15
B16
B17
B18
B19
B20
B21
C
he
ck
lis
t i
te
m
Percentage of studies
Yes No Unclear NA
 
Checklist item Quality statement 
B8 The source(s) of effectiveness estimates used are stated. 
B9 Details of the design and results of effectiveness study are given  
B10 Details of the methods of synthesis or meta-analysis of estimates are given  
B11 The primary outcome measure(s) for the economic evaluation are clearly stated. 
B12 Methods to value benefits are stated. 
B13 Details of the subjects from whom valuations were obtained were given. 
B14 Productivity changes (if included) are reported separately. 
B15 The relevance of productivity changes to the study question is discussed. 
B16 Quantities of resource use are reported separately from their unit costs. 
B17 Methods for the estimation of quantities and unit costs are described. 
B18 Currency and price data are recorded. 
B19 Details of currency of price adjustments for inflation or currency conversion are 
given. 
B20 Details of any model used are given. 
B21 The choice of model used and the key parameters on which it is based are 
justified. 
Key findings (n=21): 
• Benefits such as quality of life were not valued in any of the studies 
• Resource use was reported separately to unit costs in 9 studies 
• None of the studies developed an economic model 
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Appendix 22 Quality assessment – interpretation of results  
0% 20% 40% 60% 80% 100%
C22
C23
C24
C25
C26
C27
C28
C29
C30
C31
C32
C33
C34
C35
C
he
ck
lis
t i
te
m
Percentage of studies
Yes No Unclear NA
 
Checklist 
item 
Quality statement 
C22 Time horizon of costs and benefits is stated. 
C23 The discount rate(s) is stated. 
C24 The choice of discount rate(s) is justified. 
C25 An explanation is given if costs and benefits are not discounted. 
C26 Details of statistical tests and CIs are given for data. 
C27 The approach to sensitivity analysis is given. 
C28 The choice of variables for sensitivity analysis is justified. 
C29 The ranges over which the variables are varied are justified. 
C30 Relevant alternatives are compared. 
C31 Incremental analysis is reported. 
C32 Major outcomes are presented in a disaggregated as well as aggregated form 
C33 The answer to the study question is given. 
C34 Conclusions follow from the data reported. 
C35 Conclusions are accompanied by the appropriate caveats. 
Key findings (n=21): 
• The approach to sensitivity analysis was given in all 7 studies  
• Incremental analysis was conducted in 5 studies 
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